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Abstract	
Osteoarthritis	of	the	knee	is	a	common	condition,	affecting	more	than	10%	of	the	population	aged	over	55	years.		It	can	lead	to	pain,	functional	loss,	and	a	reduction	in	the	quality	of	life.		Total	knee	replacement	is	a	common	procedure	for	those	with	severe	osteoarthritis	with	over	90,000	procedures	performed	each	year	in	the	UK;	however,	around	20%	of	patients	are	dissatisfied	with	the	outcome.		How	to	identify	these	patients	pre-operatively	is	a	research	priority,	as	set	out	by	the	British	Orthopaedic	Association,	Arthritis	Research	U.K.,	and	the	National	Institute	for	Health	and	Care	Excellence.		The	effect	such	an	advance	would	have	on	patients’	decision-making	is	not	known.		Therefore,	in	this	thesis	I	set	out	to	understand	the	factors	important	to	patients	when	contemplating	a	knee	replacement,	how	an	outcome	prediction	tool	could	affect	that	process,	and	then	go	on	to	develop	an	prognostic	model	for	use	in	patients	considering	a	total	knee	replacement.							I	first	performed	a	systematic	review	of	factors	that	influence	patient’s	decision-making;	I	then	describe	two	qualitative	projects,	the	first	developed	a	model	of	decision-making,	the	second	investigated	how	providing	predictions	of	outcome	could	affect	expectations	and	decision-making.				This	information,	combined	with	a	systematic	review	of	the	factors	that	affect	outcome	in	knee	replacements,	allowed	me	to	develop	a	multicentre	cohort	study	designed	to	generate	a	prognostic	model.		This	study	recruited	600	patients,	and	the	linear	regression	model	accounts	for	36%	of	the	variability	in	outcome	–	more	than	any	previous	study.			This	thesis	provides	a	better	understanding	of	patients’	decision-making,	which	should	facilitate	doctor-patient	communication.		I	describe	a	model	that	can	predict	more	variability	in	outcome	than	any	previous	models.		The	usefulness	of	the	model	in	individual	prediction	and	potential	future	areas	of	study	include	how	more	variability	could	be	incorporated,	how	to	develop	such	a	model	into	a	prediction	tool,	and	other	approaches	to	addressing	poor	outcomes	after	total	knee	replacement.			
	 	
	 xiv	
Abbreviations	
ACI			 Autologous	Chondrocyte	Implantation	ACL	 Anterior	Cruciate	Ligament	ACL	 Anterior	Cruciate	Ligament	AIC	 Akaike	Information	Criteria	ANOVA		 Analysis	of	Variance	anti-CCP	 anti-Cyclic	Citrullinated	Peptide	ARC		 American	College	of	Rheumatology	BASK	 British	Association	for	Surgery	of	the	Knee	BMI	 Body	Mass	Index	BOA	 British	Orthopaedic	Association	BPT	 Best	Practice	Tariff	CBT	 Cognitive	Behavioural	Therapy	CP	 Citrullinated	Protein	DNA	 Did	Not	Attend	DoH	 Department	of	Health	EQ	5D	 EuroQol	5	Dimensions	GEH	 George	Elliot	Hospital	HADS	 Hospital	Anxiety	and	Depression	Score	HES	 Hospital	Episode	Statistics	IMD	 Index	of	Multiple	Deprivation	ISRCTN	 International	Standard	Randomised	Controlled	Trial	Number	KOOS		 Knee	injury	and	Osteoarthritis	Outcome	Score	KOPS	 Knee	Outcome	Prediction	Study	KOS/ADLS		 Knee	Outcome	Survey	Activities	of	Daily	Living	Scale	KSRS		 Knee	Society	Rating	System	KSS		 Knee	Society	Score	MACI	 Matrix-induced	Autologous	Chondrocyte	Implantation	MAR	 Missing	At	Random	MCAR	 Missing	Completely	at	Random	MCID	 Minimal	Clinically	Important	Difference	MCS	 Mental	Component	Score	MF		 Mental	Functioning	MNAR	 Missing	Not	At	Random	MRI	 Magnetic	Resonance	Imaging	NHS	 National	Health	Service	NICE	 National	Institute	for	Health	and	Care	Excellence	NIHR	 National	Institute	for	Health	Research	NJR	 National	Joint	Registry	NOS	 Newcastle	Ottawa	Scale	OA	 Osteoarthritis	OKS	 Oxford	Knee	Score	OKS	 Oxford	Knee	Score	PCS	 Pysical	Component	Score	
	 xv	
PCT	 Primary	Care	Trust	PDAs	 Patient	Decision	Aids	PF		 Physical	Functioning	PROMs	 Patient	Reported	Outcome	Measures	QALY	 Quality	Adjusted	Life	year	QIPP	 Quality,	Innovation,	Productivity,	and	Prevention	RCT	 Randomised	Controlled	Trial	RCT	 Randomised	Controlled	Trial	sd	 Standard	Deviation	SE	 Standard	Error	SF-12		 Short	Form	12	SF-36		 Short	Form	36	UHCW	 University	Hospitals	of	Coventry	and	Warwickshire	UNTRAP	 University/User	Teaching	and	Research	Action	Partnership	WOMAC		 Western	Ontario	and	McMaster	Universities	Arthritis	Index					

	 1	
Chapter	1:		Introduction	and	background	
	
This	chapter	discusses	the	epidemiology	of	knee	osteoarthritis	and	the	treatment	of	it,	
focusing	on	the	current	issues	facing	the	provision	of	knee	replacement	surgery,	namely:	
variability	in	outcome,	increasing	demands	with	financial	constrains,	and	variability	in	
utilisation.			
	
1.1 Declarations	
Aspects	of	this	chapter	have	been	published:	
T.	Barlow,	T.	Clarke,	M.	Dunbar,	A	Metcalfe,	D.	Griffin.		The	effect	of	expectation	on	satisfaction	in	total	knee	replacements:	a	systematic	review.		SpringerPlus	2016	5:167.	DOI:	10.1186/s40064-016-1804-6		
Aspects	of	this	chapter	have	been	presented	as	a	poster	at	a	regional	meeting:	
T.	Barlow,	T.	Clarke,	M.	Dunbar,	A	Metcalfe,	D.	Griffin.		The	effect	of	expectation	on	satisfaction	in	total	knee	replacements:	a	systematic	review.		West	Midland	Surgical	Society	Autumn	meeting,	2015.								
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1.2 Osteoarthritis	of	the	knee		
1.2.1 Definition	Osteoarthritis	(OA)	literally	means	inflammation	of	the	bone	and	joint.		It	has	been	defined	in	many	different	ways,	including:		 - “The	majority	of	peripheral	joint	pain	in	older	adults	(especially	at	the	knee,	hip,	hand	and	foot),	once	the	rarer	types	of	arthritis	where	inflammation	is	predominant	(e.g.	rheumatoid	arthritis	and	psoriatic	arthritis)	are	excluded.”1		 - “A	clinical	syndrome	of	joint	pain	accompanied	by	varying	degrees	of	functional	limitation	and	reduced	quality	of	life”2		Additionally,	OA	has	been	defined	by	the	morphological	changes	that	it	produces.		Plain	radiograph	findings	include	joint	space	narrowing,	osteophytes,	subchondral	sclerosis,	and	bone	cysts.3	Figure	1	demonstrates	some	of	these	common	radiographic	findings.		In	addition	to	plain	radiography,	Magnetic	Resonance	Imaging	(MRI)	criteria	now	exist.1,3		
	 3	
																														 	
Figure	1:	Plain	radiograph	of	an	osteoarthritic	knee	demonstrating	osteophytes,	reduced	joint	
space,	and	sclerosis.		Subchondral	cysts	are	not	present.		Reproduced	with	permission	from	
http://www.lookfordiagnosis.com.		
1.2.2 Diagnosis	As	to	be	expected	from	the	variation	in	definitions	of	OA,	there	are	varying	criteria	for	diagnosing	knee	OA.3		These	range	from	using	radiographic	criteria	alone	(although	there	is	no	reliable	correlation	between	radiographic	presence	and/or	severity	of	symptoms),3	clinical	symptoms	alone	(as	recommended	by	NICE),2	or	a	combination	approach	(as	described	by	the	American	College	of	Rheumatology;	ARC).4		The	ARC	also	includes	laboratory	finding	(predominantly	excluding	other	causes	of	arthritis;	e.g.	Erythrocyte	Sedimentation	Rate	less	than	40mm/hour).5		Recently,	there	has	been	a	large	amount	of	effort	in	identifying	biomarkers	specific	for	early	OA.		Recent	success	has	been	met	by	measuring	plasma/serum	citrullinated	protein	(CP),	anti-cyclic	citrullinated	peptide	(anti-CCP)	antibody	and	hydroxyproline.		The	authors	report	not	only	a	sensitive	test	for	early	arthritis,	but	also	one	that	is	specific	in	distinguishing	early	OA	from	Rheumatoid	arthritis.	However,	further	validation	is	needed.6				
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1.2.3 Classification	Classification	of	knee	OA	can	be	based	on	site	(medial,	lateral,	or	patellofemoral),	radiological	features,	or	aetiology.3,5	In	relation	to	aetiology,	OA	has	traditionally	been	divided	into	primary	(idiopathic)	and	secondary.		Secondary	OA	can	be	further	sub-divided	into	post-traumatic,	congenital	or	developmental	diseases,	calcium	deposition	disease,	other	bone	and	joint	disorders,	and	other	diseases.5	However,	as	discussed	in	the	next	section,	the	traditional	division	of	OA	into	primary	and	secondary	is	now	being	challenged	as	our	understanding	of	the	pathophysiology	and	risk	factors	for	the	development	and	progression	of	knee	OA	improves.7				
1.2.4 Risk	factors	and	pathogenesis	Risk	factors	for	the	development	of	knee	OA	have	been	widely	studied	and	a	meta-analysis	conducted	in	2015	demonstrated	that	increased	Body	Mass	Index	(BMI),	previous	knee	injury,	presence	of	Heberden’s	nodes/hand	OA,	female	gender,	older	age,	intensive	physical	activity,	certain	physical	occupational	activities	(e.g.	kneeling),	and	increased	bone	mineral	density	all	predispose	to	OA	knee.8		Additionally,	the	authors	concluded	that	good	mental	health,	oestrogen,	sitting	for	more	than	two	hours	a	day,	smoking,	and	having	an	index	finger	longer	than	the	ring	finger	may	reduce	the	risk	of	OA,	but	the	evidence	for	these	factors	is	weaker.8	Factors	not	included	in	this	meta-analysis	include	biomechanical	factors	and	genetic	factors.		There	appears	to	be	a	genetic	predisposition	to	OA	development,	with	studies	suggesting	multiple	genes	acting	in	concert.1			Malalignment	has	been	demonstrated	to	increase	the	risk	of	OA,	as	has	ligament	and	meniscal	injury	and	articular	fracture.3		It	may	be	that	these	factors	are	not	truly	primary	OA	–	this	has	led	to	some	authors	suggesting	that	OA	is	in	fact	one	disease	process	with	a	complex	interplay	between	genetic,	environmental,	and	psychological	
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processes,	or	represents	several	conditions	with	a	common	pathological	endpoint.7	Inconsistency	regarding	factors	that	predispose	to	developing	OA	compared	with	factors	that	cause	the	progression	of	the	disease	supports	this	view.		For	example,	osteoporosis	may	be	protective	against	developing	OA	knee,	but	may	lead	to	faster	progression.8,9				With	disagreement	over	the	classification	of	OA,	much	work	has	been	carried	out	trying	to	understand	the	pathophysiology.		Cartilage	changes	include	increased	synthesis	of	matrix	components	by	chondrocytes	along	with	proteolytic	degradation	of	those	components	(i.e.	increased	turn	over).		Changes	in	the	bone	are	not	as	well	understood,	and	the	interplay	between	cartilage	and	bone	changes	is	likewise	poorly	understood.		What	is	clear	is	that	inflammatory	mediators	play	a	role	in	OA,	and	a	systemic	element	is	likely.		This	could	be	a	target	for	future	treatments.7	Therefore,	there	is	a	general	consensus	that	the	“wear	and	tear”	model	of	OA	is	now	outdated.1,3	Instead,	there	is	an	interaction	between	risk	factors;	microtrauma	of	the	knee	leads	to	an	inflammatory	response	and	subsequently	a	repair	process	–	the	so	called	“tear,	flare,	repair”.1	Therefore	the	disease	is	one	that	is	not	just	isolated	to	the	joint,	but	involves	interplay	between	systemic	factors	and	local	(joint)	factors.1,3					
1.2.5 Epidemiology	and	natural	history	The	incidence	of	knee	OA	is	around	160-240	per	100,000	person	years,	with	the	prevalence	increasing	with	increasing	age.3	Approximately	20%	of	people	over	40	have	self-reported	knee	pain	–	half	of	these	(10%	of	the	population)	can	be	expected	to	have	radiographic	changes	consisted	with	knee	OA.3		For	people	over	60,	approximately	15%	have	symptomatic	knee	pain	with	radiographic	changes	(30%	of	the	population	have	radiographic	changes	in	this	population).1			
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Progression	of	knee	OA	is	normally	a	slow	process	over	the	course	of	several	years.		Rates	of	progression	reported	in	the	literature	vary	greatly,	confounded	by	follow	up	at	different	time	points	and	the	use	of	different	diagnostic	criteria	(radiographic	being	the	most	common).3,7		Table	1	demonstrates	the	rate	of	progression	of	knee	OA	from	various	studies.					
Table	1:	Natural	history	of	diagnosed	knee	OA	
Study	 Number	of	subjects	 Measure	 Follow-up	
(years)	
Proportion	
deteriorated	(%)	
Hernborg	(1977)	 84	knees	 Clinical	 15	 55	
Radiographic	 15	 56	
Danielsson	(1970)	 106	knees	 Radiographic	 15	 33	
Massardo	(1989)	 31	 Radiographic	 8	 62	
Dougados	(1991)	 353	 Clinical	 1	 28	
Radiographic	 1	 29	
Schouten	(1991)	 142	 Radiographic	 12	 34	
Spector	(1991)	 63	 Radiographic	 11	 33	
Spector	(1994)	 58	 Radiographic	 2	 22	
Ledingham	(1995)	 350	knees	 Radiographic	 2	 72	
McAlindon	(1999)	 470	 Radiographic	 4	 11	
Cooper	et	al.	
(2000)	
354	 Radiographic	 5	 22	
Table	reproduced	with	permission	from	Elsevier:	Osteoarthritis:	Epidemiology,	Nigel	Arden,	
Michael	C.	Nevitt,	Best	Practice	&	Research	Clinical	Rheumatology,	February	2006.		In	2012	Leyland	et	al.	reported	a	study	that	is	not	documented	in	the	table	above.10			They	reported	the	result	of	a	15-year	follow	up	study	using	radiographic	criteria.		Participants	were	women	aged	45	to	64	at	baseline.		The	incidence	of	new	OA	knee	was	40%,	and	the	rate	of	progression	varied	from	10	to	70%	depending	on	the	baseline	stage.	Table	2	demonstrates	a	cross	tabulation	of	results	from	this	study	–	by	far	the	largest	with	15	year	follow	up.							
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Table	2:	Cross	tabulation	of	baseline	and	15	year	follow	up	radiological	knee	score.		Chingford	
Study.	
	 K/L	grade	at	year	15	 	
Baseline	K/L	
grade	
0	
n(%)	
1	
n(%)	
2	
n(%)	
3	
n(%)	
4	
n(%)	
TKR	at	
year	15	
0	(n	=	955)	 575	(60.2)	 95	(10.0)	 157	(16.4)	 116	(12.2)	 2	(0.2)	 10	(1.1)	
1	(n	=	61)	 12	(19.7)	 4	(6.6)	 24	(39.3)	 18	(29.5)	 0	(0.0)	 3	(4.9)	
2	(n	=	76)	 0	(0.0)	 1	(1.3)	 39	(51.3)	 32	(42.1)	 0	(0.0)	 4	(5.3)	
3	(n	=	30)	 1	(3.3)	 1	(3.3)	 4	(13.3)	 19	(63.3)	 3	(10.0)	 2	(6.7)	
K/L	=	Kellegran	Lawrence	classification	
Reproduced	with	permission	from	Wiley	and	Sons:	K.	M.	Leyland,	D.	et	al.,	The	natural	history	of	
radiographic	knee	osteoarthritis:	A	fourteen-	year	population-based	cohort	study,	Arthritis	&	
Rheumatology,	Jun	26,	2012			Regardless	of	the	diagnostic	criteria	it	is	clear	that	not	all	cases	progress	and	a	proportion	of	patients	can	expect	either	a	halt	in	their	progression,	or	an	improvement	in	their	symptoms	(although	radiographic	improvement	is	rare).3,10,11	The	different	clinical	course	for	different	patients	is	likely	due	to	the	various	factors	mentioned	above.	
	
1.3 Treatment	of	knee	OA	
	There	are	generally	accepted	guidelines	on	the	treatment	of	knee	OA,	and	a	summary	is	available	in	Figure	2.2,12		
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Figure	2:	Treatment	for	OA	
Reproduced	with	permission	from	Elsevier:		Paul	A	Dieppe,	L	Stefan	Lohmander,	Pathogenesis	and	
management	of	pain	in	osteoarthritis,	The	Lancet,	18	March	2005		For	symptom	control,	core	parts	of	treatment	for	early	stage	OA	involve	exercise,	weight	loss,	and	pain	management.		To	try	and	reduce	progression	of	the	disease	interventions	are	targeted	at	known	risk	factors	–	for	example	weight	loss	and	addressing	biomechanical	factors	(e.g.	Anterior	Cruciate	Ligament	(ACL)	reconstruction).		Potential	future	targets	include	aspects	of	the	inflammatory	response	to	microtrauma	that	drive	the	progression	or	facilitate	the	repair	process	(if	such	targets	exist).1		
05/01/2016, 10:500 1,437×1,533 pixels
Page 1 of 1http://www.sciencedirect.com/cache/MiamiImageURL/1-s2.0-S01406…5710862-gr7_lrg.jpg/0?wchp=dGLbVlt-zSkzS&pii=S0140673605710862
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Patients	with	increasingly	severe	symptoms	may	require	surgery.		There	are	a	number	of	surgical	options	for	patients	with	knee	OA	including:		 - Osteotomy.		This	procedure	aims	to	offload	the	damaged	compartment	of	the	leg,	thereby	relieving	symptoms	and	slowing	the	progression	of	OA.		It	is	therefore	not	suited	to	patients	with	both	medial	and	lateral	compartment	OA.		A	recent	Cochrane	review	noted	that	comparative	studies	between	osteotomy	and	conservative	care	are	lacking,	but	case	series	suggest	osteotomy	does	relieve	symptoms	in	a	proportion	of	patients.13	Good	evidence	on	long-term	follow	up	is	lacking.		Two	recent	Randomised	Controlled	Trials	(RCTs)	have	compared	osteotomy	to	unicompartmental	knee	replacement,	with	no	difference	in	outcome	noted,	but	higher	(although	not	statistically	significant)	adverse	events	in	the	osteotomy	group.13				- Cartilage	repair/regeneration	techniques.		These	techniques	include	microfracture	and	Autologous	and	Matrix-induced	Autologous	Chondrocyte	Implantation	(ACI	and	MACI).	These	techniques	are	only	suitable	for	focal	cartilage	defects,	predominantly	on	the	femoral	side.14		- Arthroscopy.		Arthroscopy	has	been	used	for	over	70	years	in	the	treatment	of	OA	knee.		However,	a	landmark	study	by	Moseley	et	al.	comparing	arthroscopy	to	sham	surgery,	combined	with	subsequent	RCTs	found	arthroscopy	was	not	indicated	for	OA	of	the	knee.15	This	was	reflected	in	NICE	guidance	in	2008	and	again	in	2014.12	However,	many	arthroscopies	are	still	performed:		various	reasons	for	this	have	been	identified	including	the	suspicion	that	some	subgroups,	not	identified	or	included	in	the	RCTs,	may	benefit	(e.g.	those	with	meniscal	tears	and	mechanical	symptoms).15	
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1.3.1 Knee	replacement	A	proportion	of	people	go	on	to	develop	increasingly	severe	symptoms	that	affect	their	quality	of	life.		For	these	patients,	knee	replacement	is	an	option.		However,	there	are	no	agreed	criteria	for	patients	to	proceed	from	conservative	management	to	knee	replacement	because	the	patient’s	preference	plays	a	primary	role	(i.e.	this	is	a	preference-based	decision).16		This	aspect	of	the	patients’	pathway	is	explored	in	chapters	2-4.				Knee	replacement	operations	can	be	divided	into	unicompartmental	knee	replacements	(namely	the	lateral	and	medial	tibiofemoral	compartments	and	the	patellofemoral	compartment),	and	total	knee	replacements.				Unicompartmental	replacements	are	restricted	to	patients	that	have	disease	in	only	one	compartment	of	the	knee,	and	do	not	have	instability	of	the	knee.		They	have	a	good	10	year	survival	of	over	90%,	but	this	is	not	as	good	as	total	knee	replacement.17		Around	8%	of	the	replacements	performed	in	the	UK	are	unicompartmental.17				Patellofemoral	replacements	account	for	a	small	percentage	of	replacement	operations	(around	2%).		Indications	include	OA	limited	to	the	patellofemoral	compartment	of	the	knee.		These	replacements	have	a	similar	10	year	survival	of	around	10%.17			
Total	knee	replacement	The	first	total	knee	replacement	was	performed	by	Theophilus	Gluck	in	1890	using	an	ivory	hinge	secured	with	plaster	of	Paris	and	resin.18		The	term	“total”	here	refers	to	replacement	of	both	medial	and	lateral	compartments.		It	is	not	until	1970,	80	years	after	the	first	replacement,	that	more	modern	prostheses	appear.		These	early	designs	
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generally	had	high	failure	rates.		However,	improvements	in	design	have	resulted	in	a	10	year	failure	rates	of	less	than	5%.17				Total	knee	replacement	may	or	may	not	resurface	the	patella,	but	always	replaces	both	the	medial	and	lateral	tibiofemoral	compartments	and	the	femoral	trochlea.		In	the	U.K.	almost	90%	of	knee	replacements	are	total	knee	replacements.17		There	are	many	different	types	of	total	knee	replacement	(e.g.	constrained	versus	unconstrained)	and	different	methods	of	fixation.		However,	most	modern	total	knee	replacements	appear	to	provide	similar	outcomes,	and	in	the	UK	around	70%	are	fixed	bearing	cemented	total	knee	replacements.17			The	number	of	knee	replacement	operations	undertaken	in	England	and	Wales	has	increased	steadily.		The	National	Joint	Registry	(NJR)	demonstrates	that	currently	over	90,000	knee	replacements	are	performed	each	year	in	the	NHS.17	Projections	on	the	number	of	knee	replacements	required	in	the	future	vary	widely,	primarily	based	on	differing	assumptions	of	population	demographics	and	current	trends	in	utilisation	of	total	knee	replacement.		Current	estimates	vary	by	a	30%	to	a	1000%	increase	in	demand	by	2035.19				Although	knee	replacements	are	expensive	costing	around	£6,500	per	procedure,	they	are	one	of	the	most	cost-effective	interventions	for	any	illness	or	disease,	with	recent	estimates	calculating	they	cost	around	£2,101	per	Quality	Adjusted	Life	Year	(QALY).20,21				
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1.4 Problems	facing	knee	replacement	services	
	Although	knee	replacements	are	effective	both	in	terms	of	cost	and	outcome,	there	are	three	problems	facing	the	provision	of	knee	replacements.		First	and	foremost,	there	is	a	variation	in	the	outcome	–	around	17%	of	patients	are	dissatisfied	with	the	outcome	of	their	operation,	although	estimates	vary.22,23	Secondly,	and	by	no	means	specific	to	knee	replacements,	there	is	increasing	demands	coupled	with	financial	constraints.		Thirdly,	there	is	a	variation	in	the	utilisation	of	knee	replacements.		
1.4.1 Variation	in	outcome			Questions	have	been	raised	about	the	benefits	of	knee	replacements,	and	some	studies	report	up	to	17%	of	patients	are	dissatisfied	with	the	outcome	of	knee	replacement	surgery.17,22,24	The	situation	(regarding	knee	surgery	in	general)	has	been	commented	on	by	the	Secretary	of	State	for	Health,	who	was	reported	to	say	in	2012:		“An	interesting	case	in	point	is	knee	surgery;	the	data	has	now	come	back	demonstrating	half	of	knee	surgery	doesn’t	substantially	change	the	outcome	for	patients:	their	mobility	isn’t	improved	that	much,	nor	their	pain.”25		This	comment	was	met	with	disappointment	in	the	orthopaedic	community,	not	least	from	the	British	Orthopaedic	Association	(BOA)	and	the	British	Association	for	Surgery	of	the	Knee	(BASK).		They	cited	the	words	of	a	former	BOA	president	that	the	Department	of	Health	(DoH)	uses	data	like	“a	drunken	man	using	a	lamppost,	more	for	support	than	illumination”.25		Although	these	comments	were	widely	regarded	as	misrepresenting	the	data,	the	fact	remains	that	there	is	a	significant	group	of	patients	that	are	dissatisfied	with	the	outcome	of	their	surgery,	and	that	this	has	not	gone	
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unnoticed.		Patients	that	are	dissatisfied	tend	(unsurprisingly)	to	have	worse	Patient	Reported	Outcome	Measures	(PROMs)	scores,	such	that	they	display	worse	pain	outcomes	and	worse	functional	outcomes	that	those	that	are	satisfied.26			A	research	prioritisation	workshop	on	hip	and	knee	replacement,	sponsored	by	Arthritis	Research	U.K.,	the	NJR,	and	the	BOA,	identified	the	question	of	'...	which	patients	had	poor	outcomes	and	were	dissatisfied...'	as	the	most	important	research	question	in	knee	surgery	today.25		Additionally,	the	James	Lynd	alliance	priority	setting	partnership,	conducted	in	collaboration	with	the	National	Institute	for	Health	Research	(NIHR),	has	the	identification	of	pre-operative	predictors	of	success	as	one	of	its	“Top	Ten”	research	questions;	and	the	National	Institute	for	Health	and	Care	Excellence	(NICE)	has	stated	that	the	development	of	methods	to	predict	outcome	in	knee	replacement	is	a	research	priority.12				
1.4.2 Increasing	demand	with	financial	constraints	Currently	the	U.K.	government	has	ring-fenced	the	NHS	budget	against	the	austerity	measures	imposed	after	the	global	financial	crisis	of	2008.27		However,	a	King’s	Fund	report	into	NHS	performance	revealed	a	£630	million	deficit	half	way	through	financial	year	2014/15.27	They	predict	an	additional	£8	billion	in	funding	will	be	needed	each	year	by	2020.		The	present	Conservative	government	has	committed	to	meet	this	shortfall;	however,	the	financial	calculations	are	based	on	a	£22	billion	efficiency	saving	by	2020.27,28				With	efficiency	savings	as	the	goal	for	managing	budgets	within	the	NHS	for	several	years,	it	is	questionable	if	the	NHS	can	meet	its	financial	target	(efficiency	savings	inevitable	become	harder	year	on	year),	and	the	King’s	fund	has	suggested	that	additional	investment	will	be	required	to	deliver	essential	changes	to	services.27,28				
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In	any	event,	efficiency	savings	appear	to	be	a	key	strategy	to	managing	the	ever-growing	budget.28		A	more	judicious	use	of	knee	replacement	surgery,	combined	with	the	best	possible	conservative	care,	has	potential	to	decrease	the	number	of	knee	replacements	performed	(or	slow	the	increasing	numbers	needed),	and	may	go	some	way	to	relieving	the	financial	pressure.				
1.4.3 Variation	in	the	utilisation	of	knee	replacements		Variation	in	the	utilisation	of	healthcare	has	been	present	within	the	National	Health	Service	(NHS)	for	decades,	and	was	the	explicit	reason	for	the	establishment	of	NICE	in	1998	(a	move	against	the	“postcode	lottery”).29	Although	hailed	as	a	success	at	addressing	healthcare	inequalities,	NICE	has	a	limited	role	in	guiding	decisions	over	total	knee	replacement.		NICE	guidelines	on	the	treatment	of	knee	OA	are	available;2	however,	as	knee	replacement	is	a	preference-based	decision,	no	formal	criteria	have	been	agreed.16		Indeed,	the	pathway	from	patients	attending	GPs,	referral	to	orthopaedic	services,	and	receipt	of	a	joint	replacement	is	inconsistent.30			The	NHS	Atlas	of	Variation	describes	knee	replacement	utilisation	in	different	areas	of	the	country.31		Differences	in	expenditure	of	almost	fourfold	are	demonstrated	between	Primary	Care	Trusts	(PCTs)	with	regard	to	inpatient	knee	replacement	costs;	however,	those	Trusts	with	the	highest	expenditure	reveal	patients	with	the	best	pre-operative	PROM	scores.		In	other	words	those	areas	where	there	is	objectively	the	lowest	need	(as	measured	by	pre-operative	PROMS)	there	is	the	highest	rates	of	knee	replacement	–	the	so-called	“Inverse	Care	Law”.		Some	authors	dispute	the	validity	of	assessing	individual	need	based	on	PROMs;25	however,	the	case	remains	that	there	appears	a	population	level	discrepancy	in	knee	replacement	utilisation.				
	 15	
In	a	recent	systematic	review,	this	variation	in	the	utilisation	of	total	knee	replacement	has	been	described	by	age,	gender,	race,	education,	income/health	insurance	(only	studied	in	the	USA),	and	employment.32		Within	the	UK,	the	British	Medical	Journal	(BMJ)	reported	that	rates	of	knee	replacement	vary	by	age,	gender,	deprivation,	rurality,	and	ethnicity.	33		
Warranted	versus	unwarranted	variation	The	NHS	Atlas	of	Variation	defines	warranted	variation	as	that	explained	by	patient	need	or	patient	preference,	and	unwarranted	variation	as	due	to	differences	in	access	to	healthcare	and	clinical	practice.31	Simplistically,	this	could	be	divided	into	demand	(patient	preference)	and	supply	(access).				Recent	studies	have	demonstrated	that	there	is	a	marked	warranted	variation	in	knee	replacement	surgery.		Only	around	one	third	of	patients	considered	to	be	at	need	of	a	joint	replacement	would	be	willing	to	undergo	a	joint	replacement.34	Therefore	patients’	willingness	to	undergo	a	knee	procedure	will	affect	demand	(and	therefore	affect	geographical	variations	in	utilisation).				Several	studies	have	demonstrated	that	willingness	to	undergo	a	knee	replacement	varies	by	age,	race,	how	OA	is	viewed	(a	natural	process	involved	in	getting	older	compared	to	a	disease),	and	the	amount	of	pain	and	disability	that	is	required	to	justify	the	operation.32,34	Furthermore,	expectations	of	the	outcome	of	the	operation		varies	by	gender,	socioeconomic	status	and	race.35,36		Some	differences	in	utilisation	rates	by	race,	age,	income,	but	not	gender	have	been	explained	by	patient	preference.37,38			These	differences	are	key	areas	when	considering	developing	prognostic	models,	as	they	demonstrate	that	expectations	affect	the	willingness	to	undergo	knee	replacement	
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operations,	and	that	in	turn	may	affect	utilisation	of	knee	replacements	in	a	given	population.			Within	the	U.K.	it	is	clear	that	not	all	the	variation	is	warranted	(i.e.	due	to	patient	need	or	preference).		For	example,	orthopaedic	surgeons	and	general	practitioners	have	been	reported	to	be	less	likely	to	refer	a	woman	with	OA	of	the	knee	for	knee	replacement	than	a	man	(although	more	women	actually	have	the	procedure).39			Overall	the	factors	that	influence	the	variation	in	uptake	of	knee	replacement	surgery	is	likely	to	be	a	mixed	picture	of	patient	need,	patient	preference,	access	to	healthcare,	and	clinical	practice.	Understanding	how	patients	make	decisions	about	having	a	total	knee	replacement	could	explain	some	of	this	variation.					 	
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1.5 Aims	and	objectives	
	Total	knee	replacement	is	a	preference-based	decision	(i.e.	it	is	done	to	improve	quality	of	life,	and	the	decision	to	proceed	is	therefore	based	primarily	on	the	patient’s	preferences).19		If	the	decision-making	process	surrounding	knee	replacement	surgery	could	be	improved,	it	should	go	some	way	to	addressing	the	variability	in	outcome,	the	increasing	demand,	and	the	variation	in	utilisation.				Therefore,	this	thesis	has	two	aims:		 1.		To	understand	which	factors	affect	patient	decision-making	when	considering	a	knee	replacement,	and	how	prediction	of	outcome	could	affect	patients’	decision-making	process.		This	will	answer	the	following	questions:		- What	factors	are	important	in	patient	decision-making?	- Would	information	on	a	likely	outcome	alter	patient	expectations?	- Would	information	on	a	likely	outcome	alter	patients’	decision-making	process?	- What	sort	of	information	would	be	most	useful	to	patients	(e.g.	a	prediction	of	their	OKS	score,	or	a	predicted	chance	of	satisfaction)?			Chapters	2,	3,	and	4	describe	a	systematic	review	of	the	factors	that	influence	patient	decision-making,	and	report	a	qualitative	study	examining	both	the	factors	that	effect	patient	decision-making,	and	the	effect	a	fictitious	outcome	prediction	tool	may	have.					
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2.		To	develop	a	prognostic	model	that	could	be	used	to	help	the	decision-making	process	for	patients’	considering	knee	replacement	surgery.				To	do	this	the	following	objectives	need	to	be	met:		- Identification	of	the	important	pre-operative	factors	- Development	of	a	cohort	study	to	measure	those	factors	in	patients	receiving	a	knee	replacement	- Statistical	modelling	to	develop	an	algorithm	for	predicting	post-operative	outcomes	in	patients.				Chapters	5,	6	and	7	describe	a	systematic	review	identifying	the	important	pre-operative	factors,	the	subsequent	protocol	for	a	multicentre	cohort	study	of	600	patients	measuring	all	of	the	important	pre-operative	factors,	and	the	conduct	of	that	study	with	the	final	prognostic	model.				Critically,	this	body	of	work	aims	to	develop	a	new	prognostic	model	that	can	predict	more	variability	in	outcome	than	previous	attempts.		Although	the	usefulness	of	the	model	produced	is	discussed,	the	process	of	preclinical	development	and	impact	evaluation,	which	are	critical	steps	in	the	development	of	an	outcome	prediction	tool,	does	not	form	part	of	this	thesis.					 	
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1.6 Potential	implications	of	this	work	
	A	prognostic	model	may	prompt	investigation	into	modifying	patient	factors	that	are	associated	with	poor	outcome.		Patients’	functional	and	pain	outcomes	may	be	improved	by	modifying	these	factors	(e.g.	using	Cognitive	Behavioural	Therapy	to	alter	coping	strategies).				Identifying	important	pre-operative	factors	related	to	outcome	could	also	prompt	future	work	in	case-mix	adjustment.		This	is	especially	relevant	given	the	recent	publication	of	individual	surgeons’	outcomes	(although	currently	related	to	mortality),	and	the	recent	decision	to	base	the	Best	Practice	Tariff	for	hip	and	knee	replacement	partly	on	a	case-mix	adjusted	PROM	score.40						A	prognostic	model	is	also	the	first	step	in	the	development	of	an	outcome	prediction	tool.		Such	a	tool,	used	in	conjunction	with	a	surgeon’s	normal	pre-operative	counselling,	may	alter	patients’	decision-making	process.		For	example,	some	patients	who	have	been	offered	knee	replacement	may	elect	not	to	have	operation	based	on	predictions	of	poorer	outcomes	(going	some	way	to	address	increasing	demand).		Additionally,	patient’s	expectations	may	be	altered	with	outcome	prediction,	and	therefore	their	satisfaction	could	improve	(i.e.	those	patients	with	poorer	predictions	would	expect	poorer	outcomes).	There	is	conflicting	evidence	linking	pre-operative	expectation	and	post-operative	satisfaction	in	knee	replacements,	potentially	due	to	difficulties	in	measuring	these	constructs;41	however,	a	relationship	is	logically	consistent.	
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Chapter	2.		Decision-making	models	and	patients’	
decision-making	in	total	knee	replacement		
	
A	patient-centred	approach,	usually	achieved	through	shared	decision-making,	has	the	
potential	to	help	improve	decision-making	around	knee	replacement	surgery.		However,	
such	an	approach	requires	an	understanding	of	the	factors	involved	in	patient	decision-
making.		This	chapter	examines	models	of	decision-making	in	the	NHS	and	presents	a	
systematic	review	of	the	qualitative	literature	surrounding	patients’	decision-making	in	
knee	replacement	surgery,	identifying	the	factors	that	affect	patients’	decision-making.					
2.1 Declarations	
	
Aspects	of	this	chapter	have	been	published:	
T.	Barlow,	D.	Griffin,	D.	Barlow,	A.	Realpe.			Patients'	decision-making	in	total	knee	arthroplasty.	A	systematic	review	of	qualitative	research.	Bone	and	Joint	Research.		2015;4:163–169.		Dr	A.	Realpe	provided	independent	data	extraction.		Dr	D.	Barlow	provided	independent	assessment	of	references	for	inclusion.				
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2.2 Introduction	
	Understanding	patients’	decision-making	has	the	potential	to	improve	the	information	given	to	patients	(particularly	probabilistic	predictions	of	outcomes),	to	enhance	patient-centred	care,	and	to	inform	patient	decision	aids.42	Improved	pre-operative	counselling	could	help	address	the	three	problematic	areas	facing	knee	replacement	services:	(i)	a	high	dissatisfaction	rate;	(ii)	increasing	demand	with	financial	constraints;	and	(iii)	a	variation	in	the	utilisation	of	knee	replacements.42			Decision-making	within	medical	practice	is	an	area	that	has	been	intensively	studied	as	it	is	recognised	to	play	a	key	role	in	medical	interventions.43	There	are	several	models	of	decision-making,	each	with	its	own	advantages	and	drawbacks.43	Associated	with	these	models	are	interventions,	directed	towards	both	physicians	and	patients,	aimed	at	helping	the	decision-making	process.44,45	It	is	necessary	to	understand	this	background	before	the	intricacies	of	decision-making	in	knee	replacements	are	explored.		This	chapter	is	therefore	split	into	two	parts:		 - Section	2.3	Decision-making	models	in	the	NHS:	trends	over	time,	and	the	evidence	base	for	favouring	one	approach	over	another.			- Section	2.4	Systematic	review	of	current	knowledge	of	decision-making	in	knee	replacements.					Before	moving	on	to	discuss	decision-making	models,	it	is	important	to	recognise	that	knee	replacement	surgery	is	a	preference-based	decision:		this	means	that	the	patients’	decision	to	progress	to	knee	replacement	is	based	on	their	preferences	(along	with	the	surgeon’s	assessment	that	it	is	a	suitable	option).				With	the	ultimate	aim	of	
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understanding	what	is	currently	known	about	decision-making	in	knee	replacements,	preference-based	decisions	form	the	basis	of	the	literature	reviewed	here.					
2.3 Decision-making	models	in	the	NHS	
	There	are	many	descriptive	models	based	around	the	delivery	of	health	care.		For	the	purposes	of	this	review,	I	deal	with	three	models:	the	paternalistic,	the	shared	decision-making,	and	the	informed	models.43		The	paternalistic	model	of	delivery	of	healthcare	(occasionally	termed	the	traditional	medical	model)	was	historically	the	prevalent	method	of	delivering	healthcare.43	This	involved	an	interaction	where	the	clinician	chooses	the	therapy	he	or	she	deems	to	be	best.		The	patient	is	a	passenger	within	this	process.		In	contrast	stands	the	informed	medical	model	in	which	the	clinician	supplies	information	on	the	various	treatments	available	and	lets	the	patient	decide.43				Shared	Decision-making	sits	between	the	paternalistic	and	informed	models	in	that	there	is	a	transfer	of	information	between	clinician	and	patient,	and	a	decision	is	reached	together.43	It	has	been	defined	as:		“	A	process	in	which	clinicians	and	patients	work	together	to	select	tests,	treatments,	management	or	support	packages,	based	on	clinical	evidence	and	the	patient’s	informed	preferences.		It	involves	the	provision	of	evidence-based	information	about	options,	outcomes	and	uncertainties,	together	with	decision	support	counselling	and	a	system	for	recording	and	implementing	patients’	informed	preferences”.46	
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	As	such,	the	shared	decision-making	model	uses	evidence	based	medicine	(prevalent	in	the	paternalistic	model)	combined	with	a	patient-centred	approach.				One	method	of	deciding	on	which	decision-making	model	to	use	between	doctor	and	patient	is	to	determine	how	involved	patients	want	to	be	in	medical	decision-making.		A	systematic	review	by	Say	et	al.	demonstrated	that	patient	preference	for	involvement	in	medical	decisions	was	influenced	by	age,	gender	and	education,	with	young,	female,	well	educated	patients	having	a	preference	for	more	information.47	Further	factors	that	have	been	identified	are	more	complex,	and	include	patients’	experience	of	medical	care,	co-morbidity,	diagnosis,	type	of	decision,	and	interaction	with	health	professionals.47,48	It	is	also	clear	that	a	patient’s	preference	for	involvement	changes	at	different	stages	of	their	illness.48	Although	relevant	to	preference	based	decision-making,	no	specific	studies	on	preference	have	been	conducted	in	elective	knee	replacement	surgery.48		Therefore	patients’	preferences	for	information	and	involvement	in	medical	decision-making	are	varied	and	complex,	and	different	models	may	be	more	appropriate	than	others	in	different	situations.		Attempts	at	predicting	patients’	preferences	for	involvement	in	decision-making	have	so	far	been	unsuccessful,	due	in	a	large	part	to	the	complex	nature	of	the	topic.49	This	leads	to	the	question	of	which	model	to	use	primarily,	and	are	there	other	ways	of	selecting	that	model	(e.g.	based	on	health	outcomes)?					
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2.3.1 Shared	decision-making	and	Patient	Decision	Aids	Within	the	NHS	there	has	been	a	move	towards	a	“Shared-decision”	making	paradigm,	which	has	been	promoted	in	the	slogan	“No	decision	about	me,	without	me”.46	Although	this	model	might	not	serve	all	patients	all	the	time,	a	Department	of	Health	White	paper	has	committed	the	NHS	to	ensure	that	“Patients	will	be	in	charge	of	making	decisions	about	their	care”	and		“Shared	decision-making	will	become	the	norm”.28		Accompanying	this	political	drive,	NICE	has	released	quality	standards	supporting	this	philosophy	stating	that	patients	should	be	“actively	involved	in	shared	decision-making”	50		
Why	use	the	shared	decision-making	model?	This	is	based	on	three	principles:		Firstly,	some	authors	have	demonstrated	that	many	patients	(as	much	as	94%	in	some	settings)	want	more	information	about	decisions.	47	A	desire	for	more	information	does	not	mean	a	desire	for	involvement	in	decision-making	per	se,	although	the	two	have	an	association.	47		Secondly,	the	ethical	principle	of	autonomy	has	resulted	in	shared	decision-making	being	part	of	the	ethical	guidelines	for	clinicians.51			Thirdly,	there	is	evidence	that	a	patient-centred	approach	facilitates	patient	experience	and	health	outcome.			This	evidence	can	broadly	be	divided	into	two	categories:		interventions	for	providers,	and	interventions	for	patients.				
	 25	
Interventions	for	providers	A	recent	Cochrane	review	examined	43	randomised	controlled	trials	of	interventions	aimed	at	improving	patient-centred	consultations.44	A	range	of	measures	were	examined,	and	in	general	interventions	(primarily	training	sessions	for	providers	of	healthcare)	showed	positive	results	on	“clarifying	patients’	concerns	and	beliefs;	communications	about	treatment	options;	levels	of	empathy;	and	patient	perception	of	providers	attentiveness	to	them”.		Furthermore,	the	authors	analysed	health	outcomes.		Here	there	were	mixed	effects.		Most	relevant	to	knee	OA,	studies	with	complex	interventions	using	condition	specific	materials	generally	demonstrated	an	improvement	in	health	behaviour	and	satisfaction.		The	only	orthopaedic	study	included	in	the	review	involved	training	General	Practitioners	in	consultation	with	patients.		Those	patients	who	received	care	from	patient-centred-trained	GPs	had	improved	pain,	improved	PROM	function,	and	a	better	perception	of	treatment.52	However,	a	similar	study	showed	a	conflicting	result;	a	randomised	controlled	study	conducted	at	Warwick	University	found	worse	health	outcomes	for	patients	with	low	back	pain	treated	by	providers	trained	in	shared	decision-making.53.				Therefore,	shared	decision-making	on	the	part	of	the	provider	may	have	positive	results	on	how	a	patient	feels	about	the	treatment,	but	it	is	unclear	whether	it	is	helpful	or	detrimental	to	the	health	outcome.				
Interventions	for	patients	Patient	Decision	Aids	(PDA,	also	known	as	decision	aids,	decision	support	interventions,	decision	support	aids)	are	methods	of	informing	patients	about	the	treatment	options	available	to	them.		From	a	simple	one-page	summary	to	interactive	online	tools,	they	have	been	widely	implemented	within	the	NHS,	with	the	Department	
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of	Health	Quality,	Innovation,	Productivity,	and	Prevention	(QIPPs)	programme	funding	the	development	and	hosting	of	38	PDAs	to	cover	a	variety	of	conditions.		Knee	OA	is	included.46		A	recent	Cochrane	review	on	the	effectiveness	of	decision	aids	45	concluded	that	in	general:		 - Patients’	knowledge	of	the	options	improve	(high-quality	evidence);		- Patients	feels	more	informed	and	more	clear	about	what	matters	most	to	them	(high-quality	evidence);		- Patients	have	more	accurate	expectations	of	possible	benefits	and	harms	of	their	options	(moderate-quality	evidence);	and		- Patients	participate	more	in	decision-making	(moderate-quality	evidence).			Interestingly	decision	aids	have	been	found	to	reduce	the	proportion	of	people	progressing	to	elective	surgery.42,45	Although	these	studies	did	not	involve	patients	with	knee	OA,	there	are	clear	parallels	with	other	preference-based	decisions42			Currently	the	International	Standard	Randomised	Controlled	Register	(ISRCTN)	has	one	registered	trial	examining	the	effect	of	a	PDAs	in	knee	OA.54	This	trial	in	ongoing.			A	complicating	factor,	mentioned	in	both	the	Cochrane	review	and	a	review	of	PDAs	in	orthopaedics,	is	the	varying	quality	of	PDAs.42,45	Guidelines	for	the	development	and	evaluation	of	PDAs	have	been	developed	in	response	to	this.42		
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Summary	A	shared	decision-making	approach	in	knee	replacement	surgery	is	consistent	with	ethical	guidelines,	there	is	evidence	that	a	proportion	of	patients	would	prefer	it,	it	leads	to	better	patient	satisfaction	with	the	interaction,	it	is	consistent	with	current	political	targets,	and	it	is	appropriate	to	a	preference-based	decision.		However,	several	caveats	exist:	these	include	the	complex	nature	of	patient	preference	towards	the	amount	of	information;	patient	preference	for	involvement	in	decision-making;	and	concerns	over	the	quality	of	some	PDAs.		But	perhaps	the	largest	concern	is	the	unknown	effect	on	health	outcomes.		However,	shared	decision-making	appears	to	be	a	useful	method	and	may	go	some	way	to	addressing	some	of	the	problems	that	clinicians	are	currently	facing	in	knee	replacement	surgery	–	namely	limited	resources	with	increasing	financial	pressure,	a	significant	dissatisfaction	rate,	and	wide	variation	in	utilisation.				Shared	decision-making	in	knee	replacements	requires	a	firm	understanding	of	the	process	involved	in	patients’	decision-making,	and	the	factors	that	affect	that	process.		Understanding	patients’	decision-making	process	will	also	directly	help	understand	variations	in	the	warranted	utilisation	of	knee	replacements.			 	
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2.4 Systematic	review	of	factors	that	influence	patient	decision-
making	in	knee	replacements.				
	
2.4.1 Background	An	understanding	of	patients’	decision-making	will	be	helpful	not	only	in	enabling	high	quality,	patient-centred	interactions,	but	in	highlighting	areas	that	future	interventions	could	address	(particularly	interventions	aimed	at	delivering	information).				Various	attempts	at	identifying	how	patients	make	decisions	about	knee	surgery,	and	what	factors	are	important	to	them,	have	been	conducted.	Interestingly,	many	studies	have	examined	both	hip	and	knee	patients	as	one	cohort.		Additionally,	historic	attempts	at	synthesising	the	qualitative	literature	on	this	topic	have	likewise	included	both	hip	and	knee	patients	as	one	patient	group.55	Although	there	are	clear	similarities	between	these	groups,	there	are	significant	differences	that	make	combining	these	populations	potentially	unsound.		Firstly,	there	is	the	significant	difference	in	the	“success”	rate	of	hip	and	knee	replacements.		Total	knee	replacements	have	a	dissatisfaction	rate	of	around	17%.25,56	Hip	replacements	have	significantly	better	outcomes	as	regards	satisfaction,	pain,	and	function.57	Ibrahim	et	al.	examined	the	influence	of	expectations	as	an	explanatory	factor	in	some	of	the	variation	in	utilisation	rates	of	joint	replacement,	and	found	that	it	explains	some	of	the	variation.35	Therefore,	knee	replacement	decision-making	(associated	with	utilisation)	is	likely	to	be	different	to	that	for	hip	replacements,	as	the	outcome	is	not	the	same.				
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Secondly,	the	population	that	develops	hip	OA	is	different	to	the	population	that	develops	knee	OA.		A	recent	study	including	almost	2000	participants	found	that	BMI	was	correlated	with	the	development	and	progression	of	knee	OA,	but	not	hip	OA.58	This	is	particularly	relevant	to	decision-making,	as	people	with	higher	BMIs	display	different	psychological	profiles	to	the	general	population.59		Therefore	people	who	develop	hip	and	knee	OA	are	likely	to	be	different	populations,	with	different	psychological	profiles.		Additionally,	the	outcome,	and	therefore	expectation,	of	the	operations	are	different.			
2.4.2 Aim	In	this	review	I	aggregate	the	qualitative	literature	surrounding	patients’	decision-making	in	knee	replacement	surgery.		The	aim	of	this	review	was	to	provide	an	aggregation	of	studies	(cf.	a	synthesis	of	qualitative	studies).		The	difference	is	accumulation	and	summary,	rather	than	transformation.60	This	represents	an	approach	consistent	with	a	“lines	argument	synthesis”,	defined	as	“building	up	a	picture	of	the	whole”	and	represents	what	has	been	described	in	the	literature	as	a	realist	synthesis	with	narrative	review;61		however,	the	term	synthesis	here	refers	to	the	combination	of	results,	rather	than	any	second	or	third	order	interpretation	from	them.				
2.4.3 Methods	I	conducted	a	literature	search	of	Medline	and	Embase	in	January	2015.		Subject	and	topic	terms	(Knee,	Knee	prosthesis,	Knee	replacement,	Knee	arthroplasty	and	Decision-making)	were	included,	both	as	free	text	and	indexed	headings.	I	conducted	a	bibliographic	search	of	all	studies	retrieved	for	full	text	analysis	(whether	included	in	
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the	final	review	or	not).			English	only	articles	were	included.		This	search	strategy	is	consistent	with	that	used	by	the	Evidence	for	Policy	and	Practice	Information	Centre.62		Studies	that	reported	qualitative	data	on	the	decision-making	process	in	knee	replacements	were	included.		I	selected	the	relevant	papers,	and	conducted	a	bibliographic	search.		All	full	text	papers	retrieved	were	screened	by	a	second	author	(DB)	to	provide	consensus	that	papers	were	reporting	qualitative	findings	on	decision-making.		We	did	not	specifically	exclude	survey	data;	such	papers	were	required	to	provide	insights	into	decision-making	over-and-above	reporting	descriptive	or	inferential	statistics.		The	eligibility	criteria	were:		
Inclusion:	- Findings	on	how	and	why	patients	make	decisions	regarding	knee	replacement	- Recognised	as	qualitative	research		
Exclusion	- Knee	patients’	decision-making	not	reported	separately		Consistent	with	most	authors	conducting	aggregations	of	qualitative	work,	quality	assessment	was	not	performed.62,63			There	exist	many	different	methodologies	for	the	synthesis	of	qualitative	work.		These	differing	approaches	are	in	some	part	due	to	the	prolific	use	of	modified	techniques,	compounded	by	inconsistent	and	confusing	nomenclature64,65	A	common	issue	surrounds	the	terms	synthesis	itself:		many	authors	suggest	this	includes	a	transformation	of	the	data	contained	within	the	original	studies	(i.e.	new	insights	or	frameworks,	based	upon	the	original	studies	but	not	necessary	contained	within	them).		
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However,	my	aim	here	was	not	to	synthesise	the	studies	in	this	sense,	but	to	provide	a	map,	or	a	picture	of	the	whole.		This	is	consistent	with	approaches	described	in	the	literature.60-62,64,65	This	approach	involved	identifying	themes	that	the	authors	of	primary	studies	had	recognised	as	important	to	decision-making.	Themes	and,	where	appropriate,	sub-themes	are	reported	as	per	the	authors’	classification.		Therefore	the	authors’	own	findings,	in	their	own	words	as	far	as	possible,	are	reported,	and	any	clear	consistencies	or	inconsistencies	are	discussed.		I	completed	this	process,	and	the	findings	were	crosschecked	by	another	experienced	qualitative	researcher	(AR).				
2.4.4 Results	The	electronic	database	search	returned	556	papers.		Seventy	papers	remained	after	a	title	review,	and	a	further	50	papers	were	excluded	on	the	basis	of	their	abstracts.		A	further	11	papers	were	retrieved	for	full	text	review	from	the	bibliographic	search	(a	total	of	31	papers	for	full	text	review).		Of	these,	seven	were	included	in	the	review.		A	flow	diagram	of	the	included	papers	is	displayed	in	Figure	3.		
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Figure	3:	PRISMA	flow	chart	of	included	studies.		Adapted	from	Moher	et	al.66			 	
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Study	characteristics	Studies	have	examined	decision-making	in	a	population	with	knee	symptoms	but	no	diagnosis	of	knee	pain,67	patients	in	primary	care	with	a	diagnosis	of	knee	OA,68	patients	actively	considering	a	knee	replacement	in	secondary	care,69	patients	on	the	waiting	list	for	knee	replacement,70-72	and	recent	post-operative	patients.73	Of	note,	two	papers	had	a	focus	that	was	not	decision-making	in	knee	replacements;	however,	some	themes	were	relevant	so	both	papers	were	included.72,73				From	the	seven	studies,	four	different	countries	are	represented	with	234	participants.		Study	samples	range	from	nine	to	94	participants	(average	33	participants).		One	hundred	and	twenty-six	of	the	234	participants	are	African	American	(skewed	by	one	large	study	of	94	participants)67,	with	39	Kuwaiti	women,	33	“white”	or	“white	American”,	nine	European	New	Zealanders,	with	two	studies	(43	participants)	not	reporting	ethnicity.		Sixty-eight	of	the	234	participants	(29%)	were	male.		Three	studies	conducted	focus	groups,	with	four	conducting	interviews.		Analysis	was	reported	in	a	variety	of	ways,	with	different	nomenclature.	Study	characteristics	can	be	found	in	Table	3.
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Table	3:	Basic	study	characteristics	(continued	overleaf)	
Author	 Title		 Setting	 Sampling	 Participants	 Method	 Analysis	
Figaro	et	al.	 Preferences	for	Arthritis	Care	Among	Urban	African	Americans:	“I	Don’t	Want	to	Be	Cut”.			
Church	or	senior	centre	in	Manhattan,	New	York,	USA.		 Opt	in	recruitment	from	patients	who	had	pain	or	stiffness	in	one	or	both	knees.			
94	African	American/Black	participants.	(79	female,	15	male).	Mean	age	71.				82	without	and	12	with	a	knee	replacement.			
Structured	interviews	 Content	analysis	using	constant	comparative	method.			
Suarez-Almazor	 A	qualitative	Analysis	of	Decision-Making	for	Total	Knee	Replacement	in	patients	with	OA.			
Primary	care	setting	in	USA.			 Patients	identified	as	sub-population	of	another	study,	with	a	diagnosis	of	knee	OA	but	no	TKR.			
37	patients.		13	white,	9	Hispanic,	15	African	American.		14	males,	23	females.		Mean	age	64.			
Focus	group	 Thematic	analysis	using	a	grounded	theory	approach.			
Chang	et	al.	 Concerns	of	Patients	Actively	Contemplating	Total	Knee	Replacement:	Differences	by	Race	and	Gender	
Orthopaedic	surgeon’s	office.		USA	 Patients	actively	considering	a	knee	replacement.		Patients	were	recruited	in	sequence	of	attendance.			
12	male,	25	female.		20	white	American,	17	African	American.		Mean	age	60.			
Focus	group	 Thematic	content	analysis	
Al-Taiar	et	al.	 Attitudes	to	knee	OA	and	total	knee	replacement	in	Arab	women:		a	qualitative	study.		
The	only	Publicly	funded	orthopaedic	centre	in	Kuwait	 Patients	selected	from	the	waiting	list	for	knee	replacement.		Process	not	reported.			
39	Kuwaiti	female	participants.		Mean	age	62.5.			 Semi-structured	focus	group	 Thematic	analysis		
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Table	3	(cont.)	
Author	 Title		 Setting	 Sampling	 Participants	 Method	 Analysis	
Toye	et	al.	 Personal	meanings	in	the	construction	of	need	for	total	knee	replacement	surgery.	
Specialist	orthopaedic	centre,	England,	UK.			 Patient	on	waiting	list	for	TKR	and	below	average	need	as	judged	by	WOMAC	pain	and	function	score.		Invited	by	letter	(opt	in).		
18	patients	(12	male,	6	female).		Average	age	and	ethnicity	not	reported.			
Semi-structured	interviews	 Interpretive	phenomenological	analysis.			
Woolhead	et	al.	 Who	should	have	priority	for	a	knee	joint	replacement?	 Three	orthopaedic	surgeons’	waiting	lists,	UK.			 Patients	on	the	waiting	list	for	knee	replacement.		Sampling	across	age	and	gender	by	letter	(opt	in).			
25	participants	(14	female,	11	male).		Mean	age	65.			 Semi-structured	interviews	 Constant	comparison	
Marcinkowski	et	
al.	
Getting	Back	to	the	Future.		A	Grounded	Theory	Study	of	the	Patient	Perspective	of	Total	Knee	Joint	Arthroplasty.	
A	publically	funded	centre	in	New	Zealand.			 Purposive	sampling	by	age,	gender,	comorbidity	and	complications	from	patients	who	had	recently	had	a	knee	replacement.			
9	European	New	Zealand	participants	(4	male,	5	female).		Mean	age	71.			
Unstructured	interview.			 Constant	comparative	analysis	based	in	grounded	theory	
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Study	themes	A	matrix	of	study	themes	has	been	produced	(Table	4),	demonstrating	where	themes	overlap,	and	where	they	do	not.		The	description	of	themes	is	taken	from	the	relevant	papers,	but	summarised	where	necessary.		As	described	in	the	methods	section,	no	transformation	of	the	data	took	place.				Expectation	of	surgery	was	a	theme	identified	in	five	of	the	seven	studies.67-71		A	common	finding	was	the	uncertainty	surrounding	the	outcome	of	a	knee	replacement.			Four	studies	identified	various	patterns	of	coping	mechanisms,	which	were	important	in	the	decision-making	process.67,70,71,73	The	use	of	alternative	medicine	and	social	support	was	prevalent.		Two	studies	identified	religion	as	part	of	the	preferred	coping	mechanism.These	mechanisms	may	help	people	live	with	OA	and	therefore	predominantly	act	as	deterrents	to	operative	intervention;	however,	they	can	also	act	as	stimulators	(e.g.	social	support	in	helping	to	make	the	decision).				The	relationship	with	the	clinician	was	recognized	as	important	in	four	studies.		This	was	almost	universally	seen	as	a	major	factor	in	decision-making;	however,	one	paper	found	that	trust	in	physicians	was	not	an	important	factor	in	decision-making.		Related	to	this	theme,	two	papers	documented	the	role	of	“decisional	conflict”	in	decision-making.		Woolhead	et	al.,	who	examined	patients’	views	on	prioritisation	for	surgery,	found	that	decisional	conflict	existed	due	to	differences	of	opinion	between	patient	and	surgeon.72		This	was	consistent	with	finding	from	Suarez-Almazor.68		Interestingly,	patients	in	these	studies	interacted	with	both	primary	care	physicians	and	surgeons,	suggesting	conflict	can	continue	throughout	the	patients’	journey	to	knee	replacement.				
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Many	fears	were	identified	in	the	studies.		Common	fears	were	that	of	the	operation	(with	associated	anaesthesia),	recovery,	and	outcome.		One	fear	was	related	to	another	theme:	pain	(predominantly	pre-operative	pain).		Pain	was	identified	in	four	of	the	studies,	with	the	effect	on	participants’	life	being	a	major	factor	in	decision-making.			Function	(both	poor	functioning	pre-operatively	and	expected	good	functioning	post-operatively)	was	reported	in	three	studies	as	a	decision-making	factor.70,71,73		Some	authors	included	function	with	another	domain	(e.g.	Marcinkowski	et	al.	describe	physical	and	emotional	struggling	as	a	theme).	73				Psychological	aspects	(predominantly	emotional)	were	explored	in	three	papers.70,71,73		The	findings	were	quite	consistent	across	papers	involving	participants	that	were	on	the	waiting	list,	or	that	had	received	knee	replacements.		Feelings	of	frustration,	vulnerability,	letting	others	down,	and	self-image	were	discussed.				Patients’	social	network	functioned	both	as	a	source	of	perceived	pressure	and	as	an	information	source	related	to	the	social	networks’	experience	of	surgery.68,71		Related	to	this	was	a	personal	experience	of	surgery,	identified	by	two	studies.				Six	further	themes	were	identified	by	only	one	study.		These	included:		surgery	as	a	last	resort,	preference	for	continuing	their	current	state,	financial	issues,	different	sources	of	information,	and	different	preferences	for	participation	in	decision-making.					
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Table	4:	Study	themes	(continued	until	page	43)	
Summary	
theme	
Figaro	et	al.	 Suarez-
Almazor	
Chang	et	al.	 Al-Taiar	et	al.	 Toye	et	al.	 Woolhead	et	
al.	
Marcinkowski	
et	al.	
Expectations	
of	Surgery	
Negative	
expectations	of	
Knee	
replacement.		Expectation	that	surgery	“doesn’t	last”	is	a	“last-resort”,	or	that	it	introduces	something	“foreign”	into	the	body.			
Expectations	
about	
improved	
function.	
Post-operative.		Concerns	included:	benefits	from	surgery;	long	term	outcome;	recuperation	process;	function	after	surgery;	quality	of	life	after	surgery;	pain	after	surgery;	methods	of	pain	relief;	support	after	surgery	
Expectation	of	knee	
replacement.		Varied,	poor,	and	non-specific	expectations	were	noted.			
Expectations.		Knee	replacement	seen	as	a	"cure"	with	the	expectation	of	an	improvement	in	pain	and	function.			
	 	
Coping	
mechanisms	
Preference	for	
natural	
remedies.	OA	seen	as	a	natural	part	of	ageing.	Desire	to	keep	their	body	intact	and	the	use	of	natural	remedies.		
Belief	in	God’s	
control.		Over	their	health	and	eventual	death.			
	 	 Impact	of	pain	and/or	
mobility	limitation	
upon	family.		Family	support	a	critical	factor	in	coping	with	pain	See	also	Pain	
Experience	and	impact	
of	knee	pain	on	
patients.			
Dependency.		On	family	and	friends.		 	 Seeking	comfort.		Alternative	medicine	and	medication.			
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Table	4	(cont.)	
Summary	
theme	
Figaro	et	al.	 Suarez-Almazor	 Chang	et	al.	 Al-Taiar	et	al.	 Toye	et	al.	 Woolhead	et	
al.	 Marcinkowski	et	al.	
Relationship	
with	clinician	
Relationship	
with	Specialist.	TKR	was	viewed	as	rarely	offered,	and	therefore	a	last	resort.	Wary	of	having	a	knee	replacement	if	they	had	experience	of	doctors	laughing,	yelling,	or	rushing	them	to	make	a	decision.	
Relationships	
with	doctors.	Especially	trust,	information,	and	communication.			
	 Process	of	decision-
making	to	undergo	
knee	replacement	and	
pathway	of	care.		Feeling	that	knee	replacement	is	offered	once	knee	is	"totally	destroyed";	lack	of	information;	trust	in	doctor	not	identified	as	an	issue	
Medical	Model.		A	belief	that	medical	diagnosis	(confirmed	on	radiograph)	determined	need	for	knee	replacement	(and	therefore	determined	by	the	doctor);	Faith	in	the	doctor	as	"expert"	-	although	not	absolute	or	100%	consistent.			
	 	
Fear	 Fear	of	surgery	
or	death.	Fear	and	distrust	of	the	medical	system.		Fear	of	a	bad	outcome	from	surgery	
Fears.		Length	of	recovery,	fear	from	complications,	anaesthesia,	longevity	of	prosthesis,	effect	on	co-morbidities.			
Intra-operative.		Concerns	included	Technique	and	anaesthesia	
Process	of	decision-
making	to	undergo	
knee	replacement	and	
pathway	of	care.	Fear	of	the	operation,	anaesthesia,	post-operative	pain,	poor	outcome;		
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Table	4	(cont.)	
Summary	
theme	
Figaro	et	al.	 Suarez-
Almazor	
Chang	et	al.	 Al-Taiar	et	al.	 Toye	et	al.	 Woolhead	et	
al.	
Marcinkowski	
et	al.	
Pain	 	 	 Pre-operative.	Various	concerns	raised	including:	alternatives	to	knee	replacement;	pain	relief	and	addiction;	lifespan	of	prosthesis;	timing	of	knee	replacement;	employment;	finance;	trust	in	physician;	anatomy;	types	of	device;	drawbacks	to	surgery;	candidate	for	surgery	
Pain	experience	and	
impact	of	knee	pain	on	
patients.		Pain	affected	all	aspects	of	life;	pain	management	included	medicine	and	alternative	therapies;	fear	over	side	effects	and	addiction	to	medications	prevalent;	the	cause	of	OA	was	important	to	patients;	some	participants	turned	to	religion	to	help	cope.	
Pain.		Important	factor	in	determining	need;	however	difficult	to	describe.			
	 Hurting.		Pain	interfered	with	everyday	activities	and	sleep.	
Function	 	 	 	 Mobility	limitation	and	
the	need	for	assistance.		Affected	activities	of	daily	living;	fear	of	falling	was	common;	feeling	of	failure	and	less	value	with	regards	their	obligation	towards	family.			
Functional	Loss.		With	respect	to	walking	shopping	and	leisure	activities.		Functional	expectations	decreased	with	age,	reducing	the	perceived	need	for	knee	replacement.			
	 Struggling.		Physical	and	emotional	struggle	(coming	to	terms	with	how	others	viewed	them	and	their	own	self	image)	
	
	 41	
Table	4	(cont.)	
Summary	
theme	
Figaro	et	al.	 Suarez-Almazor	 Chang	et	al.	 Al-Taiar	et	al.	 Toye	et	al.	 Woolhead	et	
al.	
Marcinkowski	
et	al.	
Psychological	
implications	
	 	 	 Mobility	limitation	and	
the	need	for	assistance.		Affected	activities	of	daily	living;	fear	of	falling	was	common;	feeling	of	failure	and	less	value	with	regards	their	obligation	towards	family.			
Vulnerability.		Physical	vulnerability	related	to	the	knee	"letting	me	down".			
Low	mood	and	
fatigue.		Various	psychological	effects	identified	including	frustration,	fatigue,	and	depression.		
	 Struggling.		Physical	and	emotional	struggle	(coming	to	terms	with	how	others	viewed	them	and	their	own	self	image)	
Social	
network	
	 Personal	
Experience.		Experience	of	relatives,	friends	and	acquaintances	played	a	major	role	
	 	 Social	Network.		As	an	information	source,	and	a	source	of	pressure	to	proceed.			
	 	
Previous	
experience	of	
surgery	
	 Previous	personal	
experience	of	
surgery.	(Including	non-orthopaedic	surgery)	
	 Past	Medical	
Treatment.		Pathways	of	care	involved	may	different	doctors	in	many	different	countries	and	led	to	a	perceived	overuse	of	medications	and	a	delay	to	knee	replacement	
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Table	4	(cont.)	
Summary	
theme	
Figaro	et	al.	 Suarez-Almazor	 Chang	et	al.	 Al-Taiar	et	al.	 Toye	et	al.	 Woolhead	et	al.	 Marcinkowski	
et	al.	
Conflict	in	
opinions	
	 Conflict	in	opinions.		Conflict	between	patients,	families	and	doctors	led	to	dissatisfaction.			
	 	 	 Decisional	
conflict	between	how	patients	perceived	prioritisation	does	happen	and	should	happen	(and	whom	doctors	offer	knee	replacements	to)	
	
Themes	that	
are	not	
replicated	
across	studies	
Preference	for	
continuing	their	
current	state.	Fear	of	the	operation,	unwillingness	to	make	a	choice	that	increases	the	risk	of	death,	uncertainty	about	outcome,	and	satisfaction	with	their	current	lifestyles	all	featured.		
	
Surgery	as	a	last	resort.		Also	referred	to	as	a	"Threshold	for	decision-making".				
Financial	issues.		Although	this	was	a	concern	it	was	not	seen	as	an	insurmountable	barrier	to	knee	replacement.				
Different	sources	of	
Information.		Primary	care	physician	most	common	source	of	professional	and	medical	information		
Different	preferences	for	
participation	in	decision-
making	
	 	 Disease	
Progression.		Belief	that	the	disease	would	progress,	with	consequences	for	later	life.			
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Table	4	(cont.)	
Summary	
theme	
Figaro	et	al.	 Suarez-
Almazor	 Chang	et	al.	 Al-Taiar	et	al.	 Toye	et	al.	 Woolhead	et	al.	 Marcinkowski	et	al.	
Comments	 Overarching	
theme	of	
preference	for	
non-surgical	
treatment	and	
apprehension:		
“I	don’t	want	to	
be	cut.”	
	 Study	was	
primarily	aimed	at	
identifying	patient	
concerns	over	knee	
replacement	
Trust	in	surgeon	and	
concern	over	
healthcare	costs	were	
not	identified	as	
concerns	of	patients.			
Important	to	
identify	patients’	
personal	meaning	
during	a	clinical	
consultation	to	
effectively	
collaborate	on	
treatment	
decisions.			
The	paper	
focused	on	
prioritisation	
for	surgery.		
However,	it	
found	
patients	
perceive	a	
conflict	
between	
patients	and	
doctors	on	
how	this	
process	
works,	and	
the	process	
of	listing	for	
knee	
replacement	
This	paper	
was	a	review	
of	patients’	
whole	
experience.		It	
did	not	focus	
on	decision-
making,	but	
did	include	
some	themes	
that	were	
relevant.			
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2.4.5 Discussion	I	have	described	a	heterogeneous	group	of	studies	examining	the	decision-making	process	of	patients	when	considering	a	knee	replacement.		Some	themes	are	remarkably	consistent;	others	have	only	been	demonstrated	in	specific	samples	of	patients.		One	theme,	the	relationship	with	the	treating	physician,	was	not	found	to	be	important	in	one	study,	contrasting	with	it	being	a	major	factor	in	four	other	papers.		It	may	be	this	is	a	result	of	the	study	samples:	the	study	that	found	this	theme	was	not	important	included	patients	that	had	been	seen	by	many	doctors	in	many	different	countries.				The	themes	identified	within	this	review	are	consistent	with	the	wider	literature	of	knee	replacements.	Huduk	et	al.	investigated	a	population	of	patients	with	hip	and	knee	OA	who	had	elected	not	to	have	a	replacement.74	Patients	that	do	not	proceed	to	joint	replacement	tend	to	view	OA	as	an	inevitable	part	of	ageing,	see	others	as	worse	off	than	themselves,	and	wait	for	the	doctor	to	recommend	it.		These	finding	are	consistent	with	findings	from	our	review,	especially	with	the	samples	of	patients	who	were	earlier	in	their	treatment	course.		This	aspect	is	key	in	understanding	the	high	rate	of	patients	who	are	unwilling	to	consider	knee	replacement.34		Elwyn	et	al.	suggested	that	the	decision-making	process	can	be	split	into	deliberation	and	decision-making	(also	called	determination).75	This	would	suggest	that	the	deliberation	process	occurs	until	the	decision	to	have	surgery	is	reached	(what	Clark	et	al.	refer	to	as	the	“Decision-making	Threshold”).76	Included	studies	demonstrated	that	patients	experience	decisional	conflict;	however,	it	is	unclear	if	this	conflict	causes	a	degree	of	stress	during	the	deliberation	stage,	or	if	this	is	resolved	once	the	threshold	is	reached.		It	is	also	unclear	if	patients	would	be	willing	to	move	back	into	the	deliberation	phase	if	their	symptoms	improved.		The	relationship	between	the	
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decision-making	threshold	and	the	movement	from	deliberation	to	decision-making	is	currently	poorly	understood,	and	is	explored	in	chapters	3	and	4.				In	2007	O’Neill	conducted	a	qualitative	meta-sythesis	of	decision-making	in	joint	replacement.55	This	concluded	that	social	and	cultural	categories	shape	patients’	expectations	of	treatment	options.		Coping	strategies	and	life	context	determined	the	short	and	longer-term	outcomes	of	joint	replacement.		Interestingly	the	strongest	theme	identified	was	trust	in	the	health	professional.		This	is	broadly	consistent	with	the	findings	of	this	review;	however,	one	paper	reports	a	notable	exception.70			In	2012	Jayadev	conducted	a	review	on	Patient	Decision	Aids.42	This	included	evidence	from	a	Cochrane	review	that	concluded	decision	aids	improved	patient	knowledge,	resulted	in	less	decisional	conflict,	less	indecision,	and	greater	concordance	between	patient	values	and	chosen	options.		However,	it	also	commented	on	the	varying	quality	of	decision	aids,	finding	that	the	content	regarding	different	treatment	options	was	commonly	lacking.		Compounding	this,	our	review	would	suggest	that	there	are	various	concerns	that	patients	have	over	and	above	the	different	treatment	options	(e.g.	the	“relationship	with	clinician”).		Using	the	findings	from	this	review,	there	is	the	potential	to	tailor	the	information	in	decision	aids	to	address	patients’	major	concerns.				This	review	is	prone	to	various	weaknesses.	The	indexing	of	qualitative	work	from	electronic	databases	is	not	as	well	developed	as	that	of	quantitative	studies.64	Currently,	there	are	no	registers	of	qualitative	work	and	qualitative	studies	commonly	use	descriptive	or	imaginative	titles,	making	identification	through	standard	search	techniques	problematic.62,64	To	address	this,	I	used	a	broad	based	approach,	searching	for	only	the	subject	and	topic	terms.62	This	produced	a	large	number	of	irrelevant	studies,	and,	with	an	estimated	23%	of	studies	not	having	indexed	abstracts,	resulted	in	
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a	large	number	of	full	text	articles	being	screened.62	Furthermore,	I	conducted	a	comprehensive	bibliographic	search	of	all	full	text	articles	retrieved,	including	those	excluded	from	the	review.		This	approach	is	consistent	with	that	used	by	the	Evidence	for	Policy	and	Practice	Information	Centre.62		The	definition	of	a	qualitative	study	is	problematic,	with	experienced	qualitative	researchers	disagreeing	over	what	constitutes	qualitative	research.62	I	addressed	this	by	only	including	research	that,	in	my	and	DB’s	opinion,	was	unequivocally	qualitative	in	nature.	Studies	examining	knee	replacement	decision-making	with	other	conditions	(e.g.	hip	replacement	or	back	pain)	were	excluded.55,77,78	These	studies	may	have	contained	useful	information,	but	were	excluded	on	the	basis	that	the	themes	might	not	have	been	relevant	to	knee	replacement	decision-making.				No	synthesis	of	the	data	took	place,	although	common	themes	have	been	highlighted.			My	aim	was	to	provide	an	overview	of	what	is	know	about	how	patients	make	decisions,	and	let	the	reader	interpret	the	themes	expressed	from	each	paper.61,62,64			Various	weaknesses	were	present	in	the	studies	included	within	this	review.		Some	samples	of	patients	were	homogeneous	within	certain	characteristics	(e.g.	black	Americans).67	Additionally,	the	stage	of	the	decision-making	process	has	not	been	addressed,	with	each	included	study	focusing	on	one	stage	of	the	pathway	of	care	(although	Figaro	et	al.	did	include	some	post	operative	patients	within	their	sample,	it	represented	a	very	small	number).			The	stage	of	decision-making	is	likely	to	be	key	to	understanding	the	decision-making	process,	and	therefore	these	studies	lack	an	essential	dimension.		An	interesting	finding	was	that	reporting	positive	findings	(i.e.	themes	that	were	important	to	patients)	was	ubiquitous	throughout	all	studies;	however,	only	one	study	mentioned	a	negative	result	(i.e.	a	theme	that	was	not	
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important).70	It	is	unclear	if	authors	did	not	report	negative	findings,	or	did	not	make	any	attempts	to	investigate	certain	factors	that	could	affect	decision-making.		This	could	be	thought	of	as	a	reporting	bias.	To	what	degree	this	influenced	the	result	is	unclear.				It	is	also	unclear	from	this	work	how	individual	prediction	of	outcome	could	affect	decision-making.				The	strengths	of	this	study	is	the	systematic	method	of	identifying	studies,	the	accurate	reporting	of	themes	from	individual	papers,	and	the	process	of	validating	the	themes	that	were	extracted	from	the	papers.					
2.4.6 Conclusion	I	identified	17	individual	themes	across	seven	studies	that	covered	all	stages	of	the	decision-making	journey,	from	developing	symptoms	through	to	recovery	after	knee	replacement.		Ten	themes	were	repeated	across	studies,	with	fear,	pain,	coping	mechanisms,	expectations	of	surgery,	and	the	relationship	with	the	clinician	seen	most	frequently.				Understanding	all	facets	that	may	affect	patient	decision-making	when	considering	a	knee	replacement	is	essential	to	the	shared	decision-making	process.		This	work	can	act	as	a	framework	for	understanding	common	concerns	of	patients	considering	a	knee	replacement,	in	order	to	aid	clinicians	in	delivering	patient-centred	care.		Other	methods	of	delivering	information	to	patients	(e.g.	PDAs)	should	address	these	factors;	however,	how	best	to	integrate	these	findings	into	information	delivery	systems	for	patients	is	an	area	that	requires	greater	understanding.			
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	By	facilitating	the	patient-doctor	interaction,	a	sound	understanding	of	patient	decision-making	has	the	potential	to	address	increasing	financial	pressures,	variation	in	uptake,	and	improved	satisfaction	from	surgery.			However,	this	review	is	unable	to	provide	us	with	a	model	of	decision-making	that	is	theoretically	grounded,	and	is	also	deficient	in	that	individual	studies	did	not	include	patients	at	different	parts	of	the	decision-making	process.		The	following	chapter	aims	to	address	these	limitations.				
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Chapter	3:	A	qualitative	study	on	the	factors	affecting	
patients’	decision-making	in	knee	replacement.		
	
This	study	uses	focus	groups	and	in-depth	interviews	to	examine	the	factors	that	affect	
patient	decision-making.		I	describe	nine	themes	that	affect	patient	deliberation	over	a	
decision.		I	base	my	findings	in	a	theoretical	model,	proposed	by	Elwyn	et	al.,	that	
highlights	the	distinction	between	deliberation	and	decision-making,	and	add	to	this	
model	by	demonstrating	the	boundary	between	deliberation	and	decision-making	is	the	
decision-making	threshold.			This	provides	a	model	of	decision-making	for	patients	
considering	a	knee	replacement.					
3.1 Declarations	
	
Aspects	of	this	chapter	have	been	presented	at	an	international	conference:	
T.	Barlow,	P.	Scott,	D.	Griffin,	A.	Realpe.		What	factors	affect	patient	decision-making	in	knee	replacements?	23rd	annual	meeting	of	the	European	Orthopaedic	Research	Society.				This	study	was	approved	by	the	Dyfed	Powys	Research	Ethics	Committee	(13/WA/0140).				Dr	A.	Realpe	provided	independent	cross	checking	of	thematic	framework.		Mrs	P.	Scott	facilitated	in	focus	groups,	interviews,	and	analysis	of	qualitative	data.		An	external	company	conducted	transcription	of	focus	groups	and	interviews.			
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3.2 Background	
	In	the	previous	chapters	the	importance	of	understanding	knee	replacement	decision-making	was	explored.		This	was	focused	around	three	key	areas:		differences	in	utilisation	rates;31		a	high	dissatisfaction	rate;25		and	increasing	demands	with	financial	constraints.27	How	decision-making	could	have	an	influence	on	each	of	these	factors	was	discussed.				Previous	investigations	have	focused	on	populations	at	a	different	point	along	the	treatment	pathway.		No	previous	study	has	included	patients	at	different	stages	along	that	pathway,	focusing	instead	on	those	with	symptomatic	knee	problems,67	considering	a	knee	replacement,69	on	the	list	for	a	knee	replacement,70-72	or	those	who	had	already	had	a	knee	replacement.73	The	point	on	the	pathway	is	likely	to	be	important	in	decision-making,	and	therefore	previous	studies	lack	an	essential	dimension,	providing	only	a	“snap	shot”	of	the	decision-making	process.				An	understanding	of	patients’	decision-making	is	critical	in	informing	patient-centred	care.		It	is	also	be	helpful	in	understanding	how	an	outcome	prediction	tool	could	affect	decision-making.				Therefore	our	aim	was	to	explore	how	patients	make	decisions	around	knee	replacements,	and	to	understand	the	factors	important	in	those	decisions.						
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3.3 	Methods	
	This	study	involved	two	stages:	the	first	used	focus	groups	to	generate	a	range	of	patient	views;	the	second	used	in-depth	interviews	to	explore	those	views	to	a	depth	difficult	to	achieve	with	focus	groups	alone.79	Focus	groups	took	place	with	patients	who	had	already	had	a	replacement,	and	interviews	took	place	with	patients	who	were	either	waiting	for	a	knee	replacement,	or	considering	having	one.				
3.3.1 Research	Team	Dr	A.	Adams	and	Dr	A	Realpe	(both	part	of	my	supervision	team)	provided	methodological	advice,	facilitation	of	focus	groups,	and	independent	cross	checking	of	thematic	framework.		Both	have	an	interest	in	orthopaedic	decision-making,	and	have	been	involved	in	patients’	decision-making	in	orthopaedic	trials.		Mrs	P	Scott,	a	member	of	the	public,	facilitated	in	focus	groups,	interviews,	and	analysis	of	qualitative	data.		Mrs	Scott	was	identified	through	University/User	Teaching	and	Research	Action	Partnership	(UNTRAP),	a	university	organisation	putting	interested	members	of	the	public	in	touch	with	researchers.		Mrs	Scott	was	an	active	member	of	the	team	at	each	stage	of	the	project,	from	the	generation	of	the	study	protocol	to	the	dissemination	of	findings.	Aspects	included	public	information	leaflets,	recruitment,	relevance	of	the	aims	and	objectives,	methodology,	and	analysis.		
3.3.2 Theoretical	framework	The	concept	of	different	stages	to	decision-making	has	been	described	in	the	literature	previously.76,77	Elwyn	et	al.	describe	the	theoretical	construct	of	a	deliberation	phase	and	a	decision-making	(also	called	a	determination)	phase.75	I	used	Elwyn’s	theoretical	framework	to	inform	the	development	and	analysis	of	this	study.		Examining	different	
	 52	
points	along	the	patient	pathway	ensured	patients	representing	both	the	deliberation	and	decision-making	phases	were	included.			The	stage	of	the	decision-making	process	has	not	been	addressed	by	any	previous	study.		
3.3.3 Interview	and	focus	group	conduct	I	conducted	all	focus	groups	and	interviews.		Focus	groups	were	facilitated	by	either	Dr	Adams	or	Dr	Realpe.			Mrs	Scott,	a	patient	member	with	little	qualitative	experience,	was	present	for	both	focus	groups	and	four	interviews.				Focus	groups	and	interviews	took	place	at	the	location	most	convenient	for	the	patients.		Sites	included	University	Hospitals	of	Coventry	and	Warwickshire	(UHCW),	the	patients	home,	and	by	telephone.				
3.3.4 Sampling	Purposive	sampling	across	age	and	gender	was	conducted	to	achieve	a	spread	of	diversity	early	in	the	study.		This	was	essential	to	avoid	unnecessary	patient	interviews	(and	therefore	patient	burden).			The	ability	to	recruit	Asian,	Black,	and	Chinese	patients	was	limited	because	these	denominations	make	only	3-12%	of	the	demographic	of	the	geographic	area.80	Additionally	lower	rates	of	utilisation	can	be	expected	in	these	groups.72	However,	every	effort	was	made	to	include	these	participants.		Socioeconomic	status	was	monitored	using	the	Index	of	Multiple	Deprivation	(IMD	2010)	as	reported	through	the	national	census.81			
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3.3.5 Focus	groups	Patients	who	had	a	previous	total	knee	replacement	for	OA	at	UHCW	on	or	before	30th	April	2013	were	identified	through	medical	coding.	Sequential	patients,	working	backwards	from	the	30th	of	April,	were	send	invitation	letters	for	the	focus	groups.		One	hundred	invitation	letters	were	sent	in	October	2013	or	February	2014	using	an	“opt	in”	approach.		Focus	groups	took	place	in	December	2013	and	March	2014.		A	guide	for	the	focus	groups	was	produced	after	discussion	within	the	research	team	to	identify	key	areas	that	were	deemed	important	(see	Appendix	I).			This	was	used	as	a	guide	only,	with	the	aim	of	the	focus	group	being	the	generation	of	themes.		Focus	groups	lasted	approximately	two	hours	with	six	participants	in	each	group.	
	
3.3.6 In-depth	interviews	I	analysed	the	focus	groups	and	produced	the	interview	schedule	(see	“analysis”	below).		Dr	Adams	and	Dr	Realpe	crosschecked	both	the	analysis	and	schedule.		The	schedule	(see	Appendix	II)	was	used	as	a	guide	to	the	range	of	topics	covered	in	the	focus	groups.				I	targeted	two	study	populations	during	the	interview	phase.		The	first	was	patients	who	had	decided	to	have	a	knee	replacement	operation	(decision-making	phase).		Patients	on	the	waiting	list	for	a	knee	replacement	and	recruited	to	a	multicentre	cohort	study	over	a	one	week	period	in	July	(4th	to	the	11th)	2014	were	approached	to	participate	in	the	interviews.	The	cohort	study	was	designed	to	develop	a	prognostic	model	for	patients	considering	knee	replacement	(see	Chapters	6	and	7).82			The	second	target	population	was	patients	who	had	been	seen	in	secondary	care	but	had	not	yet	decided	to	have	a	knee	replacement	(deliberation	phase).			Patients	were	
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identified	through	operative	lists	for	knee	arthroscopy	with	a	diagnosis	of	OA	from	November	2014	to	December	2014.		Again,	an	“opt-in”	approach	was	used	with	purposive	sampling.		Although	these	patients	were	not	actively	considering	a	knee	replacement,	they	had	significant	OA	of	the	knee	such	that	they	were	being	seen	in	secondary	care.		Therefore	they	were	felt	to	be	an	appropriate	group	to	target.				
3.3.7 Analysis	Thematic	analysis	was	used	to	analyse	the	data:	this	term	has	been	used	in	many	different	situations	to	describe	different	approaches	to	qualitative	data	analysis.83	For	the	purposes	of	this	research	project,	with	the	authors	coming	from	a	predominantly	realist	perspective,	this	involved	an	inductive	(bottom	up)	thematic	analysis	with	a	predominantly	semantic	development	of	themes.79,83	This	process	took	place	within	the	bounds	of	the	theoretical	framework	of	deliberation/decision-making	previously	discussed.		I	conducted	the	analysis	with	input	from	Mrs	Scott.		Mrs	Scott	has	no	specific	training	in	the	analysis	of	qualitative	data,	but	her	role	in	providing	a	member	of	the	public’s	opinion	was	invaluable.			Focus	groups	and	interviews	were	recorded	with	a	digital	tape	recorded	and	transcribed	and	data	were	organized	with	the	help	of	computer	software.84	One	participant	of	an	interview	declined	to	have	the	conversation	recorded;	therefore	the	interviewer’s	notes	were	used	for	analysis.		At	the	start	of	focus	groups	all	patients	gave	their	names	to	aid	identification	between	participants	when	listening	to	the	recording.			Each	member	of	the	team	contributed	to	the	development	of	a	coding	framework.	This	coding	framework	was	informed	by	regular	meeting	of	the	research	team.		The	process	
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of	searching	for	themes,	reviewing	themes,	and	defining	and	naming	themes	was	conducted	in	line	with	recommendations	of	Braun	and	Clarke.83	Analysis	and	data	collection	continued	simultaneously.		This	iterative	approach	to	data	collection	and	analysis	allowed	the	full	exploration	of	emerging	themes.		Data	collection	stopped	when	no	new	themes	were	emerging	from	the	data	collected.		When	necessary,	transcripts	that	had	already	been	coded	were	revisited	when	a	modification	of	the	coding	framework	and	themes	took	place.				Dr	Realpe	cross-referenced	10%	of	the	interview	data	to	test	the	validity	and	reliability	of	the	coding	data.		Reliability	statistics	(percentage	agreement	and	Cohen’s	Kappa)	were	calculated	by	software	available	online.85	Instances	of	one	coder	using	multiple	references	when	the	other	coder	had	included	one	larger	reference	were	resolved	by	using	the	main	coding	topic	for	each	coder	and	including	it	as	one	variable.				Various	methods	were	used	to	improve	trustworthiness.		Credibility	has	been	addressed	by	triangulation	of	decision-making	stage	and	member	checking	(member	checking	refers	to	participants	of	the	study	reviewing	both	their	transcripts	and	concepts	that	had	been	derived	from	them).86	Additionally,	the	research	team	felt	that	the	participants	were	very	open,	especially	within	the	focus	groups.		Although	focus	group	setting	may	be	considered	harder	to	gain	an	inclusive	and	open	dialogue	due	to	group	dynamics,79	we	found	frank	and	open	discourse	with	an	abundance	of	personal	and	sensitive	information	disclosed.		This	was	undoubtedly	helped	by	the	involvement	of	Mrs	Scott,	a	member	of	the	public	and	advisor	on	the	study.			I	have	provided	a	thick	description	of	the	setting,	situation,	times,	and	people	to	address	issues	of	transferability;	however,	a	caveat	exists	in	that	all	participants	in	our	study	were	engaged	with	secondary	care.		Dependability	is	closely	tied	to	credibility,	and	the	use	of	
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“overlapping	methods”	of	focus	groups	and	interviews	combined	with	detailed	description	of	the	study	process	has	helped	to	address	this.86			
3.4 Results	
3.4.1 Patient	numbers	and	demographics	Six	patients	took	part	in	two	focus	groups	(12	patients	total).		This	represents	a	12%	response	rate	to	the	“opt	in”	letters.		Demographic	details	for	both	groups	can	be	found	in	Table	5.	
	
Table	5:	Demographics	of	included	patients	in	focus	groups	
Patient	 Gender	 Age	 Ethnicity	 Sociodemographic	
class	(decile)	
1	 M	 72	 White	British	 17882	(5)	
2	 F	 76	 White	British	 20924	(6)	
3	 M	 71	 White	British	 22203	(6)	
4	 F	 68	 Indian	 21358	(6)	
5	 F	 71	 White	British	 18732	(5)	
6	 F	 67	 White	British	 26766	(8)	
7	 M	 76	 White	British	 12697	(3)	
8	 M	 72	 White	British	 13458	(4)	
9	 F	 57	 White	British	 16472	(5)	
10	 F	 77	 White	British	 182	(1)	
11	 M	 72	 White	British	 22835	(7)	
12	 F	 82	 White	British	 18702	(5)	
Using	the	Index	of	Multiple	Deprivation	2010	ranks	for	Lower	lay	Super	Output	Areas	(LSOA)	
(1=most	deprived,	32,482=least	deprived).		Decile	–	data	ranked	from	1	(highest	level	of	
deprivation)	to	10	(lowest	level	of	deprivation)	by	dividing	into	10	equal	groups.			
		Eleven	patients	taking	part	in	a	cohort	study	developing	an	outcome	prediction	tool	for	patients	considering	a	knee	replacement	were	approached,82	with	six	agreeing	to	take	part	(decision-making	phase;	55%).		Eighteen	patients	either	waiting	for	or	having	received	a	knee	arthroscopy	were	approached	for	the	deliberation	phase	interviews,	with	four	taking	part	(20%).			
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	Table	6	demonstrates	the	demographic	breakdown	of	patients	involved	in	interviews.	Only	5%	of	patients	identified	for	interviews	were	of	Asian	origin,	which	does	not	reflect	the	population	that	UHCW	serves	(12-13%	Asian	origin).80		
Table	6:	Demographics	of	participants	in	interviews	
Patient	 Stage	of	
decision-
making*	
Gender	 Age	 Ethnicity	 Sociodemographic	
class**	(by	decile)	
1	 Post	(waiting	list)	 F	 68	 White	British	 31755	(9)	
2	 Post	(waiting	list)	 M	 64	 White	British		 18479	(5)	
3	 Post	(waiting	list)	 M	 68	 White	British		 32096	(9)	
4	 Post	(waiting	list)	 M	 78	 White	British		 30195	(9)	
5	 Post	(waiting	list)	 F	 52	 White	Other	 26469	(8)	
6	 Post	(waiting	list)	 M	 63	 White	British		 24905	(7)	
7	 Pre	 M	 73	 White	British	 22006	(7)	
8	 Pre	 F	 70	 White	British	 22552	(7)	
9	 Pre	 M	 51	 Asian	 11032	(3)	
10	 Pre	 M	 53	 White	British	 2030	(1)	
*Stage	of	decision	making	refers	to	deliberation	(Pre)	or	Decision-making	(Post).	*Using	the	Index	
of	Multiple	Deprivation	2010	ranks	for	Lower	lay	Super	Output	Areas	(LSOA)	(1=most	deprived,	
32,482=least	deprived).				
3.4.2 Reliability	Percentage	agreement	of	coding	into	the	major	themes	was	77%,	with	Cohen’s	Kappa	0.72.		This	represents	a	“satisfactory”	level	of	agreement,	using	both	a	liberal	and	conservative	measure	of	reliability.85				
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3.4.3 Theoretical	model	As	previously	discussed	I	used	a	theoretical	model	of	decision-making	to	inform	the	study	–	that	of	deliberation	and	decision-making.		The	original	paper	by	Elwyn	et	al.	does	not	make	clear	the	boundary	between	these	two	stages,	although	“integrating	deliberation	inputs”	to	make	a	choice	is	part	of	this.		Within	this	study,	I	found	a	decision-making	threshold	marked	the	boundary	between	these	two	stages.		This	threshold,	describing	the	point	at	which	coping	with	the	status	quo	is	no	longer	acceptable,	has	been	described	in	the	literature	previously,76,77	and	was	recognised	by	patients	in	both	the	deliberation	and	decision-making	phases.		Indeed	it	was	universal	in	our	study:		“It’s	like	little	nails	going	in	the	coffin…there	are	lots	and	lots	of	different	things	but	they	don’t	go	away,	they	just	build	up	on	you.	(Interview	6)			“But	yes,	once	I’ve	made	the	decision	and	I	say,	yeah	I	can’t	cope,	my	quality	of	life	is	really	going	down	the	pan...“	(Interview	8)			“No,	I	think	weighing	up	the	pros	and	cons	and	if	you’re	in	a	lot	of	pain	I	think	you	just	go	for	it.”	(Focus	Group	2)		“But still if your pain’s bad enough, and you can’t get about, you’ve got to have it done, and that’s the 
top and bottom of it, isn’t it?” (Focus Group 1) 	Factors	that	affect	the	deliberation	process	alter	the	point	at	which	the	threshold	is	reached	–	the	so-called	“moving	target”	referred	to	by	Dosanjh.77	This	is	key,	as	it	indicates	that	the	boundary	between	the	deliberation	and	decision	making	stages	is	the	decision-making	threshold.		Therefore,	for	the	purposes	of	this	chapter,	I	will	discuss	the	factors	that	affect	the	deliberation	process,	and	therefore	the	threshold	to	decision-
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making.		These	factors,	when	causing	a	negative	impact	on	a	patient’s	life,	are	like	“little	nails	going	into	the	coffin”,	bringing	the	person	closer	to	deciding	to	have	an	operation.				Patients	that	were	either	at	the	deliberation	or	decision-making	part	of	the	theoretical	model	were	compared	to	assess	if	there	were	differences	in	the	important	factors.		No	apparent	differences	were	found	across	the	range	of	themes	identified	in	this	study:	therefore	they	are	presented	combined.		Additionally,	member	checking	did	not	alter	the	final	results	of	the	study.			
	
3.4.4 Factors	affecting	decision-making	Nine	themes	emerged	from	the	data	that	influenced	the	deliberation	process.		These	were:			- Stress	from	deliberation		- Expectation	of	outcome	- Preferred	model	of	care	- Sources	of	information	- Personal	situation	- Mental	state	- Coping	strategies	- Loss	of	control	- Trust	in	doctor			Each	theme	is	explored	in	turn.						
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Stress	from	deliberation	Patients	reported	that	there	is	a	large	degree	of	stress	associated	with	the	deliberation	process:		"	It	is	stressful	actually…	It	is	difficult	to	make	a	decision."	(Interview	9)		“it	is	a	daunting	thought	and	I	can	understand	why	a	lot	of	elderly	people	that	have	never	had	an	operation,	never	been	in	hospital,	how	difficult	it	must	be”	(Focus	Group	2)		“It	is	an	anxious	time.”	(Focus	Group	1)			And	this	stress	is	something	that	is	constantly	there:		“at the moment it’s there and it’s hanging over you, and you know it’s there and it’ll kind of rear its 
little nasty head every now and again as well, because you know it’s there,”	(Interview	8)		However,	there	is	a	release	of	that	stress	once	the	decision	is	made:		“It	can	take	a	burden	off	you.”	(Interview	7)		“It	was	a	relief	that	I	could	see	there	was	a	way	forward	of	ending	the	pain…”	(Interview	1)		“Once	I’ve	made	the	decision	I	will	be	fine.”	(Focus	Group	1)		“it	is	like	a	weight’s	lifted	off	your	shoulder,	I	knew	that	that	I	needed	an	operation.”	(Interview	6)				
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This	idea	has	wide	ranging	implications	for	the	decision-making	process	when	considered	alongside	the	decision-making	threshold	because	it	would	suggest	that	once	that	threshold	is	reached,	it	is	unlikely	that	patients	will	move	back	into	the	deliberation	phase.		However,	any	unwillingness	of	people	to	revisit	a	decision	could	also	represent	hindsight	bias	(i.e.	people	tend	to	justify	their	decisions	when	they	think	they	made	the	right	choice).		Based	on	these	finding	is	not	possible	to	state	which	one	is	dominant,	but	one	interviewee’s	comments	suggested	that	justification	based	on	thinking	she	made	the	correct	decision	was	not	present:		"Although	you’ve	made	a	decision	there	is	still	a	worry	in	your	mind.	Not	sure	if	it	is	a	good	decision	or	a	bad	decision."	(Interview	9)		People	with	depression	are	more	likely	to	ruminate	over	decisions	than	non-depressed	people.87	Therefore,	although	relevant	throughout	our	sample	of	patients,	this	may	have	a	larger	effect	on	patients	that	have	depressive	symptoms.				
Expectation	of	Outcome	Expectation	of	outcome	relates	to	expectations	both	if	treated	with	a	knee	replacement	and	if	not	treated.		Most	people	considered	their	knee	would	get	worse	if	not	treated:		“It	was	a	worry	if	I	didn’t	get	it	done	that	it	was	only	going	to	get	worse.”	(Interview	4)		“And	that	is	why	I	thought	oh	I	had	better	have	it	done	quick	I	am	going	to	be	a	cripple	type	of	thing.”	(Interview	1)		And	they	also	considered	their	knee	would	improve	if	treated:		“It	can’t	be	as	bad	as	the	pains	you	were	going	through	before	you	had	it.”	(Focus	Group	2)	
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	“I	know	you	would	never	get	back	to	100%	but	I	would	expect	at	least	an	80%	improvement	after	a	knee	operation.”	(Focus	Group	1)		However,	some	participants	demonstrated	unrealistic	expectations:		“I	am	going	to	be	grand	and	I	can	go	back	and	do	what	I	used	to	do	i.e.	gardening,	golf,	(inaudible	00:27:32)	running,	jogging,	walking	and	everything	to	a	better	standard	than	what	I	have	at	the	moment.”	(Interview	10)		Expectations	of	outcome	were	therefore	fairly	consistent	in	that	patients	felt	they	would	get	worse	if	not	treated,	and	better	if	treated.		However,	differences	were	based	on	the	degree	of	change	in	their	health	status.		It	is	unclear	from	this	study	if	these	expectations	can	be	managed	(with	a	potential	effect	on	post-operative	satisfaction).88		
Sources	of	information	This	theme	is	intimately	linked	to	expectation	of	outcome,	as	it	is	the	information	received	that	shapes	expectation.		It	also	forms	two	parts;	the	first	is	the	sources	of	information;	the	second	the	amount	of	information.		Patients	used	a	variety	of	sources	of	information.		All	participants	had	discussed	outcome	with	friends	and	family,	particularly	with	people	who	had	previously	had	a	knee	replacement.		A	common	perception	was	that	this	was	the	most	valued	source	of	information:		“I	saw	the	GP,	consultant,	but	the	one	who	knows	most	is	the	one	who	is	going	through	it.”	(Interview	7)		
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“talking	to	various	people	that	had	had	it	done,	they	said	‘oh	you	ought	to	have	it	done’	old	rugby	mates	of	mine	who	had	had	hip	replacements	and	knees	and	everything	else,	they	reckoned	it	worked	very	well.”	(Interview	2)		“You	learn	a	lot	more	in	the	waiting	room,	because	they	have	all	gone	through	different	procedures	on	their	bodies.	A	doctor	can	go	through	what	they	can	do	for	you	and	you	can	go	through	that	procedure	but	then	you	hear	more	in	the	waiting	room	because	they	have	had	it	done.”	(Interview	7)		“You	can	see	things	on	the	Internet	and	read	things	but	when	you	actually	speak	to	somebody	who’s	done	it	and	she’s	got	no	reason	to	lie.	She’s	not	trying	to	promote	it	for	any	reason.”	(Interview	10)		“I	did	it	for	reassurance,	hoping	that	they	would	say	yes,	it	was	a	great	success,	and	I	feel	fantastic.”	(Focus	Group	1)		These	last	two	quotes	are	particularly	interesting,	as	it	suggests	some	people	are	only	looking	for	reassurance,	not	new	information.		It	also	suggests	a	level	of	distrust	of	the	medical	profession,	potentially	“trying	to	promote”	an	operation.		This	is	intimately	linked	to	the	theme	“Trust	in	doctor”.		However,	the	preference	for	information	from	friends	and	family,	although	prevalent,	was	by	no	means	ubiquitous.			“I	would	just	speak	to	the	surgeon.”	(Interview	8)		“Being	able	to	talk	to	your	surgeon…	can	give	you	an	idea	of	what	you	should	expect.”	(Interview	8)		“Yeah	I	looked	it	up	on	the	Internet	and	things	like	that… I even watched the operation.”	(Interview	3) 
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	However,	some	people	preferred	not	to	use	the	Internet	and	medical	professionals:		“I	just	wouldn’t	bother	actually	because	it	wouldn’t	even	pass	my	mind	to	look	for	any	medical	advice	or	anything	on	the	Internet.”	(Interview	10)		“I	don’t	really	talk	very	much	to	the	GP…”	(Interview	1)		Additionally,	people	wanted	to	know	different	amounts	of	information:22,47-49		“I	didn’t	want	any	pre-information	because	I	was	too	squeamish.”	(Focus	group	1)		“But	if	I	had	anything,	even	if	it	was	the	worst	scenario,	I’d	rather	know,	I’m	better	if	I	know	about	things	and	read	about	it.	Not	that	I	look	and	read	and	think,	oh,	I’ve	got	that,	that	and	that,	but	I	am	better	for,	you	know,	sort	of	knowing	about	things.”	(Focus	Group	1)		Differing	preferences	for	information	is	a	finding	consistent	with	reports	in	the	literature	regarding	other	healthcare	decisions.47,48	Interestingly,	attempts	at	trying	to	predict	the	amount	of	information	patients	may	want	have	been	unsuccessful.49		
Personal	situation	Someone’s	personal	situation	is	individual	to	him	or	her	but	can	have	a	large	effect	on	the	deliberation	phase.		Subthemes	identified	included:	motivation	(for	a	specific	task,	e.g.	walking	further),	or	a	more	generalised	return	to	a	“normal	life”:		“one	of	the	factors	I’ve	considered	is	that	I	am	now,	I	am	proud	to	say,	a	grandfather…“	(Interview	6)			
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“I’ve	got	two	children	abroad	at	the	minute	and	I	need	to	be	able	to	get	there	and	have	a	bit	of	time,	basically.”	(Interview	4)		and	work	and	financial	concerns:			“Because	I	have	cut	my	hours	down	and	it	affects	my	wages	as	well.”	(Interview	7)		“I’m	self-employed	and	the	biggest	thing	is	I’ve	got	to	be	able	to	work.”	(Interview	4)		Two	further	subthemes	deserve	special	mention.		Firstly	social	pressure	was	felt	to	occur,	especially	from	loved	ones.		This	is	intimately	linked	to	feelings	of	inadequacy	or	of	letting	people	down:		“I	said	to	them,	“My	husband	will	go	with	you,	you	go	and	I’ll	stay	at	home.”	So	they	said,	“No,	we	don’t	want	to	go	without	you,”	so	then	of	course	I	felt	bad	that	I’d	let	them	down	and	you’re	not	doing	things	you	would	normally	do	with	your	friends.”	(Interview	5)		“R:	No,	just	pressure	from	–		I:	Pressure?	R:	-	well	let’s	just	say	loved	ones	(laughter).”	(Interview	5)		Secondly,	personal	commitments	occasionally	had	an	overpowering	effect	on	the	process:		“I:	Did	you	worry	about	having	your	knees	done,	because	of	your	home	environment?		R:	It	wasn’t	worrying	for	me	having	my	knee	done,	it	was	worrying	about...		Your	son?	(Focus	group	participant	asking	the	question).			R:	My	son.”		(Focus	Group	1)		
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Mental	state	Broadly	speaking,	this	theme	can	be	divided	into	the	psychological	consequences	of	having	knee	OA,	and	the	psychological	aspects	of	considering	a	knee	replacement.		People	experienced	anxiety,	depression,	lack	of	pleasure,	feelings	of	dread,	feelings	of	inadequacy,	social	withdrawal,	and	frustration	when	suffering	from	knee	OA.				“I	had	about	48	hours	that	I	...	well	I	didn’t	answer	the	phone	for	starters.	I	didn’t	go	out	apart	from	walking	the	dog.”	(Interview	8)		“I	would	say,	yes,	I’ve	had	anxiety,	I’ve	had	depression.”	(Focus	Group	2)		“My	knee	was	so	painful	and	jarring	and	I	had	that	horrible	feeling	inside	where	every	step	you	make	is	it	going	to	be	a	jarring	pain.”	(Interview	3)		“when	it’s	just	my	husband	and	I	alone	at	home,	I	have	cried	every	now	and	then.“	(Interview	1)		However,	some	people	displayed	determination	to	continue,	despite	the	psychological	pressure:		“I	wouldn’t	give	into	it	until	I	absolutely	had	to	give	into	it.”	(Interview	8)		“Okay,	fine,	so	live	with	it,	which	I	did.”	(Interview	1)		When	considering	treatment	options	fear	was	the	main	theme	that	emerged	–	there	were	a	range	of	fears	from	damaging	the	knee	further	from	not	getting	treatment,	through	visiting	the	doctor,	fears	over	the	procedure	and	anaesthetic,	and	fears	over	the	recovery	period	and	outcome.				“It	was	a	worry	if	I	didn’t	get	it	done	that	it	was	only	going	to	get	worse.”	(Interview	2)	
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	“I	went	for	my	pre-op,	and	I	was	really,	really	scared,	and	I	just	said	to	this	woman	who	was	sitting	next	to	me	waiting,	I	said,	“Are	you	scared?”	and	she	said,	“Bloody	hell,	but	I’ve	got	to	get	on	with	it,	haven’t	I?	You	either	want	it	or	you	don’t.”	(Focus	Group	1)		“Oh	yes.	I	think	being	knocked	out	is	the	worry.”	(Interview	9)		“What	worries	me	about	a	knee	replacement	right,	how	long	does	it	last?”	(Interview	7)		
Coping	strategies	Coping	strategies	affected	the	ability	of	people	to	cope	with	their	symptoms,	feeding	into	the	deliberation	process	and	the	decision-making	threshold.		They	can	be	divided	into	physical	and	mental.		Physical	coping	strategies	included	altering	the	work/home	environment,	altering	the	way	things	are	done,	avoidance	of	activities,	getting	help	from	others	and	keeping	moving.				“My	office	is	two	floors	up	so	I	have	to	do	the	stairs…they	brought	my	laptop	down	and	said	work	from	down	here.”	(Interview	5)		“I	tend	to	try	and	walk	as	much	as	I	can	to	ease	the	problem	which	I	find	helps.”	(Interview	10)		“So	I	haven’t	played	golf	for	over	18	months	now	because	of	the	fear	of	aggravating	the	problem.”	(Interview	10)		Mental	coping	strategies	were	more	varied.		However,	a	remarkably	common	theme	emerged	of	stoicism	and	a	positive	mental	attitude.				“It’s	not	too	bad,	I	put	up	with	it.”	(Interview	2)	
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	“But	no,	people	give	in,	they	give	in	to	things	and	if	I	can’t	change	it	I	don’t	worry	about.	There’s	no	point.”	(Interview	8)		When	considered	in	light	of	the	decision-making	threshold,	it	appears	that	people	cope	using	both	the	physical	and	mental	coping	strategies	above;	however,	they	reach	a	point	in	their	personal	lives	and	symptoms	where	their	coping	strategies	are	no	longer	able	to	effectively	manage.			
Loss	of	control	Loss	of	control	can	again	be	divided	into	physical	and	mental.		Physical	loss	of	control	occurred	due	to	knee	problems	in	everyday	life,	and	affected	deliberation	directly:		“One	particular	day	I	got	halfway	round	and	I	just	couldn’t	walk	and	I	hadn’t	had	that	before.	I	felt	quite	scary	about	that,	that	you	know	it	should	come	on	so	quickly.”	(Interview	1)		“Because	I	couldn’t	suddenly	nip	out,	well	normally	if	you	are	nipping	across	the	road,	but	when	you’ve	got	bad	knees,	an	unpredictable	result	you	can’t	do	that	sort	of	thing.”	(Interview	6)		Mental	loss	of	control	was	associated	with	having	an	operation.		There	were	feelings	of	vulnerability	and	reliance	on	others	associated	with	this,	which	affected	the	deliberation	process:			“Well	you	do	lose	control	because	you’re	putting	your	hands	...	you’re	putting	your	body,	your	knees,	in	the	hands	of	another	person	and	you	don’t	have	any	control	over	that	at	all.	You	give	them	your	control	over	your	knees.”	(Interview	8)		Additionally,	it	was	clear	that	the	pathway	of	care	could	make	this	feeling	worse:	
	 69	
	“When	I	had	my	second	one	done	I	was	booked	in,	I	came	here	7	o’clock	in	the	morning,	ten	to	12	I	was	sent	back	home.	I	was	sent	for	again,	arrived	here	at	7	o’clock,	1	o’clock	I	was	sent	back	home.	I	came	in	the	second	time,	the	third	time	and	I	sat	until	1	o’clock	and	I	thought,	“Am	I	going	to	do	that	journey	to	the	theatre,	or	am	I	going	to	phone	my	husband	to	come	and	collect	me?”	but	I	went	to	the	theatre.”	(Focus	Group	2)		Or	it	could	improve	the	feeling:		“You	were	given	the	choice	of	where	you	had	it,	so	that	helped	me.”	(Focus	Group	2)		Closely	related	to	the	idea	that	loss	of	control	and	the	subsequent	feelings	of	vulnerability	could	be	improved	by	the	process	of	care	is	the	trust	that	the	patient	had	in	the	doctor,	which	is	described	in	the	next	section.				
Trust	in	doctor	A	person’s	trust	in	their	doctor	appeared	to	affect	many	other	themes	within	their	deliberation	process.		It	affected	peoples’	mental	state	positively:			“I	knew	that	I	needed	somebody	that	was	really	going	to	do	the	best	for	me	and	I	felt	that	he	was	going	to	do	that.	So	I	walked	out	of	there	in	a	far	better	frame	of	mind	than	I’d	actually	walked	in,”	(Interview	8)		“Oh	yes	you	have	got	to	have	confidence	and	trust	otherwise	you	wouldn’t	do	anything	for	anybody.”	(Interview	5)		and	negatively:		
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“But	he	didn’t	inspire	me	with	a	lot	of	confidence…I	thought	well	for	the	sake	of	five	minutes	it	was	hardly	worth	it	really.”	(Interview	9)		An	aspect	of	trust	in	the	doctor	was	based	on	the	process	of	care.		As	discussed	previously	the	process	of	care	can	harm	the	relationship	between	doctor	and	patient:			“Dr	[T]	said,	“I	will	be	doing	your	operation”	...	And	I	felt	at	ease	with	him	because	quite	frankly	he	went	through	the	procedure,	what	would	be	happening,	where	you	would	be	going.	And	I	thought	I	feel	at	ease	now,	I	feel	good.		And	when	I	saw	another	doctor	this	morning	and	I	thought	I	have	never	seen	him	before.”	(Interview	10)		Another	key	factor	in	the	establishment	of	that	relationship	was	the	patient’s	preferred	consultation	style,	and	the	style	that	they	actually	received.		Originally	this	concept	of	“Preferred	medical	model”	was	coded	together	with	“Trust	in	doctor”;	however,	during	the	process	of	reviewing	themes	they	were	included	in	the	final	model	as	two	distinct	themes.				
Preferred	medical	model	There	was	a	clear	dichotomy	of	experiences	and	views	of	patients	as	to	which	model	of	care	they	had	experienced	and	preferred.		Some	patients	had	experienced	informed	or	shared	decision-making	interactions,	where	they	were	asked	to	make	the	decision.		This	lead	to	a	variety	of	reactions,	including	it	being	received	well	and	the	belief	that	it	was	the	appropriate	way	to	conduct	the	interaction:		“I	don’t	think	anybody	can	actually	tell	you,	they	can	advise	you	to	do	it,	but	at	the	end	of	the	day	it’s	up	to	you.”	(Focus	Group	2)		
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“I	think	it	is	going	to	be	more	or	less	50/50.	I	think	he	is	advising	you	for	the	best	thing	and	you	are	going	to	turn	around	and	say	‘well	I	don’t	feel	as	though	I	want	to	do	it	or	not’.”	(Focus	Group	1)		However,	this	model	also	led	to	anxiety.		This	next	quote	is	particularly	relevant,	as	the	lady	had	already	had	one	knee	operated	on,	and	was	on	the	waiting	list	for	the	next.		She	described	the	consultation	for	her	first	operation	as	paternalistic	(which	she	thought	of	as	a	“relief”),	and	the	second	as	being	given	the	options	and	asked	to	choose	(informed	decision-making):		“I	was	just	thinking	well	hang	on	a	second	you	know	and	I	was	almost	not	believing	myself	in	it	actually	needing	doing…	I	was	feeling	that	I	wasn’t	...	I	didn’t	have	the	right	criteria	or	enough	of	the	right	criteria	to	actually	have	a	knee	op.	That	was	the	thing.	Then	it	started	making	me	think	well	maybe	I’m	not.”	(Interview	1)		She	was	so	concerned	about	the	indication	for	her	second	operation	she	wanted	reassurance	from	the	interviewers	that	it	was	indicated	–	this	was	three	months	after	the	consultation,	and	demonstrates	the	level	of	anxiety	that	can	be	provoked	by	this	model.				Also,	asking	the	patient	to	decide	can	be	seen	as	an	avoidance	of	responsibility:		“Yes,	because	I	think	if	they’re	going	to	throw	a	load	of	options	at	you	and	then	they’re	throwing	the	ball	back	in	your	court,	haven’t	they,	and	you	make	the	decision,	how	do	you	want	us	to	do	it?”	(Interview	6)		
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The	picture	for	paternalistic	care	was	also	mixed,	although	the	volume	of	responses	that	described	paternalistic	care	being	well	received	far	outweighed	the	number	of	responses	supporting	shared	or	informed	decision-making	(29	and	9	respectively).				“R:	His	comment	was,	“Yes	it	needs	doing.”	So	I	go	along	with	it.	I:	How	did	you	feel	about	that?		R:	I	thought	yes	thank	God	for	that.”	(Interview	4)		However,	it	is	not	clear	if	this	is	because	people	have	made	their	decision	before	meeting	the	orthopaedic	surgeon	(they	have	reached	their	threshold	of	coping)	and	therefore	are	happy	with	this	process	when	it	occurs:	one	comment	demonstrates	that	this	has	a	part	to	play:		“You’d	have	to	have	more	information	to	be	able	to	talk	to	your	consultant	and	convince	him	that	your	operation	is	totally	necessary.”	(Focus	Group	2)			Despite	this	ambiguity,	it	is	clear	that	in	these	patients	a	paternalistic	interaction	leads	to	a	relief	(perhaps	related	to	trust	in	the	doctor,	the	stress	from	deliberation,	and	the	decision-making	threshold),	and	increased	confidence.		Supporting	this	was	the	belief	that	the	doctor,	due	to	his	or	her	expertise,	should	be	the	one	to	decide:		“You	as	an	individual	might	make	the	wrong	one	whereas	he	is	the	professional	and	he	knows	best	with	the	problem	that	I	have	got.”	(Interview	10)		“It	was	a	relief	that	I	could	see	there	was	a	way	forward	of	ending	the	pain	and	also	that	he	was	so	confident	that	that’s	what	needed	to	be	done.”	(Interview	1)		This	contrasts	quite	starkly	with	the	pre-operative	information	theme,	where	information	from	friends	and	family	was	generally	considered	of	more	merit.		This	
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demarcates	two	important	issues	between	these	themes	–	the	patients’	desire	and	actions	to	receive	information,	and	the	patients	desire	to	be	involved	in	the	decision-making	process.		Although	it	could	be	expected	that	both	would	co-exist,	that	is	not	the	case	within	our	sample.		This	finding	is	consistent	with	other	literature	on	information	about	a	decision,	and	the	decision-making	process	itself.47,48				However,	there	were	instances	of	the	paternalistic	model	not	being	well	received,	again	consistent	with	the	finding	of	different	patients	preferring	different	styles.48:		“Right,	so	you	don’t	even	get	to	the	decision-making	process,	it’s	not	up	to	you,	it’s	somebody	else.”	(Focus	Group	2)	
	Previous	studies	have	demonstrated	that	younger	patients	have	more	desire	to	be	involved	in	medical	decision,	but	our	data	did	not	support	this.47	This	could	be	due	to	a	small	sample	size.				Overall	we	saw	a	preference	for	the	paternalistic	model	of	health	care,	however	there	were	contrasting	beliefs	of	what	approach	was	best,	and	of	how	best	to	approach	decision-making.				
3.4.5 Proposed	model	of	decision-making	The	universal	finding	of	the	“decision-making	threshold”,	combined	with	the	stress	that	the	deliberation	process	places	on	an	individual,	led	to	the	development	of	a	model	of	decision-making	(Figure	4).	Central	to	this	model	is	the	idea	that	once	a	person	has	passed	the	decision-making	threshold	and	made	their	decision	they	are	not	likely	to	pass	back	into	a	deliberation	phase.		This	is	likely	to	act	in	concert	with	the	hindsight	bias,	and	the	magnitude	of	each	effect	is	not	clear	from	this	work;	however,	the	
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implications	for	the	provision	of	information	and	the	management	of	expectations	are	significant.			
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Figure	4:	Decision-making	model	
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3.5 	Discussion	
	This	study	has	demonstrated	that	during	the	deliberation	phase	of	decision-making	for	knee	replacements	nine	key	factors	play	into	the	decision-making	process:	stress	of	deliberation,	expectation	of	outcome,	sources	of	information,	personal	situation,	mental	state,	coping	strategies,	loss	of	control,	trust	in	doctor,	and	preferred	model	of	care.		This	then	leads	to	the	decision	phase.		The	decision-making	threshold	marks	the	boundary	between	deliberation	and	decision.		Interestingly,	the	factors	that	play	into	decision-making	are	consistent	across	decision-making	stages.			The	strengths	of	this	study	include:	its	focus	on	one	area	of	decision-making,	namely	preference	based	decision-making	in	total	knee	replacement;	the	inclusion	of	people	at	various	stages	of	the	decision-making	process;	the	broad	based	research	team,	including	a	member	of	the	public	who	was	involved	at	all	stages;	the	inclusion	of	a	range	of	ages,	genders,	and	ethnicities	within	the	study;	the	comprehensive	analysis;	and	thoughtful	efforts	to	demonstrate	the	trustworthiness	of	the	study.				Weaknesses	of	this	study	include	it	being	run	over	two	sites.		Although	these	sites	cover	a	population	with	a	wide	rage	of	sociodemographic	characteristics,	the	range	of	ethnicities	that	were	present	within	the	study	population	was	limited.	This	likely	reflects	to	some	degree	the	population	the	study	was	based	in,	but	also	reflects	utilisation	rates	of	orthopaedic	services.		Medical	coding	data	was	used	to	identify	some	patients	and	this	demonstrated	the	proportions	of	ethnicities	were	not	reflective	of	the	population	as	a	whole.		Utilisation	of	healthcare	has	been	found	in	previous	studies	to	alter	by	race.37,38	To	
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counteract	this,	the	research	team	went	to	extensive	lengths	to	ensure	as	much	diversity	as	it	could,	and	the	study	population	roughly	reflects	the	population	demographics	of	the	patients	presenting	to	secondary	care	with	knee	OA.		However,	it	is	likely	that	the	ethnic	minority	participants	in	the	study	are	systematically	different	to	those	that	underutilise	healthcare.		Compounding	this	is	that	the	use	of	an	“opt	in”	procedure	to	recruit	participants	inevitably	leads	to	selection	bias.			I	have	compared	answers	from	patients	across	different	methods	of	data	collection	(focus	groups	and	interviews).		This	may	result	in	differences	being	apparent	due	to	the	collection	method,	for	example	people	in	the	focus	groups	not	feeling	able	to	speak	up,	or	providing	a	more	ubiquitous	point	of	view.79	Given	the	diversity	of	opinion	and	the	personal	nature	of	some	of	the	information	disclosed	in	the	focus	groups	I	do	not	think	this	was	a	particular	issue.		However,	some	differences	may	persist.		Additionally,	different	methods	were	used	in	conducting	the	interviews,	including	being	conducted	on	the	telephone,	in	the	patient’s	home,	or	at	UHCW.		This	could	have	altered	the	discourse,	but	we	felt	this	was	unlikely	and,	by	making	entry	into	the	study	more	convenient,	will	have	addressed	some	aspects	of	selection	bias.				Reliability	statistics	for	the	coding	framework	were	satisfactory.		I	am	confident	higher	reliability	statistics	would	have	been	achieved	if	not	for	an	oddity	in	the	coding	framework	that	allowed	the	same	reference	to	be	coded	in	two	different	places	(i.e.	“motivation”	and	“mental	state”).		Altering	this	would	have	improved	the	apparent	reliability	of	the	coding.		However,	I	felt	they	were	important	concepts	to	separate,	and	did	not	feel	it	altered	the	conclusions	of	the	work.		This	example	highlights	the	complex	interplay	of	all	nine	factors	across	the	deliberation	phase,	and	acts	as	a	caveat	for	considering	any	one	in	isolation.			
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	A	further	weakness	is	the	power	differential	generated	by	the	interviewer	being	an	orthopaedic	surgeon	in	training.		This	may	have	resulted	in	more	guarded	responses.		However,	this	effect	may	have	been	reduced	by	the	presence	of	a	member	of	the	public	for	most	interactions.46		The	themes	identified	in	this	study	are	consistent	with	themes	identified	in	other	studies	across	a	range	of	ethnicities,	countries,	settings,	and	decision-making	stages.67-69	In	contrast	to	other	investigations,	this	study	is	the	first	to	include	patients	at	all	stages	of	the	decision-making	process,	which	has	allowed	the	triangulation	of	our	results,	and	a	more	reliable	account	of	the	deliberation	process.		This	has	particular	relevance	when	considering	the	threshold	to	decision-making,	as	I	was	able	to	examine	it	from	both	sides	of	the	equation.		Additionally,	only	two	other	studies	have	examined	decision-making	in	the	U.K.,	both	using	a	population	consisting	solely	of	knee	replacement	patients.71,72	These	studies	included	only	patients	on	the	waiting	list	(i.e.	past	the	deliberation	phase)	and	are	therefore	subject	to	limitations	of	retrospective	studies.		This	study	confirms	their	findings,	but	also	improves	their	trustworthiness	and	transferability	by	including	a	wider	population	base.				Only	three	studies	have	included	only	knee	replacement	patients	in	the	deliberation	phase.67-69	All	these	studies	took	place	in	the	USA.		One	study	only	interviewed	Black	Americans,	and	therefore	has	limited	transferability.67	Another	only	focused	on	the	concerns	of	patients,	and	not	the	wider	decision-making	process.69	The	third	used	focus	groups	to	discuss	decision-making	with	patients	who	had	a	diagnosis	of	OA	knee	in	primary	care.68	This	study	demonstrated	similar	themes	but	the	use	of	focus	groups,	which	
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may	not	gain	sufficient	depth	of	understanding	of	issues,	combined	with	the	use	of	a	single	outpatient	institution	and	a	small	sample	size	encourage	the	authors	to	warn	that	“It	is	not	possible	to	assume	that	the	decision-making	factors	identified	by	the	patients	in	this	study	can	be	generalized	to	the	population	of	patients	with	OA	who	are	considering	TKA		[Total	Knee	Arthroplasty]	at	large.”	68	
Previous	literature	has	described	a	threshold	to	decision-making	in	investigations	into	decision-making	in	knee	and	hip	replacements76and	in	hip	replacements.77	I	have	taken	this	work	further,	by	demonstrating	this	threshold	as	the	boundary	between	deliberation	and	decision-making,	and	establishing	that	there	is	a	different	level	of	stress	at	these	different	stages.		This	had	particular	relevance	when	considering	the	inclusion	of	participants	at	different	stages	of	the	decision-making	process	within	this	study.		All	participants	in	our	study	demonstrated	a	threshold	to	decision-making.		This	is	the	first	study	that	has	demonstrated	this	finding	in	patients’	at	different	stages	of	the	decision-making	process	in	knee	replacements.		Understanding	this	threshold,	and	the	nine	factors	that	influence	it,	has	implications	not	only	in	routine	clinical	practice	to	facilitate	patient-centred	care,	but	also	in	the	development	of	interventions	aimed	at	supporting	decision-making,	or	facilitating	information	giving.			When	combined	with	the	finding	that	the	deliberation	process	was	stressful	(a	universal	finding	in	our	study	across	all	stages	of	decision-making),	these	finding	suggest	that	patients	are	less	likely	to	move	back	(from	decision-making	to	deliberation)	once	the	threshold	has	been	reached	(and	they	have	moved	from	deliberation	to	decision-making).		This	relationship	has	been	demonstrated	in	Figure	4.		Furthermore,	the	model	of	care	that	patients	wanted	varied,	although	there	was	a	preference	for	a	paternalistic	interaction	among	those	in	our	study.		This	is	an	interesting	
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finding	as	it	is	contrary	to	current	political	movements	within	the	NHS.46	Given	the	sample	size,	I	would	recommend	further	validation	of	this	finding	in	different	populations,	and	investigation	into	other	pathologies	and	interventions.				One	of	the	over	arching	findings	from	his	study	was	the	complex	interplay	between	all	of	the	themes.		It	appears	that	all	the	factors	identified	work	together	to	shape	a	person’s	decision,	with	different	factors	having	different	importance	to	different	people.		There	was	one	instance	of	a	patient	with	one	overriding	theme,	which	dominated	all	others	(her	personal	situation	dominating	her	thoughts	on	a	knee	replacement	due	to	caring	commitments).		However,	this	patient	finally	decided	to	have	a	knee	replacement,	again	using	a	complex	interplay	of	factors.					
3.6 	Conclusion	
	The	themes	identified	here	interacted	comprehensively	with	one	and	other,	the	result	being	a	complex	interplay	of	factors	that	affect	the	deliberation	process,	the	threshold	to	decision-making,	and	the	ultimate	decision.		An	awareness	of	the	deliberation	phase,	the	factors	that	influence	it,	the	stress	associated	with	it,	preferred	models	of	care,	and	the	influence	of	the	decision-making	threshold	will	aid	useful	communication	between	doctors	and	patients.		Future	work,	examining	how	this	information	might	be	best	translated	and	utilised	in	the	clinical	environment	is	an	exciting	avenue.		This	is	one	of	the	key	elements	in	addressing	
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the	three	crucial	areas	set	out	in	the	introduction;	differences	in	utilisation	rates,31	a	high	dissatisfaction	rate,25		and	increasing	demands	with	financial	constraints.27	One	aspect	of	this	is	understanding	how	outcome	prediction	would	affect	the	decision-making	process	for	patients,	what	information	they	would	like,	and	when	in	the	pathway	it	would	be	of	most	use.		The	next	chapter	deals	with	these	questions.		
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Chapter	4.	How	outcome	prediction	could	affect	patient	
decision-making	in	knee	replacements:	a	qualitative	
study.					
	
This	chapter	uses	focus	groups	and	interviews	to	examine	what	sort	of	information	patients	
would	want	from	an	outcome	prediction	tool,	how	it	could	affect	their	decision-making	
process,	and	at	what	part	of	the	pathway	such	a	tool	should	be	used.		The	results	demonstrate	
that	an	outcome	prediction	tool	would	have	most	effect	targeted	towards	people	at	the	start	
of	their	treatment	pathway,	with	a	“bottom	line”	prediction	of	outcome.		However,	any	effect	
of	a	poor	outcome	prediction	on	expectation	and	decision-making	is	likely	to	be	blunted	by	
the	optimism	bias.				
4.1 	Declarations	
	
Aspects	of	this	chapter	have	been	submitted	for	publication:	
T.	Barlow,	P.	Scott,	D.	Griffin,	A.	Realpe.		How	outcome	prediction	could	affect	patient	decision-making	in	knee	replacements:	a	qualitative	study.		Submitted	to	BMC	Musculoskeletal	disorders	February	2016						
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Aspects	of	this	chapter	have	been	presented	at	an	international	conference:	
T.	Barlow,	P.	Scott,	D.	Griffin,	A.	Realpe.		How	does	outcome	prediction	in	knee	replacements	affect	patient	decision-making?	23rd	annual	meeting	of	the	European	Orthopaedic	Research	Society.				This	study	was	approved	by	the	Dyfed	Powys	Research	Ethics	Committee	(13/WA/0140).				Dr	A.	Realpe	provided	independent	cross	checking	of	thematic	framework.		Mrs	P	Scott	facilitated	in	focus	groups,	interviews,	and	analysis	of	qualitative	data.		An	external	company	conducted	transcription	of	focus	groups	and	interviews.			
	
	
4.2 	Introduction	
	Many	previous	studies	have	attempted	to	identify	predictors	of	outcome,	examining	various	factors	including	surgical	factors	and	patient	factors.22,89-94	These	studies	will	be	discussed	in	detail	in	the	next	chapter;	however,	to	date,	none	have	been	successful	in	developing	a	tool	that	can	usefully	predict	outcome.		There	are	currently	several	investigations	into	the	development	of	such	a	tool,22,95		including	the	investigation	towards	developing	a	prognostic	model	described	in	chapters	5	and	6.82			Alongside	this	quantitative	research,	research	into	understanding	what	factors	are	important	in	patients’	decision-making	has	gained	momentum.		Multiple	studies	across	
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multiple	countries	have	demonstrated	a	remarkable	consistency	in	important	factors	that	influence	patients’	decision-making,	as	discussed	in	chapter	2	and	3.			A	key	concept,	and	relevant	to	outcome	prediction,	is	that	of	the	deliberation/decision-making	model	proposed	by	Elwyn.75	This	splits	decision-making	into	a	deliberation	phase,	and	a	decision-making	phase.		Additional	studies	have	demonstrated	a	“decision-making	threshold”	–	a	moving	target	of	the	point	at	which	a	patient	changes	from	deliberating	the	decision	to	making	the	decision,	usually	the	point	at	which	coping	with	the	status	quo	is	no	longer	acceptable.76,77	The	previous	chapter	reported	the	findings	from	a	qualitative	study,	where	a	novel	decision-making	model	was	presented	that	is	consistent	with	these	previous	studies.				However,	what	is	unclear,	and	has	never	been	studied	before,	is	how	an	outcome	prediction	tool	would	affect	patients’	decision-making.		Therefore	our	aim	was	to	explore	how	a	(fictitious)	outcome	prediction	tool	could	affect	patients’	decision-making.				
4.3 	Methods	
	This	study	occurred	in	parallel	with	the	investigation	into	patient	decision-making	presented	in	chapter	3,	using	the	same	research	team	(with	identical	contributions).				Two	stages	were	performed:	the	first	used	focus	groups	to	generate	a	range	of	patient	views;	the	second	used	in-depth	interviews	to	explore	those	views	to	a	depth	difficult	to	achieve	with	focus	groups	alone.79	Focus	groups	took	place	with	patients	who	had	already	had	a	knee	replacement,	and	interviews	took	place	with	patients	who	were	either	waiting	for	a	knee	replacement,	or	considering	having	one.		Examining	these	three	points	in	the	patient	
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pathway	allowed	us	to	include	the	two	stages	of	the	decision-making	process	proposed	by	Elwyn,	namely	deliberation	and	decision-making.75		
4.3.1 Conduct	of	focus	groups/interviews	The	usefulness	of	information	an	outcome	prediction	tool	may	be	able	to	provide	was	tested	with	all	participants	via	the	use	of	a	fictitious	report	containing	information	that	an	outcome	prediction	tool	may	contain.		There	were	multiple	versions	of	this	report,	which	evolved	based	on	patient	feedback	and	used	different	styles	of	presentation.		These	reports	varied	from	“bad”	to	“good”	outcomes,	with	improvements	ranging	from	5-20	on	the	Oxford	Knee	Score.		Key	aspects	included	a	summary	of	predicted	pain	post-operatively	and	a	summary	of	predicted	function	post-operatively.		Text	and	graphics	were	used,	with	comprehension	and	preferences	noted.		An	extract	from	this	report	is	on	the	following	pages,	with	an	example	of		a	full	report	available	in	Appendix	III.			
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How	the	tool	could	affect	the	decision-making	process	overall,	and	its	effect	on	factors	involved	in	decision-making,	was	explored.		Specific	questions,	based	around	topics	the	research	team	thought	would	be	important,	were	asked,	but	participants	were	encouraged	to	provide	their	own	views	and	options.		Pre-defined	areas	thought	critical	to	cover	included	perceived	benefits	of	the	tool,	perceived	sensitivities,	preference	of	delivery	of	tool,	its	effect	on	decision-making,	and	patients’	acceptability	of	being	offered	alternative	treatment	on	the	basis	of	their	personal	prediction.		Patients’	views	of	alternative	treatment	was	considered	relevant	as	psychological	factors	appear	to	account	for	a	large	amount	of	the	variability	in	outcome	and,	based	on	current	evidence,	would	be	a	potential	target	for	modifying	risk	factors.89				
	
4.3.2 Analysis	Analysis	was	identical	to	that	conducted	in	chapter	3.			
4.4 	Results	
	This	study	used	an	identical	study	population	as	that	described	in	chapter	3.		
4.4.1 Thematic	analysis	I	identified	six	major	themes	within	our	study.		Five	of	these	themes	were	those	identified	as	potentially	important	before	the	study	began	(perceived	benefits	of	the	tool,	perceived	sensitivities,	preference	of	delivery	of	tool,	its	effect	on	decision-making,	and	patients	acceptability	of	being	offered	alternative	treatment	on	the	basis	of	their	personal	prediction)	and	one	was	additional	(optimism	bias).			
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Benefits	of	outcome	prediction	Participants	were	universally	positive	about	the	principle	behind	the	tool,	feeling	that	having	such	information	would	be	helpful:		“If	they	said	that	you	were	going	to	be	pain-free	but	your	functionality	wasn’t	going	to	be	as	good,	you	may	not	be	able	to	bend	it	and	you	would	have	to	walk	with	a	stick.	Or	if	they	said	the	opposite,	you’re	still	going	to	have	some	pain	but	your	functionality	is	going	to	be	a	lot	better	then	you’ve	got	some	information	to	make	a	decision.”	(Focus	Group	2)		“Yes,	because	it’s	giving	you	a	real	expectation	of	what	to	expect,	because	basically	at	the	moment	all	I’ve	got	is	what	happened	to	my	friend”	(Interview	1)		There	was	also	the	belief	that	having	information	in	a	written	format	that	could	be	taken	away	was	a	worthwhile	aim,	especially	for	people	who	are	socially	isolated	and	may	not	have	the	contacts	with	friends	or	family	to	discuss	outcome:		“It	would	certainly	fill	that	gap.	I	mean	the	fact	that	we’ve	got	lots	of	family	here	and	down	in	the	South	lots	of	other	Africans,	it’s	not	really	a	factor	but	just	thinking	of	that	sort	of,	there	are	lots	of	other	people	that	have	come	to	live	here	from	other	countries	that	don’t	have	a	support	group,	I	think	that	would	be	really	beneficial.”	(Interview	1)		The	type	of	information	the	tool	conveyed	also	had	positive	effects.		This	was	true	for	predictions	that	were	on	the	whole	positive,	where	respondents	felt	it	gave	them	confidence	to	proceed:		
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	“I	think	that	having	made	the	decision	myself	before	the	surgeon	said	I	want	you	to,	that	would	have	confirmed	yes,	this	is	definitely	the	right	thing	to	do.”	(Interview	1)		“Yes	I,	I,	yes.	I’d	feel	great.		I:	You’d	feel	great.		R:	Yes.		I:	It’d	give	you	a	bit	more	confidence	in	going	ahead?		R:	Yes	give	me	confidence,	yes.”	(Interview	5)		Interestingly,	and	quite	unexpected,	were	the	positive	aspects	of	providing	a	report	that	was	predominantly	negative:		“And	he	kept	saying,	“I	can’t	believe	how	bad	you	are.”	And	I	said,	“Neither	can	I.”	So,	I	would	have	probably	thought,	“Okay,	I’m	going	to	be	in	the	20%;”	I	probably	wouldn’t	have	been	quite	as	
hard	on	myself,	because	I	kept	thinking,	“Well,	what’s	gone	wrong?””	(Focus	Group	2)		“But	no,	it	would	put	things	more	in	perspective	I	think	and	then	also	when	you’ve	had	the	operation	if	it	is	not	as	good	as	you	were	hoping	it,	but	you’ve	already	been	told	it	might	not	be,	then	you’ve	come	to	terms	with	that.”	(Interview	8)		A	further	aspect	of	report	was	that	people	felt	it	would	likely	affect	the	sources	of	information	that	they	went	to,	but	they	would	not	use	it	as	a	sole	source:		“If	I	had	got	that	before…because	I’d	done	all	that	before	I	came	to	the	knee	clinic,	and	for	my	pre-op,	so	I	still	would	have	asked	my	friend,	but	I	think	I	wouldn’t	have	bothered	looking	on	Google	at	the	different	things.”	(Interview	1)	
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Sensitivities	related	to	tool	Sensitivities	related	to	outcome	prediction	were	also	explored.		When	provided	with	a	poor	report	some	respondents	felt	that	it	was	a	“surprise”	and	that	such	information	could	“frighten	people	away”:		“it	isn’t	what	I	would	have	understood	heard	or	expected.”	(Interview	3)		“don’t	know	about	that,	I	don’t	know,	I	think	you	have	got	to	be	very	careful	that	you	don’t	frighten	people	away	from	what	needs	to	be	done.”	(Interview	6)		One	focus	of	enquiry,	that	was	identified	before	the	study	began	by	the	research	team,	were	that	of	a	poor	prediction	of	outcome	being	related	by	the	patients	to	a	diagnosis	of	an	“unhealthy	psychology”.		This	was	based	on	the	fact	that	psychological	factors	are	likely	to	be	the	biggest	predictor	of	outcome.89			All	participants	were	asked	to	give	their	thoughts	on	this,	particularly	relevant	for	the	first	six	participants	in	interviews,	who	had	completed	the	baseline	assessment	for	the	development	of	the	prognostic	model	described	in	chapters	6	and	7.		No	participant	displayed	any	concerns	regarding	a	poor	prediction	being	associated	with	an	“unhealthy	psychology”:		“No	I	don’t	think	it	would	do	anything	with	mental	health,	no.”	(Interview	2)		“It	probably	wouldn’t	enter	my	thinking,	no”	(Interview	4)		
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The	second	focus	of	enquiry	that	was	identified	before	the	study	began	was	that	of	patients	being	aware	that	a	prediction	was	not	a	guarantee	of	outcome.		All	study	participants	appreciated	this:		“No,	it’s	not.	The	way	you’ve	explained	it	in	there	as	well,	then	you’re	not	guaranteeing	it,	it	should	be.	You’re	not	guaranteeing	it.”	(Interview	8)	“You	can’t	say	okay	you’ve	got	50	now,	I	guarantee	you’ll	have	60.	This	is	what	you	...	I	think	you	should	have,	but	you	can’t	guarantee	it.”	(Interview	7)		However,	some	participants	expressed	concern	that	not	all	people	would	see	it	the	way	they	did:		“you’re	going	to	get	some	comeback	...	he’s	gone	the	opposite	way	round,	and	you’ve	predicted	this,	that’s	where	you’re	going	to	get	your	comeback.		Because	they’re	not	going	to	be	happy	with	what	you	predicted.”	(Interview	4)		A	further	concern	of	patients	was	the	use	of	this	information	to	rationalize	or	prioritise	patients	for	theatre.		Some	people	thought	that	this	was	a	reasonable	course	of	action,	assuming	that	“the	20%”	who	have	a	poorer	outcome	should	be	prioritised:		“But	presumably	these	lists	are	prioritised	using	a	whole	variety	of	criteria	and	this	is	just	adding	to	this	criteria,	surely.	They	would	still	have	to	be	prioritised;	the	most	urgent	get	done	first.”	(Focus	Group	2)		However,	others	were	very	concerned	that	this	sort	of	information	should	not	be	used	for	either	rationing	or	prioritisation,	and	should	only	be	used	to	provide	information	to	patients:	
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	“R:	Well	it’s	a	process	for	the	patient,	it’s	not	a	process	for	the	surgeon…“	“I:	It	would	predict	what	your	eventual	outcome	would	be.	And	should	the	surgeon	use	that	when	rationalising	whether	you	should	have	a	knee	replacement	or	not?		R:	The	answer	in	my	opinion	is	‘no’.”	(Focus	Group	2)		
Preferred	delivery	of	tool	There	are	differences	in	the	amount	of	information	that	different	patients	want	in	a	wide	range	of	medical	situations.47-49	When	it	came	to	the	outcome	prediction	tool	there	was	a	general	preference	for	a	“bottom	line”	approach	and	visual	displays:		“That	would	have	been	brilliant	...	I	like	the	picture	that	says	in	all	probability	you	may	expect	an	improvement	of	X	per	cent,	I	think	that’s	the	way	I	would	like	to	receive	the	information.”	(Focus	Group	1)		“I	think	the	fact	that	it’s	a	visual	aid	is	helpful.	I	think	again,	rather	than	simply	having	script,	to	have	a	visual	aid	is	almost	essential.	I	know	I	can	do	that.	You	can	see	it	physically.”	(Focus	Group	2)		“One	has	to	remember	that	you	are,	I	mean	the	people	who	are	having	knee	replacements	might	not	be	mathematicians	so	might	not	understand	–		I:	Yes,	absolutely.	R:	I	think	that	is	good.	[Referring	to	diagram	of	%	of	pain]”		(Interview	6)		There	was	a	feeling	that	people	would	need	someone	to	go	through	this	information	with	them	in	a	face-to-face	context:		
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“My	instinct	says	it’s	better	to	have	somebody	to	go	through	it	with	you.	I	think	just	receiving	it	…	I	found	not	the	easiest	thing	I’ve	done	in	the	last	seven	days	...	There	are	some	people	who	can’t	speak	English	or	understand,	they	have	to	be	explained	and	all	that.”	(Focus	Group	1)		Trust	in	the	output	from	the	tool	was	also	seen	as	essential:		“I	think	you’d	need	to	know	where	the	figures	are	coming	from	…	one	knows	that	these	are	just	the	opinions	or	whether	they	are	from	a	clinical	analysis	or	something,	you	know”	(Interview	6)		Two	of	these	quotes	reveal	information	that	is	particularly	relevant	to	the	development	of	a	prognostic	algorithm.		Firstly,	one	of	the	patients	thought	of	the	functional	gain	in	terms	of	“per	cent”	(when	discussing	functional	gain).		This	suggests	a	linear	scale,	which	the	Oxford	Knee	Score	is	not.		This	was	despite	information	(both	written	and	verbal)	to	the	contrary.		This	has	implications	for	how	information	is	displayed,	and	the	understanding	that	can	be	expected	from	patients	with	non-linear	scales.		Secondly,	trust	in	the	figures	was	seen	as	essential,	which	means	that	any	estimate	will	have	to	be	precise.				
The	tool’s	effect	on	decision-making	The	tool’s	effect	on	decision-making	was	tested	on	three	different	groups	of	people,	each	at	a	different	stage	of	the	decision-making	process:	those	in	the	deliberation	phase;	those	just	after	making	a	decision,	but	still	waiting	for	the	operation;	and	those	who	had	already	had	the	operation.		The	effect	of	the	tool	was	examined	in	each	group.				
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Patients	who	had	already	had	an	operation	In	this	group	patients	were	asked	how	the	tool	would	have	affected	their	deliberation	process,	and	therefore	the	difficulties	inherent	with	any	retrospective	inquiry	were	present.		However,	all	patients	thought	that	the	information	would	have	had	the	ability	to	change	their	expectations:		“R:	No,	I	think	weighing	up	the	pros	and	cons	and	if	you’re	in	a	lot	of	pain	I	think	you	just	go	for	it.		R:	You’d	lower	your	expectations	wouldn’t	you?	(Another	member	of	focus	group	asking	question)”	(Focus	Group	2)		“it	would	surely	give	you	confidence	if	you	did	the	questionnaire	and	came	out	into	a	good	category”	(Focus	group	2)		It	was	challenging	to	get	this	group	of	patients	to	distinguish	between	altering	their	decisions,	and	altering	their	expectations.		Interestingly	some	patients	felt	strongly	it	would	have	had	no	effect	on	their	expectations	if	the	predicted	outcome	was	poor,	but	would	have	improved	confidence	if	the	predicted	outcome	was	good.		This	will	be	discussed	in	more	detail	under	“optimism	bias”.				There	was	a	predominant	feeling	that	the	tool	would	not	have	affected	the	decision:		“No,	likewise,	the	same	as	well,	it	wouldn’t	have	made	any	difference	because	I	was	in	pain	and	it	needed	to	be	done.”	(Focus	Group	1)		However,	some	people	(in	the	minority)	thought	that	it	would	have:		
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“I:	do	you	think	[an	outcome	prediction	tool]	would	have	helped?		R:	Possibly;	it	would	have	been	a	lot	easier.”	(Focus	Group	2)		“It	would	probably	have	made	me	think	deeper	about	it.”	(Focus	Group	10		
Patients	who	were	on	the	waiting	list	for	a	knee	replacement	This	group	of	patients	universally	would	have	changed	their	expectations;	however,	again	there	was	a	division	on	if	it	would	have	affected	the	deliberation	phase,	with	some	patients	stating	it	would	have:		“I	think	I	certainly	would	have	thought	instead	of	that	initial	response	when	he	told	me	I	needed	to	have	it,	I	might	have	said	I	need	to	think	about	it	a	little	bit	first,”	(Interview	1)		And	others	stating	it	would	not;	however,	this	was	less	strongly	held	than	the	post-operative	group,	often	with	a	qualifier:		“it	would	have	been	nice	to	know	but	in,	in	my	situation	no	it	wouldn’t	have	[altered	my	decision].”	(Interview	5)		
Patients	who	were	contemplating	a	knee	replacement	In	this	group	all	patients	felt	that	the	information	in	the	outcome	prediction	tool	would	have	affected	their	expectation	and	their	deliberation.		This	was	a	strongly	held	belief:		"This	sort	of	information	are	enough	to	change	anybody’s	mind"	(Interview	10)		"Yes,	of	course	it	affects	expectations"	(Interview	10)		
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“Yes	I	think	it	would	be	helpful	if	people	knew	what	their	chances	were	after	an	operation.	I	think	it	would	help	them	make	the	decision	whether	to	go	ahead	or	not”	(Interview	9)		Overall	there	was	a	stark	difference	in	how	the	tool	affects	decision-making.		This	result	is	not	unexpected.		The	deliberation	phase	of	decision-making	is	stressful,	and	there	is	a	relief	once	a	decision	is	made	(Chapter	3).	Therefore,	any	new	information	that	comes	to	light	once	the	decision	is	made	is	less	likely	to	change	that	person’s	mind.		The	stress	from	the	deliberation	phase	appears	to	act	as	a	barrier	to	revisiting	an	already	made	decision.		This	is	critical	when	considering	at	what	point	in	the	pathway	of	care	an	outcome	prediction	tool	should	be	used.				When	patients	were	asked	directly	when	they	thought	this	information	should	be	given	there	was	a	complete	range	of	responses:		“I	think	I	would	like	the	GP	to	action	this	and	get	it	through.”	(Focus	Group	1)		“Pre-op	assessment.”	(Focus	Group	1)		“I	think	the	consultant	or	the	consultant’s	team	is	or	are	the	best	people.”	(Focus	Group	2)		
Acceptability	of	alternative	treatment	Alternative	treatment	(e.g.	Cognitive	Behavioural	Therapy	(CBT))	has	the	potential	to	improve	the	outcome	from	knee	replacements.		CBT	can	alter	psychological	processes,	such	as	coping	strategies.		These	factors	could	affect	outcome	in	knee	replacement	and	by	modifying	them	before	knee	replacements	outcome	could	be	improved.		This	(highly	theoretical)	option	was	posed	to	patients	by	asking	if	they	would	be	willing	to	delay	their	
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operation	to	undergo	CBT	if	it	would	be	likely	to	improve	their	outcome.		A	remarkable	division	between	pre	and	post-operative	patients	resulted,	with	post-operative	patients	universally	disagreeing	with	any	delay:		“I	don’t	want	to	suffer	another	three	months.	Go	for	it,	I	think.”	(Focus	Group	1)		And	pre-operative	patients	having	mixed	views:		“Well	I	suppose	I	would	then	if	you	felt	that	I	...	that’s	what	I	needed…Yes.	I	mean	you	have	to	listen	to	the	medical	staff,	they	do	...	you	know	to	some	degree	know	a	bit	better	than	you	do.”	(Interview	3)		“I	wouldn’t	have	wanted	it	to	be	delayed.”	(Interview	1)		Participants	were	generally	not	particularly	receptive	to	psychological	therapies,	which	is	consistent	with	the	participants’	view	that	a	poor	prediction	of	outcome	was	not	associated	with	an	“unhealthy	psychology”.			Interestingly,	the	protocol	for	a	feasibility	trial	comparing	pre-operative	CBT	against	normal	care	has	been	published	recently	(the	HAPPiKNEES	study).96	On	the	basis	of	the	findings	here,	recruitment	may	be	problematic.				
Optimism	bias	Sharot	defines	the	optimism	bias	as	the	propensity	to:		“Overestimate	the	likelihood	of	positive	events,	and	underestimate	the	likelihood	of	negative	events.	For	example,	we	underrate	our	chances	of	getting	divorced,	being	in	a	car	accident,	or	suffering	from	cancer.	We	also	expect	to	live	longer	than	objective	measures	
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would	warrant,	overestimate	our	success	in	the	job	market,	and	believe	that	our	children	will	be	especially	talented.	This	phenomenon	is	known	as	the	optimism	bias,	and	it	is	one	of	the	most	consistent,	prevalent,	and	robust	biases	documented	in	psychology	and	behavioural	economics.”97		This	bias	was	displayed	when	examining	the	effect	of	the	outcome	prediction	tool.		I	found	that	patients	who	have	already	had	a	knee	replacement	were	unwilling	to	move	their	expectations	down	with	a	poor	prediction,	but	willing	to	have	a	good	prediction	inspire	confidence.		The	optimism	bias	was	displayed	across	all	three	groups:		“No	because	I	know	within	myself	you	know	I’m	a	pretty	healthy	guy	and	I’d	like	to	think	I’d	got	a	lot	more	than.”	(Interview	5)		I:	“And	if	your	friend	had	said	it’s	fantastic,	but	you’d	got	this	bad	report,	who	would	you	have	trusted?		R:	I	would	have	trusted	her,	but	I	would	also	everyone’s	different	and	our	bodies	are	all	different	so	I	think	I	would	have	probably	gone	in	the	middle	and	my	expectations	would	have	been	a	bit	of	both.”	(Interview	1)		And	with	a	positive	outcome:		“R:	Well	I	trust	him,	I’d	believe	him.		I:	You’d	believe	it?	R:	I’d	believe	him	because	I	wanted	to.”	(Interview	8)		
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This	has	implications	for	the	implementation	of	such	a	tool,	which	will	be	explored	in	the	discussion.		The	reason	an	outcome	prediction	tool	has	been	allocated	as	a	research	priority	by	NICE	is	the	high	dissatisfaction	rate.		It	is	in	this	group	that	the	tool	would	be	most	useful	as	it	would	alter	expectations	in	line	with	predicted	outcome	and	(hopefully)	result	in	improved	satisfaction	(although	this	relationship	has	been	questioned).41		However,	what	I	have	found	here	is	that	although	patients	would	alter	their	expectations,	they	would	not	alter	their	expectations	all	the	way	towards	a	“bad”	prediction.		This	is	likely	to	dampen	the	effect	on	satisfaction	an	outcome	prediction	tool	could	have.		Additionally,	any	uncertainty	in	the	prediction	provided	by	a	tool	(as	there	will	be	with	any	prediction)	is	likely	to	be	met	with	an	optimistic	view	from	patients	–	patients	will	view	themselves	at	the	better	end	of	any	confidence	interval.		This	has	implications	for	deciding	how	good	a	prognostic	model	has	to	be	for	it	to	be	considered	useful	for	individual	patient	decision-making.		Given	the	optimism	bias,	any	prognostic	model	will	have	to	have	more	precise	estimates	if	the	aim	is	to	aid	patient	decision-making	(particularly	for	patients	who	are	at	risk	of	a	poor	outcome).		
	
4.5 Discussion	
	This	study	has	demonstrated	that	the	effects	of	an	outcome	prediction	tool	on	patients	decision-making	is	likely	to	depend	on	their	stage	of	decision-making	(deliberation	or	decision-making),	and	that	the	effects	of	a	poor	outcome	prediction	are	likely	to	be	blunted	by	the	optimism	bias.	This	has	broad	implications	for	any	future	outcome	prediction	tool,	one	of	which	is	the	precision	of	individual	estimates.		If	patients	tend	to	think	their	outcome	will	be	better,	then	they	will	assume	they	will	fall	into	the	better	end	of	any	
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confidence	interval	around	a	prediction	–	this	means	that	estimates	with	a	large	individual	confidence	interval	may	not	be	particularly	useful.			Linked	to	this	is	the	preference	for	information	from	friends	and	family.		Conflicting	information	from	a	prediction	and	a	family	member	who	has	had	the	operation	is	likely,	and	it	appears	that	patients	would	prefer	to	hear	from	someone	who	has	been	through	the	procedure.		This	may	mean	that	a	completely	different	approach	to	presenting	information	is	required:	for	example,	a	database	of	patient	experience	from	patients	that	have	had	a	knee	replacement	that	can	be	matched	to	the	baseline	characteristics	and	likely	outcome	of	a	patient	considering	a	knee	replacement.		Additionally,	the	effect	of	a	tool	on	managing	expectations	and	patient	decision-making	will	alter	depending	on	the	point	in	the	pathway	it	is	used	(patients	who	have	already	made	up	their	mind	appear	less	willing	to	change	it	based	on	new	information	–	this	could	be	due	to	the	stress	that	is	felt	from	the	deliberation	process,	discussed	in	chapter	3).		However,	it	is	clear	that	patients	welcome	such	information,	and	that	it	would	appear	to	still	have	an	effect	on	expectation	and	decision-making,	especially	if	targeted	early	in	the	patient	pathway.			The	strengths	and	weaknesses	of	this	study	are	similar	to	that	of	the	study	presented	in	Chapter	3.		This	study	included	people	at	various	stages	of	decision-making,	had	a	broad	based	research	team,	and	a	range	of	ages,	ethnicities	and	genders.		The	methodology	included	techniques	to	improve	the	trustworthiness	of	the	study.		However,	the	same	weaknesses	regarding	selection	bias,	comparison	of	views	across	research	methods,	and	power	differentials	between	participants	and	interviewers	exist.					This	study	is	the	first	of	its	kind	to	examine	outcome	prediction	in	this	way;	however,	a	wealth	of	information	is	available	on	information-giving	strategies.		Patient	Decision	Aids	
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(PDA,	also	known	as	decision	aids,	decision	support	interventions,	decision	support	aids)	are	methods	of	informing	patients	about	the	treatment	options	available	to	them.42	From	a	simple	one-page	summary	to	interactive	online	tools,	they	have	been	widely	implemented	within	the	NHS,	with	the	Department	of	Health	QIPP	programme	funding	the	development	and	hosting	of	38	PDAs	to	cover	a	variety	of	conditions.		Knee	OA	is	included.46	These	aids	are	quite	different	from	individualised	prediction	of	outcome,	particularly	outcome	based	on	predominantly	psychological	factors,	and	do	not	offer	any	potential	for	interventions	based	on	predicted	scores.		However,	the	principle	of	patients	weighing	up	probabilistic	information	is	broadly	similar.				A	recent	Cochrane	review	on	the	effectiveness	of	decision	aids45	concluded	that	in	general	they:		 - Improve	patients’	knowledge	of	the	options	(high-quality	evidence);		- Allow	patients	to	feel	more	informed	and	more	clear	about	what	matters	most	to	them	(high-quality	evidence);		- Allow	patients	to	have	a	more	accurate	expectations	of	possible	benefits	and	harms	of	their	options	(moderate-quality	evidence);	and		- Allow	patients	to	participate	more	in	decision-making	(moderate-quality	evidence).			Interestingly	decision	aids	have	been	found	to	reduce	the	proportion	of	people	progressing	to	elective	surgery.42,45	Although	these	studies	did	not	involve	patients	with	knee	OA,	there	are	similarities	in	that	it	is	a	preference-based	decision.42	There	is,	however,	a	caveat	with	informed	decision-making	–	patients	who	have	knee	OA	tend	to	prefer	a	paternalistic	
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interaction,	commonly	viewing	anything	else	as	an	attempt	to	avoid	responsibility,47-49	and	shared	decision-making	models	have	been	shown	to	have	mixed	effects	on	clinical	outcomes	(rather	than	outcomes	aimed	at	measuring	the	decision-making	process	itself).52		These	findings	are	largely	consistent	with	our	own,	and	are	particularly	relevant	when	considering	how	an	outcome	prediction	tool	should	be	used.		It	is	clear	that	the	effect	of	an	outcome	prediction	tool	is	to	a	degree	dependent	on	the	content	and	presentation,	the	point	in	the	pathway	it	is	used,	and	whether	it	is	delivering	“good”	or	“bad”	news.		The	work	on	PDAs	would	suggest	a	decrease	in	the	proportion	of	people	progressing	to	elective	surgery	could	be	expected.		Additionally,	how	the	tool	is	delivered	is	likely	to	be	key	(i.e.	as	part	of	a	shared	decision-making	model	or	part	of	a	paternalistic	model).		These	uncertainties	will	need	careful	evaluation	if	and	when	such	a	tool	becomes	available.					
4.6 Conclusion	
	This	study	has	demonstrated	that	any	prediction	tool	aimed	at	improving	patients’	decision-making	will	need	to	have	precise	estimates,	and	the	timing	of	delivery	of	predictive	information	will	alter	the	effects	of	any	future	tool	capable	of	predicting	outcome.	The	implications	from	this,	in	the	authors’	opinion,	is	that	the	timing	and	effect	(both	in	terms	of	decision-making	and	clinical	outcome)	will	have	to	be	carefully	evaluated	for	any	potential	outcome	prediction	tool	that	is	to	be	used	by	patients.		
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With	an	understanding	of	the	decision-making	process,	the	potential	effects	of	an	outcome	prediction	tool,	and	patients’	preferences	regarding	outcome	prediction,	an	understanding	of	the	potential	factors	that	could	affect	outcome	in	knee	replacements	is	required.		The	next	chapter	investigates	this.			
	 	
	 107	
Chapter	5:	The	important	factors	to	investigate	to	build	
an	outcome	prediction	algorithm		
	
This	chapter	will	first	examine	what	factors	could	be	important	in	predicting	outcome.		It	will	
then	go	on	to	a	systematic	review	examining	what	patient	factors	should	be	measured	when	
developing	a	study	to	quantify	the	relationship	between	pre-operative	factors	and	outcome.	
This	review	was	conducted	in	2012,	and	was	used	to	inform	the	development	of	the	protocol	
for	the	multicentre	Knee	Outcome	Prediction	Study,	described	in	chapters	6	and	7.		A	
narrative	update	on	important	developments	since	2012	is	provided.					
5.1 Declarations	
	
Aspects	of	this	chapter	have	been	published:	
T.	Barlow,	T.	Clarke,	M.	Dunbar,	A	Metcalfe,	D.	Griffin.		The	effect	of	expectation	on	satisfaction	in	total	knee	replacements:	a	systematic	review.		Accepted	for	publication	SpringerPlus,	February	2016			
Aspects	of	this	chapter	have	been	presented	at	an	international	conference:	Dunbar	M,	Barlow	T,	Griffin	D.		The	effect	of	patient	factors	on	outcome	in	Total	Knee	Replacement:	a	systematic	review.	Poster.		European	Federation	of	National	Associations	of	Orthopaedics	and	Traumatology,	Istanbul,	June	2013.				
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Aspects	of	this	chapter	have	been	presented	at	a	regional	conference	
T.	Barlow,	T.	Clarke,	M.	Dunbar,	A	Metcalfe,	D.	Griffin.		The	effect	of	expectation	on	satisfaction	in	total	knee	replacements:	a	systematic	review.		Poster.		West	Midland	Surgical	Society	Autumn	meeting,	Coventry,	November	2015.				Dr	M	Dunbar	and	Dr	T	Clarke	provided	independent	assessment	of	references	for	the	systematic	reviews	on	patient	factors	and	expectations	respectively.			Aspects	of	this	review	were	conducted	before	registration	for	the	degree	of	PhD.		The	work	accounted	for	no	more	that	three	months	full	time	equivalent.					
5.2 Introduction	
	The	development	of	an	outcome	prediction	tool	requires	an	understanding	of	the	potential	factors	that	could	influence	outcome.		Therefore	the	following	section	describes	previous	attempts	at	identifying	risk	factors	before	reporting	a	systematic	review	of	patient	factors	that	could	act	as	prognostic	factors.		The	result	of	this	review,	completed	in	2012,	formed	the	basis	for	the	design	of	the	cohort	study	and	is	presented	in	its	original	form	to	provide	context	for	chapters	6	and	7.		The	aim	of	this	review	was	to	identify	factors	that	could	be	important	in	predicting	outcome,	rather	than	attempting	to	quantify	those	relationships	through	meta-analysis.		To	provide	an	account	of	the	literature	to	date,	a	further	narrative	review	on	updates	since	2012	is	included.			
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5.2.1 Previous	attempts	at	identifying	risk	factors	Many	studies	on	knee	replacement	have	explored	the	effect	of	different	surgical	techniques	or	rehabilitation	on	outcome.	However,	this	has	been	unable	to	account	for	all	of	the	variability	in	outcome.	Using	data	from	the	NJR,	Baker	et	al.	analysed	surgical	factors	that	could	account	for	variability	in	Oxford	Knee	Score	(OKS)	and	EuroQol	5	Dimensions	(EQ	5D).95	This	found	that	implant	brand	and	hospital	type	were	significant	predictors,	although	they	found	that	the	difference	was	small,	and	the	variation	within	each	brand	and	hospital	was	large.		Patient	factors,	which	can	be	defined	as	being	any	factor	that	is	intrinsic	to	the	patient	and	that	is	not	rapidly	changed	by	a	change	in	environment,	had	larger	effect	sizes.98	More	recently,	the	NIHR	supported	a	Programme	Grant	examining	risk	factors	for	a	poor	outcome	in	joint	replacement	(the	Clinical	Outcomes	in	Arthroplasty	Study	–	COASt).	This	study	focused	on	peri-operative	factors,	not	specifically	patient	factors,	and	concluded	in	August	2012	that	“Other	predictive	factors	need	to	be	identified	to	improve	our	ability	to	recognize	patients	at	risk	of	poor	TKR	[Total	Knee	Replacement]	outcomes”.22		Additional	aspects	of	peri-operative	care	have	been	investigated	and	found	little	effect	on	outcome:	for	example	excision	of	the	patella	fat	pad,99	mobile	or	fixed	bearing	implants,100	and	computer	navigated	or	conventional	techniques.101				One	factor	that	had	not	been	studied	in	depth	was	the	alignment	of	the	knee	prosthesis.		Two	systematic	reviews,	of	which	I	am	the	second	author,	investigated	the	effect	alignment	has	on	either	PROMs	or	revision	rates	after	knee	replacement.		Both	found	that	alignment	has	little	effect	on	outcome,	but	the	studies	examining	the	issue	were	marred	by	several	issues	–	not	least	of	which	was	the	complex	interplay	between	the	alignment	of	two	different	prosthesis	(tibial	and	femoral)	in	three	dimensions.		Additionally,	samples	were	not	particularly	representative,	and	attempts	to	control	for	baseline	demographics	were	
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poor	in	most	studies.102	Therefore	a	further	study,	using	the	population	of	patients	described	in	chapter	six,	was	used	to	investigate	the	link.		I	am	the	senior	author	on	this	paper	and	it	found	no	link	between	malalignment	and	six	month	OKS	score	(prepared	for	publication).						Therefore,	if	the	surgical	procedure	itself	was	only	accounting	for	a	small	proportion	of	the	variability	(around	15%),22	other	factors	within	the	process	should	account	for	the	variation	in	outcome.			
5.2.2 Patient	factors	There	is	growing	evidence	that	patient	factors	significantly	affect	outcome.89			A	patient	factor	can	be	defined	as	being	any	factor	that	is	intrinsic	to	the	patient	and	that	is	not	rapidly	changed	by	a	change	in	environment.		These	factors	may	include	demographic	data	such	as	age,	gender,	and	socioeconomic	class,	functional	and	general	health	scores,	as	well	as	psychological	attributes	and	radiographic	appearances.		Therefore,	this	review	will	systematically	determine	which	pre-operatively	measurable	patient	factors	are	associated	with	post-operative	changes	in	status	as	measured	by	patient-derived	and	functional	outcomes	scoring	in	patients	who	are	about	to	undergo	total	knee	replacement	for	OA.		The	implications	this	has	for	the	development	of	methods	to	identify	patients	likely	to	have	poorer	outcomes	will	be	discussed.			
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5.3 Systematic	review	–	Patient	factors	that	influence	outcome		
	This	review	was	informed	by	a	previous	review	performed	by	one	of	my	supervisors.98	I	defined	and	conducted	the	search,	assessed	papers	for	inclusion,	performed	data	extraction,	and	collated	the	results.			
5.3.1 Patients	and	Methods	
Search	strategy	A	comprehensive	electronic	search	strategy	was	used	to	identify	studies	from	MEDLINE	(Medical	Literature	Analysis	and	Retrieval	System	Online,	Bethesda,	Maryland,	USA)	and	EMBASE	(Excerpta	Medical	Database,	Amsterdam,	The	Netherlands)	using	all	available	data	from	their	inception	until	February	the	15th	2012.		The	search	strategy	is	available	in	the	appendix	(section	IV)	and	online	via	the	Prospero	website.103		It	was	designed	to	be	as	comprehensive	as	possible	in	order	to	mitigate	the	risk	of	producing	‘precise	but	spurious	results.’104		
Eligibility	criteria	Studies	were	eligible	for	inclusion	if	they	were	prospective	cohort	studies	observing	the	effect	of	knee	replacement	on	OA.		Studies	where	information	was	retrieved	from	a	database	were	also	included	if	the	pre-operative	status	patient	factor	measurements	were	collected	prospectively.	Case	series	and	case-control	studies	were	not	included	as	there	is	a	significant	potential	for	selection	bias	with	these	types	of	study	design.105	Only	studies	that	were	presented	in	English	were	included	in	the	analysis.	
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	The	subjects	included	in	each	study	were	patients	about	to	undergo	total	knee	replacement	with	a	diagnosis	of	OA.		Where	patients	with	other	arthritic	diseases	(e.g.	traumatic	arthritis,	inflammatory	arthritis)	made	up	more	than	5%	of	the	study	population,	these	studies	were	excluded.		Studies	where	the	cohort	comprised	more	than	5%	of	patients	undergoing	revision	knee	replacement	were	also	excluded	from	the	analysis.		This	figure	was	agreed	by	the	study	group	and	included	in	the	published	protocol.		However,	studies	containing	mixed	groups	of	patients	were	included	if	there	was	subgroup	analysis	that	clearly	differentiated	the	population	of	interest;	when	this	occurs,	only	the	results	from	the	subgroup	are	discussed.				Any	study	that	collected	information	on	patient	factors	retrospectively	was	excluded	as	this	has	been	shown	to	be	unreliable.106			
Patient	measurements	All	measurements	of	patient	functional	status,	psychological	factors	and	radiological	measurements	had	to	have	been	made	using	methods	that	had	evidence	of	validity	for	patients	with	severe	knee	OA.		All	outcome	measurements	had	to	have	been	made	using	validated	patient	reported	outcome	measurement	tools.		This	method	of	measurement	has	been	shown	to	have	good	validity	and	reliability	with	a	significant	reduction	in	the	likelihood	of	assessor	bias.107	This	meant	that	the	historically	popular	Knee	Society	Score	(also	known	as	the	American	Knee	Score	or	Knee	Society	Clinical	Rating	Scale)108	was	not	included	as	it	has	several	components	that	require	objective	assessment	by	an	observer.		The	Knee	Society	Score	has	
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been	shown	to	have	poor	correlation	amongst	its	items	when	compared	with	other	more	recently	developed	patient	reported	tools.109		A	minimum	period	of	follow	up	of	three	months	was	required.		
Analytic	methods	Studies	had	to	have	made	some	attempt	to	associate	outcome	with	one	or	more	of	the	measurable	patient	factors.		Various	methods	of	regression	or	correlation	analysis	were	acceptable	as	long	as	they	were	clearly	explained	in	the	methods	section	in	order	to	determine	that	their	use	was	appropriate	for	the	type	of	data	collected.		
Quality	assessment	The	Newcastle	Ottawa	scale	provides	a	system	for	assessing	quality	across	three	domains:	selection,	comparability,	and	outcome.110	The	Newcastle-Ottawa	Scale	(NOS)	is	a	tool	developed	through	the	Delphi	process	by	the	Universities	of	Newcastle,	Australia	and	Ottawa,	Canada.	It	was	developed	to	allow	a	framework	for	assessing	the	quality	of	case-control	and	cohort	studies	(each	framework	differs	slightly).			For	cohort	studies,	the	quality	of	studies	is	judged	under	three	broad	categories:	Selection,	Comparability,	and	Outcome.		Each	domain	is	scored	with	a	star	rating	system.		Face	validity	and	inter-rater	reliability	have	been	demonstrated,	with	more	validation	work	currently	ongoing.111	The	score	is	easy	to	use,	allows	quick	comparison	between	studies,	and	is	consistent	between	raters,	hence	its	use	here.				
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However,	there	has	been	some	criticism	of	the	score	within	the	literature,	due	to	the	subjectivity	of	some	of	the	elements	within	the	scoring	system.110	With	over	86	tools	available	for	the	quality	assessment	of	non-randomised	controlled	trials,	it	is	clear	that	no	tool	is	perfect.110	However,	guidelines	on	the	conduct	of	systematic	reviews	state	that	a	scoring	system	should	be	used.110	The	caveat	to	using	such	a	system	is	the	inappropriate	weighting	of	studies	and	the	subsequent	production	of	spurious	results.		A	summary	score	is	not	provided	in	line	with	the	scoring	system	guidelines.110		
Data	extraction	After	the	initial	search	was	performed	the	studies	were	screened	for	eligibility	in	sequential	rounds	where	their	relevance	was	assessed	using	at	first	their	titles,	then	abstracts,	and	finally	full	review	of	the	paper.		Mark	Dunbar	acted	as	the	second	author,	and	independently	re-examined	each	paper	at	each	stage	to	ensure	that	they	met	the	inclusion	criteria.		Relevant	data	was	extracted	and	a	quality	assessment	performed	independently	by	both	reviewers,	resolving	any	differences	through	discussion	and	review.		Due	to	the	nature	and	heterogeneity	of	the	analyses	used	in	the	studies	no	formal	meta-analysis	was	performed.		Instead,	a	narrative	approach	was	taken	which	still	allowed	comparison	of	individual	important	factors	across	all	studies.		This	is	consistent	with	the	aim	of	this	review:	to	identify	potential	predictors	of	outcome.				
5.3.2 Results	Our	search	returned	2287	studies.		Of	these	some	were	duplicates	from	multiple	databases	that	due	to	a	technical	limitation	had	to	be	removed	by	hand	during	the	title	search.	Figure	
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5	is	a	flow	chart	detailing	the	studies	that	were	excluded.	Twenty-two	studies	are	included	in	this	review	(Table	7).	
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Table	7:	Studies	included	in	review	(continued	until	page	118)	
	
Author	 Year	 Title	 Patients	
Included	
Patients	
Lost	to	
Follow	up	
Follow	
up	
length	
Primary	
Outcome	
Secondary	
Outcome	
Analysis	 Sample	Size	
Calculation	
Sharma	et	
al.	
1996	 Prognostic	factors	for	
functional	outcome	of	total	
knee	replacement:	a	
prospective	study	
52	 5	 3	months	 SF-36	PF	 na	 Hierarchical	
multiple	
regression	 Not	reported	
Heck	et	al.	 1998	 Patient	outcomes	after	knee	
replacement	 291	 22	 2	years	 Dichotomised	SF-36	PF	 Womac	(not	
included	in	
regression	
model)	
Logistic	
Regression	 Not	reported	
Fortin	et	al.	 1999	 Outcomes	of	total	hip	and	
knee	replacement:	pre-
operative	functional	status	
predicts	outcomes	at	six	
months	after	surgery	
130	 24	 6	months	 SF-36		 WOMAC	 Multiple	
linear	
regression	 Not	reported	
Kiebzak		 2002	 The	SF-36	general	health	
status	survey	documents	the	
burden	of	OA	and	the	
benefits	of	total	joint	
arthroplasty:	but	why	should	
we	use	it?	
415	 None	
mentioned	 1	year	 SF-36		 na	 Friedman	test;	Mann	
Whitney	test	 Not	reported	
Allyson	
Jones	et	al.	
2003	 Determinants	of	function	
after	total	knee	arthroplasty	 294	 18	 6	months	 SF-36		 WOMAC	 Stepwise	multiple	
regression	 Not	reported	
Lingard	et	
al.	
2004	 Predicting	the	outcome	of	
total	knee	arthroplasty	 860	 119	 1	year	 SF-36		 WOMAC	 Hierarchical	multiple	
regression	 Not	reported	
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Table	7	(cont.)	
	
Author	 Year	 Title	 Patients	
Included	
Patients	Lost	
to	Follow	up	
Follow	
up	length	
Primary	
Outcome	
Secondary	
Outcome	
Analysis	 Sample	Size	
Calculation	
Mizner	et	al.	 2005	 Pre-operative	quadriceps	
strength	predicts	functional	
ability	one	year	after	total	
knee	arthroplasty	
40	 0	 1	year	 Timed	up	and	
go	and	stair	
climbing	test	 KOS/ADLS	and	SF-36	PCS	 Hierarchical	linear	regression	 Not	reported	
Lim	et	al.	 2006	 The	effect	of	pre-operative	
symptom	severity	on	
functional	outcome	of	total	
knee	replacement	-	patients	
with	the	lowest	pre-operative	
scores	achieve	the	lowest	
marks	
45	 0	 2	years	 OKS	 na	 Spearman	
rank;	Wilcox	
signed	rank	 Not	reported	
Nunez	et	al.	 2007	 Health-related	quality	of	life	
in	patients	with	OA	after	total	
knee	replacement:	factors	
influencing	outcomes	at	36	
months	of	follow-up	
90	 23	 3	years	 WOMAC	 na	 Multiple	
linear	
regression	 Not	reported	
Bourne	et	al.	 2007	 Influence	of	patient	factors	
on	TKA	outcomes	at	5	to	11	
years	follow	up	 728	 81	 5	years	 WOMAC	 SF-12,	KSS	 ANOVA	 Not	reported	
Escobar	et	
al.	
2007	 Effect	of	patient	
characteristics	on	reported	
outcomes	after	total	knee	
replacement	
907	 640	 6	months	 Each	domain	
of	the	WOMAC	
and	SF-36	 na	 Multiple	linear	regression	 Not	reported	
Cushnaghan	
et	al.	
2008	 Long-term	outcome	following	
total	knee	arthroplasty:	a	
controlled	longitudinal	study	 657	 332	 6	years	 SF-36	(PF	change	score	only	used	for	
analysis)	
None	 Linear	
regression	 Not	reported	
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Table	7	(cont.)	
	
Author	 Year	 Title	 Patients	
Included	
Patients	
Lost	to	
Follow	up	
Follow	
up	
length	
Primary	
Outcome	
Secondary	
Outcome	
Analysis	 Sample	Size	
Calculation	
Davis	et	al.	 2008	 Effects	of	socioeconomic	
status	on	patients'	outcome	
after	total	knee	arthroplasty	 974	 181	 24	months	 WOMAC	PF,	WOMAC	pain	 None	 Multivariate	linear	regression	 Not	reported	
Franklin	et	
al.	
2008	 The	Chitranjan	Ranawat	
Award:	functional	outcome	
after	total	knee	replacement	
varies	with	patient	
attributes	
9220	on	
registry	 1170	 12months	 KSS	 Sf-12	(PCS	and	MCS)	 Multivariate	regression	
analysis		 Not	reported	
Rajgopal	et	
al.	
2008	 The	impact	of	morbid	
obesity	on	patient	outcomes	
after	total	knee	arthroplasty	 760	on	registry	 210	 12	months	 WOMAC	 SF36	 Linear	regression.		T	test	to	
compare	
BMI	groups.	
Rule	of	
thumb	of	10	
patients	per	
variable	(6	
variables	
included	in	
model)	
Nilsdotter	et	
al.	
2009	 Knee	arthroplasty:	are	
patients'	expectations	
fulfilled?	A	prospective	study	
of	pain	and	function	in	102	
patients	with	5-year	follow-
up	
102	 22	 5	years	 KOOS	 SF-36,	ADL	
and	
Leisure	
activities	
(KOOS),	
Satisfactio
n	
Mann	
Whitney	U	
test		 Not	reported	
Nunez	et	al.	 2009	 Total	knee	replacement	and	
health-related	quality	of	life:	
Factors	influencing	long-
term	outcomes	
142	 30	 7	years	 WOMAC	 SF-36	(not	
included	in	
regression	
model)	
Multiple	
linear	
regression	 Not	reported	
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Table	7	(cont.)	
		
Author	 Year	 Title	 Patients	
Included	
Patients	
Lost	to	
Follow	up	
Follow	
up	
length	
Primary	
Outcome	
Secondary	
Outcome	
Analysis	 Sample	Size	
Calculation	
Dowsey	et	
al.	
2010	 The	impact	of	pre-operative	
obesity	on	weight	change	
and	outcome	in	total	knee	
replacement:	a	prospective	
study	of	529	consecutive	
patients	
529	 8	 12month
s	 Weight	change	 SF12	-	PCS	and	MCS,	
(KSS)	 Kruskal	Wallis	tests	 Not	reported	
Ghandi	et	
al.	
2010	 Metabolic	syndrome	and	the	
functional	outcomes	of	hip	
and	knee	arthroplasty	 889	on	registry	 222	 12months	 WOMAC	 na	 Linear	regression	 Not	reported	
Lopez-olivio	
et	al.	
2011	 Psychosocial	determinants	
of	outcomes	in	knee	
replacement	 272	 31	 6	months	 WOMAC	 KSRS	 Multiple	linear	regression	 80%	power	to	detect	a	cumulative	R2	
as	small	as	
0.067	with	10	
independent	
variables.			
Nunez	et	al.	 2011	 Factors	influencing	health-
related	quality	of	life	after	
TKA	in	patients	who	are	
obese	
63	 3	 12	
months	 WOMAC	 na	 Linear	regression	 Not	reported	
Clement	et	
al.	
2012	 The	outcome	of	primary	
total	hip	and	knee	
arthroplasty	in	patients	aged	
80	years	or	more	
677		total	
(185	cases	
>80,	492		
controls	
<80)	
None	
mentioned	 12	months	 OKS	 SF-12,	Satisfactio
n	 Mann	Whitney	U	test		 Not	reported	
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Figure	5:	Flow	diagram	of	included	studies.		Adapted	from	Moher	et	al.66	
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Additional	records	identified	through	
other	sources:	
	
e.g.	bibliographic	search,	ISRCTN	
Records	after	duplicates	removed	
(n	=2287)	
Records	screened	
(n	=2287)	
Records	excluded	
(n	=2202)	
	
	
Full-text	articles	assessed	
for	eligibility	
(n	=78)	
Full-text	articles	excluded	
(n	=	56)	
	
No	PROM	=	14		
No	attempt	to	find	an	association	
between	pre-op	factors	and	
outcome	=	13	
Not	enough	data	available	(e.g.	full	
text	not	in	English,	Conference	
proceeding)	=	9	
No	analysis	of	OA	knee	patients	
separately	=	8	
Data	already	used	in	another	
(included)	study	=	7	
Incorrect	study	design	=	5	
	
Studies	included	in	
qualitative	synthesis	
(n	=22)	
Records	identified	through	database	
searching:	
	
Medline	
Embase	
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Quality	assessment	Table	8	describes	the	quality	assessment	using	the	Newcastle	Ottawa	scale.		The	quality	of	studies	is	judged	under	three	broad	categories:	Selection	(maximum	four	stars),	Comparability	(maximum	two	stars),	and	Outcome	(maximum	3	stars).				
Table	8:	Quality	Assessment	(NOS)	
					 	
Author	 Year	 Selection	 Comparability	 Outcome	
Sharma	et	al.	 1996	 3	 0	 2	
Heck	et	al.	 1998	 3	 0	 3	
Fortin	et	al.	 1999	 3	 0	 2	
Kiebzak		 2002	 3	 0	 2	
Allyson	Jones	et	al.	 2003	 3	 0	 1	
Lingard	et	al.	 2004	 3	 2	 3	
Mizner	et	al.	 2005	 3	 1	 2	
Lim	et	al.	 2006	 2	 0	 2	
Nunez	et	al.	 2007	 3	 0	 2	
Bourne	et	al.	 2007	 3	 0	 2	
Escobar	et	al.	 2007	 4	 2	 2	
Cushnaghan	et	al.	 2008	 4	 1	 2	
Davis	et	al.	 2008	 4	 2	 3	
Franklin	et	al.	 2008	 4	 2	 2	
Rajgopal	et	al.	 2008	 4	 2	 2	
Nilsdotter	et	al.	 2009	 3	 2	 3	
Nunez	et	al.	 2009	 4	 0	 3	
Dowsey	et	al.	 2010	 4	 2	 3	
Ghandi	et	al.	 2010	 4	 2	 3	
Lopez-olivio	et	al.	 2011	 4	 1	 3	
Nunez	et	al.	 2011	 4	 0	 3	
Clement	et	al.	 2012	 4	 0	 3	
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Outcome	measures	Various	outcome	measures	were	used	including:		 - OKS	–		a	12	item,	5-point	Likert	scale	questionnaire.		Higher	scores	reflect	better	pain	and/or	function	in	the	knee.		This	is	the	PROM	used	by	the	DoH.		It	has	been	well	validated	for	patients	undergoing	knee	replacement.17,112	- WOMAC	–	the	WOMAC	measures	five	items	for	pain	(score	range	0–20),	two	for	stiffness	(score	range	0–8),	and	17	for	functional	limitation	(score	range	0–68).		Total	range	of	0-96	with	higher	scores	being	worse.	It	is	well	validated	for	this	group	of	patients.113		- KSRS	–	A	combination	of	assessment	of	instability,	pain,	range	of	motion,	and	patient	function.		This	system	has	PROM	and	physician	assessment.		Higher	sores	indicate	a	better	functioning	knee	(continuous	variable).108		- KSS	–	Assessment	identical	to	the	KSRS;	however	there	is	not	assessment	of	patient	function.108			- KOOS	–	Likert	scoring	system	over	5	subscales	(pain,	other	symptoms,	Activities	of	Daily	Living	(ADL),	sports	and	recreational	activities,	and	knee	related	quality	of	life)	producing	a	continuous	score	from	0	(extreme	symptoms)	to	100	(no	symptoms).113		- SF-36	–	a	36-item	general	health.114	The	SF-36	measures	eight	domains	of	health,	which	can	used	to	produce	summary	scores	for	Physical	and	Mental	domains.		It	is	a	continuous	variable	with	higher	scores	reflecting	better	health.		The	SF-12	is	a	shorter,	12-item	version.				
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Candidate	predictors	Table	9	displays	the	relationship	between	patient	factors	and	outcome.		This	table	has	been	produced	so	that	any	statistically	significant	associations	can	be	seen.		Of	note,	where	a	study	provided	univariate	and	multivariate	analysis,	only	the	results	of	the	multivariate	analysis	are	included	in	the	table.			In	brief,	factors	that	have	clearly	been	associated	with	a	poor	outcome	include:	- Worse	pre-operative	knee	function	scores;90-94,115-120	- Psychosocial	factors	including	decreased	social	support,	more	depression,	decreased	ability	to	cope,	and	various	general	measures	of	mental	health;90,92,94,119,120	- A	higher	number	of	other	joints	affected	(joint	co-morbidity);118,119	- Certain	anthropomorphic	measurements	designed	to	identify	short,	thick	legs.121		Factors	that	have	been	inconsistently	linked	with	outcome	include:	- Medical	co-morbidity	has,	in	some	studies,	been	associated	with	a	worse	post-operative	function,92,115,120,121	although	other	studies	of	reasonable	size	have	not	found	a	correlation;90,91,118,122-124	- BMI	has	been	associated	with	worse	outcome,92,94,117,123,125	and	more	complications,125	however	several	studies	have	found	no	correlation;115,118-120,122	- Some	studies	have	demonstrated	no	difference	in	outcome	with	female	gender,90,91,94,115,119,120,122	however,	four	large	cohort	studies	have	found	a	correlation,	suggesting	that	female	gender	is	a	predictor	of	poor	functional	outcome	following	surgery;92,118,123,126	
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- Some	studies	have	demonstrated	increasing	age	is	not	associated	with	outcome,91,117,119,120,122,	several	large	studies	have	found	a	correlation	with	worse	outcome,	92,94,115,118,127,	with	one	study	finding	an	association	with	better	outcome	(however,	this	study	dichotomised	the	SF-36	PCS).90		Education,	smoking,	ethnicity,	quadriceps	strength,	and	income	had	either	non-significant	results,	or	produced	correlations	that	were	too	small	to	be	of	clinical	significance.
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Table	9:	Factors	associated	with	outcome	in	knee	replacement	(continued	to	page	128)	
Author	 Age	 Gender	 BMI	 Knee	function	 Comorbidities	 Psychological	
measures	
Other	
Sharma	et	al.,	
1996	
Increasing	age	not	
associated	with	SF-36	
PF	(p=0.874)	 Gender	not	associated	with	SF-36	PF	(p=0.083)	 Increasing	BMI	not	associated	with	SF-36	PF	
(p=0.805)	
Physical	function	
(PF	domain	of	SF-
36)	not	associated	
with	SF-36	PF	
(p=0.103)	
Increasing	numbers	of	
comorbidities	not	
associated	with	SF-36	
PF	(p=0.053)	
Social	function	was	
associated	with	SF-36	
PF		(p=0.027),	but	
Role	functioning	
emotional	(p=0.06)	
and	Motivation	
(p=1.64)	were	not	
Lower	level	of	education	
(p=0.119),	quadriceps	
strength	(p=0.788)	and	
social	support	(p=0.466)	
were	not	associated	with	
SF-36	PF	
Heck	et	al.,1998	 Increasing	age	
associated	with	better	
SF-36	PF*	(OR	1.09)	 Gender	not	associated	with	SF-36	PF		 -	 Baseline	WOMAC	associated	with	better	SF-36	PF	(OR	
=	1.1)	
Comorbidities	not	
associated	with	SF-36	
PF	 Better	pre-operative	SF-36	MF	predicted	better	SF-36	PF	(OR	=	
1.11)	
	-	
Fortin	et	al.,	1999	 Age	not	associated	
with	SF-36	PF,	WOMAC	
Pain,	or	WOMAC	
Function	
Gender	not	
associated	with	
SF-36	PF,	WOMAC	
Pain,	or	WOMAC	
Function	
-	 Better	SF-36	PF	
associated	with	
better	SF-36	PF	
post-operative	
(0.36+/-	0.13)	and	
better	WOMAC	
function	(0.61+/-
0.11)	
Comorbidities	not	
associated	with	SF-36	
PF,	WOMAC	Pain,	or	
WOMAC	Function	
-	 Lower	level	of	education	
not	associated	with	SF-
36	PF,	WOMAC	Pain,	or	
WOMAC	Function	
Kiebzak	et	al.,	
2002	
-	 Female	gender	
associated	with	
worse	SF-36	
(p<0.04)	
-	 -	 -	 -	 	-	
Allyson	Jones	et	
al.,	2003	
Increasing	age	
associated	with	worse	
WOMAC	function	
(p=0.05;	0.35+/-25),	
but	not	with	SF-36	PF	
(p=0.12)	
Female	gender	
not	associated	
with	WOMAC	
(p=0.91)	or	SF-36	
PF	(p=0.39)	
Increasing	BMI	
not	associated	
with	WOMAC	or	
SF-36.			
WOMAC	associated	
with	better	
WOMAC	(p<0.001;	
0.3	+/-0.13)	and	SF-
36	(p<0.001;	
0.36+/-0.09)	
Increasing	number	of	
comorbidities	
associated	with	worse	
WOMAC	function	score	
(p=0.005;	1.62+/-1.13)	
but	not	pain	score	
-	 	-	
*This	result	represents	a	logistic	regression	on	a	dichotomised	SF-36	PCS	
OR	=	Odds	ratio.	P	values	combined	with	model	coefficients	and	95%	confidence	intervals	(in	parenthesis)	are	given	when	they	were	reported.		Values	are	for	the	results	
of	multiple	regression	models	when	this	was	conducted,	or	univariate	models	when	no	multivariate	model	was	performed.		
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Table	9	(cont.)	
Author	 Age	 Gender	 BMI	 Knee	function	 Comorbidities	 Psychological	
measures	
Other	
Lingard	et	al.,	
2004	
Increasing	age	
associated	with	worse	
SF-36	PF	 Female	gender	associated	with	worse	WOMAC	
pain,	but	not	
function.		
Higher	BMI	
associated	with	
worse	SF-36	PF,	
not	MF	or	
WOMAC	
Better	baseline	
WOMAC	and	SF-
36	associated	
with	better	
WOMAC	and	SF-
36	PF	
Increasing	number	of	
co-morbidities	
associated	with	worse	
SF-36	PF;	not	MF	or	
WOMAC	
Better	pre-operative	
SF-36	MF	predicted	
better	SF-36	PF	and	
better	WOMAC	
		
Mizner	et	al.,	
2005	
Increasing	age	not	
associated	with	SF-36	
PCS	 -	 	-	 -		 	-	 -		 Quadriceps’	strength	not	associated	SF-36	PCS	
Lim	et	al.,	2006	 -	 -	 -	 Better	pre-op	
OKS	associated	
with	better	OKS	
(P=0.017)	
-	 -	 -		
Nunez	et	al.,	2007	 Increasing	age	not	
associated	with	
WOMAC	 Gender	not	associated	with	WOMAC	 Severe	(Class	III)	obesity	(BMI	35-39.9	kg/m2)	was	
associated	with	
more	WOMAC	
pain	(P=0.049),	
but	not	function	
Not	reported	 -	 -	 -		
Bourne	et	al.,	
2007	
Patients	over	80	years	
of	age	had	lower	(p			
0.01)	WOMAC		
(Univariate)	
Not	significant	
(Univariate)	 Not	significant	(univariate)	 Not	reported	 -	 -	 -		
OR	=	Odds	ratio.	P	values	combined	with	model	coefficients	and	95%	confidence	intervals	(in	parenthesis)	are	given	when	they	were	reported.		Values	are	for	the	results	
of	multiple	regression	models	when	this	was	conducted,	or	univariate	models	when	no	multivariate	model	was	performed.	
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Table	9	(cont.)	
Author	 Age	 Gender	 BMI	 Knee	function	 Comorbidities	 Psychological	
measures	
Other	
Escobar	et	al.,	
2007	
Increasing	age	
associated	with	
worse	WOMAC	
pain	(p=0.04)	and	
stiffness	(p=0.046)	
but	not	functional	
limitation	(p=0.08;		
Female	gender	
associated	with	
worse	functional	
limitation	
(p=0.008)	and	
stiffness	(p=0.03)	
but	not	pain	
(p=0.06)	
-	 Better	WOMAC		
associated	with	better	
WOMAC		 Charlston	index	associated	with	WOMAC	pain	
(p=0.005),	
functional	
limitation	
(p=0.008),	but	not	
stiffness	(p=0.3)		
Better	pre-op	SF-
36	MH	
associated	with	
WOMAC	pain	
(p=0.001),	
functional	
limitation	
(p=0.005)	and	
stiffness	(p=0.03)	
Low	back	pain	associated	with	
WOMAC	pain	(p<0.001),	function	
(p=0.01),	and	stiffness	(p=0.002)	
and	lack	of	social	support	
associated	with	WOMAC	pain	
(p=0.02),	function	(p=0.002),	but	
not	stiffness	(p=0.051).		Better	
pre-op	SF-36	domains	associated	
with	WOMAC	pain,	functional	
limitation,	and	stiffness	
Cushnaghan	et	
al.,	2008	
Age	over	75	years	
associated	with	
worse	SF-36	PF	(-
9.1	(-16.9	to	-1.2))	
Female	gender	
associated	with	
worse	SF-36	PF	(-
7.5 (-14.9 to 0.0)  
		
BMI	over	30	not	
associated	with	
SF-36	PF	(-4.6 (-
14.5 to 5.3)  
		
Better	pre-op	SF-36	PF	
associated	with	worse	
SF-36	PF	change	score	
(24.6	(26.3	to	22.9)**	
Individual	
comorbidities	not	
associated	with	
worse	SF-36	PF	
change	scores	
_	 Joint	comorbidity	(joint	count)	
predicted	worse	SF-36	PF	
(p=0.03);	Smoking	(-5.1	(-17.1	to	-
6.9)	and	pre-op	radiological	status	
(5.6	(-2.8	to	14.1)	not	associated	
with	outcome.			
Davis	et	al.,	2008	 _	 _	 _	 _	 _	 _	 Lower	income	was	not	associated	
with	outcome	(WOMAC	6	and	24	
months)	except	for	WOMAC	Pain	
at	12	months	(p=0.014)	Education	
was	not	associated	with	WOMAC	
at	any	time	point	(p=	0.36-0.97)	
Franklin	et	al.,	
2008	
Age	not	associated	
with	SF-12	PCS	
(p=0.073;	model	
coefficient=	-0.031	
(-0.065	to	0.003)	
Gender	was	not	
associated	with	
SF-12	PCS	
(p=0.033)	
Higher	BMI	was	
associated	with	
worse	SF-12	PCS	
(p=0.001;	model	
coefficient	=-
1.068	(-1.689	to	-
0.447)	
Better	pre-op	SF-12	
PCS	associated	with	
worse	SF-12	PCS	
change	score**		
(p<0.001;	model	
coefficient=-0.844	(-
0.903	to	-0.784)	
_	 	Better	SF-12	
MCS	was	
associated	with	
better	SF-12	PCS	
(p=0.01;	model	
coefficient	0.038	
(0.009	to	0.066)	
_	
**The	SF-36	PF	change	score	was	used,	rather	than	adjusting	for	the	baseline	score	by	using	it	as	a	covariate	within	the	model.		This	suggests	that	the	change	score	is	
lower	for	higher	functioning	individuals,	but	does	not	reflect	the	absolute	score	achieved.	
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Table	9	(cont.)	
Author	 Age	 Gender	 BMI	 Knee	function	 Comorbidities	 Psychological	
measures	
Other	
Rajgopal	et	al.,	
2008	
Age	not	associated	
with	WOMAC	
(p=0.967;	model	
coefficient=	0.004	(-
0.169	to	0.176)	
Gender	not	
associated	with	
WOMAC	(p=0.279;	
model	coefficient	
not	displayed	as	
no	reporting	on	
reference	group)	
BMI	over	40	
associated	with	
worse	WOMAC	
(p=0.027;	model	
coefficient=	-5.188	(-
9.711	to	-0.606)				
Better	baseline	
WOMAC	
associated	with	
better	WOMAC	
(p<0.001;	model	
coefficient	=0.301	
(0.202	to	0.399)	
Worse	Charnley	Hip	
grade	had	worse	
post-operative	
WOMAC	(p=0.012;	
model	coefficient	=	-
4.897	(-8.701	to	-
1.093)	
Higher	SF-12	MCS	
associated	with		higher	
WOMAC	(p=0.005;	
model	coefficient	=	
0.210	(0.063	to	0.357)	
Prior	contralateral	TKA	
made	no	difference	to	
one	year	WOMAC	
(p=0.279;	model	
coefficient	=	3.157	(-
2.487	to	8.8))	
Nilsdotter	et	al.,	
2009	
_	 _	 _	 _	 _	 _	 Expectation	not	
associated	with	KOOS	
(univariate)	
Nunez	et	al.,	2009	 _	 Female	gender	
associated	with	
worse	WOMAC	
function	(p=0.015;	
model	coefficient	
=	14.4	(2.8	to	
25.9))		WOMAC	
stiffness	and	pain	
not	reported	
BMI	over	35	
associated	with	
worse	WOMAC	pain	
(<0.001;	model	
coefficient	=	9.7	
(4.3–14.4)),	function	
(p=0.042,	model	
coefficients	=	5.4	(0.3	
to10.8))	
Baseline	WOMAC	
not	associated	
with	WOMAC	
domains.			
Number	of	
comorbidities	not	
associated	with	
WOMAC	
_	 _	
Dowsey	et	al.,	
2010	
_	 _	 Non-obese	and	
obese	had	improved	
outcomes	compared	
with	morbidly	obese	
patients	in	12	
months	SF-36	PF	(p	=	
0.05)	
_	 _	 _	 _	
OR	=	Odds	ratio.	P	values	combined	with	model	coefficients	and	95%	confidence	intervals	(in	parenthesis)	are	given	when	they	were	reported.		Values	are	for	the	results	
of	multiple	regression	models	when	this	was	conducted,	or	univariate	models	when	no	multivariate	model	was	performed.		
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Table	9	(cont.)	
Author	 Age	 Gender	 BMI	 Knee	function	 Comorbidities	 Psychological	measures	 Other	
Ghandi	et	al.,	
2010	
Age	not	associated	with	
WOMAC		
Gender	
not	
associat
ed	with	
WOMAC	
A	diagnosis	of	
obesity	resulted	in	
worse	WOMAC	
scores	(p=0.04;	
model	coefficient	
=	3.6	(0.02,	7.2)	
Not	reported	 Increasing	number	of	
Metabolic	Syndrome	
comorbidities	(BMI	>	30	
kg/m2,	diagnosis	of	
hypercholesterolemia,	
hypertension,	or	
diabetes)	was	
associated	with	worse	
WOMAC	(pain	(p=0.02;	
function,	p=0.006)	
_	 _	
Nunez	et	al.,	
2011	
-	 -	 -	 -	 Increasing	number	of	
comorbidities	
associated	with	worse	
WOMAC	scores	
(p=0.012)	
-	 Ratio	of	length	to	girth	
of	leg	associated	to	
WOMAC	score	(i.e.	
short,	fat	legs	associated	
with	worse	WOMAC	pain	
(p=0.021)	and	function	
(p=0.023)	
Lopez-olivio	et	
al.,	2011	
-	 -	 Increased	BMI	was	
not	associated	
with	WOMAC	
function	(p=0.5;	
model	coefficients	
=	0.1	(0.05)		or	
pain	(p=0.07;	
model	coefficients	
=	0.3	(0.11)	)	
Better	baseline	
WOMAC	
associated	with	
better	WOMAC	
pain	(p<0.001;	
model	
coefficients	=	0.2	
(0.25))	
Increasing	number	of	
comorbidities	
associated	with	worse	
WOMAC	pain	score	
(p=0.008;	model	
coefficient	=	3.0	(0.17),	
but	not	function	score	
(p=0.06;	model	
coefficient	=	0.6	(0.04)).	
Increased	social	support	
(p=0.01;	model	
coefficient	=	−2.7	
(−0.15)),	less	depression	
(p=0.02;	model	
coefficient	=	0.4	(0.15)),	
and	increased	ability	to	
cope	(p=0.01;	−5.3	
(−0.20))	predicted	better	
WOMAC	function.			
Less	education	predicted	
worse	WOMAC	pain	
(p=0.01;	model	
coefficient	=	−1.6	
(−0.17).		Ethnicity	was	
not	associated	with	
WOMAC	(p>0.3,	
univariate).			
OR	=	Odds	ratio.	P	values	combined	with	model	coefficients	and	95%	confidence	intervals	(in	parenthesis)	are	given	when	they	were	reported.		Values	are	for	the	results	
of	multiple	regression	models	when	this	was	conducted,	or	univariate	models	when	no	multivariate	model	was	performed.	
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Table	9	(cont.)	
Author	 Age	 Gender	 BMI	 Knee	function	 Comorbidities	 Psychological	measures	 Other	
Clement	et	al.,	
2012	
Patients	over	80	were	
associated	with	worse	12	
month	SF-12	PCS	(p=0.04),	
but	not	OKS	(p=0.16)	or	SF-
12	MCS	(p=0.49)	
_	 _	 _	 _	 _	 _	
OR	=	Odds	ratio.	P	values	combined	with	model	coefficients	and	95%	confidence	intervals	(in	parenthesis)	are	given	when	they	were	reported.		Values	are	for	the	results	
of	multiple	regression	models	when	this	was	conducted,	or	univariate	models	when	no	multivariate	model	was	performed.		
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	The	aim	of	this	review	was	to	identify	prognostic	factors	that	could	be	tested	within	a	cohort	study	in	the	production	of	a	prognostic	model.		Therefore,	any	factor	that	had	evidence	of	an	association	was	relevant:	a	graphic	representation	of	the	candidate	patient	factors	identified	in	this	review,	and	the	number	of	studies	demonstrating	an	association	with	those	factors,	is	displayed	in		Figure	6.		Figure	7	is	an	identical	chart,	demonstrating	the	number	of	patients.
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	Figure	6:	Number	of	Studies	demonstrating	an	association	between	patient	factors	and	PROMs.		One	study	found	an	association	between	improved	SF-36	PCS	and	
increased	age;	however,	it	dichotomised	the	SF-36	outcome	measure	and	has	not	been	displayed.		This	figure	does	not	represent	any	pooled	estimates	(i.e.	meta-analysis).		
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Figure	7:	Number	of	patients	in	studies	demonstrating	an	association	between	patient	factors	and	PROMs.		One	study	found	an	association	between	improved	SF-36	PCS	
and	increased	age;	however,	it	dichotomised	the	SF-36	outcome	measure	and	has	not	been	displayed.		This	figure	does	not	represent	any	pooled	estimates	(i.e.	meta-
analysis)		 	
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5.3.3 Discussion	
Functional	Findings	The	strongest	and	most	consistent	associations	were	between	pre-operative	knee	status	and	post-operative	knee	status:	those	with	higher	pre-operative	function	had	higher	post-operative	function.		However,	the	Cushnaghan	paper	that	reviewed	change	scores	found	a	lower	change	score	for	those	with	higher	pre-operative	knee	status	suggesting	that	patients	with	lower	pre-operative	scores	achieve	lower	absolute	post-operative	scores,	but	achieve	more	health	gain	(as	measured	by	the	change	score	in	the	PROMs).		This	finding	has	been	supported	by	a	recent	paper	by	Judge.26		However,	PROMs	scores	are	not	linear	in	their	measurements,	and	different	health	gains	will	mean	different	amounts	to	each	patient.				What	is	yet	to	be	clarified	is	how	the	improvement	in	knee	status	relates	to	the	patient’s	perception	of	their	outcome.		This	has	been	explored	within	the	issues	of	patient	satisfaction,	but	so	far	there	are	no	robust	definitions	of	this	term	and	also	no	reliable	tools	available	for	its	measurement.		However,	it	does	highlight	the	issue	of	value	judgements	that	patients	make;	in	particular	to	knee	replacements,	the	judgement	about	the	timing	of	the	surgery	may	be	relevant	as	patients	with	lower	knee	status	may	well	also	have	lower	expectations	and	demands	from	their	surgery	leading	to	a	better	perception	of	outcome.		
Demographic	Factor	Findings	Age,	gender	and	BMI	demonstrated	associations	in	several	of	the	larger	cohorts	with	no	significant	findings	in	all	of	the	smaller	studies.		All	but	one	study118	looked	at	absolute	scores	as	opposed	to	change	scores.			In	general,	the	trend	was	towards	worse	
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outcomes	for	increasing	age,	female	gender	and	a	higher	BMI;	however,	the	size	of	these	changes	means	that	the	clinical	importance	in	questionable.				
Psychological	Factors	Findings	The	influence	of	psychological	factors	was	only	studied	in	six	of	the	included	papers,	but	in	each	one	there	was	a	significant	association	in	the	direction	of	improved	psychological	scores	being	associated	with	better	outcomes.		In	the	past	the	measurement	of	psychological	factors	have	been	restricted	to	general	mental	health	or	levels	of	anxiety	and	depression.		With	the	increased	popularity	of	practical	psychometric	tools	that	can	explore	dimensions	outside	of	traditional	depression,	a	marked	increase	in	the	number	of	significant	explanatory	factors	can	be	expected.		The	notion	of	modifying	psychological	attributes	and	the	effect	of	this	modification	on	outcome	is	an	interesting	avenue	that	requires	further	exploration.		
Review	limitations			The	aim	of	this	review	was	to	identify	candidate	prognostic	factors	that	could	be	tested	within	a	cohort	study	in	the	production	of	a	prognostic	model.		Therefore,	any	factor	that	had	evidence	of	an	association	was	relevant.		Formal	meta-analysis	was	not	required	to	meet	the	aim.			English	language	articles	were	specified	in	the	inclusion	criteria	for	full	paper	review,	but	not	in	the	search	strategy.		So	although	the	possibility	of	missing	important	information	from	other	sources	existed,	in	practice	there	were	no	fully	published	papers	in	other	languages	that	would	have	met	the	inclusion	criteria.		
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Several	studies	comprised	only	small	numbers	of	patients	(less	than	300)	and	therefore	may	not	have	had	the	power	to	detect	associations:	for	example,	Sharma	et	al.	included	52	patients	in	a	regression	model	with	13	explanatory	variables.		There	was	a	trend	towards	a	greater	number	of	associations	amongst	the	larger	studies.		Two	papers	that	were	not	included	in	this	review	deserve	mention.		Sullivan	et	al.	published	a	paper	in	2011	that	was	not	identified	by	our	search	criteria	at	the	time,	but	has	been	identified	running	an	identical	search	subsequently.128		A	possible	reason	for	this	is	that	there	was	a	delay	in	indexing	this	article,	which	led	to	it	being	omitted	from	our	search.		This	study	examined	120	patients	and	found	that	pain	catastrophising	(rumination	over	pain	and/or	description	of	it	in	more	exaggerated	terms)	was	associated	with	outcome.		The	second	paper,	by	Lingard	et	al.	in	2007,	used	an	identical	population	of	patients	to	the	paper	by	the	same	author	included	in	the	review.129		This	used	the	same	data,	but	dichotomised	the	SF-36	scores	into	those	who	were	psychologically	distressed	and	those	who	were	not.		Psychological	distress	was	associated	with	a	worse	outcome,	consistent	with	their	previous	findings.				There	was	some	variation	in	the	length	of	follow	up	between	studies.		This	has	the	potential	to	introduce	a	form	of	timing	bias	as	it	has	been	shown	that	the	functional	status	of	knees	after	replacement	can	improve	for	around	2	years	following	surgery,	although	patients	tend	to	follow	the	same	trajectory	(i.e.	patients	with	poorer	outcomes	at	six	months	have	poorer	outcomes	at	one	and	two	years).130		Studies	that	did	not	show	associations	in	some	domains	might	well	have	done	so	if	the	length	of	follow	up	was	extended.		Despite	using	similar	outcome	measures,	the	use	of	change	scores	in	some	studies	as	opposed	to	absolute	scores	has	the	potential	to	give	rise	to	different	degrees	of	
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association	from	the	same	population.122	Overall,	however,	it	was	felt	that	the	directions	of	these	associations	were	similar.		Systematic	reviews	are	always	subject	to	publication	bias	and	in	particular	the	delay	or	lack	of	publication	of	studies	with	negative	findings.131	I	tried	to	minimise	this	by	including	all	archived,	published	research	from	each	of	our	searched	databases.		This	resulted	in	a	large	attrition	rate	from	over	2000	papers	down	to	22,	but	the	possibility	remains	that	some	evidence	may	remain	unpublished.		This	is	more	likely	from	older,	less	well-designed	studies,	as	the	resources	required	performing	a	high	quality	modern,	observational	study	would	make	publication	more	likely	irrespective	of	the	findings.			Finally,	in	some	studies	the	parameter	estimates	of	significant	candidate	factors	were	so	small	that	they	were	unlikely	to	represent	clinically	meaningful	findings	despite	being	statistically	significant.		
5.3.4 Summary	Only	a	few	factors	have	been	demonstrated	to	consistently	affect	outcome.		These	include	pre-operative	knee	status,	psychological	wellbeing,	social	support	and	certain	anthropometric	measurements.		There	are	issues	with	the	quantification	of	the	size	of	their	influence.				To	date	no	single	study	has	sought	to	measure	them	all	adequately.		There	is	still	a	need	for	a	well-powered	study	that	uses	tools	with	adequate	resolution	to	investigate	them,	particularly	psychological	factors.	The	next	Chapter	details	the	development	of	a	protocol	for	a	multicentre	cohort	study	designed	to	develop	an	outcome	prediction	tool	for	patients	considering	a	total	knee	replacement,	based	on	this	systematic	review.	
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However,	as	this	systematic	review	was	completed	in	2012,	an	update	on	some	of	the	important	advances	since	then	is	described	in	the	following	pages.			 	
	 139	
5.4 Update	on	work	since	2012		
	The	review	described	previously	formed	the	basis	for	the	design	of	the	cohort	study	and	is	presented	in	its	original	form	to	provide	context	for	chapters	6	and	7.			Since	the	completion	of	this	review	in	2012,	there	has	been	a	plethora	of	work	on	pre-operative	variables	that	could	predict	outcome	in	knee	replacement,	combined	with	examining	variables	over	the	entire	patient	pathway.	This	section	details	the	results	from	individual,	key	studies	and	reviews	on	the	topic	to	provide	an	up	to	date	account	of	potential	prognostic	factors.				
Expectations	The	effect	pre-operative	expectations	have	on	PROMs	has	been	studied	in	detail.		Most	reviews	have	included	both	knee	and	hip	replacements	together,132-134	but	combining	these	operations	is	potentially	flawed	as	they	differ	not	only	by	outcome	(and,	one	would	expect,	by	pre-operative	expectation),17	but	also	by	patient	demographics	and	potentially	aetiology.58,59	The	findings	of	these	reviews	are	conflicting,	potentially	due	to	the	combination	of	hip	and	knee	replacements,	to	the	different	PROMs	used,	and	different	measures	on	expectation.					The	effect	of	pre-operative	expectations	on	satisfaction	has	also	been	studied.		This	has	particular	interest,	as	one	of	the	potential	effects	of	a	predictive	tool	is	to	alter	pre-operative	expectations,	and	therefore	potentially	affect	satisfaction	rates	by	decreasing	the	number	of	patients	with	a	mismatch	between	expected	and	actual	results.		To	investigate	this	relationship	I	conducted	a	systematic	review	of	the	literature	examining	if	pre-operative	expectations	were	linked	to	post-operative	satisfaction	in	total	knee	replacements.		This	review	included	only	four	papers	and	was	again	
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conflicting,	demonstrating	either	small	effects,	or	no	effects.		This	was	potentially	due	to	every	paper	using	a	different	measure	of	satisfaction	and	expectation,	and	one	of	the	main	findings	from	this	paper	was	the	inconsistency	in	measuring	tools	for	both	satisfaction	and	expectations.41						The	inconsistency	in	measuring	tools	may	be	due	to	the	difficulty	in	measuring	constructs	such	as	expectations	and	satisfaction.		Multiple	theoretical	models	exist	to	try	and	explain	some	of	the	complexity.		For	example	the	latent	state-trait	theory	suggests	that	with	measurement	instruments	we	measure	a	person’s	state,	which	will	depend	upon	the	person	(the	person’s	traits),	the	situation	(the	state	the	person	finds	themselves	in),	and	the	interaction	between	the	person	and	situation.135		This	highlights	the	difficulty	in	measuring	these	constructs	consistently	and	accurately,	and	may	go	some	way	to	explain	the	low	numbers	of	studies	examining	this	key	issue.		It	seems	likely	that	until	the	orthopaedic	community	can	reach	a	consensus	on	what	is	important	to	measure,	and	how	to	measure	it,	progress	will	be	slow.				There	are	other	studies	that	suggest	that	expectation	is	related	to	outcome.		Expectation	fulfilment	describes	if	a	patients	expectations	have	been	met	or	not	post-operatively.136		As	a	post-operative	measure,	it	is	not	useful	in	developing	a	prediction	tool,	but	it	is	logical	that	patients	whose	expectations	are	not	fulfilled	are	likely	to	be	less	satisfied.		This	would	support	the	view	that	pre-operative	expectations	are	related	to	satisfaction,	as	expectation	fulfilment	depends	not	only	on	the	function	and	pain	outcomes,	but	if	that	meets	what	the	patient	expected.		The	link	between	expectation	fulfilment	and	outcome	(function,	pain	and	satisfaction)	has	been	demonstrated	in	the	literature,136	suggesting	that	pre-operative	expectations	do	indeed	affect	satisfaction.		However,	a	further	layer	of	complexity	exists	when	the	shift	in	patients’	view	of	what	is	healthy	or	to	be	expected	over	the	course	of	their	treatment	(response	shift)	is	
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considered.137		This	means	that	what	a	patient	expects	changes	over	the	course	of	their	treatment,	and	therefore	pre-operative	expectations	cannot	be	used	as	a	measure	of	whether	or	not	a	patient’s	expectations	have	been	met	post-operatively	(as	they	may	have	changed).		What	is	clear	from	this	body	of	work	is	that	if	a	patient	feels	their	expectations	have	been	met	(even	if	their	pre-operative	expectations	have	not	been	met)	they	are	more	likely	to	be	satisfied.136,138-140			
Psychological	factors	In	2012	Vissers	et	al.l	conducted	a	systematic	review	of	psychological	factors	associated	with	outcome	in	knee	replacement.141	Results	were	similar	to	the	review	presented	above,	with	poorer	mental	health,	measured	by	the	SF-12	or	SF-36,	demonstrating	poorer	pain	and	function	outcomes.		Pain	catastrophisation	was	associated	with	more	pain	post-operatively;	pre-operative	depression	and	expectations	had	conflicting	evidence	of	an	effect	on	outcome.		A	systematic	review	and	meta-analysis	from	Lewis	et	al.	in	2014	examining	factors	that	predicted	persistent	pain	concluded	that	mental	health	and	catastrophising	predicted	post-operative	pain.142	In	2012	Judge	et	al.	reported	on	a	cohort	of	almost	2000	patients,	detailing	that	anxiety	and	depression	were	among	the	main	determinants	of	outcome.22	Clement	also	reported	a	paper	detailing	the	improvement	in	mental	health	that	patients	experience	over	the	course	of	a	knee	replacement.143		In	2015,	Baert	et	al.	conducted	a	review	on	the	effect	central	modulation	of	pain	has	on	outcome	in	knee	replacement.144		Central	modulation	was	thought	to	occur	via	a	biopsychosocial	model	–	inherent	to	this	is	the	proposition	that	altered	inhibitory	and	facilitatory	pain	mechanisms	lead	to	altered	sensory	processing	in	the	brain.		Emotions	and	cognitions	can	regulate	pain	pathways	(so	called	“cognitive	emotional	modulation”).		The	review	found	three	broad	methods	of	testing	for	central	modulation	
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of	pain:		psychosocial	variables	(cognitive	emotional	modulation)	as	measured	by	questionnaires	testing	various	psychological	constructs	(e.g.	locus	of	control,	depression,	anxiety,	catastrophising);	clinical	manifestations	of	altered	central	pain	modulation	(only	one	study	examined	this	using	pain	at	rest	as	representing	altered	central	pain	modulation);	and	quantitative	sensory	testing	(using	stimulation	to	test	pain	thresholds).		For	psychosocial	variables	the	authors	concluded	that	catastrophic	thinking,	poor	coping	strategies,	and	depression	could	affect	outcome,	whereas	anxiety	is	unlikely	to.		Pain	at	rest	is	associated	with	worse	pain	post-operatively,	although	the	authors	point	out	that	pain	at	rest	may	not	be	due	to	central	sensitisation,	but	pain	from	structural	factors	in	the	joint	itself.		Pain	threshold	testing	found	that	patients	with	lower	pain	thresholds	pre-operatively	had	poorer	pain	outcomes.				
Co-morbidities	In	2013,	Clement	et	al.	reported	a	study	including	over	2000	patients,	where	low	back	pain	was	an	independent	predictor	of	worse	post-operative	OKS	and	satisfaction,145	and	Lewis	found	that	co-morbidities	were	predictive	of	post-operative	pain.142		
Socioeconomic	class	In	2013	Clement	et	al.,	using	the	same	cohort	of	patients	that	identified	back	pain	as	a	predictor	of	outcome,	reported	that	socioeconomic	class	was	an	important	determinant	of	outcome,146	with	higher	socioeconomic	class	associated	with	better	outcome.		This	was	consistent	with	a	finding	by	Judge	et	al.	in	2012.22				
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National	Registry	data	Baker	at	al	has	published	studies	using	data	from	the		HESS	and	the	NJR.		One,	mentioned	in	the	introduction	to	this	chapter,	used	over	20,000	patients,	and	found	that	pre-operative	PROM	score,	pre-operative	general	health	rating,	and	the	presence	of	anxiety	and	depression	were	the	largest	predictors	of	outcome.95		In	2013,	Baker	at	al	again	used	national	registry	data	to	assess	the	value	of	pre-operative	variables	on	satisfaction,	finding	that	they	were	not	as	important	in	determining	satisfaction	as	post-operative	variables.147		A	caveat	to	this	finding	is	the	limited	amount	of	data	on	psychological	factors	the	NJR	dataset	produces.			
	
The	link	between	satisfaction	and	PROMs	Two	papers	of	note	have	examined	the	link	between	the	OKS	and	satisfaction.		Judge	et	al.	identified	cut	off	for	the	absolute	and	change	scores	that	splits	patients	into	extremely	high	levels	of	satisfaction	and	high	levels	of	satisfaction.26		Kiran	et	al.,	from	the	same	unit,	suggested	a	method	of	using	change	scores	corrected	for	baseline	score	–	the	Percentage	of	Potential	Change	Score	(PoPC).148	Although	these	papers	are	not	directly	linked	to	pre-operative	prediction,	they	demonstrate	that	PROMs	and	satisfaction	are	intimately	linked.				
Radiographic	severity	Greater	radiographic	severity	has	been	linked	to	greater	improvement	over	the	course	of	a	knee	replacement.149				
	 144	
Predicting	outcome	Various	tools	are	currently	available	for	the	prediction	of	some	outcomes	for	knee	replacement.		These	were	recently	reviewed	by	Konopka	et	al.150		Tools	for	predicting	discharge	to	extended	care	facilities	are	available	and	their	use	has	been	reported	to	decrease	length	of	stay	(the	Risk	Assessment	and	Prediction	Tool	(RAPT)	and	the	Predicting	Location	after	Arthroplasty	Nomogram	(PLAN)).150	Additionally,	tools	for	predicting	post-operative	complications	are	available;	however,	their	usefulness	is	limited	as	they	require	validation.		Prediction	models	for	length	of	stay	in	total	and	unicompartmental	knee	replacements	have	been	produced	by	a	centre	in	Singapore,	although	it	accounts	for	less	than	a	third	of	the	variability	and	its	external	validity	has	been	questioned.		To	date	models	attempting	to	predict	functional	and	pain	outcomes	have	been	unsuccessful.		This	is	largely	due	to	the	inability	to	account	for	enough	variation	in	the	outcome	measure.			
Case	mix	adjustment	In	April	2015	case	mix	adjusted	PROMs	scores	were	used	as	part	of	the	criteria	for	the	Best	Practice	Tariff	in	knee	replacements.		The	case	mix	methodology	was	based	on	a	linear	regression	model	developed	from	national	datasets	–	these	datasets	represented	information	that	is	routinely	collected	as	part	of	the	national	census,	Hospital	Episode	Statistics	(HES),	and	the	NJR.		Linking	of	this	data	gave	the	ability	to	generate	a	model	based	on	over	30,000	observations.		Explanatory	variables	included	gender,	age,	ethnicity,	self-reported	disability,	self-reported	comorbidities,	type	of	knee	replacement,	diagnosis,	intervention,	length	of	stay,	patient	demographics,	co-morbidities,	deprivation,	type	of	operation,	length	of	stay	and	whether	assisted	to	complete	the	questionnaire.		Therefore,	the	model	was	massively	powerful	to	generate	statistically	significant	results,	even	though	the	effects	of	individual	explanatory	
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variables	may	be	small.		Additionally,	the	model	uses	peri-	and	post-operative	factors	that	would	not	be	available	to	a	pre-operative	prediction	model.	This	model	is	able	to	account	for	“around	a	quarter”	of	the	variability	in	outcome.40				Analysis	using	a	hold-out	sample	demonstrated	that	the	model	tends	to	over-predict	for	lower	post-operative	scores	and	under-predict	for	higher	post-operative	scores,	but	that	as	a	predictor	of	mean	post-operative	scores	it	performed	adequately	with	a	high	correlation	observed	between	mean	predicted	and	actual	post-operative	scores.		However,	it	is	debatable	if	case	mix	adjustment	is	a	reasonable	strategy	when	three	quarters	of	the	variability	is	unaccounted	for.		Determining	how	much	variability	needs	to	be	achieved	to	make	case	mix	adjustment	worthwhile	is	a	difficult	task,	and	one	that	is	not	likely	to	reach	unanimous	consensus.		This	is	especially	true	when	the	unknown	variability	could	be	a	result	of	untested	or	unknown	patient	factors,	as	opposed	to	provider	factors.		Financial	incentives/penalties	when	this	is	not	known	seems	questionable.				
Ongoing	studies	There	are	various	studies	ongoing	that	are	examining	the	prediction	of	outcome	in	knee	replacements.		The	Arthroplasty	Candidacy	Help	Tool	(ACHE),	run	through	the	University	of	Oxford,	is	examining	the	prediction	of	outcomes	in	knee	replacement.151			ACHE	aims	to	“develop	a	tool	for	GPs	and/or	hospitals	to	use	to	identify	patients	who	are	highly	likely	to	benefit	from	hip	or	knee	replacement	surgery	and	guide	those	unlikely	to	benefit	to	other	treatment	options.”		This	study	is	using	existing	databases	to	generate	data,	and	therefore	may	not	include	some	of	the	more	recent	psychological	factors.				
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Another	NIHR-funded	grant,	run	through	Southampton	University,	is	aiming	to	use	existing	national	and	hospital	databases	to	test	established	factors	that	affect	outcome,	and	then	derive	a	model	based	on	these	(the	Clinical	Outcomes	in	Arthroplasty	Study;	COASt).152	A	prospective	arm,	validating	this	model,	will	then	be	conducted	and	it	due	to	complete	in	2018.				The	COmmunity	based	Rehabilitation	after	Knee	Arthroplasty	(CORKA),	is	a	randomised	controlled	study	examining	different	protocols	for	post-operative	physiotherapy.		This	study	uses	a	screening	tool	developed	from	the	COASt	study	(as	yet	unpublished),	to	assess	patients	at	high	risk,	and	then	randomises	to	different	physiotherapy	arms.		It	may	be	that	different	physiotherapy	interventions	are	able	to	account	for	additional	variability	in	outcome	over	and	above	pre-operative	variables;	however,	this	is	of	limited	use	for	a	prediction	tool.							Funded	by	Arthritis	Research	U.K.	the	Targeted	Rehabilitation	to	Improve	Outcome	after	knee	replacement	(TRIO)	study	is	examining	the	effect	of	targeted	physiotherapy	to	patients	who	are	functioning	poorly	in	the	early	post-operative	period.153	Similar	to	the	CORKA	trial,	this	study	is	focussing	on	post-operative	care	as	a	variable	in	patient	outcome.				To	date,	none	of	these	trials	have	produced	a	prediction	tool	for	patients	with	knee	OA.		Therefore,	there	is	a	need	for	a	cohort	study	to	examine	the	relationship	between	the	explanatory	variables	identified	in	this	chapter,	and	outcome.		The	next	chapter	describes	the	methodology	for	such	a	study.			
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Chapter	6.		Development	of	a	prognostic	model	for	
patients	considering	a	total	knee	replacement	
	
The	previous	chapter	identified	the	factors	that	have	been	reported	as	important	
predictors	of	outcome	after	knee	replacement.		This	chapter	describes	the	methodology	
used	in	designing	and	carrying	out	the	multicentre	cohort	study	to	develop	a	prognostic	
model	for	patients	considering	a	knee	replacement.			
	
The	development	of	such	a	model	is	the	first	step	in	the	development	of	an	outcome	
prediction	tool,	which	would	typically	include	external	validation	and	impact	assessment	
of	the	prognostic	model.	External	validation	and	impact	assessment	does	not	form	part	of	
this	thesis,	although	a	discussion	of	future	work	from	the	development	of	the	prognostic	
model	is	included.					
6.1 	Declarations	
	
Aspects	of	this	chapter	have	been	published:	
Barlow	T,	Dunbar	M,	Sprowson	A,	Parsons	N,	Griffin	D.	Development	of	an	outcome	prediction	tool	for	patients	considering	a	total	knee	replacement	-	the	Knee	Outcome	Prediction	Study	(KOPS).	BMC	Musculoskeletal	Disorders	2014,	15:451		Mrs	P.	Scott	and	the	Arthritis	Care	Support	Group	(West	Midlands)	advised	on	the	patient	information	material.				
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This	study	has	been	approved	by	the	Northampton	National	Research	Ethics	Service	(12/EM/0336),	and	all	relevant	local	approvals	at	all	participating	sites.				
	
6.2 Design		
6.2.1 Introduction	I	undertook	a	prospective	multicentre	cohort	study	including	all	six	hospitals	(NHS	and	private)	that	provide	total	knee	replacements	to	the	population	of	Coventry	and	Warwickshire.	Six	hundred	patients	were	recruited,	measuring	potential	predictors	pre-operatively	and	outcome	at	six	and	12	months	post-operatively.						The	work	presented	in	this	thesis	concerns	the	development	of	a	prognostic	model	to	predict	outcome	in	individual	patients.		This	work	is	distinct	from	the	protocol	presented	in	the	associated	publication,	which	includes	techniques	involved	in	the	development	of	an	outcome	prediction	tool	(e.g.	internal	validation).		This	work	is	ongoing	within	the	KOPS	team.			
6.2.2 Pre-study	work	Before	conducting	a	cohort	study	examining	patient	factors,	several	issues	require	addressing.		These	include	how	best	to	measure	certain	factors	(e.g.	expectations),	whether	multiple	questionnaires	can	be	given	simultaneously,	and	what	outcome	measures	to	use.		Previous	work,	conducted	by	my	supervisors,	addressed	these	questions.		The	systematic	review	presented	in	Chapter	5	of	this	PhD	thesis	generated	an	up-to-date	account	of	what	was	known	regarding	patient	factors	that	were	important	in	predicting	outcome,	and	allowed	the	development	of	a	strategy	for	measuring	patient	factors.			An	important	point	to	note	is	that	pain	catastrophisation,	a	
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tendency	to	describe	pain	in	an	exaggerated	way	or	ruminate	over	it,	was	not	included,	given	the	already	significant	patient	burden,	the	lack	of	evidence	at	the	time	of	their	link	to	outcome,	and	the	overlap	between	catastrophisation	and	other	psychological	measures	used	in	our	study	(e.g.	Anxiety,	depression,	helplessness).154	However,	since	the	development	of	the	protocol,	there	is	increasing	evidence	of	the	role	of	pain	catastrophisation,	as	discussed	in	chapter	5.				With	knowledge	of	the	explanatory	factors	that	were	required,	and	how	to	measure	them,	it	is	possible	to	estimate	how	many	patients	were	required	in	the	cohort	study.			
6.2.3 Patient	involvement	To	refine	the	draft	protocol	I	used	UNTRAP	(Universities/User	Teaching	and	Research	Action	Partnership)	to	identify	two	members	of	the	public	that	have	had	training	in	user	involvement.	One	of	the	members	was	awaiting	knee	replacement	surgery	at	the	time.	These	members	formed	a	collaboration	with	the	research	team	in	the	refinement	of	the	study	protocol.		Subsequently,	the	study	protocol	and	patient	information	sheets	were	presented	and	discussed	with	two	local	Arthritis	Care	support	groups	for	further	feedback.	Revisions	to	the	information	sheets	were	made,	and	the	feedback	regarding	the	design,	content,	and	importance	of	the	study	was	exceedingly	positive.		During	the	research	one	members	of	the	public	was	actively	involved	in	the	study	steering	committee.			
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6.3 Methods	
6.3.1 Setting	Patients	listed	for	a	knee	replacement	within	Coventry	and	Warwickshire	(private	and	NHS	hospitals)	were	screened	for	eligibility.		The	participating	hospitals	were:	University	Hospitals	of	Coventry	and	Warwickshire	NHS	Trust	(UHCW);	Hospital	of	St.	Cross,	Rugby	(UHCW);	Warwick	Hospital	(South	Warwickshire	Hospital	NHS	Trust);	George	Elliot	Hospital	(George	Eliot	Hospital	NHS	Trust;	GEH);	BMI	Meriden	Hospital,	Coventry;	and	Nuffield	Hospital	Warwick,	Leamington	Spa.		
6.3.2 Eligibility	criteria	Inclusion	criteria:	- A	diagnosis	of	primary	OA	- Managed	with	a	primary	total	knee	replacement	during	the	study	period	- Able	to	complete	questionnaires	and	give	informed	consent	- Aged	over	50	years		Exclusion	Criteria:		- Unable	or	unwilling	to	give	informed	consent	- Unicompartmental	knee	replacement	or	revision	procedure		
6.3.3 Recruitment	At	each	participating	centre	the	pre-operative	pathway	for	patients	was	examined,	and	opportunities	to	“block	book”	the	assessment	of	patients	having	knee	replacements	were	identified.		This	process	allowed	each	site	to	be	visited	once	or	twice	a	week	to	allow	access	to	all	patients	on	the	waiting	list	for	a	knee	replacement.		For	example,	at	Warwick	Hospital	patients	requiring	knee	replacement	were	block	booked	into	their	
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pre-operative	assessment	on	a	Wednesday	morning;	at	UHCW	patients	attending	their	pre-operative	education	class	(which	was	a	requirement	to	progress	to	surgery	in	the	trust)	were	approached.		The	tailored	approach	required	longer	run	in	times	in	setting	up,	and	was	subject	to	variation	in	recruitment	rates	due	to,	for	example,	pre-operative	patient	pathways	changing	at	an	institutional	level	and	patients	being	unable	to	attend	certain	days.		However,	it	allowed	flexibility	at	each	site	to	adapt	to	changes	over	the	course	of	the	study,	and	it	would	have	required	a	very	large	research	team	to	achieve	the	recruitment	targets	without	this	approach.		All	patients	were	sent	by	post	an	invitation	letter	and	a	Patient	Information	Sheet	before	they	attended	the	recruitment	clinic.				Patients	were	recruited	from	their	pre-operative	clinic	appointment	where	a	baseline	assessment	of	patient	factors	took	place.		Factors	assessed	were	those	identified	in	Chapter	5	as	being	important,	and	the	method	of	measurement	was	either	identical	to	the	original	studies,	or,	where	no	consensus	on	methods	existed,	questionnaires	developed	specifically	for	this	purpose.98					 	
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The	factors	measured	were:			 - Age	- BMI	- Social	support	(measured	by	living	alone)	- Deprivation	(postcode,	through	the	2011	Census	data)	- Knee	status	and	knee	pain	(Oxford	Knee	Score	-	OKS)17,112	- General	health	(Short	Form-36	-	SF-36,	which	has	eight	domains	across	two	subscales	(mental	and	physical	functioning))	114	- Medical	co-morbidity	(Co-morbidity	questionnaire)98	- Joint	co-morbidity	(Joint	Co-morbidity	questionnaire)98	- Psychological	co-morbidity	(Hospital	Anxiety	and	Depression	Score)155	- Helplessness	and	coping	style	(Arthritis	Helplessness	Index)154	- Expectation	(Knee	Expectation	Questionnaire)98	- Radiographic	status	(Ahlback	Score	–	the	Ahlback	score	was	measured	using	templates	as	described	by	Dieppe).156		Patients	were	followed	up	at	six	and	12	months	by	postal	questionnaire	using	the	OKS,	the	SF-36,	and	several	satisfaction	scores.		Satisfaction	scores	included	a	version	of	the	satisfaction	score	developed	and	validated	by	Mahomed.157			Patients’	general	preference	for	a	bottom	line	prediction	of	outcome	(as	described	in	Chapters	3	and	4)	led	to	the	addition	of	a	question	measuring	decision	regret.		This	question	has	been	used	in	the	literature	previously,	but	has	not	been	validated:158,159		“Knowing	what	you	know	now,	would	you	still	have	the	operation	on	your	knee”		
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All	questionnaires	used	in	the	study	can	be	found	in	the	appendix	(section	V).				
6.3.4 Outcome	Measures	The	primary	outcome	measure	was	knee	function	as	measured	by	the	OKS	at	one	year	after	operation.112	This	condition-specific	measure	is	a	12-item	Patient	Reported	Outcome	Measure	(PROM),	specifically	designed	to	measure	knee	pain	and	function.	It	has	been	well	validated	for	this	group	of	patients	and	is	used	by	the	Department	of	Health.17		The	secondary	outcome	measures	were	the	SF-36,114	a	36-item	patient	reported	measure	of	general	health,	which	measures	eight	domains	of	health,	including	both	physical	and	mental	wellbeing.		The	two	measures	of	satisfaction	described	above	were	also	included.				The	primary	aim	of	this	research	was	to	develop	a	prognostic	algorithm.		Therefore,	two	private	hospitals,	as	well	as	teaching	and	district	general	hospitals	were	included	in	the	sample.		It	was	therefore	expected	(and	desirable)	to	have	some	differences	in	the	inpatient	management	–	this	forms	the	basis	of	having	a	sample	that	is	representative	of	the	U.K.	population	as	a	whole,	and	is	one	of	the	main	strengths	of	the	study.	The	knee	replacement	procedure	(inpatient	stay,	operation,	and	post-operative	care)	was	treated	as	a	single,	common	intervention.	This	approach	is	pragmatic,	and	it	is	likely	that	a	proportion	of	the	variance	in	patients’	post-operative	scores	will	be	missed	by	intra-	and	post-operative	factors.		However,	the	aim	was	to	develop	a	prognostic	model	applicable	to	many	different	settings.		Additionally,	previous	reports	have	suggested	that	the	proportion	of	the	variance	accounted	for	by	intra-	and	post-operative	care	is	small.22			
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6.3.5 Sample	Size	I	designed	the	study	to	have	an	80%	power	to	detect	associations,	at	the	5%	level,	between	pre-operative	factors	and	outcome,	with	a	correlation	coefficient	of	0.2.		This	will	predict	factors	that	account	for	more	than	4%	of	the	variation	in	the	primary	outcome	measure	(cohens	effect	size	equal	to	0.042),	which	is	below	the	clinically	detectable	changes	for	the	OKS,	allowing	for	10	explanatory	variables	included	in	the	final	model.160		This	requires	analyse	of	400	patients	(calculation	performed	by	Dr	Parsons	using	the	pwr	package	in	the	statistical	software	R,161	which	implements	the	methods	of	Cohen	for	a	linear	model).162		This	calculation	is	consistent	with	rule	of	thumb	methods	available	for	determination	of	sample	size,	that	typically	allow	10	patients	per	explanatory	factor.			Our	recruitment	target	was	600	patients.		This	allowed	for	a	loss	to	follow	up	of	20%	(although	a	loss	of	around	10-15%	was	expected	in	line	with	similar	cohort	studies),	89-
92,122,163	and	a	further	80	patients	to	allow	for	unexpected	events.				Feasibility	work,	used	in	the	development	of	some	of	the	questionnaires,	demonstrated	that	80%	of	eligible	patients	consent	to	participate.98	The	participating	hospitals	conduct	around	1500	knee	replacements	each	year.			When	planning	the	study	I	expected	over	1000	patients	would	be	eligible	for	inclusion	in	the	study,	and	800	would	consent	to	participate	over	one	year.	The	recruitment	target	of	600	patients	was	somewhat	lower	than	this	to	allow	for	any	unexpected	recruitment	problems.		Although	no	serious	problems	in	reaching	this	target	were	anticipated,	the	pilot	study	took	place	at	one	institution,	and	a	potential	drop	in	recruitment	rate	when	extending	the	study	over	multiple	sites	was	possible.	Additionally,	the	amount	of	data	to	be	completed	by	each	patient	was	higher	than	in	the	development	work	–	the	volume	of	data	requested	was	tested	with	our	UNTRAP	members	and	through	a	series	of	focus	
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groups.		It	was	thought	to	be	acceptable;	however,	any	more	would	have	been	“too	much”.			
6.3.6 Data	analysis	The	primary	analysis	used	multiple	linear	regression	models	to	identify	patient	factors	that	were	significantly	associated	with	the	OKS,	the	SF-36	(the	primary	and	secondary	outcome	measures	–	both	have	been	validated	for	this	group	of	patients).		Logistic	regression	models	to	assess	dichotomous	outcomes	(satisfaction)	are	also	used.	Diagnostic	analysis	was	used	to	assess	model	assumptions.			
Model	building	Before	model	building	I	decided	that	age,	gender	and	OKS	should	be	included	as	necessary	parts	of	the	model.		This	allows	the	model	to	be	corrected	for	basic	demographics	and	knee	function	of	patients	presenting	for	knee	replacement.		Complete	case	analysis,	reflecting	participants	that	had	no	missing	data	for	any	of	the	variables	entered	into	the	model	(whether	included	or	not),	was	used.		Forward	stepwise	analysis,	using	a	p-value	of	0.05	for	inclusion	and	0.1	for	exclusion,	was	then	used	for	explanatory	variable	selection	using	SPSS	version	22.164	Examination	of	each	included	variable	using	drop	one	diagnostics	was	performed.		The	Akaike	Information	Criterion	(AIC),	which	is	a	measure	of	how	well	a	model	fits	the	observed	data	and	includes	a	penalty	for	the	complexity	of	the	model,	was	included	in	the	drop	one	diagnostics	to	aid	explanatory	variable	selection.165	The	AIC	was	used	to	protect	against	over	fitting	the	model,	which	is	a	risk	with	forward	stepwise	regression.165				
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Assumption	testing	Formal	testing	for	independence	of	observations	is	not	considered	necessary	because	it	was	assumed	that	each	case	(person)	was	independent	of	the	next	(no	patient	was	included	twice	in	the	study).		Linearity	of	associations	between	each	explanatory	variable	and	the	dependent	variable	was	assessed	informally	by	scatterplots.		Multicollinearity	was	assessed	by	entering	all	explanatory	variables	into	a	linear	regression	model	in	SPSS.		This	allowed	the	generation	of	Pearson’s	correlation	coefficients	between	all	variables.	The	assumption	of	homoscedasticity	of	residuals	(indicating	the	variance	of	the	residuals	is	the	same	for	all	values	of	predicted	variable)	and	normality	of	residuals	were	tested	on	the	fitted	model.		Homoscedasticity	and	normality	of	residuals	were	assessed	informally	using	residual	versus	prediction	scatterplots	and	QQ	plots	respectively.			A	loss	to	follow	up	of	10-15%	was	expected	and	complete	case	analysis	as	the	primary	analysis	was	used.		As	a	sensitivity	analysis	to	explore	the	effects	of	missing	data,	multiple	imputation	using	standardised	methods	available	through	SPSS	version	22	(i.e.	Multiple	Imputation	using	Chained	Equations)	was	used.164	Results	of	both	imputational	analysis	and	complete	case	analysis	are	presented.			The	statistical	analysis	allows	weighting	of	the	significant	pre-operative	factors,	providing	an	estimation	of	outcome.				
6.3.7 Assessment	of	recruitment	strategy	Two	approaches	were	used	to	demonstrate	the	representativeness	of	the	study	population.		Firstly,	baseline	data	on	the	knee	replacements	that	were	performed	at	each	of	the	centres	over	the	recruitment	period	was	obtained.		These	data	were	generated	from	hospital	coding	data,	and	included	the	numbers	of	knee	replacements,	
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along	with	the	age	and	gender	of	the	patients.		This	allowed	an	estimation	of	the	number	of	patients	that	were	missed	by	the	screening	strategy,	and	a	basic	comparison	of	demographics	between	those	groups.		Secondly,	comparison	of	the	study	population	to	basic	demographic	data	from	the	National	Joint	Registry	is	presented.17					
6.4 Reflection	on	the	design	of	the	cohort	study		
	This	section	describes	the	justification	for	conducting	a	multicentre	cohort	study	using	patient	factors	to	develop	a	prognostic	algorithm	in	patients	considering	a	knee	replacement.		If	this	algorithm	is	able	to	predict	enough	variability,	it	could	be	used	to	develop	an	outcome	prediction	tool	that	supports	patients’	decision-making,	hence	improving	quality	of	care.	It	would	also	facilitate	interpretation	of	evidence	from	published	observational	studies	of	different	interventions	by	determining	whether	groups	of	patients	were	similar,	and	allow	post	hoc	adjustment	of	clinical	effectiveness	studies	for	risk	profile.	The	ability	to	adjust	samples	for	case	mix	is	particularly	topical	in	view	of	the	Best	Practice	Tariff	for	knee	replacements,	and	the	publication	of	individual	surgeon	data.			The	main	strength	of	this	study	is	the	breadth	and	comprehensiveness	of	the	patient	factors	selected	for	inclusion	in	the	model-building	process;	many	of	these	factors	have	previously	been	shown	to	correlate	with	important	outcomes	after	surgery.		Another	strength	is	the	size	and	demographic	of	the	patient	population	sampled,	which	includes	both	NHS	and	private	patients.		Although	this	represents	a	relatively	small	geographical	area,	that	area	lies	in	a	region	with	diverse	ethnicities	and	deprivation	indices,	and	
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should	provide	adequate	coverage	of	the	spread	of	data	required	to	develop	a	prognostic	model.				However	several	limitations	of	this	approach	exist.		Selection	bias	may	be	present	depending	on	the	personality	of	patients	who	are	more	likely	to	agree	to	take	part.		Feasibility	work	(not	part	of	this	thesis)	suggested	that	around	80%	of	patients	who	are	eligible	to	take	part	consent	to	do	so.		Examination	of	the	basic	demographics	of	patients	who	refuse	allowed	comparison	between	this	group	and	the	study	population.				An	additional	factor	that	could	have	influenced	selection	bias	is	missing	patients	that	may	have	been	eligible.		Our	approach	to	this	issue	has	been	the	development	of	protocols	to	identify	eligible	patients	at	each	site.		This	process	was	tested	by	comparing	those	screened	against	those	not	screened	by	using	hospital	coding	data.	This	approach	has	several	caveats.		Given	the	large	populations	involved	(approximately	1000	patients	screened,	and	500	not	screened),	statistical	tests	between	groups	are	powerful,	and	are	capable	of	showing	statistical	significance	for	small,	potentially	meaningless,	differences.		For	example,	a	t-test	for	a	sample	size	this	large	comparing	ages	is	likely	to	be	able	to	detect	a	difference	smaller	than	one	year.		All	ages	were	rounded	down,	and	therefore	the	power	of	the	study	at	least	equals	the	error	in	the	recording	of	data.	Additionally,	the	reliability	of	the	coding	data	is	questionable.		Previous	studies	have	demonstrated	errors	in	coding	data	of	between	1.1	and	45.8%,	with	an	average	of	around	7%.166			It	may	not	be	possible	to	predict	enough	variability	in	outcome	to	produce	a	clinically	useful	tool.		As	our	model	is	based	on	a	systematic	review	that	identified	known	prognostic	factors	and	has	included	all	of	them,	it	is	highly	likely	to	explain	more	of	the	
	 159	
variability.		However,	the	variability	that	each	factor	can	account	for	will	not	be	simply	additive.		Recently	identified	factors,	for	example	pain	catastrophising,	have	not	been	included	in	our	model.141,142		The	presence	of	pain	catastrophising	does	have	an	important	bearing	on	outcome,	but	it	is	not	only	its	presence,	but	also	how	it	influences	a	patient's	behaviour	and	ability	to	cope.		This	score	was	not	included	in	the	original	protocol,	as	it	was	unclear	how	strong	the	association	was	at	the	time	of	development.		However,	it	is	likely	that	some	(if	not	all)	of	the	variability	this	factor	predicts	will	be	captured	by	the	HADS,	Arthritis	Helplessness	Index	(which	includes	the	dimensions	of	internality	and	helplessness	–	closely	correlated	with	catastrophisation)	and	several	dimensions	of	the	SF-36	(vitality,	bodily	pain,	emotional	role	functioning,	social	role	functioning,	mental	health).154		The	OKS	may	not	have	enough	discriminatory	power	in	high	functioning	individuals	(ceiling	effect).		However,	it	is	good	at	discriminating	between	moderate	and	poor	functioning	individuals	(the	groups	that	are	of	more	interest).		Additionally,	measures	of	satisfaction	are	being	used.		Although	satisfaction	is	not	as	robust	a	measure	of	outcome	as	the	OKS,	it	provides	a	“bottom	line”	prediction	that	patients	generally	prefer	(as	discussed	in	chapters	3	and	4).			
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Chapter	7	–	Results	and	discussion	of	multicentre	
cohort	study	
	
This	chapter	reviews	the	screening	and	recruitment	process,	with	a	view	to	describing	and	
testing	for	possible	selection	bias.		Patient	retention,	baseline	characteristics,	and	missing	
data	are	described.		Multiple	imputation	is	used	as	a	sensitivity	analysis	to	explore	
patterns	of	missingness.			
	
A	multiple	linear	regression	model	is	described	for	predicting	six	month	OKS	and	12	
month	OKS,	SF-36,	and	satisfaction.		Logistic	regression	is	used	to	generate	a	prediction	
model	for	decision	regret.		The	properties	of	the	models	are	described	and	their	usefulness	
for	predicting	outcome	is	explored.				
7.1 Declarations	
Patient	recruitment	was	assisted	by	the	Research	Associates	of	Warwick	Orthopaedics	(approximately	20%).		Database	set	up	was	conducted	in	collaboration	with	Warwick	Orthopaedic	staff.		Follow	up	of	patients	was	assisted	by	Warwick	Orthopaedic	staff	(75%).		Data	input	was	conducted	by	Warwick	Orthopaedic	staff.			Dr	I	Ahmed,	Dr	D	Bhatt,	Mr	B	Mishra	assisted	in	grading	of	pre-operative	radiographs.		Mr	J	Skliros	designed	the	layout	of	the	questionnaire	packs.	Calculation	of	domain	scores	for	SF-36	was	conducted	by	Dr	N	Parsons.						
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7.2 Results	
	
7.2.1 Patient	screening	and	recruitment	Nine	hundred	and	ninety-nine	patients	were	screened	for	inclusion	into	the	study	from	March	2013	to	July	2014.	Six	hundred	patients	were	recruited	into	the	study.		Table	10	shows	the	reasons	for	patients	not	being	included	in	the	study.				Of	note,	65	patients	were	screened	that	were	not	listed	for	a	total	knee	replacement,	but	other,	related	operations	(e.g.	unicompartmental	knee	replacement).		Twenty	patients,	who	were	initially	recruited	to	the	study,	were	removed.		These	patients	did	not	have	an	operation,	could	not	adhere	to	the	study	protocols	(not	return	questionnaires),	or	had	an	operation	other	than	a	total	knee	replacement	(unicompartmental	knee	replacement).		For	the	majority	of	patients	(approximately	80%)	I	assessed	capacity	at	the	time	of	recruitment.		This	assessment	was	performed	by	the	Research	Associates	for	the	remainder	of	the	patients.	Only	three	patients	were	thought	to	lack	the	capacity	to	complete	the	questionnaires.										 	
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Table	10:	Numbers	of	Patients	Screened	
	 UHCW*	 Rugby*	 Warwick*	 George	Elliot*	 Nuffield*	 BMI*	 Total	
Lacks	Capacity	 2	(0.6%)	 0	 0	 1	(0.9%)	 0	 0	 3	(0.3%)	
	 	 	 	 	 	 	 	
Not	OA	 7	(2.2%)	 2	(0.7%)	 0	 0	 0	 0	 9	(0.9%)	
	 	 	 	 	 	 	 	
Poor	English	 6	(1.9%)	 1	(0.4%)	 8	(3.6%)	 4	(3.4%)	 0	 2	(5.6%)	 21	(2.1%)	
	 	 	 	 	 	 	 	
Unable	to	complete	 5	(1.6%)	 3	(1.0%)	 3	(1.4%)	 2	(1.7%)	 0	 0	 13	(1.3%)	
	 	 	 	 	 	 	 	
Not	total	knee	replacement	 24	(7.5%)	 33	(11.7%)	 3	(1.4%)	 4	(3.4%)	 0	 1	(2.8%)	 65	(6.5%)	
	 	 	 	 	 	 	 	
Too	young	 8	(2.5%)	 9	(3.2%)	 5	(2.3%)	 3	(2.6%)	 3	(13.0%)	 0	 28	(2.9%)	
	 	 	 	 	 	 	 	
Previously	recruited	 0	 1	(0.4%)	 4	(1.8%)	 1	(0.9%)	 0	 1	(2.8%)	 7	(0.7%)	
	 	 	 	 	 	 	 	
Refused	 91	(28.2%)	 71	(25.2%)	 37	(16.8%)	 23	(19.8%)	 6	(26.1%)	 5	(13.9%)	 233	(23.4%)	
	 	 	 	 	 	 	 	
Removed	from	study	 9	(2.8%)	 5	(1.8%)	 2	(0.9%)	 4	(3.4%)	 0	 0	 20	(2%)	
	 	 	 	 	 	 	 	
Recruited		 170	(52.8%)	 157	(55.7%)	 158	(71.8%)	 74	(63.8%)	 14	(60.9%)	 27	(75.0%)	 600	(60%)	
	 	 	 	 	 	 	 	
Total	number	screened		 322	(100%)	 282	(100%)	 220	(100%)	 116	(100%)	 23	(2.3%)	 36	(100%)	 999	(100%)	
*Percentages	by	individual	hospital	site	
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Process	of	screening	and	recruitment	
By	site	At	all	sites	a	recruitment	process	was	set	up:	this	generally	took	several	weeks,	and	inevitably	resulted	in	some	patients	being	missed	to	recruitment.		The	process	followed	at	each	hospital	was:	
UHCW	and	Rugby	St	Cross	Patients	were	recruited	from	their	pre-operative	education	class.		This	class	is	a	compulsory	part	of	their	pre-operative	pathway.		Research	Associates	predominantly	recruited	patients	at	UHCW,	and	I	recruited	all	patients	at	St	Cross.			
Warwick,	Nuffield	and	the	BMI	Patients	were	recruited	from	their	pre-operative	assessment.		This	is	a	compulsory	part	of	their	pre-operative	pathway.		Patients	were	block-booked	into	one	pre-operative	clinic,	where	I	was	present.		This	process	led	to	patients	being	missed	due	to	requesting	other	dates,	capacity	issues	in	the	designated	recruitment	clinic	necessitating	patients	attend	on	alternative	days,	and	administrative	errors	(especially	during	the	set-up	of	clinics).			
GEH	In	GEH	the	original	pathway	involved	patients	who	were	listed	for	a	knee	operation	being	given	a	date	for	their	pre-operative	assessment.		The	study	originally	targeted	these	clinics	for	assessment,	with	patients	listed	for	knee	replacement	being	block	booked	into	clinics.		However,	due	to	a	hospital	wide	alteration	in	the	pathway	for	pre-operative	patients,	an	alternative	approach	was	needed	from	September	2013	onwards.		Patients	who	
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were	listed	were	offered	an	appointment	straight	away	with	the	pre-operative	nurses	for	pre-operative	assessment.		This	change	was	initiated	to	decrease	the	number	of	visits	for	patients,	in	an	attempt	to	create	a	“one	stop	shop”.	Providing	the	manpower	to	recruit	patients	at	every	clinic	referring	patients	for	a	knee	replacement	was	not	feasible.				As	a	compromise,	I	targeted	patients	at	their	pre-operative	knee	physiotherapy	group.		This	group	had	a	significant	non-attendance	rate.		To	address	this	I	arranged	with	the	orthopaedic	department,	in	collaboration	with	the	Clinical	Director	for	Surgery,	to	highlight	to	all	patients	that	this	formed	a	compulsory	part	of	their	care.		This	did	not	completely	remove	the	non-attendance	at	the	pre-operative	clinic	appointments.		Overall,	51	patients	did	not	attend	(DNA)	that	would	have	been	appropriate	to	take	part	in	the	study	(44%);	however,	for	the	study	overall,	DNA	patients	made	up	only	5.8%	of	the	screened	population.														
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Recruitment	Rate	Table	11	shows	the	number	of	patients	recruited	from	each	site,	with	Figure	8	providing	a	line	graph	for	the	cumulative	number	of	patients	recruited	by	site.				
Table	11:	Numbers	recruited	by	site	
			
Month	 UHCW	 Warwick	 Rugby	 GEH	 Nuffield	 BMI	 Total	
March	2013	 1	 0	 0	 0	 0	 0	 1	
April	2013	 12	 0	 0	 0	 0	 0	 12	
May	2013	 6	 14	 0	 0	 0	 0	 20	
June	2013	 14	 14	 3	 0	 0	 0	 31	
July	2013	 11	 10	 15	 8	 0	 0	 44	
August	2013	 9	 18	 2	 4	 0	 0	 33	
September	2013	 4	 7	 9	 0	 1	 0	 9	
October	2013	 7	 13	 15	 8	 2	 3	 59	
November	2013	 13	 5	 15	 6	 1	 0	 37	
December	2013	 10	 4	 10	 5	 2	 1	 35	
January	2014	 12	 18	 13	 17	 2	 1	 63	
February	2014	 10	 11	 11	 5	 1	 6	 44	
March	2014	 15	 10	 11	 6	 2	 2	 46	
April	2014	 27	 6	 11	 8	 2	 2	 56	
May	2014	 2	 18	 24	 4	 1	 10	 60	
June	2014	 13	 8	 7	 2	 0	 2	 30	
July	2014	 5	 3	 11	 1	 0	 0	 20	
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Figure	8:	Recruitment	rate	by	site			
Variations	in	recruitment	rate	There	was	a	drop	in	recruitment	in	July	2013	at	Rugby	St	Cross	Hospital.			This	coincided	with	annual	leave.				A	large	drop	in	recruitment	was	seen	in	August	and	September	2013	across	all	sites.		Discussion	with	members	of	staff	at	all	sites	revealed	that	this	was	a	yearly	occurrence	due	to	the	amount	of	annual	leave	taken	by	staff	over	this	period.		This	resulted	in	less	patients	being	listed	for	orthopaedic	procedures	(due	to	less	orthopaedic	clinics	being	run)	and	less	patients	going	though	pre-operative	clinics	due	to	decreased	staff	numbers.		These	factors	are	thought	to	be	responsible	for	another,	smaller	drop	in	recruitment	in	December	2013.			
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	The	third	drop	is	seen	in	June	and	July	2014,	at	the	very	end	of	recruitment.		This	was	due	to	two	factors.		Firstly,	at	both	private	hospitals	(BMI	and	the	Nuffield)	the	pathway	for	patients	attending	pre-operative	clinics	was	altered	(these	changes	happened	simultaneously,	but	independently	of	each	other).		This	required	the	re-arrangement	of	the	recruitment	strategy	for	the	study.		On	the	basis	that	few	patients	were	required	to	fulfil	the	study’s	target,	recruitment	was	shut	down.	Secondly,	Research	Associates	were	relied	upon	for	recruitment	at	one	site	(UHCW).		Due	to	difficulties	with	staffing,	clinics	over	a	three-month	period	(May	to	July)	were	intermittently	staffed.					
	
Deficiencies	in	the	screening	process		By	examining	the	process	of	screening	and	recruitment,	and	the	reasons	that	some	patients	were	not	approached	to	enter	the	study,	some	assertions	can	be	made	on	the	presence	of	selection	(sampling)	bias.		Although	representativeness	is	not	a	requirement	of	building	a	prognostic	model	(the	requirement	is	rather	ensuring	that	a	full	spread	of	data	is	available	for	analysis	in	the	model),	a	representative	sample	of	600	patients	is	likely	to	give	a	sufficient	spread	of	data.			
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Patients	that	were	not	screened,	but	are	likely	to	be	no	different	to	the	study	population	Patients	who	were	not	screened,	but	are	likely	to	be	no	different	to	the	study	population,	include	those	patients	that		 - Were	not	screened	due	to	staffing	issues	(e.g.	annual	leave)	that	resulted	in	designated	pre-operative	clinics	not	being	staffed.			- Were	not	screened	due	to	capacity	issues	within	designated	pre-operative	clinics	- Were	booked	into	alternative	clinics	due	to	administrative	errors	- Requested	alternative	pre-operative	clinic	dates	within	the	normal	working	week			Due	to	the	processes	that	resulted	in	their	not	being	screened,	it	is	unlikely	that	they	were	significantly	different	to	the	screened	population.			
Patients	that	were	not	screened,	but	could	be	different	to	the	study	population	There	are	two	groups	that	were	not	screened	that	could	represent	sub-populations	that	are	different	to	the	study	population:		 - Patients	who	Did	Not	Attend	(DNA)	their	appointments	- Patients	who	altered	their	pre-operative	appointment	to	a	weekend		Patients	who	do	not	attend	appointments	may	do	so	for	various	reasons	(e.g.	work	commitments,	childcare	commitments,	limited	mobility).		With	this	study,	a	psychological	difference	between	patients	who	do	attend	and	who	do	not	attend	has	a	
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logical	consistency,	and	informed	the	original	development	of	the	local	protocols	at	each	site.		Also,	patients	who	do	attend	may	have	different	expectations	compared	to	those	who	do	not.				Table	12	gives	the	rates	of	DNA	at	each	site.		One	site	(GEH)	had	a	large	number	of	DNA	appointments	(30.5%	of	total	patients	screened);	however,	DNAs	made	up	less	than	4%	at	each	other	site,	and	only	5.8%	of	the	total	study	population.				
Table	12:	Did	not	attend	(DNA)	rates	by	site	
	 UHCW	 Rugby	 Warwick	 George	
Elliot	
Nuffield	 BMI	 Total	
Did	Not	
Attend	
0	 9	(3.1%)	 0	 51	(30.5%)	 0	 1	(2.7%)	 61	(5.8%)			Demographic	analysis	of	patients	who	DNA	against	those	who	did	attend	was	undertaken	for	GEH.	Analysis	of	the	study	as	a	whole	was	not	undertaken.		Due	to	the	disproportionate	amount	of	DNA	at	GEH,	comparing	the	DNA	population	to	the	study	population	as	a	whole	is	similar	to	comparing	the	population	of	GEH	to	the	study	as	a	whole.		The	baseline	demographics	demonstrate	that	GEH	patients	are,	on	average,	three	years	younger.		Therefore	there	is	likely	to	be	a	difference	based	on	the	different	proportions	of	patients	from	each	hospital	site,	rather	than	any	difference	between	patients	that	DNA	and	those	that	did	not.		Table	13	gives	the	mean	ages	and	standard	deviations	for	each	group	from	GEH.		There	was	no	significant	difference	using	a	t-test.		Also,	a	chi-squared	test	was	not	significant	(p=0.994)	for	a	difference	between	groups	with	regards	to	gender.						
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Table	13:	Age	of	those	who	attended	and	DNA	for	GEH	
	 Group	 N	 Mean	 Std.	Deviation	 Std.	Error	
Mean	
Significance	
Age	
		
DNA	 49	 66.5	 9.2	 1.3	 0.202	Not	DNA	 95	 68.5	 8.8	 0.9	
	
	Patients	who	altered	their	pre-operative	appointment	to	a	weekend	are	the	second	group	that	may	cause	selection	bias.		For	several	months	in	2015	(April	to	July)	there	were	pre-operative	appointments	occurring	at	the	weekend	at	one	site	(UHCW).		This	process	was	in	place	to	cover	a	backlog	of	patients	that	had	developed	due	to	a	lack	of	throughput	in	the	pre-operative	assessment	process.		It	is	reasonable	to	assume	that	the	subpopulation	of	patients	that	requested	weekend	pre-operative	appointments	were	different	(for	example	they	could	be	a	younger,	working	population).	There	was	no	selection	process	in	place	for	weekend	lists,	so	there	is	no	reason	to	believe	that	patients	on	these	lists	were	significantly	different,	unless	they	had	specifically	requested	a	weekend.				The	total	number	of	patients	that	went	through	the	weekend	lists	was	small	(roughly	100	in	total).		Additionally,	this	is	also	the	time	that	staffing	issues	among	the	research	associates	were	at	their	height,	and	this	will	have	diluted	the	effect	of	this	subpopulation	of	patients.		This	means	that	the	overall	effect	on	the	demographics	of	the	study	sample	is	likely	to	be	minimal.	To	test	this	an	exploration	of	differences	by	age	and	gender	of	patients	who	where	not	identified	during	the	screening	process	is	provided	in	the	next	section.	
	
Assessment	of	patients	missed	by	the	screening	process	The	aim	of	this	study	is	to	develop	a	prognostic	algorithm,	and	therefore	patients	with	a	wide	range	of	factors	should	be	included	in	the	model	building	phase.			A	representative	
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sample	will	give	confidence	that	a	wide	cross-section	of	the	population	of	interest	has	been	included:	this	does	not	mean	that	the	sample	has	to	be	truly	representative	of	the	general	population	having	knee	replacements,	but	is	does	have	to	represent	that	cross	section.			Therefore,	the	representativeness	of	the	study	sample	was	explored.				Baseline	data	on	the	knee	replacements	that	were	performed	in	each	of	the	sites	over	the	recruitment	period	was	obtained.		This	data	was	generated	from	hospital	coding	data,	and	included	the	numbers	of	knee	replacements,	along	with	the	age	and	gender	of	the	patients.		This	allows	an	estimation	of	the	number	of	patients	that	were	missed	by	the	screening	strategy,	and	a	basic	comparison	of	demographics	between	those	groups.				This	approach	has	several	caveats.		Given	the	large	baseline	population	the	statistical	tests	are	powerful,	and	may	reveal	statistically	significant	differences	that	are	smaller	than	the	measurement	error	(e.g.	differences	of	smaller	than	one	year).		Therefore	any	statistical	differences	need	to	be	treated	with	caution.				Also,	the	reliability	of	hospital	coding	data	is	questionable.		Previous	studies	have	demonstrated	errors	in	hospital	coding	data	of	between	1.1	and	45.8%,	with	an	average	of	around	7%.166	The	data	collected	was	relatively	straightforward,	so	it	is	reasonable	to	expect	it	to	fall	on	the	lower	end	of	this	range.		However,	compounding	this	error	rate,	there	are	additional	issues	with	the	hospital	coding	data	within	our	study.		For	example,	some	hospital	sites	were	unable	to	provide	coding	data	for	patients	that	only	had	knee	OA	(and	therefore	the	coding	data	included	patients	with	other	types	of	arthritis).		Given	the	prevalence	of	each	condition	this	is	unlikely	to	alter	the	results	to	a	large	extent,	but	could	account	for	inflation	in	the	numbers	of	patients	in	the	coding	data	by	around	5%,	and	could	alter	the	population	demographics.				
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Additionally,	at	UHCW	and	Rugby,	the	time	from	pre-operative	appointment	to	operation	could	be	up	to	12	months.		This	resulted	in	difficulties	in	calculating	the	timeframe	that	patients	would	have	been	eligible	during	the	recruitment	period	–	this	was	resolved	by	using	Korner	weeks	(the	length	of	time	from	referral	to	operation)	to	correct	for	the	time	delay.		This	has	problems	in	itself	as	the	referral	and	the	time	of	recruitment	were	not	identical	(although	closer	than	the	time	of	recruitment	and	actual	operation	data).		This	likely	increases	the	number	of	patients	included	in	the	coding	data	(particularly	when	theatre	throughput	is	the	limiting	factor,	as	was	the	case	at	UHCW	and	Rugby	St	Cross).		This	approach	also	introduces	a	further	source	of	error	by	using	additional	datasets	within	the	coding	framework,	and	inevitably	led	to	several	weeks	at	the	beginning	and	the	end	of	the	recruitment	period	that	were	highly	unlikely	to	include	patients	that	were	eligible,	but	had	to	be	included	in	the	coding	data	so	as	not	to	miss	any	recruited	patients.		Again	this	would	increase	the	number	of	patients	in	the	coding	data.			Combined,	there	are	three	factors	that	are	likely	to	cause	an	overestimate	of	the	number	of	people	“missed”	by	the	recruitment	strategy.		The	result	of	this	is	a	highly	conservative	estimate	of	the	success	of	the	recruitment	strategy.		Additionally	this	could	alter	the	demographics	of	the	population	of	patients	that	were	not	screened	that,	when	combined	with	high	(but	unknown)	error	rates	in	the	coding	data,	make	any	statistical	inference	of	difference	prone	to	error.				Despite	these	weaknesses	an	assessment	of	age	and	gender	for	all	patients	who	would	have	been	eligible	for	the	study	at	each	site	was	conducted	by	examining	the	hospital	coding	records	at	each	site.		This	allowed	comparison	of	those	who	were	screened	against	those	who	were	not.				
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Overall	715	patients	were	identified	in	hospital	coding	that	were	not	screened.		Their	mean	age	was	70	years	(sd	8.9)	and	31%	were	male.		This	was	compared	to	the	population	of	patients	that	were	screened,	excluding	those	that	were	unlikely	to	appear	in	hospital	coding	(e.g.	not	a	total	knee	replacement,	or	too	young).		This	group	consisted	of	848	patients	with	a	mean	age	of	70	years	(sd	8.9)	and	42%	male.		Ages	were	not	significantly	different	(p=	0.595;	independent	samples	t-test),	whereas	gender	was	(p<0.001;	chi-squared	test).				The	significant	result	is	subject	to	the	limitation	described	above;	however,	given	the	difference	in	genders	between	those	screened	and	those	not	screened,	comparison	of	those	screened	with	the	population	of	patient	having	knee	replacement	in	England	and	Wales	was	undertaken	using	information	from	the	National	Joint	Registry	(2013).		Using	this	data,	the	median	age	of	someone	undergoing	a	knee	replacement	is	70	years,	with	58%	being	female	(42%	male).		This	compares	favourable	with	our	study	(mean	age	70	years,	44%	male),	and	our	screened	population	(mean	age	70	years,	42%	male)	(Table	14).		This	provides	strong	external	evidence	that	our	processes	to	screen	patients	to	this	study	were	sound	and	likely	to	provide	high	quality,	reliable	and	representative	data.		
Table	14:	Age	and	gender	of	different	populations	
Population	 Mean	age		 Percentage	male	
National	joint	registry	 70	 42%	
Coding	data	from	included	
hospitals	
70		 31%	
Patients	screened	 70	 42%	
Patients	in	study	 70	 44%	
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Deficiencies	in	the	recruitment	process	Seventy-two	per	cent	of	eligible	patients	consented	to	take	part,	with	28%	refusing.		Patients	who	refused	to	participate	are	a	key	group,	as	it	is	reasonable	to	think	that	these	patients	could	be	different	from	the	rest	of	the	study	population.	Data	on	the	reasons	for	refusal	were	not	compulsory	for	patients	to	complete	and	was	not	routinely	collected.		However,	the	most	common	reason	cited	to	the	study	team	was	the	time	it	would	take	to	complete	the	study	paperwork.				To	examine	if	this	group	was	different	to	the	study	population,	age	and	gender	were	compared.	Table	15	demonstrates	a	significant	difference	between	populations	as	regards	age	(p<0.001;	t-test),	with	those	who	refused	tending	to	be	older.		The	difference	in	mean	age	is	approximately	three	years.		Although	this	difference	is	significant,	it	is	unlikely	to	be	important.		A	difference	of	three	years	is	small,	and	the	study	included	patients	from	50	years	to	91	years.				
Table	15:	Comparison	of	age	of	those	recruited	and	those	who	refused	
	 Group	 N	 Mean	 Std.	
Deviation	
Std.	Error	
Mean	
Significance	
Age	
		
Recruited	 600	 69.0	 8.75	 0.36	 <0.001			Refused	 228	 72.1	 9.06	 0.60			Gender	proportions	were	similar	across	groups	with	no	significant	difference	between	patients	who	refused	or	those	who	accepted	entry	to	the	trial	(p=0.370;	chi-squared	test).					 	
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7.2.2 Patient	retention	Figure	9	shows	the	number	of	patients	at	each	stage	of	the	study.	Six	hundred	patients	were	recruited	into	the	study.		Overall	83	patients	were	excluded	from	the	study:	Operation	cancelled	(17);	not	a	total	knee	replacement	(2);	incomplete	or	missing	data	(7);	died	(3);	protocol	breach	(too	young	at	time	of	operation	-	2);	withdrew	(1);	and	over	six	months	between	recruitment	and	operation	(40).	The	team	agreed	that	patients	who	waited	over	six	months	between	recruitment	and	operation	should	be	excluded	to	safeguard	against	baseline	measurements	changing	by	the	time	of	operation.			A	further	11	patients	with	significant	complications	(Fracture	(n=3),	revision	(excluding	revision	for	pain)	(n=5),	patella	tendon	rupture	(n=1),	significant	medical	co-morbidity	(e.g.	dense	stroke)	(n=2))	were	excluded	from	analysis.		Significant	complications	were	excluded	because	our	aim	was	to	produce	an	outcome	prediction	model.		Complications	were	not	going	to	form	part	of	that	model,	and	the	rate	of	complications	is	well	established	for	knee	replacements.		Therefore,	an	outcome	prediction	model	excluding	complications	could	be	used	for	all	patients	with	the	normal	pre-operative	counselling	regarding	the	risk	of	complication.						After	exclusions,	517	patients	were	eligible	for	follow	up	at	six	months.		A	further	patient	was	excluded	at	12	months	following	a	stroke.					
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Figure	9:		Flow	diagram	of	patients	included	in	KOP	Study			 	
		
Patients	screened	(n=999)		
Excluded	(n=165)	Lacks	Capacity	(n=3)	Not	total	knee		(n=65)	Poor	English	(n=21)	Unable	to	complete	(n=13)	Removed	from	study	before	operation	(n=20)		 Did	not	have	operation	(n=3)		 Operation	other	than	knee	replacement	(n=11)		 Unable	to	adhere	to	study	procedure	(n=6)			
Eligible	patients	(n=834)		
Refused	(n=234)		
	
Patients	enrolled	in	study	(n=600)		
Excluded	(n=83)	Operation	cancelled	(n=17)	Not	total	knee		(n=2)	Incomplete	or	missing	data	(n=7)	Died	(n=3)	Protocol	breach	(too	young	at	time	of	operation)	(n=2)	Withdrew	(n=1)	Greater	than	six-months	between	recruitment	and	follow	up	(n=40)	Complications	(n=11)		
Lost	to	follow	up	(n=28,	5.4%)		 	
Six	month:		Complete	follow	up	(n=497,	94.6%)		 12	month:		Complete	follow	up	(n=480,	93.0%)		
Lost	to	follow	up	(n=36,	7.0%)		 	
Patients	eligible	for	six	month	
follow	up	(n=517,	100%)		 Patients	eligible	for	12	month	follow	up	(n=517,	100%)		
Additional	Exclusions:	Stroke	(n=1)		
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7.2.3 Baseline	patient	demographics	The	mean	age	of	participants	was	70	years	(sd=8.8)	and	56%	were	female.		Patients	waited	a	median	of	27	days	(range	1-182	days)	between	measurement	of	baseline	characteristics	and	operation.			Table	16	demonstrates	means	and	standard	deviations	for	all	explanatory	scale	variables	assumed	to	be	approximately	normally	distributed,	and	Table	17	shows	means	and	interquartile	ranges	for	other	explanatory	scale	variables.	Boxplots	of	all	scale	variables	are	presented	in	Figure	11	to	Figure	23.		Proportions	for	all	categorical	explanatory	variables	are	displayed	in	Table	18.		Severity	of	arthritis	was	assessed	using	the	Ahlback	grade	(grades	1-5)	which	was	then	dichotomised	into	severe	(grades	3-5)	and	not	severe	(grades	1-2)	as	per	the	methods	used	by	Riis	et	al.149			
Table	16:	Explanatory	scale	variables	(assumed	approximately	normally	distributed)	
Variable	 Mean	 Std.	Deviation	 N	
Age	 68.7	 8.6	 517	
OKS	Baseline	 19.7	 8.1	 502	
Body	Mass	Index	(BMI)	 30.5	 5.7	 457	
Helplessness	 12.4	 2.7	 485	
Internality	 14.1	 2.7	 485	
Co-morbidity	(number	of	
conditions)	
3.2	 1.6	 487	
Physical	Capacity	Score	
(PCS)	
21.3	 9.0	 466	
Mental	Capacity	Score	
(MCS)	
52.5	 12.3	 466	
BMI	is	weight	(kg)/height	(m)2;	OKS,	Oxford	Knee	Score,	measured	from	0	(poor	function)	to	48	
(high	function);	Helplessness,	measured	from	5	(low	helplessness)	to	20	(high	helplessness),	
Internality,	measured	from	6	(low	internality)	to	24	(high	internality);	PCS,	SF-36	physical	domain,	
measured	from	0	to	100;	and	MCS,	SF-36	psychological	domain,	measured	from	0	to	100.					
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Table	17:	Explanatory	scale	variables	(assumed	to	be	non-normally	distributed)	
Variable	 Median	 Interquartile	range	 Number	
Deprivation	Score	 12.5	 6.3	-	18.7	 517	
Expectation	Score	 43	 39.5	-	46.5	 488	
Anxiety	Score	 5	 2.4	-	7.6	 488	
Depression	Score	 3	 1	-	5	 490	
Joint	co-morbidity	 3	 1.5	-	4.5	 451	
Deprivation	score,	from	the	Index	of	Multiple	Deprivation	(UK	Census);	Expectation	Score,	from	0	
(low)	to	48	(high);	Anxiety	Score,	Hospital	Anxiety	and	Depression	(HAD)	sub-score,	from	0	(low)	
to	20	(high),	Depression	score,	HADs	sub-score,	from	0	(low)	to	20	(high),	joint	co-morbidity	used	
count	of	number	of	joints	with	pain	in	last	week.			
Table	18:	Explanatory	binary	variables	
Variable	 	 Number	(Percentage)	
Gender	 Male	 214	(41%)	
	 Female	 303	(59%)	
Severe	Arthritis	 No	 239	(48%)	
	 Yes	 262	(52%)	
Live	alone	 No	 363	(76%)	
	 Yes	 118	(24%)	
Previous	arthroscopy	 No	 319	(71%)	
	 Yes	 133	(29%)	
Lower	back	pain	 No	 247	(55%)	
	 Yes	 204	(45%)			A	key	for	Figure	11	to	Figure	23	is	available	below	(Figure	10).		Boxes	show	interquartile	range	(25-75%	extent	of	data)	and	bar	is	median	(50%	point).	Whiskers	(bars)	are	1.5	times	IQR.		Outliers	are	defined	by:	
ο = Outlier (value is less than or equal to the first quartile minus 1.5 times the interquartile 
range, or is greater than or equal to the third quartile plus 1.5 times the interquartile range) 
* = Outlier (value less than or equal to the first quartile minus 3 times the interquartile range 
or greater than the third quartile plus 3 times the interquartile range)  
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Figure	10:	Key	to	boxplots				
	
Figure	11:	Distribution	of	age	(range	50	to	92) 
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Figure	12:	Distribution	of	baseline	OKS.	Range	of	possible	scores	0	to	48	(higher	score	reflects	
better	function) 
 
 
	
Figure	13:	Distribution	of	BMI.		Range	of	BMI	14.5	to	57.1.	 
 
 
	
Figure	14:	Distribution	of	joint	count.		Range	of	joint	count	1	to	18.		 
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Figure	15:	Distribution	of	comorbidities.		Range	of	comorbidities	0	to	10.		 			
	
Figure	16:	Distribution	of	deprivation	score.		Range	of	possible	deprivation	scores	0	to	100.		Lower	
scores	reflect	less	deprivation.		 
 
 
 
	
Figure	17:	Distribution	of	expectation	scores.	Range	of	possible	scores	from	0	to	48.		Higher	scores	
reflect	higher	expectations. 
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Figure	18:	Distribution	of	helplessness	scores.		Range	of	possible	scores	5	to	30.		Higher	scores	
reflect	greater	helplessness. 
 
 
 
	
Figure	19:	Distribution	of	internality	scores.		Range	of	possible	scores	from	5	to	30.		Higher	scores	
reflect	more	internality. 
 
 
 
	
Figure	20:	Distribution	of	PCS	Scores.		Range	of	possible	scores	from	0	to	100.		Higher	scores	reflect	
better	function. 
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Figure	21:	Distribution	of	MCS	scores.		Range	of	possible	scores	from	0	to	100.		Higher	scores	reflect	
better	mental	health. 
 
 
 
	
Figure	22:	Distribution	of	depression	scores.		Range	of	possible	scores	from	0	to	21.		Higher	scores	
reflect	more	depressive	symptoms. 
 
 
 
	
Figure	23:	Distribution	of	anxiety	scores.		Range	of	possible	scores	from	0	to	21.		Higher	scores	
reflect	higher	anxiety.		 
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7.2.4 Missing	data	Missing	data	were	present	in	6.5%	of	values	for	all	explanatory	variables	tested	in	the	model.		Complete	cases	were	found	in	284	cases	(55%).		Table	19	demonstrates	the	number	of	cases	with	missing	data	broken	down	by	explanatory	variable.				
Table	19:	Missing	data	in	explanatory	variables	
Variable	 N	 Missing	(Count)	 Missing	(Per	cent)	
Age	 517	 0	 0%	
Gender	 517	 0	 0%	
OKS	Baseline	 502	 15	 2.9%	
BMI	 457	 60	 11.6%	
Severe	Arthritis	 501	 16	 3.1%	
Joint	count	 451	 66	 12.8%	
Back	Pain	 451	 66	 12.8%	
Comorbidities	 487	 30	 5.8%	
Live	Alone	 481	 36	 7%	
Deprivation	Score	 517	 0	 0%	
Previous	Arthroscopy	 452	 65	 12.6%	
Expectation	 488	 29	 5.6%	
Helplessness	 485	 32	 6.2%	
Internality	 485	 32	 6.2%	
PCS	 466	 51	 9.9%	
MCS	 466	 51	 9.9%	
Depression	 488	 29	 5.6%	
Anxiety	 490	 27	 5.2%			
Item-missingness	in	scores	For	variables	that	consisted	of	scores,	item-missingness	was	examined:		item-missingness	refers	to	the	individual	items	that	make	up	the	composite	score.		Two	patterns	emerged	with	the	baseline	OKS	and	the	expectation	questionnaires.		With	the	OKS	questionnaire	five	patients	missed	the	first	five	questions	but	completed	all	other	items,	and	nine	patients	missed	the	last	seven	questions	but	completed	all	other	items.		This	reflects	the	break	in	the	page	that	the	questionnaire	was	spread	over,	and	likely	reflects	patients	missing	a	page.			The	expectation	questionnaire	demonstrates	a	similar	
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pattern	for	items	7	to	9	and	items	10	to	12.		A	summary	of	item	missingness	for	all	scores	can	be	found	in	Table	20.				
Table	20:	Missingness	by	item	for	score	variables	
Score	 Number	of	items	 Per	cent	missing	
OKS	 12	 1.5%	
Expectation	 12	 3	%	
Helplessness	 6	 4.7%	
Internality	 5	 4.7%	
Depression	 7	 3.8%	
Anxiety	 7	 3.7%	
SF-36*	 8	 3.8%	
*this	figure	represents	the	SF-36	domains.			All	the	patterns	of	missingness	are	available	in	Figure	24	–	of	these	missing	value	patterns,	the	10	most	frequent	patterns	are	displayed	in	Figure	25.		As	was	expected,	the	most	common	pattern	identified	was	that	of	no	missing	values.		All	other	patterns	were	infrequent.						
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Figure	24:	Patterns	of	missingness 
	
Figure	25:	Frequency	of	the	most	common	patterns	of	missing	data 
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Handling	missing	data	The	overall	amount	of	missing	data	was	low.		Two	patterns	within	the	item	missingness	for	scores	emerged	and	likely	reflected	patients	missing	pages	of	the	questionnaire.		This	mechanism	accounts	for	a	low	proportion	of	missing	items,	and	is	unlikely	to	be	non-ignorable	(i.e.	missing	not	at	random;	MNAR).		Missing	at	Random	(MAR)	requires	that	“given	the	observed	data,	the	missingness	mechanism	does	not	depend	on	the	unobserved	data”.		Given	the	likely	cause	for	this	pattern	of	missingness	it	seems	reasonable	to	assume	data	are	MAR,	and	as	such	conventional	statistical	modelling	(e.g.	regression	analysis)	is	appropriate,	with	the	expectation	that	resultant	coefficient	estimates	and	inferences	will	be	unbiased,	provided	the	appropriate	variables	are	included	in	the	models.					As	a	sensitivity	analysis	for	this	missingness	pattern,	models	using	a	complete	case	analysis	for	all	included	explanatory	variables	in	the	final	model	(as	opposed	to	a	complete	case	analysis	of	all	tested	explanatory	variables)	and	multiple	imputation	models	were	used.				
7.2.5 Six	Month	Data	analysis	At	six	months,	28	patients	were	lost	to	follow	up,	leaving	489	(94%)	of	eligible	participants	with	complete	OKS	six	month	scores.		All	follow	up	took	place	after	six	months	with	a	median	of	seven	months	(IQR=6	-	7.5).		The	median	OKS	score	at	six	months	was	36	(IQR=29	–	41),	compared	with	the	mean	baseline	score	of	19.7	(sd=8.1)				Table	21	shows	the	results	of	a	univariate	analysis	(Pearson	correlation	coefficients)	between	each	explanatory	variable	and	OKS	at	six	months.					
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Table	21:	Univariate	correlation	between	each	variables	and	six	month	OKS	
Variable	 6	month	OKS	 n	 p-value	
6	month	OKS	 1	 489	 .	
Age	 0.062	 489	 0.086	
Female	Gender	 -0.07	 489	 0.061	
OKS	Baseline	 0.336	 475	 <0.001	
BMI	 -0.142	 432	 0.001	
Severe	Arthritis	 0.153	 478	 <0.001	
Live	Alone	 0.044	 454	 0.177	
Deprivation	
Score	
-0.193	 489	 <0.001	
Previous	
Arthroscopy	
(yes/no)	
-0.039	 425	 0.214	
Joint	Count	 -.294	 429	 <0.001	
Low	Back	Pain	 -.178	 429	 <0.001	
Comorbidities	 -.216	 463	 <0.001	
Expectations	 0.324	 461	 <0.001	
Helplessness	 -0.36	 459	 <0.001	
Internality	 -0.148	 459	 0.001	
PCS	 0.191	 441	 <0.001	
MCS	 0.428	 441	 <0.001	
Depression	 -0.327	 463	 <0.001	
Anxiety	 -0.283	 464	 <0.001			
Assumption	testing	for	linear	model	Formal	testing	for	independence	of	observations	was	not	considered	necessary	because	it	was	assumed	that	each	case	(person)	was	independent	of	the	next.		Linearity	of	associations	between	each	explanatory	variable	and	the	dependent	variable	was	informally	assessed	by	scatterplots.		Each	scatterplot	is	presented	in	the	appendix	(section	VI),	and	this	assumption	was	thought	to	hold.		Multicollinearity	was	assessed	by	entering	all	explanatory	variables	into	a	linear	regression	model	in	SPSS.		This	allowed	the	generation	of	Pearson’s	correlation	coefficients	between	all	variables.		No	variables	had	a	correlation	coefficient	above	0.7;	however,	MCS	and	depression	(0.59),	
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MCS	and	anxiety	(0.699),	and	depression	and	anxiety	(0.549)	were	high.		This	collinearity	between	these	measures	was	to	be	expected	given	that	they	are	measuring	similar	psychological	metrics.		It	was	felt	the	assumption	of	non-collinearity	was	met	(please	see	appendix	section	VI	for	correlation	coefficients).		The	assumption	of	homoscedasticity	of	residuals	(indicating	the	variance	of	the	residuals	is	the	same	for	all	values	of	predicted	variable)	and	normality	of	residuals	were	tested	on	the	fitted	model.		The	results	of	the	homoscedasticity	of	residuals	can	be	found	in	the	residual	versus	prediction	scatterplot	in	the	appendix	(section	VI).		Normality	of	residuals	was	assed	informally	using	QQ	plots	and	histograms,	which	are	available	in	the	appendix	(section	VI).		Overall	the	assumptions	required	for	a	linear	regression	model	were	valid.				
Model	building	Before	model	building	I	decided	that	age,	gender	and	OKS	should	be	included	as	necessary	parts	of	the	model.		This	allows	the	model	to	be	corrected	for	basic	demographics	and	knee	function	of	patients	presenting	for	knee	replacement.		Complete	case	analysis	(including	cases	that	had	not	missing	data	for	any	variable	tested	in	the	modelling)	was	used,	which	allowed	analysis	of	271	cases.				Forward	stepwise	analysis,	using	a	p-value	of	0.05	for	inclusion	and	0.1	for	exclusion,	was	then	used	for	explanatory	variable	selection	using	SPSS	version	22.164	Examination	of	each	included	variable	using	drop	one	diagnostics	was	performed.		The	Akaike	Information	Criterion	(AIC),	which	is	a	measure	of	how	well	a	model	fits	the	observed	data	and	includes	a	penalty	for	the	complexity	of	the	model,	was	included	in	the	drop	one	diagnostics.165		
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The	variables	age,	gender,	baseline	OKS,	MCS,	expectations	and	depression	were	included	in	the	model.	Patients	with	higher	baseline	OKS,	higher	(better)	MCS,	higher	expectations,	and	lower	levels	of	depression	have	higher	(better)	OKS	scores	at	six	months.		The	model	summary	with	no	interaction	terms	is	displayed	below	in	Table	22.		The	fitted	model	characteristics	were	F	(6,	265)	=	22.2,	p<0.001,	R=0.579,	R2=0.335,	SE=7.7.		(	F	(x,y)	=	the	F	statistic,	with	x	representing	the	number	of	coefficients	in	the	model,	and	y	the	degrees	of	freedom;	R	=	correlation	coefficient	that	when	squared	(R2)	gives	the	amount	of	variability	the	model	predicts;	S.E	–	standard	error	of	the	regression	which	is	the	square	root	of	the	mean	sum	of	squares	residuals).		The	Adjusted	R2	is	0.32	(this	value	corrects	for	the	number	of	explanatory	variables	in	the	model).		This	means	that	the	model	describes	32%	of	the	variability	in	outcome.			
Table	22:	Coefficients	for	first	order	fitted	model	(six	month	OKS)	
Explanatory	
variable	
z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Beta	 t	 p	
(Constant)	 10.557	 6.787	 -2.806	 23.921	 	 1.556	 0.121	
Age	 -0.034	 0.057	 -0.147	 0.079	 -0.031	 -0.593	 0.553	
Female	Gender	 0.844	 0.993	 -1.111	 2.798	 0.044	 0.85	 0.396	
OKS	Baseline	 0.223	 0.069	 0.087	 0.359	 0.183	 3.233	 0.001	
MCS	 0.23	 0.051	 0.13	 0.331	 0.301	 4.505	 <0.001	
Expectations	 0.283	 0.103	 0.08	 0.485	 0.147	 2.752	 0.006	
Depression	 -0.527	 0.201	 -0.922	 -0.131	 -0.168	 -2.621	 0.009	
z=	the	estimated	regression	correlation	coefficient	
Beta=	the	standardized	regression	correlation	coefficient.		This	reflects	the	number	of	standard	
deviations	the	response	variable	will	alter	with	one	standard	deviation	change	in	the	explanatory	
variable.		These	are	directly	comparable	across	explanatory	variables.					Drop	one	diagnostics	were	used	to	assess	relative	contributions	to	the	final	model	from	each	explanatory	variable.		This	involves	removing	each	variable	from	the	model	and	assessing	the	model	fit.		When	drop	one	diagnostics	is	used,	the	AIC	can	compare	the	two	models.		Models	with	a	lower	AIC	fit	the	data	better,	taking	into	account	the	number	of	variables	in	the	model.			The	results	can	be	found	in	Table	23	where	model	
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terms	are	ordered	in	importance	to	the	overall	model	fit.		The	model	without	age	included	provides	a	higher	R2	of	0.322	and	a	lower	AIC,	suggesting	a	model	that	fits	the	data	better.		Similarly,	gender	provides	a	higher	R2	of	0.321,	with	a	lower	AIC.		All	other	variables	contribute	to	the	model	with	lower	AIC	and	higher	R2	when	included.		Depression	provides	the	least	amount	of	explanatory	power	(about	1.7%	of	the	total	variability	the	model	can	predict)	whereas	MCS	provides	the	most	(around	5%	of	the	total	variability	the	model	can	predict).				
Table	23:	Drop	one	diagnostics	(six	month	OKS)	
Model	 R	 R2	 Adjusted	
R2	
Std.	Error	
of	the	
Estimate	
R2	
Change	
p	 AIC	
Full	model	 0.579	 0.335	 0.32	 7.68496	 -	 -	 1116.3	
Age	 0.578	 0.334	 0.322	 7.67559	 -0.001	 0.553	 1114.6	
Female	Gender	 0.578	 0.334	 0.321	 7.68094	 -0.002	 0.396	 1115.0	
Depression	 0.564	 0.318	 0.305	 7.76928	 -0.017	 0.009	 1121.2	
Expectations	 0.562	 0.316	 0.304	 7.7793	 -0.019	 0.006	 1121.9	
Baseline	OKS	 0.556	 0.309	 0.296	 7.82027	 -0.026	 0.001	 1124.8	
MCS	 0.533	 0.284	 0.271	 7.95878	 -0.051	 <0.001	 1134.3	
R=Pearson’s	correlation	coefficient;	R2=Pearson’s	product	moment	correlation	coefficient;	
Adjusted	R2=R2	adjusted	for	the	number	of	explanatory	variables	in	model;	AIC=	Akaike	
Information	Criterion,	which	is	a	measure	of	how	well	a	model	fits	the	observed	data,	including	a	
penalty	for	the	complexity	of	the	model		
Variables	that	were	not	significant	in	the	final	model	Deprivation	was	close	to	statistical	significance	(p=0.099)	but	was	not	include	in	the	model.		All	excluded	variables	are	displayed	in	Table	24.								
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Table	24:	Excluded	variables	(six	month	OKS)	
Explanatory	Variable	 z	 t	 p	
BMI	 -.052	 -0.909	 0.364	
Severe	Arthritis	 .078	 1.532	 0.127	
Joint	Count	 -.080	 -1.404	 0.161	
Lower	back	pain	 -.037	 -0.701	 0.484	
Number	of	co-morbidities	 -.023	 -0.401	 0.689	
Live	Alone	 .045	 0.855	 0.393	
Deprivation	Score	 -.085	 -1.653	 0.099	
Previous	Arthroscopy	 .002	 0.035	 0.972	
Helplessness	 -.098	 -1.564	 0.119	
Internality	 -.018	 -0.336	 0.737	
PCS	 .066	 0.897	 0.371	
Anxiety	 .061	 0.812	 0.418	
z=the	standardised	correlation	coefficient	(equivalent	to	Beta	in	the	model	tables)	if	this	term	were	
included	in	the	model.					
Interaction	terms	Pairwise	interaction	terms	were	introduced	into	the	fitted	model	and	were	selected	using	the	same	forward	stepwise	regression.		Only	terms	that	were	already	included	in	the	model	were	introduced	as	interaction	terms.		All	variables	were	mean-centred	which	allows	easier	interpretation	of	model	coefficients	(i.e.	the	model	coefficients	describe	the	effect	of	one	explanatory	variable	on	another’s	mean).						The	interaction	terms	between	depression	and	age,	and	expectation	and	gender	were	statistically	significant	model	terms.		To	investigate	the	meaning	of	the	interaction	terms	in	more	detail	age	was	divided	into	three	equal	groups	(50	to	65,	66	to	73,	and	74	and	over).		This	allowed	us	to	plot	the	interaction	terms	of	depression	and	age,	and	gender	and	expectation.		Each	variable	was	then	plotted	against	predicted	outcome	(Figure	26	and	Figure	27)	to	allow	exploration	of	the	relationship.						
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Figure	26:	Interaction	between	age	and	depression		Age	has	little	effect	on	the	relationship	between	depression	and	OKS	for	low	levels	of	depression.		However,	for	higher	levels	of	depression	lower	ages	have	worse	OKS	scores.		This	effect	becomes	more	marked	the	higher	the	depression	score.		Depression	has	less	of	an	effect	on	outcome	in	those	aged	66	years	and	over.								
	 194	
	
Figure	27:	Interaction	effect	of	gender	and	expectations		Males	with	low	expectations	demonstrate	lower	six	month	OKS	scores	than	females	with	low	expectations,	but	this	relationship	is	reversed	with	high	expectation	(males	with	high	expectations	demonstrate	higher	six	month	scores	that	females	with	high	expectations).		Expectations	have	more	of	an	effect	on	males	than	on	females.				
Variables	that	were	not	significant	in	the	model	Table	25	demonstrates	all	excluded	variables	after	the	interaction	terms	were	fitted.		Severe	arthritis	(p=0.079)	and	the	interaction	term	between	depression	and	MCS	(p=0.082)	are	very	nearly	significant	predictors	in	the	model	with	the	significant	interaction	terms	modelled.			
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Table	25:	Excluded	variables	including	interaction	terms	(six	month	OKS)	
Variable	 z	 t	 p	
BMI	 -0.052	 -0.921	 0.358	
Deprivation	Score	 -0.075	 -1.479	 0.14	
Comorbidity	 -0.037	 -0.655	 0.513	
Joint	Count	 -0.077	 -1.358	 0.176	
Helplessness	 -0.09	 -1.446	 0.149	
Internality	 -0.012	 -0.219	 0.827	
PCS	 0.064	 0.878	 0.381	
Anxiety	 0.048	 0.646	 0.519	
Severe	Arthritis	 0.089	 1.762	 0.079	
Lower	back	pain	 -0.019	 -0.375	 0.708	
Previous	Arthroscopy	 -0.002	 -0.041	 0.967	
Live	Alone	 0.052	 0.995	 0.321	
Interaction	Gender/OKS	 0.074	 0.976	 0.33	
Interaction	Gender/Age	 -0.036	 -0.44	 0.661	
Interaction	Gender/MCS	 0.099	 1.063	 0.289	
Interaction	Depression/Gender	 -0.089	 -1.154	 0.25	
Interaction	Depression/MCS	 0.095	 1.745	 0.082	
Interaction	Depression/Expectations	 -0.046	 -0.895	 0.372	
Interaction	Depression/OKS	 -0.054	 -0.974	 0.331	
Interaction	Expectations/OKS	 -0.056	 -0.994	 0.321	
Interaction	Expectations/Age	 0.031	 0.603	 0.547	
Interaction	Expectations/MCS	 0.028	 0.519	 0.604	
Interaction	OKS/Age	 0.015	 0.294	 0.769	
Interaction	OKS/MCS	 -0.056	 -1.071	 0.285	
Interaction	Age/MCS	 -0.036	 -0.527	 0.598	
z=the	standardised	correlation	coefficient	(equivalent	to	Beta	in	the	model	tables)	if	this	term	were	
included	in	the	model.					
Drop	one	diagnostics	Drop	one	diagnostics	were	performed	for	all	explanatory	variables	included	in	the	model	after	the	interaction	terms	were	fitted.	Table	25	displays	the	results.			The	inclusion	of	the	interaction	terms	decreased	the	AIC,	therefore	all	terms	were	included	
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in	the	final	model.		Both	interaction	terms	contribute	around	1%	of	unique	variability	to	the	final	model.		No	third	order	terms	were	included	in	the	model,	as	it	would	involve	including	non-significant	second	order	terms.			 		
Table	26:	Drop	one	diagnostics	after	inclusion	of	interaction	terms	
Model	
	
	 	
R	 R2	 Adjusted	
R2	
Std.	Error	
of	the	
Estimate	
R2	
Change	
p	 AIC	
Full	Model	 0.599	 0.359	 0.339	 7.57778	 -	 -	 1110.6	
Female	Gender	 0.597	 0.357	 0.34	 7.57547	 -0.002	 0.36	 1109.4	
Age	 0.597	 0.356	 0.339	 7.57631	 -0.002	 0.344	 1109.5	
Expectations/Ge
nder	
0.591	 0.349	 0.331	 7.62151	 -0.01	 0.045	 1112.7	
Depression/	
Age	
0.588	 0.346	 0.328	 7.63887	 -0.013	 0.022	 1114.0	
Depression	 0.586	 0.344	 0.326	 7.6513	 -0.015	 0.014	 1114.9	
Expectation	 0.576	 0.331	 0.314	 7.72259	 -0.027	 0.001	 1119.9	
Baseline	OKS	 0.575	 0.331	 0.313	 7.72657	 -0.028	 0.001	 1120.2	
MCS	 0.559	 0.312	 0.294	 7.834	 -0.047	 <0.001	 1127.7	
R=Pearson’s	correlation	coefficient;	R2=Pearson’s	product	moment	correlation	coefficient;	
Adjusted	R2=R2	adjusted	for	the	number	of	explanatory	variables	in	model;	AIC=	Akaike	
Information	Criterion,	which	is	a	measure	of	how	well	a	model	fits	the	observed	data,	including	a	
penalty	for	the	complexity	of	the	model	
	
Final	fitted	model	The	overall	fitted	model	was	F	(8,	263)	=	18.4,	p<0.001,	Adj	R2	=	0.339	(R=0.599,	R2=0.359)	(SE=7.6).		Regression	coefficients,	confidence	intervals,	and	the	proportion	of	unique	variability	each	explanatory	variable	can	account	for	can	be	found	in	Table	27.						
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Table	27:	Coefficients	of	final	model	(six	month	OKS)	
Variable	 z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Beta	 t	 p	
(Constant)	 34.484	 0.763	 32.981	 35.988	 	 45.171	 <0.001	
Female	Gender	 0.902	 0.984	 -1.036	 2.839	 0.047	 0.916	 0.36	
Age	 -0.054	 0.057	 -0.166	 0.058	 -0.048	 -0.948	 0.344	
Baseline	OKS	 0.232	 0.069	 0.097	 0.368	 0.191	 3.387	 0.001	
MCS	 0.221	 0.051	 0.122	 0.321	 0.289	 4.377	 <0.001	
Expectations	 0.497	 0.149	 0.204	 0.789	 0.258	 3.345	 0.001	
Depression	 -0.495	 0.2	 -0.889	 -0.102	 -0.158	 -2.479	 0.014	
Interaction	
depression/	
age	
0.041	 0.018	 0.006	 0.076	 0.116	 2.297	 0.022	
Interaction	gender/	
expectations	
-0.388	 0.193	 -0.768	 -0.009	 -0.149	 -2.014	 0.045	
z=	the	estimated	regression	correlation	coefficient	
Beta=	the	standardized	regression	correlation	coefficient.		This	reflects	the	number	of	standard	
deviations	the	response	variable	will	alter	with	one	standard	deviation	change	in	the	explanatory	
variable.		These	are	directly	comparable.							In	summary:	- This	model	accounts	for	33.9%	of	the	variability	found	in	OKS	at	six	months.		- MCS	accounts	for	the	greatest	amount	of	unique	variability	(almost	5%),	with	expectations	and	baseline	OKS	accounting	for	around	2.5%,	and	the	other	variables	around	1%	each.		Age	and	gender	have	small,	insignificant	effects.			- Better	baseline	OKS,	higher	(better)	MCS	and	higher	expectations	result	in	higher	(better)	six	month	OKS	scores.	- Higher	age	and	higher	levels	of	depression	result	in	lower	(worse)	OKS	scores.
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Performance	of	prediction	model	A	scatter	plot	of	predicted	values	against	actual	values	is	presented	below	in	Figure	28,	with	a	95%	confidence	interval	for	the	mean	(i.e.	a	population	based	estimate).					
	
Figure	28:	Predicted	against	actual	six	month	OKS 
 
 When	a	95%	confidence	interval	for	the	individual	is	included,	it	is	apparent	that	a	large	variation	in	actual	against	predicted	scores	would	occur	at	the	individual	level	(Figure	29).		The	usefulness	of	this	model	is	discussed	is	section	8.2.				
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Figure	29:	Actual	against	predicted	six	month	OKS 	
Alternative	outcome	measures:	OKS	pain	and	function	scores		Pain	and	function	sub	scores	of	the	OKS	may	provide	more	useful	models	for	prediction.		An	identical	method	of	generating	the	final	model	was	used	as	that	of	the	full	OKS	score.		
	
Pain	subscale	of	OKS	The	final	model	for	pain	was	F	(10,	261)=12.9,	p<0.001,	Adjusted	R2=0.305	(R=0.575,	R2=	0.331).		Table	28	demonstrates	a	table	of	coefficients.		Included	variables	were:		age;	gender;	OKS	(baseline);	MCS;	expectation;	and	depression	(identical	to	the	full	model).		Significant	interaction	terms	were:	depression	and	age;	depression	and	expectation;	depression	and	MCS;	and	gender	and	expectations.		Therefore,	this	model	
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included	two	interaction	terms	not	in	the	full	OKS	six	month	outcome	model.		All	effects	were	of	similar	magnitude	and	direction	as	those	for	the	full	OKS	outcome	score.		This	model	did	not	represent	any	improvement	on	prediction	over	the	model	for	the	full	OKS	score.				
Table	28:	Coefficients	with	six	month	OKS	pain	as	outcome	
Variable	 z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Beta	 t	 p	
(Constant)	 74.735	 1.853	 71.086	 78.384	 	 40.331	 <0.001	
Female	Gender	 4.315	 2.259	 -0.133	 8.764	 0.101	 1.91	 0.057	
Age	 0.014	 0.131	 -0.244	 0.271	 0.006	 0.106	 0.916	
Baseline	OKS	 0.37	 0.157	 0.06	 0.68	 0.136	 2.35	 0.02	
MCS	 0.418	 0.117	 0.187	 0.648	 0.244	 3.571	 <0.001	
Depression	 -0.872	 0.47	 -1.798	 0.054	 -0.124	 -1.855	 0.065	
Expectations	 1.149	 0.343	 0.474	 1.824	 0.267	 3.351	 0.001	
Interaction	Age/	
Depression	
0.079	 0.041	 -0.002	 0.16	 0.101	 1.932	 0.054	
Interaction	
Depression/	
MCS	
0.102	 0.031	 0.041	 0.162	 0.208	 3.301	 0.001	
Interaction	
Depression/	
Expectations	
-0.178	 0.07	 -0.315	 -0.041	 -0.151	 -2.556	 0.011	
Interaction	
Gender/	
Expectations	
-0.912	 0.45	 -1.798	 -0.025	 -0.157	 -2.024	 0.044	
z=	the	estimated	regression	correlation	coefficient	
Beta=	the	standardized	regression	correlation	coefficient.		This	reflects	the	number	of	standard	
deviations	the	response	variable	will	alter	with	one	standard	deviation	change	in	the	explanatory	
variable.		These	are	directly	comparable.				
Function	subscale	of	OKS	Included	terms	when	function	alone	was	modelled	were:	age;	gender;	OKS	(baseline);	MCS;	expectations;	joint	count;	depression;	interaction	of	joint	count	and	MCS;	and	the	interaction	of	gender	and	expectations.		This	altered	from	the	full	OKS	score	model	by	including	joint	count	and	the	interaction	between	joint	count	and	MCS,	and	excluding	
	 201	
the	interaction	between	depression	and	age.		All	relationships	were	in	the	same	direction	as	the	full	model,	with	similar	magnitude.		Increasing	number	of	joints	being	affected	resulted	in	poorer	functional	outcomes,	but	only	accounted	for	0.5%	of	the	unique	variability	predicted	by	the	model.		Overall	the	model	accounted	for	37.5%	of	the	variability	in	functional	outcome	at	six	months.						The	final	model	was	F	(9,262)	=	23.1,	p<0.001,	Adjusted	R2	=	0.375	(R=0.629,	R2=0.396).		Coefficients	and	confidence	intervals	for	the	final	model	are	presented	in	Table	29.		Figure	30	displays	a	scatterplot	of	actual	against	predicted	functional	scores,	with	95%	confidence	intervals	for	individual	scores.
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Table	29:	Coefficients	with	six	month	OKS	function	as	outcome	
Variable	 z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Beta	 t	 p	
(Constant)	 69.872	 1.645	 66.633	 73.111	 	 42.475	 <0.001	
Female	Gender	 -0.686	 2.086	 -4.794	 3.423	 -0.017	 -0.329	 0.743	
Age	 -0.256	 0.119	 -0.49	 -0.022	 -0.107	 -2.151	 0.032	
Baseline	OKS	 0.559	 0.144	 0.276	 0.842	 0.214	 3.894	 <0.001	
MCS	 0.382	 0.108	 0.17	 0.595	 0.232	 3.541	 <0.001	
Joint	Count	 -0.576	 0.401	 -1.365	 0.213	 -0.088	 -1.438	 0.152	
Expectations	 1.054	 0.313	 0.438	 1.669	 0.255	 3.37	 0.001	
Depression	 -0.897	 0.415	 -1.715	 -0.08	 -0.133	 -2.161	 0.032	
Interaction	
Gender/	
Expectations	
-1.054	 0.406	 -1.853	 -0.255	 -0.189	 -2.598	 0.01	
Interaction	
Joint	count/	
MCS	
0.047	 0.022	 0.005	 0.09	 0.125	 2.195	 0.029	
z=	the	estimated	regression	correlation	coefficient	
Beta=	the	standardized	regression	correlation	coefficient.		This	reflects	the	number	of	standard	
deviations	the	response	variable	will	alter	with	one	standard	deviation	change	in	the	explanatory	
variable.		These	are	directly	comparable.			
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Figure	30:	Predicted	against	actual	functional	scores	at	six	months	(OKS) 
 
 
Usefulness	of	alternative	outcome	scores	Both	pain	and	function	sub	scores	of	the	OKS	did	not	generate	a	more	useful	model	than	that	provided	by	the	complete	score.		
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Sensitivity	analysis	–	Multiple	imputation	Multiple	imputations	by	chained	equations	were	used	to	provide	10	models	with	imputed	data.		This	procedure	was	undertaken	in	SPSS	and	involves	imputing	missing	data	based	on	a	regression	model	from	known	values	combined	with	a	random	draw	from	the	distribution	of	residuals.		This	process	was	repeated	(in	this	case	10	times)	to	allow	for	variation	in	the	randomly	selected	residuals.			The	final	model	for	the	OKS	at	six	months	was	then	fitted	to	the	data.		A	model	summary	of	each	imputed	case	is	presented	in	Table	30.		Of	note,	when	producing	the	model,	complete	case	analysis	of	all	explanatory	variables	(whether	included	in	the	model	or	not)	was	conducted.		The	procedure	described	here	used	a	complete	case	analysis	of	all	explanatory	variables	that	were	included	in	the	final	model,	therefore	included	a	larger	proportion	of	the	patients.				The	pooled	results	for	the	imputed	models		(together	with	the	original	model	coefficients	for	comparison)	are	given	in	Table	31.		The	pooled	model	was	statistically	significant	(p<0.001),	with	F	(8,508)=25.251,	and	an	adjusted	R2	of	0.264	(Standard	Error=8.29).				The	model	fit	is	similar	for	the	imputed	data	(27.6%	of	the	variability),	the	“original	data”	(i.e.	the	complete	case	analysis	of	only	those	factors	included	in	the	model;	28.4%	of	the	variability).		The	model	fitting	procedure,	using	only	those	cases	that	had	complete	data	for	all	variables	tested,	whether	included	or	not,	could	account	for	slightly	more	of	the	variability	in	that	sample	(33.9%);	however	the	results	are	similar	indicating	the	pattern	of	missingness	is	likely	to	be	MAR.
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Table	30:	Model	parameters	for	imputed	data	sets	(six	month	OKS)	
Imputation	Number	 R	 R2	 Adjusted	
R2	
Std.	Error	
of	the	
Estimate	
F	statistic	 p	
Original	data	 0.546	 0.298	 0.284	 8.02277	 21.015	 <0.001	
1	 0.538	 0.29	 0.279	 8.29787	 25.907	 <0.001	
2	 0.537	 0.289	 0.277	 8.41328	 25.75	 <0.001	
3	 0.562	 0.316	 0.305	 8.2214	 29.317	 <0.001	
4	 0.532	 0.283	 0.272	 8.34657	 25.076	 <0.001	
5	 0.531	 0.282	 0.271	 8.29066	 24.982	 <0.001	
6	 0.549	 0.302	 0.291	 8.18733	 27.451	 <0.001	
7	 0.544	 0.295	 0.284	 8.22649	 26.626	 <0.001	
8	 0.537	 0.288	 0.277	 8.19388	 25.684	 <0.001	
9	 0.5	 0.25	 0.239	 8.52502	 21.207	 <0.001	
10	 0.53	 0.28	 0.269	 8.41214	 24.744	 <0.001	
R=Pearson’s	correlation	coefficient;	R2=Pearson’s	product	moment	correlation	coefficient;	
Adjusted	R2=R2	adjusted	for	the	number	of	explanatory	variables	in	model.		
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Table	31:	Original	and	pooled	coefficients	for	Multiple	Imputation	of	six	month	OKS	
Dataset	 Variable	 z	 Std.	Error	 Lower	
Bound	
Upper	
Bound	
t	 p	
Original	
data	
(Constant)	 33.701	 0.65	 32.424	 34.978	 51.88	 <0.001	
Age	 0.036	 0.048	 -0.058	 0.13	 0.749	 0.454	
Baseline	OKS	 0.18	 0.057	 0.067	 0.293	 3.123	 0.002	
Expectations	 0.499	 0.136	 0.231	 0.767	 3.665	 <0.001	
MCS	 0.231	 0.043	 0.147	 0.315	 5.411	 	 <0.001	
Depression	 -0.29	 0.17	 -0.625	 0.045	 -1.703	 0.089	
Interaction	
gender/	
expectations	 -0.214	 0.164	 -0.536	 0.109	 -1.301	 0.194	
Interaction	
depression/	
age	 0.033	 0.015	 0.005	 0.062	 2.28	 0.023	
Female	Gender	 1.246	 0.858	 -0.441	 2.932	 1.452	 0.147	
Pooled	 (Constant)	 33.621	 0.594	 32.456	 34.786	 56.567	 	 <0.001	
Age	 0.043	 0.045	 -0.045	 0.131	 0.963	 0.335	
Baseline	OKS	 0.189	 0.054	 0.084	 0.295	 3.514	 <0.001	
Expectations	 0.507	 0.129	 0.255	 0.759	 3.943	 <0.001	
MCS	 0.229	 0.043	 0.144	 0.314	 5.301	 <0.001	
Depression	 -0.221	 0.164	 -0.543	 0.101	 -1.345	 0.179	
Interaction	
gender/	
expectations	 -0.183	 0.158	 -0.493	 0.127	 -1.16	 0.247	
Interaction	
depression/	
age	 0.038	 0.014	 0.011	 0.065	 2.77	 0.006	
Female	Gender	 0.975	 0.79	 -0.573	 2.523	 1.235	 0.217	
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7.2.6 12	month	data	analysis	
OKS	At	six	months,	38	patients	were	lost	to	follow	up,	leaving	480	(92.8%)	of	eligible	participants	with	complete	OKS	12	month	scores.		The	median	OKS	score	at	12	months	was	39	(IQR=13),	compared	with	the	mean	baseline	score	of	19.7	(sd=8.1).		Two	hundred	and	sixty-two	patients	were	available	for	complete	case	analysis.				Table	32	shows	the	results	of	a	univariate	analysis	(Pearson	correlation	coefficients)	between	each	explanatory	variable	and	OKS	at	six	months.		
Table	32:	Univariate	correlations	of	explanatory	variables	to	12	month	OKS	
Variable	 Twelve	Month	OKS	 n	 p-value	
Twelve	Month	OKS	 1	 480	 .	
Age	 0.024	 480	 0.302	
Female	Gender	 -0.052	 480	 0.13	
OKS	Baseline	 0.394	 465	 <0.001	
BMI	 -0.165	 423	 <0.001	
Severe	Arthritis	 0.108	 465	 0.01	
Joint	Count	 -0.249	 418	 <0.001	
Lower	back	pain	 -0.192	 418	 <0.001	
Number	of	co-
morbidities	
-0.248	 450	 <0.001	
Live	Alone	 0.042	 445	 0.186	
Deprivation	Score	 -0.238	 480	 <0.001	
Previous	Arthroscopy	 -0.016	 417	 0.371	
Expectations	 0.326	 454	 <0.001	
Helplessness	 -0.382	 450	 <0.001	
Internality	 -0.201	 450	 <0.001	
PCS	 0.245	 432	 <0.001	
MCS	 0.429	 432	 <0.001	
Depression	 -0.326	 455	 <0.001	
Anxiety	 -0.302	 456	 <0.001					
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Model	building	Assumption	testing	for	12	month	OKS	was	identical	to	that	described	for	6	month	OKS	and	results	can	be	found	in	the	appendix	(section	VI).		Overall	the	assumptions	required	for	a	linear	regression	model	were	valid.				The	process	for	building	the	model	was	identical	to	that	described	for	the	six	month	OKS.				The	first	order	terms	of	age,	gender,	baseline	OKS,	MCS,	and	expectations	were	included	in	the	final	model	(cf.	the	six	month	model	that	also	included	depression).	The	interaction	term	between	gender	and	expectations	was	also	included	(cf.	the	six	month	model	that	also	included	the	interaction	between	age	and	depression).		The	directions	of	all	effects	were	identical	to	the	six	month	model	(better	MCS,	OKS,	higher	expectations,	and	female	gender	all	lead	to	higher	predicted	12	month	scores).		The	interaction	between	gender	and	expectations	was	identical	to	that	described	for	the	six	month	data.		Table	33	shows	model	coefficients.				The	fitted	model	characteristics	were	F	(6,	256)	=	21.5,	p<0.001,	R=0.579,	R2=0.335,	SE=7.8.		The	Adjusted	R2	is	0.32	(this	value	corrects	for	the	number	of	explanatory	variables	in	the	model).		This	means	that	the	model	describes	32%	of	the	variability	in	outcome.									
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Table	33:	Model	coefficients	for	12	month	OKS	
Explanatory	
variable	
z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Beta	 t	 p	
(Constant)	 35.311	 0.789	 33.758	 36.865	 	 44.767	 <0.001	
Female	Gender	 2.531	 1.027	 0.508	 4.554	 0.131	 2.464	 0.014	
Age	 -0.073	 0.059	 -0.189	 0.044	 -0.064	 -1.23	 0.22	
Baseline	OKS	 0.293	 0.071	 0.153	 0.433	 0.24	 4.118	 <0.001	
MCS	 0.283	 0.045	 0.195	 0.371	 0.37	 6.358	 <0.001	
Expectation	 0.546	 0.155	 0.241	 0.85	 0.285	 3.53	 <0.001	
Interaction	
Gender/	
Expectations	
-0.506	 0.197	 -0.895	 -0.118	 -0.198	 -2.565	 0.011	
z=	the	estimated	regression	correlation	coefficient	
Beta=	the	standardized	regression	correlation	coefficient.		This	reflects	the	number	of	standard	
deviations	the	response	variable	will	alter	with	one	standard	deviation	change	in	the	explanatory	
variable.		These	are	directly	comparable	across	explanatory	variables.						Drop	one	diagnostics	were	used	to	assess	relative	contributions	to	the	final	model	from	each	explanatory	variable.		The	results	can	be	found	in	Table	34	where	they	have	been	organised	in	order	of	relative	contribution.		The	model	without	age	included	provides	a	lower	AIC,	suggesting	a	model	that	fits	the	data	better.		All	other	variable	contribute	to	the	model	with	lower	AIC	and	higher	R2	when	included.		Age	contributes	the	least	explanatory	power	to	the	model	(less	than	1%),	and	MCS	contributes	the	most	at	over	10%.										
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Table	34:	Drop	one	diagnostics	for	12	month	OKS	
Model	 R	 R2	 Adjusted	
R2	
Std.	Error	
of	the	
Estimate	
R2	
Change	
p	 AIC	
Full	Model	 0.579	 0.335	 0.32	 7.83	 0.017	 0.011	 1089.6	
Age	 0.575	 0.331	 0.318	 7.84	 -0.004	 0.22	 1089.2	
Female	Gender	 0.565	 0.319	 0.306	 7.91	 -0.016	 0.014	 1093.8	
Interaction	
Expectations/G
ender	
0.564	 0.318	 0.305	 7.92	 -0.017	 0.011	 1094.3	
Expectation	 0.55	 0.303	 0.289	 8.01	 -0.032	 0	 1100.1	
Baseline	OKS	 0.539	 0.291	 0.277	 8.07	 -0.044	 0	 1104.5	
MCS	 0.48	 0.23	 0.215	 8.41	 -0.105	 0	 1126.2	
R=Pearson’s	correlation	coefficient;	R2=Pearson’s	product	moment	correlation	coefficient;	
Adjusted	R2=R2	adjusted	for	the	number	of	explanatory	variables	in	model;	AIC=	Akaike	
Information	Criterion,	which	is	a	measure	of	how	well	a	model	fits	the	observed	data,	including	a	
penalty	for	the	complexity	of	the	model			In	summary	the	12	month	model:		 - Predicts	32%	of	the	variability	in	outcome	- Better		(higher)	MCS,	better	(higher)	baseline	OKS,	higher	expectations,	and	female	gender	all	lead	to	higher	predicted	12	month	scores	- The	MCS	accounts	for	around	10%	of	the	variability,	with	the	baseline	OKS	accounting	for	around	5%.										
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OKS	sub	scores	The	models	for	the	OKS	subscores	did	not	improve	greatly	on	the	model	for	the	complete	score,	accounting	for	25%	and	35%	of	the	variability	in	outcome	for	the	pain	and	function	domains	respectively.		The	coefficients	are	displayed	below.			
Pain	The	final	fitted	model	for	12	month	OKS	pain	scores	included	age,	gender,	baseline	OKS,	MCS,	and	depression.		No	interaction	terms	were	included.	The	model	predicted	around	25%	of	the	variability	in	outcome.		Table	35	shows	the	model	coefficients.				
Table	35:	Model	coefficients	for	12	month	OKS	-	Pain	
Explanatory	variable	 z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Beta	 t	 p	
(Constant)	 76.707	 1.812	 73.138	 80.276	 	 42.325	 <0.001	
Female	Gender	 5.945	 2.378	 1.263	 10.627	 0.139	 2.501	 0.013	
Age	 -0.124	 0.135	 -0.39	 0.142	 -0.05	 -0.917	 0.36	
Baseline	OKS	 0.535	 0.16	 0.22	 0.85	 0.198	 3.341	 0.001	
MCS	 0.533	 0.122	 0.293	 0.773	 0.316	 4.381	 <0.001	
Depression	 -0.963	 0.476	 -1.901	 -0.025	 -0.139	 -2.022	 0.044	
z=	the	estimated	regression	correlation	coefficient	
Beta=	the	standardized	regression	correlation	coefficient.		This	reflects	the	number	of	
standard	deviations	the	response	variable	will	alter	with	one	standard	deviation	change	
in	the	explanatory	variable.		These	are	directly	comparable	across	explanatory	variables.					
Function	The	explanatory	variables	included	in	the	function	model	were	identical	to	that	of	the	model	for	the	full	OKS	score.		Directions	of	effects	were	similar	and	the	overall	amount	of	variability	that	could	be	explained	by	the	model	was	similar	at	35%.		Table	36	shows	the	model	coefficients.				
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Table	36:	Model	coefficients	for	12	month	OKS	-	Function	
Explanatory	variable	 z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Beta	 t	 p	
(Constant)	 70.733	 1.669	 67.447	 74.02	 	 42.378	 <0.001	
Female	Gender	 2.858	 2.171	 -1.417	 7.133	 0.068	 1.316	 0.189	
Age	 -0.278	 0.125	 -0.523	 -0.032	 -0.113	 -2.226	 0.027	
Baseline	OKS	 0.791	 0.15	 0.495	 1.087	 0.298	 5.26	 <0.001	
MCS	 0.532	 0.094	 0.346	 0.717	 0.32	 5.643	 <0.001	
Expectations	 1.221	 0.327	 0.577	 1.865	 0.294	 3.732	 <0.001	
Interaction	
Expectations/	Gender	
-0.931	 0.418	 -1.753	 -0.108	 -0.168	 -2.227	 0.027	
z=	the	estimated	regression	correlation	coefficient	
Beta=	the	standardized	regression	correlation	coefficient.		This	reflects	the	number	of	
standard	deviations	the	response	variable	will	alter	with	one	standard	deviation	change	
in	the	explanatory	variable.		These	are	directly	comparable	across	explanatory	variables.					
SF-36	-	PCS	The	model	building	and	testing	of	assumptions	was	identical	for	both	domains	of	the	SF-36	as	for	the	OKS;	however,	age,	gender	and	the	baseline	score	of	the	dependent	variable	were	included	as	co-variates	(cf.	age,	gender	and	baseline	OKS).				Fifty-eight	patients	(11.2%)	did	not	have	complete	data	at	follow	up	(459	did;	88.8%).		The	mean	score	was	34.9	(sd=3.5),	compared	with	a	baseline	mean	score	of	21.3	(sd=8.1).		Two	hundred	and	fifty-two	patients	were	available	for	complete	case	analysis.		The	first	order	explanatory	variables	age,	gender,	PCS,	MCS,	comorbidity,	BMI	and	expectations	were	included	in	the	model,	along	with	the	interaction	terms	between	gender/expectations	and	PCS/comorbidities.		Of	note,	the	interaction	terms	for	Gender/MCS	was	excluded	with	a	p-value	of	0.052,	and	the	first	order	explanatory	variable	OKS	was	excluded	with	a	p-value	of	0.092.				The	overall	fitted	model	was	F	(9,	243)	=	20.6,	p<0.001,	Adj	R2	=	0.411	(R=0.657,	R2=0.432)	(SE=10.5).		Regression	coefficients	and	confidence	intervals	can	be	found	in	
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Table	37.		Baseline	PCS	accounted	for	the	most	variability	(8.4%),	with	gender	accounting	for	the	least	(less	then	0.1%).				
Table	37:	Model	coefficients	for	SF-36	-	PCS	at	12	months	
Explanatory	
variable	
z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Beta	 t	 p	
Female	Gender	 0.441	 1.434	 -2.383	 3.265	 0.016	 0.308	 0.759	
Age	 -0.251	 0.088	 -0.425	 -0.077	 -0.153	 -2.842	 0.005	
PCS	 0.51	 0.085	 0.342	 0.678	 0.309	 5.973	 <0.001	
MCS	 0.254	 0.064	 0.129	 0.379	 0.227	 3.987	 <0.001	
Comorbidity	 -1.783	 0.495	 -2.759	 -0.807	 -0.207	 -3.598	 <0.001	
BMI	 -0.382	 0.128	 -0.634	 -0.131	 -0.164	 -2.993	 0.003	
Expectations	 0.831	 0.239	 0.361	 1.301	 0.285	 3.48	 0.001	
Interaction	
Gender/	
Expectations	
-0.835	 0.301	 -1.428	 -0.242	 -0.224	 -2.775	 0.006	
Interaction	PCS/	
Comorbidity	
0.114	 0.052	 0.012	 0.216	 0.113	 2.204	 0.028	
z=	the	estimated	regression	correlation	coefficient	
Beta=	the	standardized	regression	correlation	coefficient.		This	reflects	the	number	of	standard	
deviations	the	response	variable	will	alter	with	one	standard	deviation	change	in	the	explanatory	
variable.		These	are	directly	comparable	across	explanatory	variables.						This	model	indicates	that	better	baseline	PCS,	MCS,	higher	expectations,	lower	BMI,	fewer	comorbidities,	and	lower	age	all	predicted	better	outcomes.				
Drop	one	diagnostics	Table	38	demonstrates	the	results	from	the	drop	one	diagnostics	for	SF-36	PCS.		The	AIC	for	all	variables	is	lower	when	that	variable	is	included	in	the	model,	except	for	gender.		This	indicates	that	all	variables	included	in	the	final	model	(apart	from	gender)	improve	the	model	fit.						
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Table	38:	Drop	one	diagnostics	for	SF-36	-	PCS	at	12	months	
Model	 R	 R2	 Adjusted	
R2	
Std.	Error	
of	the	
Estimate	
R2	
Change	
p	 AIC	
Full	model	 .657	 0.432	 0.411	 10.52845	 0.011	 0.028	 1200.9	
Female	Gender	 .657	 0.432	 0.413	 10.5089	 0	 0.759	 1199.1	
Interaction	
PCS/	
Comorbidity	
.649	 0.421	 0.402	 10.61132	 -0.011	 0.028	 1204.0	
Interaction	
Gender/	
Expectations	
.644	 0.414	 0.395	 10.672	 -0.018	 0.006	 1206.9	
Age	 .643	 0.413	 0.394	 10.68007	 -0.019	 0.005	 1207.2	
BMI	 .641	 0.411	 0.392	 10.69873	 -0.021	 0.003	 1208.1	
Expectations	 .636	 0.404	 0.384	 10.76554	 -0.028	 0.001	 1211.3	
Comorbidity	 .634	 0.402	 0.382	 10.78305	 -0.03	 <0.001	 1212.1	
MCS	 .629	 0.395	 0.375	 10.84511	 -0.037	 <0.001	 1215.0	
PCS	 .591	 0.349	 0.327	 11.25168	 -0.083	 <0.001	 1233.6	
R=Pearson’s	correlation	coefficient;	R2=Pearson’s	product	moment	correlation	coefficient;	
Adjusted	R2=R2	adjusted	for	the	number	of	explanatory	variables	in	model;	AIC=	Akaike	
Information	Criterion,	which	is	a	measure	of	how	well	a	model	fits	the	observed	data,	including	a	
penalty	for	the	complexity	of	the	model			
Interaction		The	interaction	effect	between	gender	and	expectations	was	similar	to	that	described	for	both	six	and	12	month	OKS.		To	explore	the	relationship	between	PCS	and	comorbidity,	comorbidity	was	split	into	three	approximately	equal	groups:		up	to	2	comorbidities	(n=168),	3	comorbidities	(n=145),	and	4	and	above	comorbidities	(n=175).		Figure	31	shows	this	relationship:		for	up	to	3	comorbidities	there	is	a	similar	effect,	with	higher	baseline	PCS	predicting	higher	12	month	PCS;	patients	with	4	comorbidities	or	more	have	lower	PCS	at	12	months	when	their	baseline	PCS	is	low,	but	higher	PCS	at	12	months	when	their	baseline	PCS	is	high.		In	other	words,	the	PCS	at	12	months	in	patients	with	high	numbers	of	comorbidities	were	more	affected	by	baseline	PCS	scores	that	for	patients	with	low	numbers	of	comorbidities.			
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Figure	31:	Interaction	between	PCS	and	comorbidities	(SF-36) 		In	summary	the	full	model	for	SF-36	PCS:	- Accounts	for	41.1%	of	the	variability	in	the	PCS	score	at	12	months	- Baseline	PCS	accounts	for	the	most	individual	variability	(8.4%)	- Contrary	to	the	OKS	model,	age	is	significant	and	predicts	1.9%	of	the	variability	in	outcome.						
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Prediction	Figure	32	predicted	(x-axis)	against	actual	PCS	scores	at	12	months.		A	best	fit	line	with	95%	confidence	intervals	for	individual	values	is	included.					
	
Figure	32:	Predicted	against	actual	SF-36	PCS 		
SF-36	-	MCS	Fifty-eight	patients	(11.2%)	did	not	have	complete	data	at	follow	up	(459	did;	88.8%).		The	mean	score	was	52.1	(sd=10.1),	compared	with	the	baseline	of	52.5	(sd=12.3).		Two	hundred	and	fifty-two	patients	were	available	for	complete	case	analysis.		The	first	
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order	explanatory	variables	age,	gender,	MCS,	comorbidity,	and	depression	were	included	in	the	model.		No	interaction	terms	were	included.		Of	note,	the	explanatory	variables	of	living	alone	(p=0.072)	and	anxiety	(p=0.065)	were	excluded.				The	overall	fitted	model	was	F	(5,	247)	=	33.9,	p<0.001,	Adj	R2	=	0.395	(R=0.638,	R2=0.407)	(SE=8.3).		Regression	coefficients	and	confidence	intervals	can	be	found	in	Table	39.		Baseline	MCS	accounted	for	the	most	variability	(9.9%),	with	age	accounting	for	the	least	(less	then	0.2%).		
Table	39:	Model	coefficients	for	SF-36	-	MCS	at	12	months	
Explanatory	
variable	
z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Beta	 t	 p	
(Constant)	 52.05	 0.843	 	 50.39	 53.71	 61.77	 <0.001	
Female	Gender	 1.165	 1.098	 0.054	 -0.998	 3.329	 1.061	 0.29	
Age	 -0.055	 0.064	 -0.043	 -0.181	 0.071	 -0.864	 0.388	
MCS	 0.363	 0.057	 0.419	 0.252	 0.475	 6.432	 <0.001	
Comorbidity	 -1.368	 0.365	 -0.205	 -2.087	 -0.649	 -3.747	 <0.001	
Depression	 -0.589	 0.221	 -0.167	 -1.024	 -0.154	 -2.666	 0.008	
z=	the	estimated	regression	correlation	coefficient	
Beta=	the	standardized	regression	correlation	coefficient.		This	reflects	the	number	of	standard	
deviations	the	response	variable	will	alter	with	one	standard	deviation	change	in	the	explanatory	
variable.		These	are	directly	comparable	across	explanatory	variables.					
Drop	one	diagnostics	Table	40	demonstrates	the	results	from	the	drop	one	diagnostics	for	SF-36	MCS.		The	AIC	for	all	variables	is	lower	when	that	variable	is	included	in	the	model,	except	for	age	and	gender.		This	indicates	that	all	variables	included	in	the	final	model	(apart	from	age	and	gender)	improve	the	model	fit.							
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Table	40:	Drop	one	diagnostics	SF-36	MCS	at	12	months	
Model	 R	 R2	 Adjusted	
R2	
Std.	Error	
of	the	
Estimate	
R2	
Change	
p	 AIC	
Full	Model	 0.638	 0.407	 0.395	 8.27375	 0.017	 0.008	 1075.2	
Age	 0.636	 0.405	 0.395	 8.26953	 -0.002	 0.388	 1073.9	
Female	Gender	 0.636	 0.404	 0.395	 8.27584	 -0.003	 0.29	 1074.3	
Depression	 0.624	 0.39	 0.38	 8.37498	 -0.017	 0.008	 1080.3	
Comorbidity	 0.611	 0.373	 0.363	 8.48848	 -0.034	 <0.001	 1087.1	
MCS	 0.555	 0.307	 0.296	 8.92171	 -0.099	 <0.001	 1112.3	
R=Pearson’s	correlation	coefficient;	R2=Pearson’s	product	moment	correlation	coefficient;	
Adjusted	R2=R2	adjusted	for	the	number	of	explanatory	variables	in	model;	AIC=	Akaike	
Information	Criterion,	which	is	a	measure	of	how	well	a	model	fits	the	observed	data,	including	a	
penalty	for	the	complexity	of	the	model			
Prediction	Figure	33	shows	predicted	(x-axis)	against	actual	MCS	scores	at	12	months.		A	best	fit	line	with	95%	confidence	intervals	for	the	mean	is	included.				
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Figure	33:	Predicted	against	actual	SF-36	MCS 
 
 
 
Satisfaction	Satisfaction	was	measured	by	a	scale	devised	and	validated	by	Mohmed.157	Mahomed	recommends	analysis	of	the	satisfaction	score	as	a	scale	variable	therefore	linear	regression	was	performed.			
 Fifty	patients	(9.9%)	did	not	have	complete	data	at	follow	up;	466	patients	(90.1%)	did	have	complete	follow	up	data.		The	median	score	was	94	(IQR=25;	Range=75).		Two	hundred	and	sixty-four	patients	were	available	for	complete	case	analysis.		The	first	order	explanatory	variables	age,	gender	and	OKS	were	covariates,	with	a	stepwise	procedure	as	described	previously	to	model	further	terms.		Depression	and	MCS	were	
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significant.		Of	note,	the	explanatory	variable	internality	(p=0.056)	was	excluded.		No	interaction	terms	were	significant.				The	overall	fitted	model	was	F	(5,	259)	=	12.6,	p<0.001,	Adj	R2	=	0.183	(R=0.446,	R2=0.199)	(SE=8.3).		Regression	coefficients	and	confidence	intervals	can	be	found	in	Table	41.		Baseline	depression	and	MCS	accounted	for	the	most	variability	in	the	model	(3.8%	and	3.7%	respectively).	
 
Table	41:	Model	coefficients	for	12	month	satisfaction	
Explanatory	variable	 z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Beta	 t	 p	
(Constant)	 85.619	 1.589	 82.489	 88.749	 	 53.87	 0	
Female	Gender	 2.986	 2.086	 -1.121	 7.094	 0.084	 1.432	 0.153	
Age	 -0.042	 0.12	 -0.278	 0.195	 -0.02	 -0.349	 0.727	
Baseline	OKS	 0.044	 0.141	 -0.233	 0.321	 0.02	 0.314	 0.753	
Depression	 -1.418	 0.411	 -2.228	 -0.608	 -0.246	 -3.447	 0.001	
MCS	 0.361	 0.105	 0.153	 0.568	 0.256	 3.424	 0.001	
z=	the	estimated	regression	correlation	coefficient	
Beta=	the	standardized	regression	correlation	coefficient.		This	reflects	the	number	of	standard	
deviations	the	response	variable	will	alter	with	one	standard	deviation	change	in	the	explanatory	
variable.		These	are	directly	comparable	across	explanatory	variables.						
Model	fit	The	QQ	plot	demonstrates	that	the	residuals	were	not	normally	distributed	(left	skewed).		A	common	transformation	to	deal	with	left	skewed	data	is	to	square	or	cube	the	response	variable	(Tukey’s	ladder	of	transformations).165		Therefore,	the	response	variable	was	squared	and	cubed,	and	models	compared.		The	cubed	model	met	the	necessary	assumptions	for	normality	of	residuals	(QQ	plots	and	histogram	available	in	the	appendix	section	VI).				
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The	overall	fitted	model	for	satisfaction	cubed	included	identical	variables	and	was	F	(5,	259)	=	13.7,	p<0.001,	Adj	R2	=	0.196	(R=0.460,	R2=0.212)	(SE=64.3).		Regression	coefficients	and	confidence	intervals	can	be	found	in	Table	42.		Baseline	depression	and	MCS	accounted	for	the	most	variability	in	the	model	(4%	and	3.5%	respectively).		Therefore	the	model	has	only	changed	very	slightly	with	the	transformation.				
Table	42:	Model	coefficients	for	12	month	satisfaction	(cubed)	
Explanatory	
variable	
z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Beta	 t	 p	
(Constant)	 713371	 26963	 660270	 766472	 	 26.457	 <0.001	
Female	Gender	 41141	 35385	 -28543	 110827	 0.068	 1.163	 0.246	
Age	 -1097	 2036	 -5107	 2913	 -0.031	 -0.539	 0.591	
OKS	Baseline	 1761	 2385	 -2935	 6458	 0.046	 0.739	 0.461	
Depression	 -25182	 6980	 -38929	 -11436	 -0.255	 -3.608	 <0.001	
MCS	 6038	 1787	 2517	 9560	 0.25	 3.378	 0.001	
z=	the	estimated	regression	correlation	coefficient	
Beta=	the	standardized	regression	correlation	coefficient.		This	reflects	the	number	of	standard	
deviations	the	response	variable	will	alter	with	one	standard	deviation	change	in	the	explanatory	
variable.		These	are	directly	comparable	across	explanatory	variables.						
Drop	one	diagnostics	Table	43	demonstrates	the	results	from	the	drop	one	diagnostics	for	satisfaction.				The	AIC	for	variables	that	were	included	as	covariates	(age,	gender	and	OKS)	is	lower	than	that	for	the	full	model,	indicating	that	they	are	not	related	to	satisfaction.		Only	the	variables	MCS	and	depression	improve	the	model	fit.								
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Table	43:	Drop	one	diagnostics	for	satisfaction	
R=Pearson’s	correlation	coefficient;	R2=Pearson’s	product	moment	correlation	coefficient;	
Adjusted	R2=R2	adjusted	for	the	number	of	explanatory	variables	in	model;	AIC=	Akaike	
Information	Criterion,	which	is	a	measure	of	how	well	a	model	fits	the	observed	data,	including	a	
penalty	for	the	complexity	of	the	model		
 
Decision	regret	Decision	regret	was	measured	by	a	yes/no	question:		“Knowing	what	you	know	now,	would	you	still	choose	to	have	the	operation	on	your	knee”158,159		Four	hundred	and	sixty-one	patients	(89.2%)	responded	to	this	question,	with	50	patients	reporting	regretting	having	the	procedure	(10.8%).				Logistic	regression	was	used	to	build	a	model	to	predict	which	patients	were	at	high	risk	of	decision	regret.		A	similar	model	building	strategy	was	used,	with	age,	gender	and	OKS	at	baseline	included	within	the	model,	and	then	a	forward	conditional	stepwise	procedure	in	SPSS	used	to	add	model	terms.		This	procedure	includes	terms	if	they	are	significant,	based	on	the	Wald	statistic.		
Model	 R	 R2	 Adjusted	
R2	
Std.	Error	
of	the	
Estimate	
R2	
Change	
p	 AIC	
Full	Model	 0.46	 0.212	 0.196	 266390.81	 0.035	 0.001	 6502.1	
Age	 0.459	 0.211	 0.199	 266019.78	 -0.001	 0.591	 6500.4	
Baseline	
OKS	
0.458	 0.21	 0.198	 266153.25	 -0.002	 0.461	 6500.7	
Female	
Gender	
0.456	 0.208	 0.195	 266574.52	 -0.004	 0.246	 6501.5	
MCS	 0.42	 0.177	 0.164	 271772.93	 -0.035	 0.001	 6511.6	
Depression	 0.414	 0.172	 0.159	 272595.25	 -0.04	 <0.001	 6513.1	
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Using	complete	case	analysis	255	patients	were	included	in	the	model,	with	23	(9%)	expressing	decision	regret.				The	final	model	included	the	terms	age,	gender,	OKS,	depression,	MCS	and	the	interaction	between	age	and	gender.		Model	coefficients	are	demonstrated	below	in	Table	44.				
Table	44:		Model	coefficients	for	decision	regret	
Variables	 B	 S.E.	 Wald	 p	 Odds	
Ratio	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Age	 -0.01	 0.038	 0.065	 0.799	 0.99	 0.92	 1.066	
Female	
Gender	
-7.638	 4.171	 3.352	 0.067	 0	 0	 1.713	
Baseline	OKS	 0.028	 0.033	 0.684	 0.408	 1.028	 0.963	 1.097	
MCS	 -0.052	 0.024	 4.591	 0.032	 0.949	 0.904	 0.996	
Depression	 0.227	 0.089	 6.522	 0.011	 1.255	 1.054	 1.495	
Age	by	Gender	 0.121	 0.06	 4.035	 0.045	 1.128	 1.003	 1.269	
Constant	 -1.132	 2.865	 0.156	 0.693	 0.322	 	 	
Gender	is	for	females	compared	to	males;	B=regression	coefficient;	S.E.-	standard	effort:	Wald=	
Wald	statistic		This	table	demonstrates	that	patients	with	poorer	baseline	MCS	(low	scores)	and	higher	levels	of	depression	(high	scores)	are	more	likely	to	express	decision	regret	after	their	operation.		The	Nagelkerke	R2	for	this	model	was	0.221.		A	contingency	table	demonstrating	the	ability	of	the	model	to	predict	decision	regret	is	shown	in	Table	45.	The	sensitivity	of	this	model	is	8.7%,	and	the	specificity	is	99.1%.		The	positive	predictive	value	(predicting	decision	regret)	is	50%,	and	the	negative	predictive	value	is	91.6%.		Although	this	represents	excellent	specificity	and	negative	predictive	values,	this	is	more	a	reflection	on	the	low	number	of	patients	with	decision	regret.						
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Table	45:	Contingency	table	of	decision	regret	model	
Observed	 Predicted	 Percentage	Correct	
	 No	regret	 Regret	 	
No	regret	 230	 2	 99.1	
Regret	 21	 2	 8.7	
Overall	percentage	 	 	 91			
Assumption	testing	Linearity	of	explanatory	variables	to	logit	of	the	response	variable	was	tested	using	the	Box-Tidwell	procedure.		The	results	are	available	in	the	appendix	(section	VI)	demonstrating	that	this	assumption	was	met.						
7.2.7 Sensitivity	analysis	Multiple	imputations	by	chained	equations	were	used	to	provide	10	models	with	imputed	data.		The	final	models	for	all	outcomes	at	12	months	were	then	fitted	to	the	data.		Of	note,	when	producing	the	linear	regression	models,	complete	case	analysis	of	all	explanatory	variables	(whether	included	in	the	model	or	not)	was	conducted.		The	procedure	described	here	used	a	complete	case	analysis	of	all	explanatory	variables	that	were	included	in	the	final	model,	therefore	included	a	larger	proportion	of	the	patients.									
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OKS	12	months	The	model	summary	for	each	data	set	is	given	in	Table	46.		
Table	46:	Imputation	models	for	OKS	12	months	
Imputation	
Number	
R	 R	Square	 Adjusted	R	
Square	
Std.	Error	
of	the	
Estimate	
F	statistic	 p	
Original	data	 0.539	 0.291	 0.28	 8.30648	 27.465	 <0.001	
1	 0.511	 0.261	 0.252	 8.58046	 29.967	 <0.001	
2	 0.505	 0.255	 0.246	 8.50426	 29.06	 <0.001	
3	 0.502	 0.252	 0.244	 8.46358	 28.693	 <0.001	
4	 0.509	 0.259	 0.25	 8.53967	 29.679	 <0.001	
5	 0.495	 0.245	 0.236	 8.56932	 27.58	 <0.001	
6	 0.52	 0.271	 0.262	 8.45111	 31.538	 <0.001	
7	 0.517	 0.268	 0.259	 8.58909	 31.046	 <0.001	
8	 0.505	 0.255	 0.246	 8.55219	 29.044	 <0.001	
9	 0.509	 0.259	 0.25	 8.54436	 29.728	 <0.001	
10	 0.512	 0.263	 0.254	 8.50087	 30.273	 <0.001	
R=Pearson’s	correlation	coefficient;	R2=Pearson’s	product	moment	correlation	coefficient;	
Adjusted	R2=R2	adjusted	for	the	number	of	explanatory	variables	in	model			The	pooled	results	for	the	imputed	models		(together	with	the	original	model	coefficients	for	comparison)	are	given	in	Table	47.		The	pooled	model	was	statistically	significant	(p<0.001),	with	F	(6,510)=32.41,	and	an	adjusted	R2	of	0.250	(Standard	Error	=8.53).				The	model	fit	is	similar	for	the	imputed	data	(25.0%	of	the	variability),	the	“original	data”	(i.e.	the	complete	case	analysis	of	only	those	factors	included	in	the	model;	28.0%	of	the	variability).		The	model	fitting	procedure,	using	only	those	cases	that	had	complete	data	for	all	variables	tested,	whether	included	or	not,	could	account	for	slightly	more	of	the	variability	in	that	sample	(32%);	however,	a	drop	in	R2	based	from	the	development	dataset	(complete	case	analysis)	to	the	pairwise	and	imputation	
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datasets	is	to	be	expected.		Additionally	the	correlation	coefficients	are	a	similar	size	and	direction,	indicating	the	pattern	of	missingness	is	likely	to	be	MAR.				
Table	47:	Model	coefficients	(imputed	and	original)	for	12	month	OKS	
Dataset	 Variable	 z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
t	 p	
Original	
data	
(Constant)	 35.055	 0.667	 33.745	 36.365	 52.595	 <0.001	
Female	Gender	 2.308	 0.88	 0.579	 4.037	 2.624	 0.009	
Age	 0.011	 0.048	 -0.084	 0.106	 0.229	 0.819	
Baseline	OKS	 0.275	 0.059	 0.159	 0.391	 4.668	 <0.001	
MCS	 0.255	 0.038	 0.181	 0.329	 6.789	 <0.001	
Expectations	 0.484	 0.14	 0.209	 0.759	 3.456	 0.001	
Interaction	
Gender/	
Expectations	
-0.245	 0.167	 -0.574	 0.084	 -1.464	 0.144	
Pooled	 (Constant)	 35.195	 0.616	 33.987	 36.403	 57.128	 <0.001	
Female	Gender	 1.796	 0.818	 0.192	 3.401	 2.195	 0.028	
Age	 0.028	 0.046	 -0.062	 0.118	 0.61	 0.542	
Baseline	OKS	 0.266	 0.055	 0.159	 0.373	 4.87	 <0.001	
MCS	 0.24	 0.037	 0.166	 0.313	 6.394	 <0.001	
Expectations	 0.46	 0.131	 0.203	 0.718	 3.504	 <0.001	
Interaction	
Gender/	
Expectations	
-0.131	 0.157	 -0.439	 0.177	 -0.837	 0.403	
z=correlation	coefficient		
	
SF-36	PCS	The	pooled	results	for	the	imputed	models		(together	with	the	original	model	coefficients	for	comparison)	are	given	in	Table	48.	The	pooled	model	was	statistically	significant	(p<0.001),	with	F	(9,507)=27.69,	and	an	adjusted	R2	of	0.318	(Standard	Error	=11.24).					
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Table	48:	Imputation	models	for	SF-36	PCS	
Imputation	
Number	
R	 R	Square	 Adjusted	R	
Square	
Std.	Error	
of	the	
Estimate	
F	statistic	 p	
Original	data	 0.598	 0.357	 0.34	 10.99674	 20.144	 <0.001	
1	 0.564	 0.319	 0.306	 11.37377	 26.33	 <0.001	
2	 0.569	 0.324	 0.312	 11.18115	 26.982	 <0.001	
3	 0.586	 0.343	 0.332	 11.16263	 29.455	 <0.001	
4	 0.567	 0.322	 0.31	 11.33123	 26.731	 <0.001	
5	 0.569	 0.324	 0.312	 11.13046	 26.991	 <0.001	
6	 0.581	 0.337	 0.326	 11.23586	 28.686	 <0.001	
7	 0.571	 0.326	 0.314	 11.21872	 27.246	 <0.001	
8	 0.566	 0.321	 0.309	 11.19762	 26.593	 <0.001	
9	 0.593	 0.352	 0.34	 11.17564	 30.58	 <0.001	
10	 0.571	 0.326	 0.314	 11.36593	 27.287	 <0.001	
R=Pearson’s	correlation	coefficient;	R2=Pearson’s	product	moment	correlation	coefficient;	
Adjusted	R2=R2	adjusted	for	the	number	of	explanatory	variables	in	model			The	model	fit	is	similar	for	the	imputed	data	(31.8%	of	the	variability)	and	the	“original	data”	(i.e.	the	complete	case	analysis	of	only	those	factors	included	in	the	model;	34.0%	of	the	variability).		The	model	fitting	procedure,	using	only	those	cases	that	had	complete	data	for	all	variables	tested,	whether	included	or	not,	could	account	for	slightly	more	of	the	variability	in	that	sample	(41.1%);	however,	a	drop	in	R2	based	from	the	development	dataset	(complete	case	analysis)	to	the	pairwise	and	imputation	datasets	is	to	be	expected.		Additionally	the	correlation	coefficients	are	a	similar	size	and	direction,	indicating	the	pattern	of	missingness	is	likely	to	be	MAR.								
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Table	49:	Model	coefficients	(imputed	and	original)	for	SF-36	PCS	
Dataset	 Variable	 z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
t	 p	
Original	
data	
(Constant)	 34.624	 1.008	 32.641	 36.607	 34.349	 <0.001	
Female	Gender	 1.024	 1.305	 -1.543	 3.591	 0.785	 0.433	
Age	 -0.188	 0.078	 -0.341	 -0.034	 -2.403	 0.017	
MCS	 0.25	 0.055	 0.142	 0.358	 4.541	 <0.001	
Expectations	 0.702	 0.227	 0.254	 1.149	 3.086	 0.002	
Interaction	
Gender/	
Expectations	
-0.54	 0.276	 -1.082	 0.002	 -1.96	 0.051	
PCS	 0.463	 0.075	 0.315	 0.611	 6.151	 <0.001	
BMI	 -0.359	 0.118	 -0.591	 -0.127	 -3.044	 0.003	
Comorbidity	 -1.337	 0.454	 -2.23	 -0.445	 -2.949	 0.003	
Interaction	PCS/	
Comorbidity	
0.127	 0.046	 0.036	 0.219	 2.744	 0.006	
Pooled	 (Constant)	 34.413	 0.861	 32.722	 36.104	 39.978	 <0.001	
Female	Gender	 0.957	 1.108	 -1.218	 3.132	 0.864	 0.388	
Age	 -0.128	 0.065	 -0.256	 -0.001	 -1.972	 0.049	
MCS	 0.256	 0.05	 0.157	 0.355	 5.09	 <0.001	
Expectations	 0.535	 0.182	 0.177	 0.894	 2.935	 0.003	
Interaction	
Gender/	
Expectations	
-0.31	 0.217	 -0.735	 0.116	 -1.43	 0.153	
PCS	 0.472	 0.064	 0.346	 0.598	 7.344	 <0.001	
BMI	 -0.239	 0.106	 -0.447	 -0.03	 -2.253	 0.025	
Comorbidity	 -1.275	 0.37	 -2.002	 -0.548	 -3.445	 0.001	
Interaction	PCS/	
Comorbidity	
0.101	 0.036	 0.03	 0.173	 2.789	 0.006	
z=correlation	coefficient			
SF-36	MCS	The	pooled	results	for	the	imputed	models		(together	with	the	original	model	coefficients	for	comparison)	are	given	in	Table	50.	The	pooled	model	was	statistically	significant	(p<0.001),	with	F	(5,511)=51.25,	and	an	adjusted	R2	of	0.327	(Standard	Error	=8.85).				
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Table	50:	Imputed	models	for	SF-36	MCS	
Imputation	
Number	
Model	 R	 R2	 Adjusted	
R2	
Std.	Error	
of	the	
Estimate	
F	statistic	 p	
Original	data	 1	 .595	 0.354	 0.345	 8.84345	 40.911	 <0.001	
1	 1	 .572	 0.327	 0.321	 8.89612	 49.759	 <0.001	
2	 1	 .566	 0.32	 0.313	 8.97588	 48.062	 <0.001	
3	 1	 .578	 0.335	 0.328	 8.75108	 51.384	 <0.001	
4	 1	 .583	 0.34	 0.334	 9.00654	 52.654	 <0.001	
5	 1	 .559	 0.313	 0.306	 8.92258	 46.558	 <0.001	
6	 1	 .589	 0.346	 0.34	 8.68916	 54.178	 <0.001	
7	 1	 .579	 0.335	 0.329	 8.85992	 51.593	 <0.001	
8	 1	 .583	 0.34	 0.334	 8.83908	 52.655	 <0.001	
9	 1	 .576	 0.332	 0.326	 8.86394	 50.816	 <0.001	
10	 1	 .591	 0.349	 0.343	 8.6983	 54.876	 <0.001	
R=Pearson’s	correlation	coefficient;	R2=Pearson’s	product	moment	correlation	coefficient;	
Adjusted	R2=R2	adjusted	for	the	number	of	explanatory	variables	in	model			The	model	fit	is	similar	for	the	imputed	data	(32.7%	of	the	variability)	and	the	“original	data”	(i.e.	the	complete	case	analysis	of	only	those	factors	included	in	the	model;	34.5%	of	the	variability).		The	model	fitting	procedure,	using	only	those	cases	that	had	complete	data	for	all	variables	tested,	whether	included	or	not,	could	account	for	slightly	more	of	the	variability	in	that	sample	(39.5%);	however,	a	drop	in	R2	based	from	the	development	dataset	(complete	case	analysis)	to	the	pairwise	and	imputation	datasets	is	to	be	expected.		Additionally	the	correlation	coefficients	are	a	similar	size	and	direction,	indicating	the	pattern	of	missingness	is	likely	to	be	MAR.			
Satisfaction	The	pooled	results	for	the	imputed	models		(together	with	the	original	model	coefficients	for	comparison)	are	given	in	Table	51.		The	pooled	model	was	statistically	significant	(p<0.001),	with	F	(5,511)=14.45,	and	an	adjusted	R2	of	0.115	(Standard	Error	=66.2).				
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Table	51:	Model	Coefficients	for	satisfaction	(original	and	imputed)	
Dataset	 Variable	 z	 Std.	
Error	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
t	 p	
Original	
data	
(Constant)	 694872	 22978	 649697	 740048	 30.241	 <0.001	
Female	
Gender	
34252	 30927	 -26551	 95056	 1.108	 0.269	
Depression	 -19018	 6045	 -30903	 -7133	 -3.146	 0.002	
MCS	 5286	 1549	 2239	 8332	 3.412	 0.001	
Age	 1294	 1722	 -2092	 4681	 0.751	 0.453	
Baseline	OKS	 2712	 2026	 -1270	 6696	 1.339	 0.181	
Pooled	 (Constant)	 693744	 20675	 653216	 734272	 33.555	 <0.001	
Female	
Gender	
26438	 28010	 -28498	 81375	 0.944	 0.345	
Depression	 -20443	 5922	 -32106	 -8781	 -3.452	 0.001	
MCS	 4658	 1449	 1816	 7501	 3.215	 0.001	
Age	 1617	 1531	 -1386	 4621	 1.056	 0.291	
Baseline	OKS	 2204	 1840	 -1403	 5812	 1.198	 0.231	
z=correlation	coefficient		Table	52	shows	that	the	model	fit	is	similar	for	the	imputed	data	(11.5%	of	the	variability)	and	the	“original	data”	(i.e.	the	complete	case	analysis	of	only	those	factors	included	in	the	model;	13.2%	of	the	variability).		The	model	fitting	procedure,	using	only	those	cases	that	had	complete	data	for	all	variables	tested,	whether	included	or	not,	could	account	for	slightly	more	of	the	variability	in	that	sample	(19.6%);	however,	a	drop	in	R2	based	from	the	development	dataset	(complete	case	analysis)	to	the	pairwise	and	imputation	datasets	is	to	be	expected.		Additionally	the	correlation	coefficients	are	a	similar	size	and	direction,	indicating	the	pattern	of	missingness	is	likely	to	be	MAR.								
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Table	52:	Imputed	models	for	satisfaction	
Imputation	
Number	
R	 R2	 Adjusted	
R2	
Std.	Error	of	the	
Estimate	
F	statistic	 p	
Original	data	 0.378	 0.143	 0.132	 289866.2833	 13.095	 <0.001	
1	 0.364	 0.132	 0.124	 289013.7349	 15.563	 <0.001	
2	 0.355	 0.126	 0.117	 288396.8579	 14.737	 <0.001	
3	 0.347	 0.12	 0.112	 292501.7304	 13.956	 <0.001	
4	 0.338	 0.114	 0.106	 289883.7977	 13.187	 <0.001	
5	 0.345	 0.119	 0.111	 291847.4735	 13.852	 <0.001	
6	 0.353	 0.125	 0.116	 291381.5924	 14.584	 <0.001	
7	 0.364	 0.133	 0.124	 287463.4821	 15.632	 <0.001	
8	 0.371	 0.137	 0.129	 292653.5154	 16.286	 <0.001	
9	 0.336	 0.113	 0.104	 290939.8146	 13.021	 <0.001	
10	 0.343	 0.118	 0.109	 291779.944	 13.651	 <0.001	
R=Pearson’s	correlation	coefficient;	R2=Pearson’s	product	moment	correlation	coefficient;	
Adjusted	R2=R2	adjusted	for	the	number	of	explanatory	variables	in	model		
Decision	regret	The	individual	classification	tables	for	each	model	are	given	below	(Table	53).		Pooled	model	coefficients	(along	with	the	original	model)	are	given	in	Table	54.		Overall,	the	sensitivity	of	this	model	is	around	2%.			The	model	coefficients	are	similar	and	in	a	similar	direction,	suggesting	the	missing	data	is	likely	to	be	MAR.														
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Table	53:	Classification	table	for	decision	regret	(imputed	data)	
Imputation	
Number	
Observed	 Predicted	 Percentage	
Correct	
Decision	Regret	 	
No	regret	 Regret	 	
Original	data	 Decision	
Regret	
No	regret	 355	 0	 100	
Regret	 38	 1	 2.6	
Overall	Percentage	 	 	 90.4	
1	 Decision	
Regret	
No	regret	 459	 0	 100	
Regret	 57	 1	 1.7	
Overall	Percentage	 	 	 89	
2	 Decision	
Regret	
No	regret	 460	 0	 100	
Regret	 56	 1	 1.8	
Overall	Percentage	 	 	 89.2	
3	 Decision	
Regret	
No	regret	 462	 0	 100	
Regret	 54	 1	 1.8	
Overall	Percentage	 	 	 89.6	
4	 Decision	
Regret	
No	regret	 457	 0	 100	
Regret	 59	 1	 1.7	
Overall	Percentage	 	 	 88.6	
5	 Decision	
Regret	
No	regret	 455	 1	 99.8	
Regret	 60	 1	 1.6	
Overall	Percentage	 	 	 88.2	
6	 Decision	
Regret	
No	regret	 456	 0	 100	
Regret	 60	 1	 1.6	
Overall	Percentage	 	 	 88.4	
7	 Decision	
Regret	
No	regret	 462	 0	 100	
Regret	 54	 1	 1.8	
Overall	Percentage	 	 	 89.6	
8	 Decision	
Regret	
No	regret	 460	 0	 100	
Regret	 56	 1	 1.8	
Overall	Percentage	 	 	 89.2	
9	 Decision	
Regret	
No	regret	 455	 0	 100	
Regret	 61	 1	 1.6	
Overall	Percentage	 	 	 88.2	
10	 Decision	
Regret	
No	regret	 460	 0	 100	
Regret	 56	 1	 1.8	
Overall	Percentage	 	 	 89.2					
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Table	54:	Coefficients	for	decision	regret	(imputed	and	original)	
	 Variables	 B	 S.E.	 Wald	 p	 Odds	
Ratio	
95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Original	
data	
Age	 -0.027	 0.026	 1.087	 0.297	 0.974	 0.926	 1.024	
Female	
Gender	
-4.418	 2.976	 2.205	 0.138	 0.012	 0	 4.112	
Baseline	OKS	 -0.006	 0.025	 0.067	 0.796	 0.994	 0.946	 1.044	
MCS	 -0.046	 0.018	 6.455	 0.011	 0.955	 0.922	 0.99	
Depression	 0.114	 0.064	 3.183	 0.074	 1.121	 0.989	 1.271	
Age	by	
Gender	
0.067	 0.043	 2.454	 0.117	 1.07	 0.983	 1.163	
Constant	 1.339	 2.004	 0.446	 0.504	 3.815	 	 	
Pooled	 Age	 -0.02	 0.022	 	 0.36	 0.98	 0.939	 1.023	
Female	
Gender	
-2.77	 2.745	 	 0.315	 0.063	 0	 14.183	
Baseline	OKS	 0.009	 0.021	 	 0.652	 1.01	 0.969	 1.052	
MCS	 -0.04	 0.016	 	 0.012	 0.96	 0.931	 0.991	
Depression	 0.114	 0.058	 	 0.05	 1.121	 1	 1.255	
Age	by	
Gender	
0.039	 0.039	 	 0.316	 1.04	 0.963	 1.123	
Constant	 0.598	 1.728	 	 0.729	 1.819	 0.061	 54.197	
Gender	is	for	females	compared	to	males;	B=regression	coefficient;	S.E.-	standard	effort:	Wald=	
Wald	statistic		 	
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7.3 Discussion	
	
7.3.1 Summary	of	results	I	have	described	the	results	of	a	multicentre	cohort	study	designed	to	develop	a	prognostic	model	that	characterises	the	association	between	pre-operative	factors	and	outcome	at	six	and	12	months.		This	study	took	place	over	six	sites,	with	an	estimated	pool	of	1500	patients,	of	which	999	were	screened	for	inclusion.		Six	hundred	patients	were	recruited,	with	516	patients	eligible	for	follow	up	at	12	months.		Of	those	eligible	for	follow	up	over	90%	completed	follow	up	at	six	and	12	months.		The	linear	regression	models	developed	can:		 - Predict	33.9%	of	the	variability	in	OKS	scores	at	six	months	- Predict	32%	of	the	variability	in	OKS	scores	at	12	months		The	explanatory	variables	included	in	these	models	were	similar,	with	similar	effects:		Poorer	MCS	scores	(reflecting	poorer	mental	health)	resulted	in	poorer	OKS	scores,	poorer	baseline	OKS	scores	resulted	in	poorer	OKS	outcome,	and	people	with	high	expectations	achieved	higher	OKS	scores.		Gender	and	expectations	interacted,	such	that	males	with	low	expectation	achieved	lower	scores	than	females,	and	males	with	high	expectations	achieved	higher	scores	than	females	(i.e.	expectations	had	a	larger	effect	on	males	than	on	females).		Age	and	gender	did	not	lead	to	large	changes	in	the	models.		Depression	was	a	significant	predictor	in	the	six	month	model,	but	not	in	the	12	month	model.				
	 235	
Multiple	imputation	techniques	demonstrated	that	the	models	predict	27.6%	of	the	variability	at	six	months,	and	25%	of	the	variability	at	12	months.		This	drop	is	to	be	expected,	as	the	model	was	being	expanded	beyond	the	cases	used	to	generate	it.				Additional	linear	regression	models	were	able	to:		 - Predict	41.1%	of	the	variability	in	SF-36	PCS	at	12	months	- Predict	39.5%	of	the	variability	in	SF-36	MCS	at	12	months	- Predict	19.6%	of	the	variability	in	satisfaction	at	12	months		Of	the	above	models,	the	ability	to	predict	PCS	was	the	most	promising.		This	was	due	to	the	MCS	score	changing	very	little	from	baseline	(mean	of	52.5	to	52.1),	and	the	satisfaction	linear	regression	model	was	unable	to	predict	more	than	20%	of	the	variability.					The	PCS	model	demonstrated	a	fall	in	the	amount	of	variability	it	could	predict	to	31.8%	when	using	multiple	imputations.		As	discussed	previously	this	is	to	be	expected,	and	likely	reflects	the	predictive	power	of	the	model	in	the	general	population	more	closely.		The	model	indicates	that	better	baseline	PCS,	MCS,	higher	expectations,	lower	BMI,	less	comorbidities,	and	lower	age	all	predicted	better	outcomes.		Interaction	effects	are	similar	between	expectations	and	gender	as	that	for	the	OKS	model.		This	model	accounts	for	a	greater	amount	of	variability	than	any	of	the	other	models.				A	logistic	regression	model	was	used	to	predict	patients	at	risk	of	decision	regret.		The	model	performance	was	disappointing,	with	a	sensitivity	of	8.7%,	and	a	specificity	of	99.1%.		The	positive	predictive	value	(predicting	decision	regret)	was	50%,	and	the	negative	predictive	value	was	91.6%.			
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7.3.2 Study	validity	The	external	validity	of	the	models	presented	depends	upon	the	model	covering	a	full	cross	section	of	patients	it	could	be	used	on.		I	used	representativeness	of	the	study	population	as	a	proxy	for	this:	the	representativeness	of	the	population	screened;	the	representativeness	of	those	patients	that	agreed	to	take	part;	and	the	representativeness	of	those	patients	included	in	the	analysis.		I	investigated	each	of	these	mechanisms.		The	population	screened	and	the	population	that	took	part	closely	reflected	the	general	population	of	the	UK	that	undergo	knee	replacement	(data	for	the	NJR)	and	the	population	of	the	hospitals	included	in	the	study,	when	compared	across	age	and	gender.		Although	there	were	some	differences	between	some	groups	(e.g.	between	the	baseline	group	of	all	knee	replacements	performed	at	all	sites	over	the	study	period	and	those	patients	screened),	the	differences	were	small,	the	coding	data	used	was	of	dubious	quality,	and	the	tests	were	very	powerful.		However,	age	and	gender	were	included	as	covariates	in	all	the	models	to	allow	correction	for	any	differences.		This	approach	does	not	account	for	potential	selection	bias	in	patients	who	refused	to	take	part	–	indeed	it	is	likely	that	the	psychological	profile	of	those	agreeing	and	those	refusing	to	take	part	is	different.				The	representativeness	of	the	data	analysed	was	tested	though	assessing	the	missingness	patterns.		Overall	the	study	had	low	levels	of	missing	data	(6.5%),	with	good	follow	up	rates	of	over	90%.	Given	the	likely	cause	for	this	pattern	of	missingness	I	thought	it	reasonable	to	assume	data	are	MAR.		This	allowed	me	to	undertake	conventional	statistical	modelling	(e.g.	regression	analysis)	with	the	expectation	that	resultant	coefficient	estimates	and	inferences	will	be	unbiased,	provided	the	appropriate	variables	were	included	in	the	models.			The	result	of	the	multiple	imputation	analysis	supports	this	assumption.			
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	I	used	a	complete	case	analysis	as	the	primary	analysis.		This	can	result	in	bias,165	and	resulted	in	around	270	cases	being	used	to	build	the	model.		This	reduces	the	power	of	the	analysis,	and	it	is	possible	that	factors	that	were	significant	were	not	included.		However,	given	the	point	estimates	of	factors	that	were	excluded	for	the	model,	I	do	not	think	they	would	have	added	a	great	deal	to	the	predictive	power,	even	if	they	were	significant.		A	smaller	sample	size	also	leads	to	less	precise	estimates.			To	assess	the	missingness	mechanism	multiple	imputation	was	uses,	as	described	above.		As	expected	the	results	of	the	multiple	imputation	revealed	less	predictive	power	from	the	models,	but	similar	significance,	size,	and	direction	of	effect	for	all	coefficients.				
7.3.3 Comparison	with	previous	attempts	at	outcome	prediction	Previous	attempts	at	outcome	prediction	have	predicted	less	than	20%	of	the	variability.		Currently,	case	mix	adjustment	used	by	the	DoH	uses	pre-	and	post-operative	factors	and	accounts	for	around	a	quarter	of	variability	in	OKS	at	six	months.		The	variability	that	the	models	presented	here	can	account	for	represent	an	improvement	over	the	current	methods;	however,	these	models	have	not	been	validated	on	an	independent	sample	of	patients,	and	such	validation	is	likely	to	produce	estimates	closer	to	the	multiple	imputation	results	that	I	have	presented.		This	would	account	for	around	27%	of	the	variability	in	six	month	OKS,	25%	of	the	variability	in	12	month	OKS,	and	31%	of	the	variability	in	12	month	PCS.					
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7.3.4 Does	this	model	predict	enough	variability	to	be	useful	for	individual	
outcome	prediction?		The	question	of	development	of	an	outcome	prediction	tool	from	this	prognostic	model	is	a	matter	of	judgment.		Some	would	argue	that	any	improvement	in	the	pre-operative	information	available	to	patients	is	worthwhile,	and	while	the	amount	of	variability	that	is	accounted	for	by	the	model	is	modest,	it	is	in	line	with	other	prediction	tools	used	to	assist	clinical	decision-making	in	the	NHS	(e.g.	the	Framingham	cardiovascular	risk	calculator	accounts	for	around	30%	of	the	variability	in	outcome).167		The	key	to	this	question	is	to	put	it	in	context	of	the	decision	that	is	being	made,	and	the	knowledge	and	skills	of	the	people	making	the	decision.		This	thesis	is	concerned	with	informing	individual	patient	decision-making	(cf.	the	Framingham	tool	which	is	used	to	inform	decisions	around	cardiovascular	risk	for	the	individual	patient,	with	the	expectation	of	improving	population	outcomes).					Therefore,	it	is	a	matter	of	judgement	if	individual	prediction	is	worthwhile	when	the	models	reported	here	can	account	for	around	30%	of	the	variability	in	outcome.	This	means	around	70%	of	the	variability	is	unaccounted	for:	therefore,	individual	confidence	intervals	are	still	wide	(around	80%	as	wide	as	for	a	model	based	only	on	the	mean).		Particularly	for	the	primary	outcome	measure	(the	OKS	at	one	year),	the	confidence	interval	for	the	individual	that	has	the	lowest	prediction	overlaps	with	the	confidence	interval	for	the	individual	that	has	the	highest	prediction.			When	we	consider	that	the	baseline	OKS	alone	accounts	for	around	15%	of	the	variability	in	outcome,	it	seems	unlikely	that	we	can	justify	the	use	of	this	tool	in	clinical	practice	for	the	purpose	of	informing	individual	patient	choice.		The	additional	variability	that	can	be	explained	by	the	model	is,	in	my	opinion,	unlikely	to	change	patients’	decision-making	(i.e.	we	know	that	patients	with	low	baseline	OKS	scores	are	unlikely	to	achieve	high	post-operative	OKS	scores,	and	patients	with	high	baseline	OKS	scores	are	likely	to	
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achieve	high	post-operative	scores;	therefore	the	additional	information	that	can	be	provided	is	limited).		Additionally,	chapter	4	described	concerns	from	patients	over	the	reliability	of	any	information	that	a	tool	provided.		With	individual	confidence	intervals	being	as	large	as	they	are,	it	is	unlikely	patients	would	respond	well	to	the	accuracy	of	the	model	–	the	optimism	bias	suggests	that	patients	would	tend	to	favour	their	own	chances	of	having	a	good	outcome.		Therefore	the	wide	confidence	intervals	are	likely	to	result	in	patients	assuming	they	would	be	the	small	proportion	that	are	at	the	higher	end	of	the	interval	for	a	prediction	of	poor	outcome.		Furthermore,	these	models	have	not	been	validated	on	an	independent	sample	of	patients,	and	it	would	be	expected	that	the	performance	of	the	model	would	be	poorer	on	an	external	sample.			The	models	presented	here	present	a	step	forward	in	the	amount	of	variability	that	can	be	explained	by	pre-operative	factors.		However,	based	on	the	findings	from	Chapter	3	and	4,	I	do	not	think	they	provide	the	basis	for	individual	prediction.		This	opens	up	the	opportunity	to	use	this	model	in	different	ways,	and	prompts	further	investigation	into	additional	factors	that	can	predict	more	variability.			
7.3.5 Other	applications	for	the	model		
Rationing	of	care	The	effects	of	an	outcome	prediction	tool	are	dependent	on	how	it	is	used:	medical	professionals,	commissioning	groups,	and	surgeons	could	use	it	to	ration	care	(i.e.	not	offering	knee	replacements	to	patients	at	high	risk	of	worse	outcomes).		A	form	of	rationing	has	been	present	in	the	NHS	for	some	time,	with	some	commissioning	groups	limiting	access	to	knee	replacements	based	on	knee	function	scores	and	BMI.25	Although	rationing	care	by	blocking	access	to	certain	groups	of	patients	could	be	a	feasible	application	of	this	work,	it	is	not	its	aim.	However,	the	model	presented	here	
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would	be	an	improvement	on	the	current	situation	of	rationing	care	based	on	baseline	knee	scores	but,	as	discussed	previously,	the	confidence	intervals	around	individual	prediction	are	wide,	and	therefore	this	approach	is,	in	my	option,	open	to	question.		Indeed,	many	in	the	orthopaedic	community	have	questioned	the	usefulness	of	using	rationalisation	based	on	OKS	scores,	and	these	arguments	are	valid	here.168	Additionally,	regardless	of	the	current	rationing	practices,	predicting	outcome	has	ethical	consideration:		is	it	ethical	to	limit	access	to	a	treatment	based	on	an	outcome	prediction	tool,	especially	when	those	that	are	likely	to	have	poorer	outcomes	still	improve	significantly,	and	the	individual	confidence	intervals	of	the	prediction	are	still	wide	(even	if	the	population	level	confidence	interval	is	relatively	narrow)?		Also,	removing	the	patient	from	the	decision-making	process	is	ethically	questionable,	and	is	against	current	political	movement	in	the	NHS	towards	shared	decision-making.28,46,50			
Use	of	model	for	case	mix	adjustment	The	Department	of	Health	could	incorporate	this	prognostic	algorithm	into	their	case	mix	adjustment	for	PROMs	(described	in	chapter	5).	Case	mix	adjustment	for	PROMs,	based	on	pre-operative	and	post-operative	factors,	has	been	introduced	as	part	of	the	best	practice	tariff	from	April	2015.169			The	research	presented	here	is	aimed	at	informing	the	decision-making	process	of	the	patient	with	an	outcome	prediction	tool.		However,	future	work	combining	peri-	and	post-operative	factors	to	the	pre-operative	model	may	produce	a	case-mix	adjustment	that	can	account	for	more	variability	than	currently	used	(the	DoH	uses	a	case	mix	adjustment	tool	based	on	NJR	and	HES	data	that	predicts	around	a	quarter	of	the	six	month	OKS).		I	would	expect	the	model	presented	here	to	have	roughly	the	same	predictive	power	as	the	current	case	mix	tool;	however,	this	leads	to	the	question	of	how	much	variability	could	be	predicted	if	everything	in	the	literature	were	combined	
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with	those	factors	described	here?		It	is	unlikely	there	would	be	much	improvement	given	the	factors	not	included	in	our	model	do	not	add	a	great	deal	of	explanatory	power,	and	that	explanatory	power	is	unlikely	to	be	additive.		Additionally,	a	fairly	modest	improvement	in	the	power	of	the	case	mix	adjustment	model	would	require	a	significant	investment	in	time	and	money:		the	costs	associated	with	licences	around	the	SF-36	questionnaire	(although	the	SF-36	RAND	questionnaire	is	licence-free,	it	was	not	used	in	this	model	building,	so	further	work	would	be	needed	to	assess	it);	larger	amount	of	data	collection;	new	studies	validating	the	work	done	here;	further	studies	to	combine	pre-	and	post-operative	explanatory	variables;	and	an	increase	in	patient	burden.		Assuming	no	interaction	between	terms	included	in	previous	models	and	the	models	presented	here,	there	would	be	around	a	maximum	of	9-10%	increase	in	the	variability	accounted	for	(although	interaction	is	highly	likely).		The	improvement	is	therefore	unlikely	to	justify	the	time	and	expense	required	to	achieve	it.						Finally,	predicting	around	30%	of	the	variability	may	not	be	sufficient,	as	70%	of	the	variability	is	still	unaccounted	for.		This	means	that	trusts	may	get	rewarded	or	penalized	on	the	basis	of	this	uncorrected	and	unaccounted	variability.				
Targeting	factors	that	have	been	identified	as	predictive	of	outcome	This	study,	combined	with	the	studies	discussed	in	Chapter	5,	provide	a	basis	for	studies	aimed	at	modifying	prognostic	factors	in	an	effort	to	improve	outcomes.		Some	efforts	in	this	area	are	already	going	on,	for	example	the	HAPPiKNEES	study	being	conducted	through	Nottingham	University	is	examining	Cognitive	Behavioural	Therapy	to	address	depression	and	anxiety	before	knee	replacement.96		This	type	of	study	could	target	each	of	the	modifiable	prognostic	factors	identified	by	the	prognostic	model.			
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	It	may	be	that	such	interventions	change	outcome	by	a	small	amount,	and	large	trials	would	therefore	be	needed	to	demonstrate	any	improvement.		Traditionally	trials	in	medicine	are	focused	on	interventions	that	result	in	a	predefined	change	in	the	outcome	measure	(e.g.	the	Minimally	Clinical	Important	Difference:	the	smallest	difference	that	a	patient	identifies	as	important).165	As	such,	such	trials	may	not	detect	a	small	change,	or	if	they	do	it	may	not	result	in	widespread	adoption.				An	alternative	approach	would	be	going	down	the	route	of	“marginal	gains”.		This	idea	was	popularised	by	Sir	Dave	Brailsford,	the	British	Cycling	Performance	director:			“If	you	broke	down	everything	you	could	think	of	that	goes	into	riding	a	bike,	and	then	improved	it	by	one	per	cent,	you	will	get	a	significant	increase	when	you	put	them	all	together,”		It	may	be	that	additive	changes	to	modifiable	predictive	factors	can	improve	outcome;	however,	this	would	require	a	large	amount	of	investment	to	demonstrate	efficacy.									
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7.3.6 Other	factors	that	could	be	responsible	for	the	(unaccounted)	variation	in	
outcome	There	is	currently	a	large	amount	of	variability	that	is	not	accounted	for.		As	a	knee	replacement	is	a	complex	intervention,	there	are	many	areas	that	introduce	this	variability:		 - Pre-admission	care.		Pre-operative	classes	are	commonplace	in	orthopaedic	units,	with	some	evidence	of	benefit.170		It	may	be	that	certain	pathways	are	better	than	others,	or	that	some	patients	respond	to	some	pathways	differently.			- Admission	care.		Organisational	issues,	surgical	technique,	and	anaesthetic	type	are	all	factors	that	could	influence	outcome.170			- Post-admission	care.		There	are	currently	trials	ongoing	to	assess	the	effect	of	different	post-operative	regimens	on	patients	at	high	risk	of	poor	outcomes.151,153			- The	patient.		There	may	be	factors	that	I	have	not	measured	(e.g.	catastrophisation,	or	biochemical	factors)	that	influence	outcome.		To	enable	greater	ability	to	predict,	more	in-depth	analysis	may	be	required	(e.g.	in-depth	psychometric	testing).		Given	feedback	from	participants	in	this	study,	running	a	study	with	a	larger	patient	burden	may	result	in	difficulties	in	patient	recruitment.			- Pathology.		A	large	number	of	the	population	have	OA	of	the	knee.		It	may	be	that	the	diagnosis	of	“OA	knee”	does	not	reflect	one	pathological	process,	but	may	reflect	a	heterogeneous	group	of	conditions	with	a	similar	pathological	endpoint.1,3,7	These	different	conditions	could	react	differently	to	joint	replacement.				
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Of	the	factors	above,	some	exciting	work	is	being	conducted	on	humeral	reactions	to	operation,	stress,	and	cell	signalling.171-173	Of	specific	note	is	the	preliminary	work	emerging	from	Stamford,	USA	on	cell	surface	antigens	and	intracellular	signalling	in	immune	cells.172,173				These	finding	(based	on	small	sample	sizes)	suggest	that	they	could	account	for	over	50%	of	the	variability	in	outcome.		Combining	these	biomarkers	with	the	patient	factors	described	in	this	thesis	could	be	a	productive	avenue	of	research.		Additionally,	several	trials	on	post-operative	rehabilitation	procedures	are	ongoing.151,153				It	is	feasible	that	in	the	future	meaningful	prediction	will	be	possible;	this	may	represent	individual	prediction,	or	risk	stratification	(i.e.	allocating	patients	into	different	risks	of	having	poorer	outcomes).				 	
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Chapter	8:		Conclusions	
	In	this	thesis	I	set	out	to	understand	the	factors	important	to	patients	when	contemplating	a	knee	replacement,	how	an	outcome	prediction	tool	could	affect	that	process	and	what	patients	would	want	from	such	a	tool.		I	then	went	on	to	identify	prognostic	factors	and	perform	a	multicentre	cohort	study	to	develop	a	prognostic	algorithm	that	could	help	patients	make	a	decision	about	progressing	to	a	knee	replacement.		Such	an	algorithm	could	have	uses	outside	of	supporting	individual	patient	decision-making,	and	those	uses	have	been	discussed.				To	begin,	I	performed	a	systematic	review	of	factors	that	influence	patients’	decision-making.		I	identified	17	individual	themes	across	seven	studies	that	included	patients	from	the	period	of	developing	symptoms	through	to	recovery	after	knee	replacement.		Understanding	the	factors	that	affect	a	patients’	decision-making	when	considering	a	knee	replacement	is	essential	to	the	shared	decision-making	process	and	can	act	as	a	framework	for	understanding	common	concerns	patients	have.	However,	this	review	was	unable	to	provide	a	model	of	decision-making	that	is	theoretically	grounded,	and	was	also	deficient	in	that	individual	studies	did	not	include	patients	at	different	parts	of	the	decision-making	process.				I	proceeded	to	report	an	original	qualitative	research	project	that	developed	a	model	of	decision-making.		I	identified	nine	major	themes	that	were	important	to	patients	when	contemplating	a	knee	replacement:		stress	of	deliberation;	expectation	of	outcome;	sources	of	information;	personal	situation;	mental	state;	coping	strategies;	loss	of	control;	trust	in	doctor;	and	preferred	model	of	care.		The	themes	interacted	comprehensively	with	one	and	other,	the	result	being	a	complex	interplay	of	factors	
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that	affect	the	deliberation	process,	the	threshold	to	decision-making,	and	the	ultimate	decision.		Interestingly	there	was	a	general	preference	for	“bottom	line”	information	married	to	a	paternalistic	decision-making	process.		This	is	in	contrast	to	current	political	movements	within	the	profession.		Additionally,	once	the	decision	was	made,	patients	were	unlikely	to	revisit	it,	as	there	was	stress	associated	with	the	deliberation	for	the	decision.				An	awareness	of	the	deliberation	phase,	the	factors	that	influence	it,	the	stress	associated	with	it,	preferred	models	of	care,	and	the	influence	of	the	decision-making	threshold	will	aid	useful	communication	between	doctors	and	patients.		Future	work,	examining	how	this	information	might	be	best	translated	and	utilised	in	the	clinical	environment	is	an	exciting	avenue.		This	is	one	of	the	key	elements	in	addressing	the	three	crucial	areas	set	out	in	the	introduction:	differences	in	utilisation	rates,31			a	high	dissatisfaction	rate25		and	increasing	demands	with	financial	constraints.27		I	then	went	on	to	conduct	a	qualitative	analysis	of	how	providing	predictions	of	outcome	could	affect	expectations	and	decision-making.		This	work	developed	our	understanding	of	the	effects	predicting	outcome	could	have	on	patients,	and	demonstrated	that	the	effect	of	an	outcome	prediction	tool	is	to	a	degree	dependent	on	the	content	and	presentation,	the	point	in	the	pathway	it	is	used,	and	whether	it	is	delivering	“good”	or	“bad”	news.		Work	assessing	the	effect	of	PDAs	would	suggest	a	decrease	in	the	proportion	of	people	progressing	to	elective	surgery	could	be	expected.		Additionally	how	the	tool	is	delivered	is	likely	to	be	key	(i.e.	as	part	of	a	shared	decision-making	model	or	part	of	a	paternalistic	model).		These	uncertainties	will	need	careful	evaluation	if	and	when	such	a	tool	becomes	available.				
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Additionally,	this	aspect	of	the	thesis	demonstrated	that	the	timing	of	delivery	of	predictive	information,	along	with	the	optimism	bias,	would	have	an	effect	on	any	future	tool	capable	of	predicting	outcome.	The	optimism	bias	may	mean	that	the	effect	on	satisfaction	rates	that	are	hoped	for	with	outcome	prediction	may	not	be	realised.		This	effect	may	mean	that	any	outcome	prediction	tool	may	need	to	have	tight	confidence	intervals	at	the	individual	level,	as	any	uncertainty	is	likely	to	be	used	to	justify	higher	expectations.		There	was	also	concern	that	some	patients	may	see	it	as	a	guarantee	of	outcome	(rather	than	a	prediction).		Linked	to	this	is	the	preference	for	information	from	friends	and	family.		Conflicting	information	from	a	prediction	and	a	family	member	who	has	had	the	operation	is	likely,	and	it	appears	that	patients	would	prefer	to	hear	from	someone	who	has	been	through	the	procedure.		This	may	mean	that	a	completely	different	approach	to	presenting	information	is	required:	for	example,	a	database	of	patient	experience	from	patients	that	have	had	a	knee	replacement	that	can	be	matched	to	the	baseline	characteristics	and	likely	outcome	of	a	patient	considering	a	knee	replacement.		Additionally,	the	effect	of	a	tool	on	managing	expectations	and	patient	decision-making	will	alter	depending	on	the	point	in	the	pathway	it	is	used	(patients	who	have	already	made	up	their	mind	appear	less	willing	to	change	it	based	on	new	information	–	this	could	be	due	to	the	stress	that	is	felt	from	the	deliberation	process).		However,	it	is	clear	that	patients	welcome	such	information,	and	that	it	would	appear	to	still	have	an	effect	on	expectation	and	decision-making,	especially	if	targeted	early	in	the	patient	pathway.			Future	work	of	any	prediction	tool	would	require	examination	of	how	big	an	effect	the	optimism	bias	would	have,	and	how	big	an	effect	modifying	expectations	pre-operatively	would	have	on	satisfaction.				
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The	next	step	in	the	body	of	work	was	a	systematic	review	of	the	literature	surrounding	patient	factors	that	affect	outcome,	in	which	I	identified	several	candidate	predictors.		These	included	pre-operative	knee	status,	psychological	wellbeing	and	medical	comorbidity.		The	review	demonstrated	that	no	single	study	has	sought	to	measure	them	all	within	the	same	cohort,	and	therefore	it	was	unknown	how	much	variability	could	be	predicted	if	all	were	combined.				Using	the	candidate	prognostic	factors	identified	in	the	systematic	review	I	developed	a	multicentre	cohort	study	designed	to	generate	a	prognostic	algorithm.		This	study	recruited	600	patients,	and	the	linear	regression	model	accounts	for:		 - 33.9%	of	the	variability	in	OKS	scores	at	six	months	- 32%	of	the	variability	in	OKS	scores	at	12	months	- 41.1%	of	the	variability	in	SF-36	PCS	at	12	months		These	models	explain	more	of	the	variability	in	outcome	of	total	knee	replacement	for	OA	knee	than	any	previously	described	model.		However,	widespread	clinical	use	for	individual	prediction	is	probably	not	warranted.			This	opinion	is	based	on	the	poor	precision	of	the	individual	estimates,	combined	with	the	results	from	the	qualitative	work.		Although	there	is	an	obligation	to	ensure	patients	are	well	informed	before	their	operation,	it	seems	likely	that	predictions	with	wide	confidence	intervals	will	not	be	as	useful	to	patients	as	a	report	from	someone	that	has	had	the	procedure	(especially	when	considering	the	optimism	bias	and	the	preference	for	information	from	friends	and	family).		It	may	be	that	a	future	algorithm	that	can	provide	more	precise	estimates	should	be	presented	by	using	a	database	of	past	patient	experiences,	and	matching	that	to	current	patients’	predictions.				
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Future	work	should	be	aimed	at	several	areas	including	attempting	to	modify	prognostic	factors	that	have	been	identified	in	this	and	previous	work,96,151,153	and	identifying	further	potential	prognostic	factors	that	could	improve	the	precision	of	the	individual	estimates.		Once	a	model	with	sufficient	explanatory	power	is	developed	(the	definition	of	which	is	subjective)	external	validation	and	impact	assessment	can	follow.			I	have	also	discussed	rationing	care	and	case	mix	adjustment,	the	latter	particularly	relevant	with	the	advent	of	Best	Practice	Tariffs	based	on	adjusted	outcome	scores.		The	allocation	of	funds	based	on	case	mix	adjustment	that	can	only	account	for	25%	of	the	variability	in	outcome	is,	in	my	opinion,	unsound,	and	the	models	presented	here,	although	likely	to	be	an	improvement,	do	not	offer	such	an	advance	as	to	warrant	the	extra	burden.		Rationing	care	through	a	prognostic	model	is	a	potential	use	for	this	work,	but	the	additional	cost,	requirement	for	transparency,	ethical	and	political	motivations,	and	patient	views	(brought	out	in	the	qualitative	interviews)	may	make	this	a	problematic	area	for	future	research.				Future	areas	that	have	the	potential	to	provide	greater	explanatory	power	have	been	discussed.		Humoral	factors,	stress,	and	resilience	are	promising,	if	poorly	understood,	areas.		It	seems	likely	that	in	the	future	more	precise	outcome	prediction	will	be	possible;	it	remains	to	be	seen	if	such	models	will	be	precise	enough	to	effectively	aid	patient	decision-making	and	improve	outcomes.								
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8.1 Future	work	
	Future	work	is	required	identifying	further	explanatory	variables	that	can	account	for	variability	in	outcome.		There	are	various	factors	that	are	under	investigation	currently	and	with	these	variables	included	in	a	prediction	algorithm,	individual	prediction	of	outcome	is	likely.		However,	this	does	lead	to	two	questions.		The	first	is	that	perhaps	there	are	many	factors	that	account	for	a	very	small	amount	of	variability	each,	and	that	the	development	of	a	prognostic	algorithm	will	be	too	time-consuming	and	resource-rich	to	ever	achieve.		Until	current	promising	areas	of	research	have	been	explored	this	will	be	unknown.			If	this	is	the	case,	it	may	be	that	a	programme	of	“marginal	gains”	needs	to	be	adopted;	however,	this	approach	is	also	likely	to	be	expensive,	with	no	guarantee	that	each	marginal	gain	will	be	additive.					The	second	question	is,	what	is	the	“cut	off”	for	a	useful	individual	predication	of	outcome	(or	the	cut	off	to	move	from	the	development	of	the	algorithm	to	the	external	validation	and	impact	assessment)?		I	have	asserted	here	that	the	models	presented	fall	below	that	cut	off,	and	that	it	is	likely	patients	would	use	any	uncertainty	in	a	poor	outcome	to	justify	higher	expectations.		Ultimately	this	decision	would	have	to	be	based	on	an	expectation	of	a	demonstrable	and	cost-effective	alteration	in	practice	(with	the	difficulties	intrinsic	in	defining	and	measuring	this).		I	would	argue	that	the	presence	of	the	optimism	bias	makes	the	importance	of	precise	estimates	even	greater.				If	a	tool	is	developed	that	has	individual	discriminatory	power	that	is	considered	sufficient	to	base	predictions	on,	then	several	questions	will	require	answering.		Firstly,	although	I	have	investigated	the	effect	a	tool	will	have	on	expectations	and	decision,	I	have	in	no	way	attempted	to	quantify	this	relationship.		It	is	also	unclear	how,	or	if,	a	poor	prediction	will	affect	outcome.		An	impact	study,	investigating	these	effects,	would	
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be	required	of	any	tool	capable	of	individual	risk	prediction.		Additionally,	work	examining	different	pathways	for	patients	with	different	risks	would	be	required.		This	could	focus	on	modifying	predictors	of	poor	outcome	(an	approach	that	appeared	to	have	some	traction	with	patients	in	the	qualitative	work),	or	altering	pathways	towards	alternative	treatments	for	those	with	non-modifiable	risk	factors.		A	concern	from	patients	was	that	this	tool	could	be	used	to	rationalise	care,	although	others	felt	this	was	a	reasonable	approach.				Assuming	a	validated	and	useful	prediction	algorithm,	the	work	that	follows	on	from	such	an	algorithm	is	complex.		Quantifying	the	tool’s	effect	on	expectations,	decision-making	and	outcome	(both	in	terms	of	PROMs	and	health	economics)	would	be	required.		Modifying	risk	factors	to	improve	outcomes,	along	with	altering	pathways	for	patients	with	risk	factors	that	cannot	be	modified,	would	require	complex	interventions	to	be	assessed,	likely	as	part	of	multiple	RCTs.						 	
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8.2 Summary	
	In	this	thesis	I	have	reviewed	the	epidemiology	and	treatment	of	knee	OA,	highlighting	some	of	the	issues	with	providing	knee	replacement	services.		The	approach	to	help	solve	these	issues	has	included:			- An	examination	of	the	factors	affecting	patient	decision-making	- The	development	of	a	model	of	decision-making	for	patients	considering	a	knee	replacement	- An	examination	of	how	an	outcome	prediction	tool	could	affect	that	decision-making	- The	identification	of	factors	that	influence	outcome	in	knee	replacements	- The	development	of	a	study	to	quantify	the	relationship	between	pre-operative	factors	and	outcome	- The	conduct	of	a	multicentre	cohort	study	which	produced	a	prognostic	algorithm	for	patients	considering	a	total	knee	replacement.		I	have	been	successful	in	identifying	important	factors	that	influence	patients’	decision-making,	and	identifying	that	the	optimism	bias	could	affect	any	future	outcome	prediction	tool.		The	multicentre	cohort	study	was	ultimately	unable	to	offer	clinically	useful	individualised	predictions	of	outcomes;	however,	it	is	able	to	account	for	more	of	the	variation	in	outcome	than	any	previous	report.	This	is	certainly	a	step	forward	in	the	goal	of	individual	outcome	prediction.					 	
	 253	
Appendices	
9.1 Appendix	I:	Focus	group	schedule	
	
WELCOME		
 
Thanks for agreeing to be part of the focus group. We appreciate your willingness to 
participate. 
	
INTRODUCTIONS      
Moderator; assistant moderator 
“I will ask everyone to make their own introductions shortly, but before I do I want to cover 
some things.”  
 
PURPOSE	OF	FOCUS	GROUPS   
This focus group is aimed at understanding patients’ views on decision-making for knee 
replacements.  We need your input and want you to share your honest and open thoughts 
with us. 
Before we start I would like to go through: - Ground rules - Plan for the afternoon 
 
Ground	Rules	
 
 1. WE WANT YOU TO DO THE TALKING. 
We would like everyone to participate.   I may call on you if I haven't heard from you in a 
while. 
2. THERE ARE NO RIGHT OR WRONG ANSWERS   
Every person's experiences and opinions are important. Please speak up whether you agree 
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or disagree.   We want to hear a wide range of opinions. 
3. WHAT IS SAID IN THIS ROOM STAYS HERE   
We want everyone to feel comfortable sharing when sensitive issues come up. 
4. WE WILL BE TAPE RECORDING THE GROUP 
 We want to capture everything you have to say.   We don't identify anyone by name in our 
report. You will remain anonymous. 
 
Plan	for	the	afternoon		I	am	shortly	going	to	ask	you	all	to	complete	a	consent	form.		I	will	come	round	each	of	you	in	turn	and	ask	you	to	sign	it.		While	I	am	doing	that	I	would	like	you	to	talk	to	the	person	next	to	you.		I	will	then	ask	you	to	introduce	them	to	the	rest	of	the	group.				
PURPOSE	OF	FOCUS	GROUP	This	focus	group	is	aimed	at	understanding	how	you	made	decisions	about	having	a	knee	replacement	and	how	a	new	tool,	which	we	will	explain	fully	later,	might	have	influenced	your	decisions.			We	would	like	to	record	the	conversation.		This	recording	will	be	used	by	the	research	team	to	ensure	we	don’t	miss	anything.		It	will	be	transcribed	(typed	out)	for	us	to	analyse.		We	will	ensure	it	is	kept	confidential	at	all	times,	and	we	will	destroy	the	recording	once	the	transcripts	have	been	prepared.		You	will	have	the	opportunity	to	look	through	the	transcript	and	let	us	know	if	you	would	like	to	change	anything.			We	will	combine	this	focus	group	with	others,	including	some	interviews.		Some	things	you	say	may	be	used	in	a	publication;	however,	we	will	make	every	effort	to	ensure	you	remain	anonymous.			I	expect	this	focus	group	to	take	around	1.5	to	2	hours.		If,	at	any	time,	you	feel	tiered	or	want	to	stop	please	tell	us.				
HOW	DID	YOU	GET	HERE?		Can	you	tell	us	a	little	about	yourself,	and	the	events	that	lead	to	you	to	have	a	knee	replacement	please?		Prompts:	- How	was	the	knee	affecting	your	life?	- Is	it	difficult	to	cope	with	the	knee?	
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- Were	there	things	you	could	not	do?	- Have	you	though	about	if	it	gets	worse?	- What	were	the	most	important	things	that	made	you	decide	a	knee	replacement	was	for	you?	- Do	you	think	the	problem	with	your	knee	is	affected	by	the	way	you	think,	or	the	way	you	view	the	world?		Try	to	elicit	a	sense	of	the	patient’s	beliefs	over	the	effect	of	psychological	factors	on	outcome.	- Where	did	you	go	to	get	your	information	that	helped	you	make	a	decision	on	your	knee	replacement?		Why?	- How	much	information	do	you	like?		Why?		(??	Fear)	- Where	you	afraid	of	anything	to	do	with	your	treatment?	- What	is	the	fear	of	–	predominantly	of	the	operation	or	of	a	poor	outcome?	- Would	this	fear	be	affected	by	any	delays	to	the	operation	(e.g.	would	a	delay	mean	that	you	would	feel	more	fear)?	
	
	
Is	there	anything	else	you	would	like	to	say	about	decision-making	in	knee	
replacements?	
	
	
	
Introduce	OPT	--	What	is	an	outcome	prediction	tool		The	outcome	after	knee	replacement	is	variable	–	it	is	safe	to	say	that	almost	all	patients	improve	after	a	knee	replacement;	however,	some	patients	improve	more	than	others.		We	measure	this	improvement	in	various	ways,	but	two	of	the	most	common	are:	function	(i.e.	how	well	the	knee	does	things	we	want	it	to,	like	climbing	stairs	and	getting	into	and	out	of	a	car	–	this	is	normally	measured	via	questionnaires);	the	second	is	pain	–	some	people	have	ongoing	pain	after	a	knee	replacement.			Currently,	we	are	not	able	to	tell	which	patients	will	do	very	well	from	a	functional	point	of	view	(up	and	down	stairs,	kneeling),	and	which	patients	will	have	ongoing	pain.		Patients	who	have	ongoing	pain	tend	to	have	worse	function.			We	are	currently	developing	a	questionnaire	that	may	be	able	to	predict	outcome	–	i.e.	it	will	be	able	to	tell	which	patients	are	likely	to	develop	pain	and	what	functional	improvement	a	patient	can	expect.		This	is	what	we	mean	by	outcome	prediction	tool.			Do	you	have	any	questions?					
What	do	you	think	of	the	outcome	prediction	tool?		I	would	like	to	start	by	going	through	a	couple	of	examples	of	how	an	outcome	prediction	tool	could	look.		I	hope	this	will	help	you	understand	the	type	of	information	that	will	be	included,	and	we	would	be	interested	in	your	views	on	how	it	is	presented,	and	how	easy	it	is	to	understand.				
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Prompts	- Do	you	find	the	charts	helpful?	- Do	you	find	identifying	which	patient	you	are	helpful?	- Are	rating	things	into	categories	a	good	idea?	- Do	you	understand	the	information	–	is	there	anything	that	could	be	improved?	- Is	there	too	much	information	or	too	little?	- Is	there	too	much	detail	or	too	little?			
	
	
Do	you	think	that	having	a	prediction	of	the	outcome	would	have	been	helpful	to	you?		
	Prompts	- Would	you	have	trusted	it?	- Would	it	have	altered	your	decision	(either	way)?	- Would	it	have	altered	your	expectations?	- Would	it	have	affected	your	confidence	or	fear?			- Would	it	have	given	you	more	confidence	to	go	ahead?	- If	the	outcome	was	good	would	you	want	an	earlier	TKR?	- If	you	had	this	information,	would	you	have		not	gone	to,	for	example,	your	family	or	friends,	or	a	website.		Why?			
Does	an	OPT	alter	the	fear	of	the	procedure	itself?	
	
Who	do	you	think	should	decide	if	you	have	a	knee	replacement?			
	Prompts:	
	 - Should	the	surgeons	decide?	- Should	you	have	access	to	it	whenever	you	like?	
	
How	would	you	have	coped	if	you	had	a	poor	outcome?	(Est	time	10	min)	
	Prompts	- Suspicious?	- Not	believe?	- Take	it	personally	–	would	it	feel	like	a	personal	attack?	- Would	it	feel	like	a	diagnosis?	- Do	you	think	it	would	help	you	cope	after	the	operation?				Need	to	push	here	on	the	use	of	psychological	factors.		May	need	an	explanation	at	this	point,	and	an	exploration	of	how	they	answer	the	above	questions	in	the	light	of	that.				
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Possibility	of	delaying	Knee	Replacement	to	modify	other	factors	(e.g.	CBT	for	coping	
strategies).		What	are	your	views	on	this?		
	Prompts	- Acceptable	- What	if	outcome	is	still	poor	- Would	you	have	been	amenable	to	CBT	or	Motivational	interviews	or	physio/increased	physical	exercise?			
	
	
	
Who	do	you	think	should	do	the	outcome	prediction	tool	–	the	patient	himself	or	herself,	
with	the	GP,	a	specialist	nurse,	or	when	they	see	the	surgeon?		
	
	
Is	there	anything	else	you	would	like	to	say	about	outcome	prediction	in	knee	
replacements?		 	
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9.2 Appendix	II:	Interview	schedule	
	
WELCOME			Thanks	for	agreeing	to	take	part.	We	appreciate	your	willingness	to	participate.	
	
PURPOSE	OF	INTERVIEW	- This	interview	is	aimed	at	understanding	how	you	came	to	make	a	decision	to	go	ahead	with	a	knee	replacement.				We	need	your	input	and	want	you	to	share	your	honest	and	open	thoughts	with	us.		We	would	then	like	to	understand	how	a	new	tool,	which	we	will	explain	fully	later,	might	have	influenced	your	decisions.			- We	would	like	to	record	the	conversation.		This	recording	will	be	used	by	the	research	team	to	ensure	we	don’t	miss	anything.		It	will	be	transcribed	(typed	out)	for	us	to	analyse.		We	will	ensure	it	is	kept	confidential	at	all	times,	and	we	will	destroy	the	recording	once	the	transcripts	have	been	prepared.		You	will	have	the	opportunity	to	look	through	the	transcript	and	let	us	know	if	you	would	like	to	change	anything.			- We	will	combine	this	interview	with	several	other,	including	some	focus	groups.		Some	things	you	say	may	be	used	in	a	publication;	however,	we	will	make	every	effort	to	ensure	you	remain	anonymous.			- I	expect	this	interview	to	take	around	30-40	minutes.		If,	at	any	time,	you	feel	tiered	or	want	to	stop	please	tell	us.				
Personal	situation	and	physical	state		Can	you	tell	us	a	little	about	yourself,	and	the	events	that	lead	to	you	being	listed	for	a	knee	replacement	please?		Prompts:	- How	was	the	knee	affecting	your	life?	- Is	it	difficult	to	cope	with	the	knee?	- Were	there	things	you	could	not	do?	- Have	you	though	about	if	it	gets	worse?	- What	were	the	most	important	things	that	made	you	decide	a	knee	replacement	was	for	you?	- Do	you	think	the	problem	with	your	knee	is	affected	by	the	way	you	think,	or	the	way	you	view	the	world?		Try	to	elicit	a	sense	of	the	patient’s	beliefs	over	the	effect	of	psychological	factors	on	outcome.			
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Sources	of	Information:		Where	did	you	go	to	get	your	information	that	helped	you	make	a	decision	on	your	knee	replacement?		Why?	Prompts:	- Friends	family	- Website	- GP	How	much	information	do	you	like?		Why?		(??	Fear)	The	above	are	likely	to	be	linked	to	consultation	style	preference	–	may	need	to	discuss	fear	before	discussing	this,	but	if	you	get	the	opportunity	it	could	be	explored	here.				
Fear	Are	you	afraid	of	anything	to	do	with	your	treatment?	What	is	the	fear	of	–	predominantly	of	the	operation	or	of	a	poor	outcome?	Would	this	fear	be	affected	by	any	delays	to	the	operation	(e.g.	would	a	delay	mean	that	you	would	feel	more	fear)?		
Introduce	OPT	--	What	is	an	outcome	prediction	tool		The	outcome	after	knee	replacement	is	variable	–	it	is	safe	to	say	that	almost	all	patients	improve	after	a	knee	replacement;	however,	some	patients	improve	more	than	others.		We	measure	this	improvement	in	various	ways,	but	two	of	the	most	common	are:	function	(i.e.	how	well	the	knee	does	things	we	want	it	to,	like	climbing	stairs	and	getting	into	and	out	of	a	car	–	this	is	normally	measured	via	questionnaires);	the	second	is	pain	–	some	people	have	ongoing	pain	after	a	knee	replacement.			Currently,	we	are	not	able	to	tell	which	patients	will	do	very	well	from	a	functional	point	of	view	(up	and	down	stairs,	kneeling),	and	which	patients	will	have	ongoing	pain.		Patients	who	have	ongoing	pain	tend	to	have	worse	function.			We	are	currently	developing	a	questionnaire	that	will	be	able	to	predict	outcome	–	i.e.	it	will	be	able	to	tell	which	patients	are	likely	to	develop	pain	and	what	functional	improvement	a	patient	can	expect.		This	is	what	we	mean	by	outcome	prediction	tool.			Does	you	have	any	questions?			
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What	do	you	think	of	the	outcome	prediction	tool?			I	would	like	to	start	by	going	through	a	couple	of	examples	of	how	an	outcome	prediction	tool	could	look.		I	hope	this	will	help	you	understand	the	type	of	information	that	will	be	included,	and	we	would	be	interested	in	your	views	on	how	it	is	presented,	and	how	easy	it	is	to	understand.				Prompts	- Do	you	find	the	charts	helpful?	- Do	you	find	identifying	which	patient	you	are	helpful?	- Are	rating	things	into	categories	a	good	idea?	- Do	you	understand	the	information	–	is	there	anything	that	could	be	improved?	- Is	there	too	much	information	or	too	little?	- Is	there	too	much	detail	or	too	little?		
	
Do	you	think	that	having	a	prediction	of	the	outcome	would	have	been	helpful	to	you?		
	Prompts	- Would	you	have	trusted	it?	- Would	it	have	altered	your	decision	(either	way)?	- Would	it	have	altered	your	expectations?	- Would	it	have	affected	your	confidence	or	fear?			- Would	it	have	given	you	more	confidence	to	go	ahead?	- If	the	outcome	was	good	would	you	want	an	earlier	TKR?	- If	you	had	this	information,	would	you	have		not	gone	to,	for	example,	your	family	or	friends,	or	a	website.		Why?	- Make	sure	both	good	and	bad	outcomes	are	covered	and	get	a	sense	for	
optimism	bias			
Does	an	OPT	alter	the	fear	of	the	procedure	itself?		
	
Who	do	you	think	should	decide	if	you	have	a	knee	replacement?			
	Prompts:	
	 - Should	the	surgeons	decide?	- Should	you	have	access	to	it	whenever	you	like?	- Do	you	think	that	things	going	on	just	now	limit	your	ability	to	decide	(e.g.	struggling	to	do	certain	things	with	the	knee	(cope),	fear	of	the	operation).			
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How	would	you	have	coped	if	you	had	a	poor	outcome?	(Est	time	10	min)	
	Prompts	- Suspicious?	- Not	believe?	- Take	it	personally	–	would	it	feel	like	a	personal	attack?	- Would	it	feel	like	a	diagnosis?	- Do	you	think	it	would	help	you	cope	after	the	operation?				Need	to	push	here	on	the	use	of	psychological	factors.		May	need	an	explanation	at	this	point,	and	an	exploration	of	how	they	answer	the	above	questions	in	the	light	of	that.				
	
Possibility	of	delaying	Knee	Replacements	to	modify	other	factors	(e.g.	CBT	for	coping	
strategies).		What	are	your	views	on	this?		
	Prompts	- Acceptable	- What	if	outcome	is	still	poor	- Would	you	have	been	amenable	to	CBT	or	Motivational	interviews	or	physio/increased	physical	exercise.			
	
	
	
Who	do	you	think	should	do	the	outcome	prediction	tool	–	the	patient	himself	or	herself,	
with	the	GP,	a	specialist	nurse,	or	when	they	see	the	surgeon?		
	
	
	
Is	there	anything	else	you	would	like	to	say	about	outcome	prediction	in	knee	
replacements?	
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9.3 Appendix	III:		Example	of	a	fictitious	outcome	prediction	tool				
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9.4 Appendix	IV:	Search	strategy	–	patient	factors	related	to	
outcome		
	
1. controlled.tw. 
2. design.tw. 
3. evidence.tw. 
4. extraction.tw. 
5. randomized controlled trials/ 
6. meta-analysis.tw. 
7. review.tw. 
8. sources.tw. 
9. studies.tw. 
10. or/1-9 
11. letter.pt. 
12. comment.pt. 
13. editorial.pt. 
14. or/11-13 
15. 10 not 14 
16. clinical trial.pt. 
17. clinical trial, phase II.pt. 
18. clinical trial, phase I.pt. 
19. clinical trial, phase III.pt. 
20. clinical trial, phase IV.pt. 
21. controlled clinical trial.pt. 
22. randomized controlled trial.pt. 
23. or/16-22 
24. 23 not 14 
25. 15 or 24 
26. cohort studies/ 
27. exp case-control studies/ 
28. exp cross-sectional studies/ 
29. or/25-28 
30. arthroplasty, replacement, knee/ 		
31. knee prosthesis/ 
32. exp arthroplasty/ 
33. joint prosthesis.mp.  
34. exp "prostheses and implants"/ 
35. or/32-34 
36. knee/ 
37. knee joint/ 
38. 36 or 37 
39. 35 and 38 
40. 30 or 31 or 39 
41. 29 and 40 
42. exp osteoarthritis/ 
43. 41 and 42 	
	 276	
	
9.5 Appendix	V:	Questionnaires	for	KOPS	
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9.6 Appendix	VI:		Appendix	for	the	results	
	
Six	month	data	analysis		Linearity	of	explanatory	variables	to	response	variables	was	visually	assessed	using	scatterplots	of	each	explanatory	scale	variable	against	OKS	at	six	months.				
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Multicollinearity	Correlation	co-efficients	between	each	variable	are	displayed	below	(Table	continued	over	next	six	pages)	
	 	 OKS	Six	
months	
Age	 Gender	 OKS	
Baseline	
BMI	 Severe	
Arthritis	
Joint	
Count	
Lower	
back	
pain	
Number	of	co-
morbidities	
Live	
Alone	
Pearson	
Correlation	
OKS	Six	months	 1	 0.062	 -0.07	 0.336	 -0.142	 0.153	 -0.294	 -0.178	 -0.216	 0.044	
	 Age	 0.062	 1	 -0.064	 0.032	 -0.32	 0.151	 -0.162	 -0.087	 0.005	 0.236	
	 Female	Gender	 -0.07	 -0.064	 1	 -0.197	 0.137	 -0.111	 0.222	 0.127	 0.143	 0.189	
	 OKS	Baseline	 0.336	 0.032	 -0.197	 1	 -0.197	 0.051	 -0.311	 -0.206	 -0.274	 -0.04	
	 BMI	 -0.142	 -0.32	 0.137	 -0.197	 1	 -0.075	 0.206	 0.119	 0.223	 -0.059	
	 Severe	Arthritis	 0.153	 0.151	 -0.111	 0.051	 -0.075	 1	 -0.115	 -0.097	 -0.088	 0.068	
	 Joint	Count	 -0.294	 -0.162	 0.222	 -0.311	 0.206	 -0.115	 1	 0.441	 0.36	 0.032	
	 Lower	back	pain	 -0.178	 -0.087	 0.127	 -0.206	 0.119	 -0.097	 0.441	 1	 0.324	 0.035	
	 Co-morbidities	 -0.216	 0.005	 0.143	 -0.274	 0.223	 -0.088	 0.36	 0.324	 1	 0.102	
	 Live	Alone	 0.044	 0.236	 0.189	 -0.04	 -0.059	 0.068	 0.032	 0.035	 0.102	 1	
	 Deprivation	Score	 -0.193	 -0.098	 -0.015	 -0.191	 0.109	 -0.152	 0.199	 0.161	 0.17	 -0.002	
	 Previous	
Arthroscopy	
-0.039	 -0.179	 -0.041	 0.013	 0.055	 -0.077	 0.004	 0.062	 -0.015	 -0.096	
	 Expectations	 0.324	 -0.06	 -0.125	 0.325	 -0.123	 0.024	 -0.318	 -0.188	 -0.358	 -0.051	
	 Helplessness	 -0.36	 0.03	 0.165	 -0.553	 0.078	 -0.075	 0.261	 0.112	 0.297	 0.016	
	 Internality	 -0.148	 -0.064	 0.096	 -0.3	 0.051	 0.003	 0.114	 0.001	 0.135	 0.037	
	 PCS	 0.191	 -0.094	 -0.139	 0.659	 -0.14	 -0.016	 -0.21	 -0.196	 -0.233	 0.014	
	 MCS	 0.428	 0.07	 -0.263	 0.435	 -0.164	 0.157	 -0.335	 -0.148	 -0.36	 -0.087	
	 Depression	 -0.327	 -0.027	 0.103	 -0.355	 0.138	 -0.056	 0.251	 0.138	 0.322	 0.044	
	 Anxiety	 -0.283	 -0.09	 0.281	 -0.347	 0.113	 -0.116	 0.3	 0.169	 0.339	 0.112	
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Multicollinearity table (cont.) 
	 	 OKS	Six	
months	
Age	 Gender	 OKS	
Baseline	
BMI	 Severe	
Arthritis	
Joint	
Count	
Lower	
back	
pain	
Number	of	co-
morbidities	
Live	
Alone	
Sig.	(1-tailed)	 OKS	Six	months	 .	 0.086	 0.061	 0	 0.001	 0	 0	 0	 0	 0.177	
	 Age	 0.086	 .	 0.074	 0.24	 0	 0	 0	 0.032	 0.458	 0	
	 Gender	 0.061	 0.074	 .	 0	 0.002	 0.006	 0	 0.003	 0.001	 0	
	 OKS	Baseline	 0	 0.24	 0	 .	 0	 0.131	 0	 0	 0	 0.192	
	 BMI	 0.001	 0	 0.002	 0	 .	 0.058	 0	 0.008	 0	 0.108	
	 Severe	Arthritis	 0	 0	 0.006	 0.131	 0.058	 .	 0.008	 0.022	 0.028	 0.073	
	 Joint	Count	 0	 0	 0	 0	 0	 0.008	 .	 0	 0	 0.254	
	 Lower	back	pain	 0	 0.032	 0.003	 0	 0.008	 0.022	 0	 .	 0	 0.238	
	 Number	of	co-
morbidities	
0	 0.458	 0.001	 0	 0	 0.028	 0	 0	 .	 0.014	
	 Live	Alone	 0.177	 0	 0	 0.192	 0.108	 0.073	 0.254	 0.238	 0.014	 .	
	 Deprivation	Score	 0	 0.013	 0.368	 0	 0.01	 0	 0	 0	 0	 0.481	
	 Previous	
Arthroscopy	
0.214	 0	 0.193	 0.393	 0.131	 0.055	 0.465	 0.109	 0.377	 0.023	
	 Expectations	 0	 0.094	 0.003	 0	 0.005	 0.301	 0	 0	 0	 0.139	
	 Helplessness	 0	 0.254	 0	 0	 0.054	 0.052	 0	 0.01	 0	 0.369	
	 Internality	 0.001	 0.08	 0.017	 0	 0.144	 0.475	 0.009	 0.496	 0.002	 0.213	
	 PCS	 0	 0.021	 0.001	 0	 0.002	 0.369	 0	 0	 0	 0.386	
	 MCS	 0	 0.065	 0	 0	 0	 0	 0	 0.001	 0	 0.035	
	 Depression	 0	 0.274	 0.011	 0	 0.002	 0.111	 0	 0.002	 0	 0.178	
	 Anxiety	 0	 0.024	 0	 0	 0.01	 0.006	 0	 0	 0	 0.008	
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Multicollinearity table (cont.) 
 
	 	 OKS	Six	
months	
Age	 Gender	 OKS	
Baseline	
BMI	 Severe	
Arthritis	
Joint	
Count	
Lower	
back	
pain	
Number	of	co-
morbidities	
Live	
Alone	
N	 OKS	Six	months	 489	 489	 489	 475	 432	 478	 429	 429	 463	 454	
	 Age	 489	 517	 517	 502	 457	 501	 451	 451	 487	 481	
	 Gender	 489	 517	 517	 502	 457	 501	 451	 451	 487	 481	
	 OKS	Baseline	 475	 502	 502	 502	 446	 486	 437	 437	 475	 470	
	 BMI	 432	 457	 457	 446	 457	 441	 405	 405	 435	 440	
	 Severe	Arthritis	 478	 501	 501	 486	 441	 501	 438	 438	 473	 465	
	 Joint	Count	 429	 451	 451	 437	 405	 438	 451	 451	 437	 424	
	 Lower	back	pain	 429	 451	 451	 437	 405	 438	 451	 451	 437	 424	
	 Number	of	co-
morbidities	
463	 487	 487	 475	 435	 473	 437	 437	 487	 456	
	 Live	Alone	 454	 481	 481	 470	 440	 465	 424	 424	 456	 481	
	 Deprivation	Score	 489	 517	 517	 502	 457	 501	 451	 451	 487	 481	
	 Previous	
Arthroscopy	
425	 452	 452	 441	 414	 438	 402	 402	 431	 439	
	 Expectations	 461	 488	 488	 475	 432	 473	 431	 431	 464	 456	
	 Helplessness	 459	 485	 485	 475	 431	 469	 426	 426	 464	 452	
	 Internality	 459	 485	 485	 475	 431	 469	 427	 427	 464	 452	
	 PCS	 441	 466	 466	 461	 413	 451	 414	 414	 442	 433	
	 MCS	 441	 466	 466	 461	 413	 451	 414	 414	 442	 433	
	 Depression	 463	 488	 488	 475	 432	 474	 432	 432	 464	 454	
	 Anxiety	 464	 490	 490	 476	 434	 475	 433	 433	 465	 456	
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Multicollinearity table (cont.) 
	 	 Deprivation	
Score	
Previous	
Arthroscopy	
Expectations	 Helplessness	 Internality	 PCS	 MCS	 Depression	 Anxiety	
Pearson	
Correlation	
OKS	Six	months	 -0.193	 -0.039	 0.324	 -0.36	 -0.148	 0.191	 0.428	 -0.327	 -0.283	
	 Age	 -0.098	 -0.179	 -0.06	 0.03	 -0.064	 -0.094	 0.07	 -0.027	 -0.09	
	 Gender	 -0.015	 -0.041	 -0.125	 0.165	 0.096	 -0.139	 -0.263	 0.103	 0.281	
	 OKS	Baseline	 -0.191	 0.013	 0.325	 -0.553	 -0.3	 0.659	 0.435	 -0.355	 -0.347	
	 BMI	 0.109	 0.055	 -0.123	 0.078	 0.051	 -0.14	 -0.164	 0.138	 0.113	
	 Severe	Arthritis	 -0.152	 -0.077	 0.024	 -0.075	 0.003	 -0.016	 0.157	 -0.056	 -0.116	
	 Joint	Count	 0.199	 0.004	 -0.318	 0.261	 0.114	 -0.21	 -0.335	 0.251	 0.3	
	 Lower	back	pain	 0.161	 0.062	 -0.188	 0.112	 0.001	 -0.196	 -0.148	 0.138	 0.169	
	 Number	of	co-
morbidities	
0.17	 -0.015	 -0.358	 0.297	 0.135	 -0.233	 -0.36	 0.322	 0.339	
	 Live	Alone	 -0.002	 -0.096	 -0.051	 0.016	 0.037	 0.014	 -0.087	 0.044	 0.112	
	 Deprivation	Score	 1	 0.014	 -0.137	 0.13	 0.124	 -0.023	 -0.239	 0.203	 0.204	
	 Previous	
Arthroscopy	
0.014	 1	 0.062	 -0.019	 0.089	 0.019	 -0.029	 0.024	 -0.035	
	 Expectations	 -0.137	 0.062	 1	 -0.3	 -0.072	 0.292	 0.267	 -0.244	 -0.255	
	 Helplessness	 0.13	 -0.019	 -0.3	 1	 0.369	 -0.405	 -0.495	 0.424	 0.412	
	 Internality	 0.124	 0.089	 -0.072	 0.369	 1	 -0.191	 -0.277	 0.3	 0.174	
	 PCS	 -0.023	 0.019	 0.292	 -0.405	 -0.191	 1	 0.018	 -0.195	 -0.092	
	 MCS	 -0.239	 -0.029	 0.267	 -0.495	 -0.277	 0.018	 1	 -0.59	 -0.699	
	 Depression	 0.203	 0.024	 -0.244	 0.424	 0.3	 -0.195	 -0.59	 1	 0.548	
	 Anxiety	 0.204	 -0.035	 -0.255	 0.412	 0.174	 -0.092	 -0.699	 0.548	 1			
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Multicollinearity table (cont.) 
	 	 Deprivation	
Score	
Previous	
Arthroscopy	
Expectations	 Helplessness	 Internality	 PCS	 MCS	 Depression	 Anxiety	
Sig.	(1-tailed)	 OKS	Six	
months	
0	 0.214	 0	 0	 0.001	 0	 0	 0	 0	
	 Age	 0.013	 0	 0.094	 0.254	 0.08	 0.021	 0.065	 0.274	 0.024	
	 Gender	 0.368	 0.193	 0.003	 0	 0.017	 0.001	 0	 0.011	 0	
	 OKS	Baseline	 0	 0.393	 0	 0	 0	 0	 0	 0	 0	
	 BMI	 0.01	 0.131	 0.005	 0.054	 0.144	 0.002	 0	 0.002	 0.01	
	 Severe	
Arthritis	
0	 0.055	 0.301	 0.052	 0.475	 0.369	 0	 0.111	 0.006	
	 Joint	Count	 0	 0.465	 0	 0	 0.009	 0	 0	 0	 0	
	 Lower	back	
pain	
0	 0.109	 0	 0.01	 0.496	 0	 0.001	 0.002	 0	
	 Number	of	
co-
morbidities	
0	 0.377	 0	 0	 0.002	 0	 0	 0	 0	
	 Live	Alone	 0.481	 0.023	 0.139	 0.369	 0.213	 0.386	 0.035	 0.178	 0.008	
	 Deprivation	
Score	
.	 0.381	 0.001	 0.002	 0.003	 0.312	 0	 0	 0	
	 Previous	
Arthroscopy	
0.381	 .	 0.099	 0.347	 0.033	 0.353	 0.277	 0.308	 0.232	
	 Expectations	 0.001	 0.099	 .	 0	 0.062	 0	 0	 0	 0	
	 Helplessness	 0.002	 0.347	 0	 .	 0	 0	 0	 0	 0	
	 Internality	 0.003	 0.033	 0.062	 0	 .	 0	 0	 0	 0	
	 PCS	 0.312	 0.353	 0	 0	 0	 .	 0.348	 0	 0.026	
	 MCS	 0	 0.277	 0	 0	 0	 0.348	 .	 0	 0	
	 Depression	 0	 0.308	 0	 0	 0	 0	 0	 .	 0	
	 Anxiety	 0	 0.232	 0	 0	 0	 0.026	 0	 0	 .	
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Multicollinearity table (cont.) 
	 	 Deprivation	
Score	
Previous	
Arthroscopy	
Expectations	 Helplessness	 Internality	 PCS	 MCS	 Depression	 Anxiety	
N	 OKS	Six	
months	
489	 425	 461	 459	 459	 441	 441	 463	 464	
	 Age	 517	 452	 488	 485	 485	 466	 466	 488	 490	
	 Gender	 517	 452	 488	 485	 485	 466	 466	 488	 490	
	 OKS	Baseline	 502	 441	 475	 475	 475	 461	 461	 475	 476	
	 BMI	 457	 414	 432	 431	 431	 413	 413	 432	 434	
	 Severe	
Arthritis	
501	 438	 473	 469	 469	 451	 451	 474	 475	
	 Joint	Count	 451	 402	 431	 426	 427	 414	 414	 432	 433	
	 Lower	back	
pain	
451	 402	 431	 426	 427	 414	 414	 432	 433	
	 Number	of	
co-
morbidities	
487	 431	 464	 464	 464	 442	 442	 464	 465	
	 Live	Alone	 481	 439	 456	 452	 452	 433	 433	 454	 456	
	 Deprivation	
Score	
517	 452	 488	 485	 485	 466	 466	 488	 490	
	 Previous	
Arthroscopy	
452	 452	 427	 429	 431	 410	 410	 429	 431	
	 Expectations	 488	 427	 488	 463	 463	 444	 444	 474	 475	
	 Helplessness	 485	 429	 463	 485	 481	 443	 443	 465	 466	
	 Internality	 485	 431	 463	 481	 485	 444	 444	 465	 466	
	 PCS	 466	 410	 444	 443	 444	 466	 466	 444	 444	
	 MCS	 466	 410	 444	 443	 444	 466	 466	 444	 444	
	 Depression	 488	 429	 474	 465	 465	 444	 444	 488	 488	
	 Anxiety	 490	 431	 475	 466	 466	 444	 444	 488	 490	
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Homoscedasticity	of	residuals			This	was	tested	using	a	residual	versus	prediction	scatterplot.		An	even	spread	of	residual	values	across	the	range	of	predicted	values	suggests	heteroscedasticity	and	linearity.					
 
 
 		
Normality	of	residuals		Normality	of	residuals	was	assessed	informally	using	QQ	plots:		
Residual against Predicted values 
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12	month	data	analysis		Scatterplots	of	each	explanatory	variable	against	each	scale	response	variable	is	plotted	below:			
12	month	OKS				
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Homoscedasticity		This	was	tested	using	a	residual	versus	prediction	scatterplot.		An	even	spread	of	residual	values	across	the	range	of	predicted	values	suggests	heteroscedasticity	and	linearity.				
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Normality	of	residuals		Normality	of	residuals	was	assessed	informally	using	a	QQ	plot:		
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12	month	PCS		Scatterplots	of	each	explanatory	variable	against	each	scale	response	variable	is	plotted	below:				
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Homoscedasticity	
 This	was	tested	using	a	residual	versus	prediction	scatterplot.		An	even	spread	of	residual	values	across	the	range	of	predicted	values	suggests	heteroscedasticity	and	linearity.			
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Normality	of	residuals	
 Normality	of	residuals	was	assed	informally	using	QQ	plots:	
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12	Month	MCS		Scatterplots	of	each	explanatory	variable	against	each	scale	response	variable	is	plotted	below:				
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Homoscedasticity		This	was	tested	using	a	residual	versus	prediction	scatterplot.		An	even	spread	of	residual	values	across	the	range	of	predicted	values	suggests	heteroscedasticity	and	linearity.				
		 341	
 
 
 		
Normality	of	residuals		Normality	of	residuals	was	assed	informally	using	QQ	plots:		
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12	month	satisfaction		Scatterplots	of	each	explanatory	variable	against	each	scale	response	variable	is	plotted	below:				
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Homoscedasticity		This	was	tested	using	a	residual	versus	prediction	scatterplot.		An	even	spread	of	residual	values	across	the	range	of	predicted	values	suggests	heteroscedasticity	and	linearity.				
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Normality	of	residuals	
 
 The	QQ	plot	below	demonstrates	that	the	residuals	were	not	normally	distributed.				
		 351	
	
 
 
 
 The	plot	suggested	the	data	was	left	skewed	(as	demonstrated	by	the	histogram	in	below.						
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 A	common	transformation	to	deal	with	left	skewed	data	is	to	square	the	data	(Tukey's	ladder	of	transformations).165	Therefore,	the	response	variable	was	squared	and	cubed,	and	models	compared.		The	cubed	model	provided	the	following	QQ	plot:		
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 These	data	still	display	some	skewness,	but	I	felt	that	the	requirement	for	linear	regression	was	met.		 		
Decision	regret			To	assess	for	linearity	between	explanatory	variables	and	the	logit	of	the	response	variable	the	Box-Tidwell	procedure	was	used.		This	models	interaction	between	the	explanatory	variable	and	its	natural	log.		Any	statistically	significant	results	(with	a	Bonferroni	correction)	suggest	non-linearity.		The	table	is	available	on	the	next	page.			
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	 B	 S.E.	 Wald	 Sig.	 Exp(B)	 95%	CI	
Lower	
Bound	
95%	CI	
Upper	
Bound	
Age	 -1.066	 2.775	 0.147	 0.701	 0.345	 0.001	 79.259	
Gender	(1)	 -14.206	 8.435	 2.837	 0.092	 0	 0	 10.235	
Baseline	OKS	 -0.759	 0.822	 0.853	 0.356	 0.468	 0.094	 2.344	
BMI	 0.383	 1.624	 0.056	 0.814	 1.466	 0.061	 35.39	
Severe	Arthritis	 -0.642	 0.725	 0.785	 0.375	 0.526	 0.127	 2.178	
Joint	Count	 -2.059	 0.781	 6.955	 0.008	 0.128	 0.028	 0.589	
Back	Pain	 -0.485	 0.748	 0.421	 0.517	 0.616	 0.142	 2.666	
Comorbidities	 1.401	 1.815	 0.596	 0.44	 4.06	 0.116	 142.494	
Live	Alone	 0.061	 0.766	 0.006	 0.937	 1.063	 0.237	 4.766	
Deprivation	Score	 0.223	 0.288	 0.598	 0.44	 1.25	 0.71	 2.2	
Previous	Arthroscopy	 -0.138	 0.647	 0.046	 0.831	 0.871	 0.245	 3.097	
Expectations	 -0.412	 2.973	 0.019	 0.89	 0.662	 0.002	 224.558	
Helplessness	 -2.031	 2.932	 0.48	 0.488	 0.131	 0	 41.087	
Internality	 4.691	 5.4	 0.754	 0.385	 108.922	 0.003	 430534
2.661	
PCS	 1.119	 1.15	 0.947	 0.331	 3.062	 0.321	 29.169	
MCS	 -0.274	 0.911	 0.091	 0.763	 0.76	 0.127	 4.534	
Depression	 0.905	 1.552	 0.34	 0.56	 2.472	 0.118	 51.775	
Anxiety	 -0.229	 0.68	 0.113	 0.737	 0.796	 0.21	 3.019	
Age	by	Baseline	OKS	 0.009	 0.006	 2.119	 0.145	 1.009	 0.997	 1.022	
Age	by	Gender(1)	 0.169	 0.098	 2.981	 0.084	 1.184	 0.977	 1.433	
Age	by	MCS	 -0.004	 0.004	 0.871	 0.351	 0.996	 0.988	 1.004	
Age	by	Depression	 -0.008	 0.017	 0.206	 0.65	 0.992	 0.96	 1.026	
Gender(1)	by	O	
Baseline	OKS	
0.01	 0.1	 0.009	 0.923	 1.01	 0.83	 1.228	
Gender(1)	by	MCS	 0.03	 0.071	 0.176	 0.675	 1.03	 0.896	 1.185	
Depression	by	
Gender(1)	
0.32	 0.289	 1.226	 0.268	 1.377	 0.781	 2.427	
MCS	by	Baseline	OKS	 -0.001	 0.006	 0.035	 0.851	 0.999	 0.988	 1.01	
Age	by	LnAge	 0.211	 0.529	 0.16	 0.689	 1.236	 0.438	 3.482	
LnOKS	by	Baseline	OKS	 0.042	 0.227	 0.034	 0.854	 1.043	 0.669	 1.626	
BMI	by	LnBMI	 -0.077	 0.359	 0.046	 0.83	 0.926	 0.458	 1.871	
Joint	Count	by	LnJoint	
Count	
0.67	 0.265	 6.385	 0.012	 1.954	 1.162	 3.285	
Comorbidities	by	
LnComorbidities	
-0.58	 0.782	 0.549	 0.459	 0.56	 0.121	 2.594	
Deprivation	Score	by	
LnDeprivation	
-0.055	 0.069	 0.638	 0.424	 0.946	 0.826	 1.084	
Expectations	by	
LnExpectations	
0.092	 0.639	 0.021	 0.886	 1.096	 0.313	 3.834	
Helplessness	by	
LnHelplessness	
0.547	 0.834	 0.431	 0.512	 1.728	 0.337	 8.857	
Internality	by	
LnInternality	
-1.21	 1.452	 0.694	 0.405	 0.298	 0.017	 5.139	
LnPCS	by	PCS	 -0.277	 0.286	 0.942	 0.332	 0.758	 0.433	 1.327	
LnMCS	by	MCS	 0.102	 0.203	 0.254	 0.615	 1.108	 0.744	 1.648	
Depression	by	
LnDepression	
-0.16	 0.309	 0.267	 0.605	 0.853	 0.466	 1.561	
Anxiety	by	LnAnxiety	 0.1	 0.221	 0.204	 0.651	 1.105	 0.717	 1.703	
Constant	 -1.251	 52.624	 0.001	 0.981	 0.286	 	 	
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9.7 Appendix	VII:		The	effect	of	expectation	on	satisfaction	in	
total	knee	replacements:	a	systematic	review.	
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9.8 Appendix	VIII:	Patients'	decision-making	in	total	knee	
arthroplasty.	A	systematic	review	of	qualitative	research.	
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9.9 Appendix	IX:		Development	of	an	outcome	prediction	tool	for	
patients	considering	a	total	knee	replacement	-	the	Knee	
Outcome	Prediction	Study	(KOPS).	
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